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Abstract 
 
The Tasmanian devil (Sarcophilus harrisii) is a carnivorous marsupial endemic to the 
island-state of Tasmania, Australia and is currently under threat from a devastating 
disease named Devil Facial Tumour Disease (DFTD).  This disease has been identified 
as a tumour, which starts in, or around, the mouth, face or neck and invariably causes 
the death of the affected animal within a few months after the first signs of disease. 
Recent cytogenetic and molecular research led to the proposal that the tumour is 
transmitted as an allograft after cellular inoculation (probably by biting) from an 
infected to a healthy animal. The transmissibility of this tumour by cell implantation 
raises many questions about the status of immune responses of Tasmanian devils and 
the MHC diversity of the species.  
Several aspects of the immune response of the Tasmanian devil were investigated to 
determine whether a lack of immune competence may account for the ability of DFTD 
to be established in recipient devils. Using histology and immunohistochemistry 
techniques, the immune tissues of healthy and diseased devils were described and 
provided evidence that the species has the necessary structural components for immune 
responses. However, DFTD tumours were also analysed using histology and 
immunohistochemistry and there appeared to be a lack of immune cell infiltration in the 
tumour grafts, suggesting that DFTD develops unrecognised by the immune system. 
To test the functional competency of cellular and humoral immune responses, a series 
of in vitro and in vivo assays was undertaken. Neutrophils and lymphocytes isolated 
from healthy and DFTD-affected Tasmanian devils utilised in in vitro neutrophil 
phagocytosis and lymphocyte mitogen stimulation showed competent cellular function. 
In vivo immunisation of Tasmanian devils with horse red blood cells resulted in 
prominent humoral immune responses. These results provided support for the concept 
that the species is not severely immunosuppressed and transmission of DFTD is not a 
consequence of an impaired immune response.  
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Analyses of the allo-reactivity of the devil population were performed through in vitro 
mixed lymphocyte reactions and in vivo skin grafts between unrelated devils. Results 
from these experiments demonstrated that most devils had functional allo-recognition. 
Importantly, skin grafts between unrelated devils were immunologically rejected, 
indicating that spreading of DFTD is not simply due to a lack of MHC diversity in this 
species.  
To investigate whether immunity against DFTD could be induced, six Tasmanian devils 
were immunised with inactivated DFTD tumour cells. Most of these animals exhibited a 
very weak immune response against DFTD. Three of these devils were challenged with 
live DFTD tumour cells and succumbed to the disease. However, one devil had a more 
prominent antibody response against DFTD and was protected against a first challenge, 
suggesting that immunity was protective, but likely to be short-term.  
A survey for natural immune recognition of DFTD tumour cells in the devil population 
found one devil with antibodies against DFTD, and this animal was found a year later 
with no signs of the disease. This provided an insight that some individual devils might 
recognise and reject the tumour allograft.  
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1.1 – Introduction 
The Tasmanian devil (Sarcophilus harrisii) is the world’s largest extant marsupial 
carnivore and is a member of the family Dasyuridae, a group of specialized 
Polyprotodont marsupials. Devils have been confined to the 68,300 km2 island-state of 
Tasmania, Australia, for 10-12,000 years, since the flooding of the Bass Strait. The 
population of Sarcophilus became extinct on the Australian continent approximately 
400 years ago, probably due to competition with the introduced dingo (Canis lupus 
dingo) and humans (Gill 1971; Archer and Baynes 1972; Corbett 1995; Johnson and 
Wroe 2003; Jones et al. 2003a; Jones et al. 2003b). Since the extinction of the thylacine 
(Thylacinus cynocephalus), the devil has played the role of the principle native 
carnivore, even though it is predominantly a carrion-feeding carnivore (Buchmann and 
Guiler 1977; Hawkins et al. 2006). 
Although devil numbers appear to have declined and recovered in the past (Guiler 1964; 
Guiler 1992; Bradshaw and Brook 2005), an emergent transmissible disease, Devil 
Facial Tumour Disease (DFTD), has caused Tasmanian devil numbers to fall 
dramatically and the species is now considered to be threatened with extinction. This 
fatal neoplasia has affected wild devils since at least 1996, when the first cases were 
photographed in the far north east of Tasmania (Hawkins et al. 2006). Since then, the 
devil population has decreased substantially (Lachish et al. 2007) and in 2005 the 
species was added to the lists of both the State and Commonwealth Threatened Species 
legislations; in 2008 this listing was upgraded from ‘vulnerable’ to an ‘endangered’ 
animal.  
This disease is characterised by deforming soft-tissue growths (tumours) on the face and 
within the oral cavity, which eventually enlarge and can affect the animal’s ability to 
feed and forage for food. In devils with advanced disease, the tumour may metastasize 
to a range of internal organs, such as regional lymph node, lung, spleen, liver and 
kidney. The course of the disease is approximately five to six months and, to date, it is 
thought that no affected devil has survived the disease (Hawkins et al. 2006; Loh et al. 
2006a). 
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A unique characteristic of this tumour is its mode of transmission. Through cytogenetic 
studies it has been hypothesised that DFTD is transmitted as a tumour cell allograft 
between individual devils (Pearse and Swift 2006). Genetic research at multiple 
microsatellite and major histocompatibility complex (MHC) loci supported this 
hypothesis, as all analysed DFTD tumours were genetically identical at these loci, 
suggesting a clonal evolution, and were distinct from the host, indicating that the 
tumours had originated from another animal (Siddle et al. 2007). It was therefore 
proposed that the pathobiology of DFTD is analogous to a species-specific allograft that 
evades immune rejection in the new host. Furthermore, as a disease entity, these 
transferred neoplastic cells have developed the ability to grow uncontrolled in the 
tissues of a newly infected host and successfully transfer to other cohort devils through 
facial biting, thereby perpetuating its own survival by disseminating itself throughout 
the devil population.  
A transmissible graft in a wild population is highly unusual and few explanations can 
account for the transmissibility of this disease. One possible explanation is that 
Tasmanian devils are severely immunosuppressed and are not able to mount an effective 
immune response against the tumour cells. In comparison with eutherian counterparts, 
many aspects of the marsupial immune system are poorly understood (Deane and Miller 
2000). Generally, the marsupial immune function has been considered to be more 
primitive, as demonstrated by inferior humoral immune responses (e.g. non-anamnestic 
responses, poor antibody class switching) and lowered efficiency in T-lymphocyte 
responses (e.g. delayed second-set graft rejection) (Wilkinson et al. 1994; Stone et al. 
1997). The immune system of the Tasmanian devil is virtually unstudied and analyses 
of the immune responses of this species are warranted to determine whether a lack of 
immune competency is, in any way, responsible for the susceptibility of the natural 
transmission of this tumour cell allograft.  
Successful transplantation of tissue or cell allografts can occur between individuals with 
identical MHC genes (homozygous twins) or when the recipient of the allograft is either 
deliberately immunosuppressed or otherwise immunodeficient (Berlanda et al. 2008). 
The explanation that the limited genetic diversity within the devil population is, in part, 
related to the successful, devil-to-devil graft transfer has been proposed (Siddle et al. 
2007). Through analysis of several microsatellite loci, the genetic diversity of the 
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Tasmanian devil has been shown to be low compared to other carnivorous mammals 
and is comparable to that of the cheetah (Acynonyx jubatus). Cheetahs are now 
recognised as one of the most inbred free-living mammals on Earth, and comprehensive 
research has shown that individual cheetahs accept skin grafts from unrelated donors 
(Menotti-Raymond and O'Brien 1995). In the past, the geographically restricted 
population of devils in Tasmania is thought to have undergone a period of dramatic 
fluctuation in density; this could account for the measured low heterozygosity indices of 
the current population (Jones et al. 2004). In addition, the DFTD-affected devil 
population has shown a remarkable poverty of MHC Class I diversity, even lower than 
the highly inbred population of Asiatic lions (Panthera leo persica) in Gir, India, 
suggesting that lack of MHC diversity might allow transferred tumour cells to evade 
recognition by a recipient devil’s immune system and then proliferate unimpeded 
(Siddle et al. 2007). A series of functional assays to study the histocompatibility within 
the devil population could therefore help to understand the mechanisms of successful 
entry, establishment and spread of transferred DFTD cells between devils.   
Other explanations for the successful transmission of DFTD cells would include lack of 
MHC I expression or manipulation of the MHC machinery by the tumour cells to avoid 
immune detection. Local secretion of immunosuppressive or immunotoxic factors by 
the tumour cells may also account for successful establishment of DFTD tumours. 
Long-term studies of identified devils in DFTD-affected populations have shown no 
indication of any natural resistance to the establishment of the tumours (Hawkins et al. 
2006). Furthermore, no known individual devil has had any signs of DFTD tumour 
remission. Because this lack of specific immunity against the disease and the clonal 
aspect of DFTD, concerns about the immune status and the genetic diversity of the devil 
populations have been raised.  
 
 
 
 
Chapter 1: Literature Review 
 
− 6 − 
1.2 – Marsupials 
1.2.1 – Origins and taxonomy 
The evolutionary relationship among placentals (eutherians), marsupials (metatherians) 
and monotremes (prototherians) is an important point with which to address 
immunological research in marsupials. Two hypotheses for the separation of mammals 
into the three current sub-classes exist; the Marsupionta hypothesis unites marsupials 
and monotremes as a sister group, branching off from the eutherian counterparts earlier 
on evolution (Janke et al. 1997; Penny and Hasegawa 1997); the most accepted view, 
however, is that monotremes diverged earlier and left marsupials and placentals as a 
sister group, the Theria hypothesis (Killian et al. 2001; van Rheede et al. 2006). The 
divergence from the most recent ancestor of marsupials and placentals is believed to 
have occurred from 170 to 186 millions of years ago, and the monotremes branching 
20-35 millions of years before this (Kumar and Hedges 1998; Luo et al. 2003; 
Woodburne et al. 2003; van Rheede et al. 2006). Marsupials, therefore, represent an 
alternative path of mammalian evolution, which branched off the eutherian counterparts 
at least 170 millions of years ago, and developed many different aspects of the immune 
response compared to placentals (Deane and Miller 2000). 
Marsupials are represented by only 334 species, compared to more than 5,000 eutherian 
species (Wilson and Reeder 2005), but a resolution of all the phylogeny of this subclass 
has proven to be much more difficult (Asher et al. 2004). Biochemical, molecular and 
genetic studies, using either organelles and/or nuclear markers have been undertaken 
with morphological data in order to elucidate the marsupial phylogeny. One of the 
classifications divides marsupials in two main orders, Polyprotodonta and Diprotodonta. 
The Polyprotodonta order is mainly comprised of carnivorous and omnivorous 
marsupials (e.g. South American marsupials and Australasian Dasyurids and 
bandicoots), and the Diprotodonta order which includes the herbivorous Macropods, 
wombats, koala and phalangerids. A more detailed classification is given in Appendix 1 
(Tyndale-Biscoe 2005). Appendix 2 lists the common and Latin names of all mammals 
cited in this thesis. 
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Dasyurids are thought to have their origin in Australia between the Miocene and early 
Pleistocene, when changes in climate (increasing aridity) and geography (new landscape 
features) occurred in the Australasian continent. Speciation and diversification in size, 
physiology and behaviour are explained by these dramatic changes in ancient Australian 
biogeography (Crowther and Blacket 2003). According to more recent classifications, 
the family Dasyuridae has 66 species (Krajewski and Westerman 2003) divided in two 
sub-families, Dasyurinae (two tribes: Dasyurini and Phascogalini) and Sminthopsinae 
(two tribes: Sminthopsini and Planigalini) (Krajewski et al. 2000). These two sub-
families contain all the extant Dasyurids; comparatively they range from shrew-sized 
planigales, the arboreal phascogales (the size of a small mustelid), the quolls (up to the 
size of a domestic cat) and the Tasmanian devil. Molecular and combined analyses 
show Notoryctes (the marsupial mole) as a sister group of Dasyurids (Asher et al. 2004). 
Tasmanian devils are classified in the tribe Dasyurini and are the only remaining species 
of the genus Sarcophilus. 
1.2.2 – Dasyurids 
Dasyurids are carnivorous marsupials and their diet is composed of vertebrates (larger 
Dasyurids, such as quolls and the Tasmanian devil) or invertebrates (smaller Dasyurids, 
such as antechinuses and planigales) (Hume 2003). All Dasyurids appear to be 
opportunistic feeders (Lee and Cockburn 1985). Tooth morphology and dental formula 
of the Dasyuridae family are similar to its placental counterparts as is the rest of its 
digestive tract, and is consistent to their dietary preferences. Although exhibiting 
different body size, the family Dasyuridae does not show great variation in body shape, 
as this is not possible among species that hunt. Apart from the kultarr (Antechinomys 
laniger), which hops on its hind legs and has different hind limb morphology (as long as 
gerbil-mouse rodents), a compact body and unspecialised legs are the most common 
pattern (van Dick and Strahan 2008). Specialised adaptation for climbing is seen in 
several species such as the phascogales (Phascogale spp.) and spotted-tailed quoll 
(Dasyurus maculatus). 
Differences in morphology are mainly related to size, pouch, number of teats and coat 
colour. Dasyurids range in size from 2-10 g in the ningauis (Ningaui spp.) and planigale 
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(Planigale maculata) up to 14 kg in the Tasmanian devil (Tyndale-Biscoe 2005; Jones 
et al. 2008). Phascogales do not have a pouch, but a patch of base skin on the abdomen. 
Other species develop lateral folds at the sides of the teats, which provide little 
protection for the young. Some species, such as Tasmanian devils and kultarrs have a 
permanent pouch. In habitats where the environment is more variable, Dasyurids tend to 
have a higher number of teats, which is directly related to the number of offspring. 
Dasyurids usually produce a larger number of embryos than they have teats (super 
foetation), and only the ones able to attach themselves to a teat will survive. Variation in 
teat number may be as much as 12 in some planigale and antechinus species and as few 
as four teats in the Tasmanian devil (Lee and Cockburn 1985; Tyndale-Biscoe and 
Renfree 1987; van Dick and Strahan 2008). Variation among species also occurs in the 
timing of reproduction and different life history strategies, special adaptations to arid 
environments and adaptations to minimise heat loss (Dickman 2003; Geiser 2003; 
McAllan 2003). 
Dasyurids occur throughout Australasia. About 75% live in Australia, with the rest in 
New Guinea and neighbouring islands. Usually the smaller species are present in arid 
regions, but in low densities. Around 50% of all Dasyurids are found in arid Australia. 
The largest species, Tasmanian devil, spotted-tailed quoll and eastern quoll (Dasyurus 
viverrinus) prefer forested and heath habitats and can occur in low or high densities. 
Currently, Tasmania is the last refuge for the eastern quoll, which became extinct in 
southeastern Australia by the 1960’s and for the Tasmanian devil, which became extinct 
on the mainland around 430 years ago. The spotted-tailed quoll inhabits forested areas 
of eastern Australia and Tasmania, but occurs in low densities (Menkhorst 1995; Jones 
and Rose 1996; Dickman 2003) and the species is now listed as a threatened species in 
all the Australian states where it has historically been found.  
1.2.3 – Life history strategies 
Dasyurids show a wide range of life history strategies and much research interest has 
been aroused from this variability (Lee and Cockburn 1985; Naylor et al. 2008). 
Different life history strategies are thought to result from evolution of reproductive 
physiologies with semelparity being one of the most unusual reproductive features for a 
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mammal.  Some small members of this family show semelparity (suicidal or one-time 
reproduction, as opposed to iteroparity), where females have a highly synchronised 
oestrus each year and males commit totally to find mates. Males die in a short space of 
time after the mating season and females die shortly after offspring reaches 
independence. In mammals, this pattern of reproduction is known only in some small 
Dasyurids and two South American marsupials. One important ecological implication 
for this is that if a population is unable to breed in one year, there will be local 
extinction of that group on the following year (Oakwood et al. 2001; Bradley 2003).  
The cause of male die-off in Dasyurids exhibiting semelparity appears to be a collapse 
of the immune and inflammatory responses following a chronic increase in 
corticosteroid levels and a failure on the negative feedback suppression by 
adrenocorticotropin secretion (Oakwood et al. 2001; Naylor et al. 2008). At the end of 
the mating season, males show a high level of glucocorticoid plasma concentration, 
exacerbated by an androgen-dependent decrease in plasma corticosteroid binding 
globulin concentration. This phenomenon leads to an elevation of protein catabolism via 
gluconeogenesis, negative nitrogen balance, anaemia, gastro-intestinal haemorrhage, 
immunosuppression, diseases, unspecified degeneration of major organs and changes in 
renal morphology (Bradley 2003). Small-sized Dasyurids (< 200 g) are unable to store 
fat supplies and, additionally, males (e.g. Antechinus spp.) do not feed at this time and 
energy, therefore, is obtained from protein catabolism.  
These causes of death, however, are not applicable to two Dasyurid species, the 
semelparous, medium-sized northern quoll (Dasyurus hallucatus) and the large 
Tasmanian devil. The northern quoll does not appear to have such elevated 
corticosteroid levels during the breeding season and males, which can weigh up to 
1120 g, appear to have areas of fat storage in the base of the tail. Male die off in this 
species may be the result of an unexplained phylogenetic predisposition towards post-
reproductive senescence (Oakwood et al. 2001). The Tasmanian devil, however, 
normally exhibits iteroparity, but has become semelparous since the emergence of 
DFTD in affected areas. DFTD preferentially affects adult devils over 2 years of age 
and therefore, the age structure of the population changes dramatically. This has caused 
a precocious sexual maturity of the remaining individuals; females in populations where 
DFTD is endemic are showing the capability to produce a litter of offspring in their first 
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year of life and are then potentially removed through DFTD infection by the next 
breeding season. DFTD is considered the first infectious disease to lead to semelparity 
in a species (Jones et al. 2008). 
1.2.4 – Diseases 
Diseases have been incriminated as a cause of decline of some mammals in Australia, 
specially in the beginning of 20th Century (Wood-Jones 1923; Guiler 1964; Green 
1973). Evidence for a link to specific diseases, however, is anecdotal. Diseases 
described in Dasyurids are almost restricted to animals kept in captivity, with fewer 
cases involving free-living animals.  
1.2.4.1 – Infectious diseases 
Some infectious diseases of Dasyurids include toxoplasmosis and mycobacterial 
infections. Marsupials have an apparent susceptibility to toxoplasmosis, as many species 
in captivity have been found hosting this pathogen. Rapid death and neurological 
symptoms are related, while some degree of immunosuppression is believed to affect 
animals just before symptoms/death. Several free-living marsupials have also been 
found with antibodies against Toxoplasma gondii, such as wild Macropods, possums 
and bandicoots (Attwood et al. 1975; Canfield et al. 1990a). A survey in Australian 
mammals found six Dasyurids hosting another protozoan infection, Sarcocystis sp., 
including one Tasmanian devil (Munday et al. 1978).  
It is suspected that some marsupials have a predisposition to mycobacterial diseases. 
Subcutaneous atypical mycobacteriosis manifested as pyogranulomatous panniculitis 
similar to that found in humans and domestic animals was found in 9 of 37 captive 
spotted-tailed quolls and it is thought that this species can have a failure in its cellular 
immune response (Raymond et al. 2000). Introduced free-ranging brushtail possums 
(Trichosurus vulpecula) in New Zealand, Matschie’s tree kangaroos (Dendrolagus 
matschiei), koalas (Phascolarctos cinereus) and bettongs (Bettongia spp.) show a higher 
susceptibility to mycobacterial infections (Mycobacterium spp.). It has been 
hypothesised that marsupials have a limited ability of interaction between macrophages 
and T-cells, given that these two cell populations have to interact in order to respond to 
such infections (Buddle and Young 2000).  
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1.2.4.2 – Non-Infectious diseases  
Free-living Dasyurids have a shorter lifetime span than would be expected in eutherian 
mammals of the similar size. Captive conditions increase their life span as much as 
twice or three times, due to improvements in health conditions (Tell et al. 1993) and 
therefore, age-related diseases have been found more often in captive Dasyurids. 
Age-related degeneration of central nervous system, causing blindness, ataxia of the 
hindquarters and lesions of the spinal cord, have been described in larger Dasyurids, 
such as Tasmanian devils and quolls (Tell et al. 1993; Holz and Little 1995).  
Neoplasms are found in this group with unusual frequency and it appears that there is an 
enhanced susceptibility to proliferative lesions. Most cases, however, are described in 
captive old animals and it has been hypothesised that the zoo environment increases the 
lifespan and hence the expression of degenerative and geriatric conditions. 
Alternatively, a genetic predisposition might be involved. (Griner 1979; Twin and 
Pearse 1986; Canfield et al. 1990b).  
It is apparent that Dasyurids are prone to a diverse range of hyperplastic and neoplastic 
conditions, both benign and malignant. Cell proliferations (benign and malignant) 
affecting skin and adnexa, including mammary gland, endocrine tissues and 
lympho-reticular tissues are commonly recorded at necropsy in adult and senile captive 
devils. It has also been suggested that Tasmanian devils may be particularly prone to 
develop proliferative lesions. This is based on pathology registry databases from 
zoological collections of devils held in captivity around the world, which describe 
several neoplastic conditions, such as squamous cell carcinomas, lymphosarcomas and 
adenocarcinomas. A high incidence of lympho-reticular system neoplasia in 
Pseudantechinus macdonnellensis has been observed (Attwood and Woolley 1973; 
Griner 1979; Canfield et al. 1990b) and neoplasms in a young wild caught eastern quoll 
with a malignant mixed salivary tumour and a mammary adenocarcinoma has been 
described (Twin and Pearse 1986).   
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1.3 –Tasmanian devil profile 
1.3.1 – Distribution and habitat  
Tasmania is an island-state of Australia, located at 42ºS 147ºE with a landmass of 
approximately 68,300 km2. The ecosystem of the island is varied, with alpine, 
rainforest, sclerophyll and buttongrass moorland habitats. The central region of the 
island is mountainous whilst along the northern and eastern coasts there are flat coast 
plains, which have historically been rich wildlife rangelands for the complete diversity 
of Tasmanian terrestrial fauna. The west and south west of the island are more densely 
forested (with temperate rainforest dominated by Gondwanan flora) with vast areas of 
buttongrass moorland. The climate in Tasmania is cool-temperate with four well-
defined seasons (Smith and Banks 1990).   
Tasmania became separated from mainland Australia at about 10,000 years ago, at the 
end of the last glaciation, when the shallow Bassian Plain flooded to form the waterway 
that now separates Tasmania from continental Australia (Bass Strait). Because of this 
isolation, Tasmania developed into a refuge for many Australian animals that on 
continental Australia succumbed to the pressures of changing habitats, human hunting 
and settlement and introduction of placental predators, such as dingoes, cats (Felis 
catus) and red foxes (Vulpes vulpes).  Before the last glaciation the Tasmanian devil 
occurred over large areas of Australia from its southern extremity, Tasmania, to the 
northern land connection of New Guinea; now it is restricted to Tasmania. Devils were 
extinct on mainland Australia at about 400 years ago, the cause is not fully understood, 
however direct competition with dingoes and Aboriginal people has been postulated 
(Gill 1971; Archer and Baynes 1972; Johnson and Wroe 2003). Tasmania has no record 
of dingoes and after the extinction of the thylacine following European colonisation, 
devils assumed the status of the largest mammalian predator of the island, an important 
role within the terrestrial ecosystems of Tasmania (Hawkins et al. 2006).  
Devils are non-territorial and have an average area of occupancy of 10 km2 (Guiler 
1970a; Hawkins et al. 2006). The species occupies a wide range of habitats, from dry 
sclerophyll forest, open eucalypt environments and coastal woodland to pasture and 
agricultural areas where carrion (from domestic livestock and Macropod populations) is 
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abundant (Guiler 1970a; Rounsevell et al. 1991; Jones and Barmuta 2000). Prior to 
DFTD, high-density populations were found in the eastern half and in the north west of 
Tasmania (Hawkins et al. 2006). The only island off-shore Tasmania harbouring the 
species was Badger Island. Both sexes of Tasmanian devils were illegally released on to 
this small island off the north east coast of Tasmania where they established; they were 
removed around 10 years later by the state government (M. Jones, personal 
communication).  
1.3.2 – Description and diet 
The first colonisers of Tasmania were not very generous or correct when describing the 
Tasmanian devil, as illustrated by this report to the King George IV of England in 1829: 
“The devil, or as naturalists term it “Dasyurus ursinus", is very properly 
named, if it is meant as a designation for the most forbidding and ugly of the 
animal creation. It is as great a destroyer of young lambs as the hyena; and, 
generally speaking, is as large as a middling–sized dog. The head resembles 
that of an otter in shape, but is out of proportion with the rest of its body; 
the mouth is furnished with three rows of double teeth; the legs are short, 
with the feet similar to the cat, being covered with a tough skin free from 
hair. The skin resembles the sable in colour; the tail is short and thick: it is 
generally found in the clefts of rocks contiguous to the mountains, or on 
stony hills.” (Widowson 1829). 
Devils are the size of a medium dog and are sexually dimorphic, with males having a 
thicker neck and a broader head than females. Males weight up to 14 kg and females up 
to 9 kg, but more typical weights are 9-12 Kg for males and 6-8 Kg for females (Guiler 
1970a; Jones et al. 2004; Jones et al. 2008). Tasmanian devils are short-lived animals, 
living only up to 6 years in the wild and up to 8 years in captivity. Devils have black 
fur, with white flashes on the chest and on the rump that may or may not be present. 
These are mainly nocturnal animals and hide in underground burrows made by other 
animals, rock dens or in log cavities during the day.  
Devils are specialist carrion feeders, but are able to hunt prey (although probably not 
prey as large as a lamb), particularly those weakened by disease, injury or old age. 
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There is a wide spectrum of food that the species will eat as carrion, mainly composed 
of wallabies, wombats and sheep. Artificial food sources are composed of livestock 
carrion, road killed animals, shot and 1080-poisoned wildlife (such as Macropods and 
possums) and from rubbish dumps (Guiler 1970a; Hamede et al. 2008). The proportion 
of hunting to scavenging is unknown (Jones and Barmuta 2000; Hamede et al. 2008). 
1.3.3 – Reproduction  
Female devils are monoestrus and breeding appears to be synchronous throughout the 
population. Females can have another oestrus (around one month later) if there is a 
failure to become pregnant or the litter is lost. This species (as in many Dasyurids) is 
polyovular, and give birth to up to 40 embryos (a phenomenon also called 
super-foetation). Females have a permanent pouch, which opens to the back, with just 
four teats in the pouch cavity. Because only four nipples are present, this is the 
maximum number of offspring it is possible to raise. The average litter size is of three 
young per season. Sexual maturity is reached at 2 years of age for females and, prior to 
DFTD, only a few females would breed at 1 year of age (Guiler 1970b; Lee and 
Cockburn 1985; Jones et al. 2008; Lachish et al. 2008).  
Mating occurs in February and March and females give birth after 21 days of gestation. 
The young are carried in the pouch until they are 4 to 5 months old, when they are left 
in a den. Weaning occurs at 5 to 8 months of age, usually in December, and 
independence occurs in January-February. Two-year old devils are considered adults 
(Figure 1.1 A-F) (van Dick and Strahan 2008). 
1.4 – The marsupial immune system 
1.4.1 – Introduction 
Studies of the immune system of marsupials started around the beginning of the 20th 
Century, with descriptions of the thymus of many marsupial species (Symington 1898, 
1900). Since then, much knowledge has been acquired about the immune responses of 
these animals, although much still remains to be learnt. Recently, the genome of the first 
marsupial was sequenced (the grey short-tailed opossum – Monodelphis domestica) 
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(Mikkelsen et al. 2007), creating new opportunities to analyse the immune genes of this 
group in great detail.  
Marsupials are ideal candidates for developmental immunology studies due to their 
early stage of birth (Belov et al. 2007). The development of Monodelphis domestica as a 
laboratory animal has triggered many studies in tumour immunology and photobiology 
in this species, and therefore a renewed interest in the marsupial immune response has 
arisen (VandeBerg 1989; Deane and Miller 2000; Ley et al. 2000; Wang et al. 2003; 
Wang and Vandeberg 2005; Wang et al. 2009). In addition, the apparent susceptibility 
of some marsupials to various diseases, such as toxoplasmosis (Canfield et al. 1990a; 
Bettiol 2000; Bettiol et al. 2000), mycobacteriosis (Mitchell et al. 1984; Montali et al. 
1998; Buddle and Young 2000; Raymond et al. 2000), and Chlamydia sp. infections 
(Hemsley and Canfield 1997; Jackson et al. 1999; Higgins et al. 2005) also have 
prompted attention in the immune responses of this group. 
Despite this increased interest in marsupial immunology research since the past decade, 
there remains a lack of reagents that would allow the identification of specific cell 
populations and further studies on different components of the immune system (Old and 
Deane 2003a, b; Young et al. 2003). The description of antibodies to the surface 
markers, CD3, CD5 and CD79b in the late 1980’s (Mason et al. 1989) to identify the 
appearance and distribution of T- and B-cells in a range of marsupial species (Mason et 
al. 1989; Jones et al. 1993; Coutinho et al. 1994; Coutinho et al. 1995; Hemsley et al. 
1995; Canfield and Hemsley 2000; Cisternas and Armati 2000; Old et al. 2003b) has led 
to a new understanding of the structure and development of the marsupial’s immune 
system. In addition, the recent cloning of a marsupial T-cell receptor constant region 
(TCR) (Zuccolotto et al. 2000) led to the development of a new anti-TCRα antibody, 
which was shown to recognise tammar wallaby (Macropus eugenii) T-cells (Old and 
Deane 2002). However, the number of antibodies available that cross-react with 
marsupial tissues is still limited. For example, antibodies against marsupial CD4+ and 
CD8+ T-cell subsets are still non-existent (Old and Deane 2002; Old et al. 2004b). 
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1.4.2 – Cells and tissues of the marsupials’ immune system 
1.4.2.1 – Cells of the immune system 
Several cells participate in the innate and adaptive immune response. Most of these cells 
circulate in the blood or are strategically located in lymphoid organs, but to effectuate 
the immune response, they have to migrate to the injured tissue. Some immune cells are 
in an immature state until they are specifically activated, when they have the capability 
to differentiate and develop into effector cells. The morphology of immune cells of 
marsupials and eutherians are similar and, given the similarities in gene expression, it is 
also likely that the functions are also analogous. (Brozek et al. 1992; Canfield 1998; 
Deakin et al. 2006; Belov et al. 2007). 
1.4.2.1.1 – Lymphocytes  
Lymphocytes are heterogeneous cells of the acquired immune system, and the only cells 
capable of specificity and memory. In eutherians, lymphocytes range from 8-10 µm in 
diameter and have a large rounded nucleus. When activated, lymphocytes increase the 
size of the cytoplasm and become larger cells, ranging from 10 to 12 µm. Lymphocytes 
originate in the bone marrow from lymphoid stem cells and differentiate in two main 
subsets, B- and T-lymphocytes (also referred as B- and T-cells), which are the main 
effector cells of the acquired immune response. The same precursor also gives rise to an 
important cell of the innate immune system, the natural killer cell (NK cell) (Tizard 
2008). 
B-lymphocytes are so called because in birds they mature in the bursa of Fabricius (or 
just bursa). In mammals, which do not have an equivalent organ, the early stages of 
B-lymphocyte maturation take place in the bone marrow. Stem B-cells proliferate and 
mature when they come in contact with stromal cells of the bone marrow under the 
action of interleukin-7 (IL-7). During this maturation stage, B-cells express 
immunoglobulin-M (IgM) or IgD on the cell surface on association with Igα and Igβ. 
This structure is called the B-cell antigen receptor complex, which triggers further 
maturation when bound to antigen. If self-antigens bind strongly to this complex, the 
cell undergoes apoptosis (cell death), but if self-antigens are weakly bound, the B-cell 
will survive and enter the circulation. Mature B-cells migrate from their originator bone 
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marrow sites to populate all the secondary lymphoid tissues of the body, such as spleen, 
lymph nodes and mucosa-associated lymphoid tissue (Abbas et al. 2007; Kierszenbaum 
2007).  
B-cells have three distinct functions: 1) to produce antibodies, 2) to present antigens to 
effector T-cells and 3) to differentiate into memory cells. In the secondary lymphoid 
tissues (in the lymphoid follicle), B-cells may encounter specific antigens, migrate to 
the T-cell areas of the organ and become activated under the influence of helper T-cells 
(CD4+). These activated B-cells may differentiate further and become plasma cells, 
which are the ultimate antibody secreting cells. Other activated B-cells migrate to other 
follicles nearby, which become secondary follicles with germinal centres and undergo 
affinity maturation. In this location, B-cells differentiate further in non-dividing B-cells, 
which switch the class of antibody produced (e.g. from IgM to IgG). When the antigenic 
challenge has ceased, some B-cells that survived the affinity maturation process 
transform into high affinity resting memory cells with class switched antigen receptor. 
B-cells are, therefore, principally involved in the humoral immune response. In 
addition, B-cells can function as professional antigen presenting cells (APC), 
undertaking antigen endocytosis and selectively presenting antigen epitopes to activated 
T-cells (Parham 2005; Rodriguez-Pinto 2005; Kierszenbaum 2007). 
T-lymphocytes also originate in the bone marrow but migrate to the thymus to undergo 
maturation. Once in the thymus, immature T-cells (thymocytes) interact with thymic 
epithelial cells and bone marrow-derived macrophages and dendritic cells. These 
non-lymphoid cells express high levels of MHC Class I and II, which will define what 
subset of T-cell the immature thymocytes will become. The thymic cells also produce 
cytokines, such as IL-7, which stimulates the thymocytes to differentiate and proliferate. 
After this first interaction in the thymus, thymocytes express a T-cell receptor (TCR), 
which is analogous to the immunoglobulin (Ig) receptor of B-cells, and both 
co-receptors CD4 and CD8. Cells that recognise self-MHC antigens undergo further 
maturation and express one of the two co-receptors, CD4 or CD8. Those cells that do 
not recognise self-MHC molecules undergo apoptosis. In eutherian mammals, T-cell 
receptors may be of two types: TCRαβ, which is expressed by most T-cells and bind to 
antigens on MHC I or II molecules, or TCRγδ, which bind to non-MHC molecules or 
antigens directly (Kierszenbaum 2007; Parra et al. 2007). The marsupial TCRαβ 
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receptor was cloned and revealed sequence similarities with TCR of eutherians 
(Zuccolotto et al. 2000; Parra et al. 2008). Marsupials, however, were found to have a 
novel TCR, TCRµ, not present in eutherian mammals, but found also in lower 
vertebrates, such as sharks. It was suggested that this receptor is a phylogenetically 
early form of receptor, and represents an ancient component of the cell-mediated 
immune system (Parra et al. 2007).  
In eutherians, T-cells that express CD4 receptor (CD4+ cells) recognise MHC Class II 
molecules and are called helper T-cells. Activated helper T-cells secrete a range of 
cytokines and attract other cells of the immune system, such as B-cells, which in turn 
differentiate into plasma cells and produce antibodies. Three subsets of CD4+ cells have 
been characterised: TH1, TH2 and TH17. The TH1 subset is involved in the immune 
response against intracellular antigens and collaborates with macrophages, producing 
mainly interferon-γ (INF-γ). The TH2 subset regulates the immune response against 
intestinal parasites, such as helminths, produces mainly IL-4 and IL-13 and interacts 
with plasma cells, basophils and eosinophils. The third subset (TH17) has been shown to 
secrete IL-17 and is involved in autoimmunity (Kierszenbaum 2007; Romagnani 2008). 
T-cells that express the CD8 peptide (CD8+ cells) recognise MHC Class I molecules 
and are called cytotoxic T-cells. These cells attach to the MHC I-antigen complex of 
APCs through cell adhesion molecules and release cytolytic substances (perforins) that 
destroy the target cell. This process is mediated by IL-1 (released by APCs) and IL-2 
(released by the cytotoxic T-cell) (Abbas et al. 2007). 
Natural killer (NK) cells are large lymphocytes with granular cytoplasm that contribute 
to the innate immune response. These cells are thymus-independent cells, do not possess 
TCR or Ig receptors and are capable of killing without previous activation. Killing of 
cells with low level of MHC I expression and virally infected cells is performed by the 
same mechanism used by cytotoxic T-cells (CD8+ cells). In addition, NK cells produce 
a range of cytokines and other factors to regulate the immune response (Andoniou et al. 
2008). 
Reagents that recognise CD4, CD8 and NK cells have not been developed for 
marsupials, and those reagents developed for eutherians do not appear to recognise the 
equivalent cells in marsupial tissues (Old and Deane 2002). However, recent genomic 
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research has identified a range of genes expressed in Monodelphis domestica and the 
Tammar wallaby, which share varying degrees of amino acid identity with CD4, CD8 
and NK cell receptors of eutherian mammals (Belov et al. 2007; Duncan et al. 2007, 
2009). 
1.4.2.1.2 – Neutrophils  
In eutherians, neutrophils originate and mature in the bone marrow and are the most 
abundant of the immune cells in the circulation. They measure approximately 12-15 µm 
in diameter and possess characteristic multilobed nuclei and primary and secondary 
granules in the cytoplasm. The main function of neutrophils is to engulf and kill 
microorganism in the inflamed tissue (phagocytosis), which is one of the first processes 
of defence of the innate immune system (Parham 2005). 
Neutrophils in the blood stream migrate to the injured tissue (extravasation) in response 
to cytokines (including tumour necrosis factor and IL-1) released by resident 
macrophages. Their function activation is a three-step process (adherence, rolling and 
diapedesis). It occurs as a cascade, which is initiated by the recognition of microbes (or 
other inflammatory stimulus) by tissue macrophages and subsequent release of 
cytokines (and chemokines) that cause the endothelial cells nearby to express high 
affinity adhesion molecules (vascular cell adhesion molecule-1 – VCAM-1). The 
circulating neutrophils adhere to these endothelial molecules (rolling) and undergo a 
reorganisation of the cytoskeleton, allowing for the diapedesis (migration through the 
vascular endothelium into the tissue intercellular space) to occur. Once in the tissue, 
neutrophils follow the chemotactic gradient towards the site of injury to execute their 
function (Strell and Entschladen 2008).  
1.4.2.1.3 – Macrophages  
Macrophages are large, irregular-shaped mononuclear cells (15-20 µm in diameter) 
resident in most bodily tissues as sentinels of the immune system of eutherian 
mammals. These cells have different names according to the tissue of residence: 
Kupffer cells in the liver, microglia in the brain, osteoclasts in bone and so on. An 
immature form of macrophage is the monocyte, which circulates in the blood stream 
waiting for a stimulus. Macrophages are multi-functional cells, which play important 
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roles in both innate and acquired immune responses. In innate immunity, these cells are 
activated by microbial products (such as lippopolysaccharide – LPS) and perform active 
phagocytosis of microorganisms and cellular debris in injured tissues. Macrophages also 
phagocytose dead or aged cells in healthy tissues (e.g. phagocytosis of aged red blood 
cells in the spleen and bone marrow) (Kierszenbaum 2007).  
In acquired immunity, macrophages are activated by IFN-γ producing T-cells 
(CD4+ TH1 and CD8+ T-cells), which enhance greatly the phagocytic ability of 
macrophages, stimulate the macrophage production of various cytokines and 
chemokines that promote inflammation (and recruitment of neutrophils) and stimulate 
macrophages to repair the injured tissue through the secretion of several growth factors. 
Activated macrophages also have an improved APC function, expressing increased 
levels of MHC II molecules and producing cytokines (such as IL-2) that enhance the 
T-cell response. If the cause of inflammation is not cleared (eliminated), macrophages 
continue producing inflammatory cytokines (that damage the healthy tissue) resulting in 
excessive fibrosis, which is a characteristic of chronic inflammation. Macrophages may 
undergo changes in their cytoplasm and cytoplasmatic granules in response to chronic 
inflammation; some times they resemble skin epithelial cells, and when clustered 
together are given the description of epithelioid cells. These cells may form clusters 
around antigen particles, forming granulomas. This tissue response is often observed in 
the chronic pathology of Mycobacterium spp. infection in the lung (Parham 2005; 
Abbas et al. 2007). 
Marsupials appear to be more susceptible to Mycobacterium spp. infection than other 
mammals (Buddle and Young 2000). The deliberate introduction of the brushtail 
possum to New Zealand has resulted in this marsupial becoming an overpopulous pest 
and the main wildlife reservoir of M. bovis, the causative agent of bovine tuberculosis 
(Ekdahl et al. 1970). Several other marsupial species, in the wild and in captivity, have 
been shown to succumb to mycobacterial infections, such as the rufous hare-wallaby 
(Lagorchestes hirsutus), Matschie’s tree kangaroos, and the spotted-tailed quoll, 
amongst others (Montali et al. 1998; Raymond et al. 2000; Young et al. 2003). It has 
been speculated that marsupial macrophages have weak phagocytic enzyme activity, 
lack responsiveness to chemotactic factors and show lower levels of activation 
compared to eutherian mammals (Barbour 1972; Moriarty and Thomas 1986), although 
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more recent studies have shown that macrophages extracted from possums function at 
similar levels to bovine alveolar macrophages against M. bovis (Cooke et al. 1999; 
Buddle and Young 2000). 
1.4.2.1.4 – Eosinophils, basophils and mast cells 
Eosinophils, basophils and mast cells of eutherian mammals are actively involved in the 
inflammatory process through the release of several toxic proteins from their granules, 
which have the primary function to killing microorganisms. These cells are mediators of 
inflammation, releasing a range of chemokines and cytokines into the injured tissue. 
These cells have high affinity for IgE, which is important in immunity against metazoan 
parasites and in allergic reactions (Parham 2005).  
Eosinophils are present in the blood stream, but are found in higher numbers in the 
tissues underlying the epithelial linings of the respiratory and gastrointestinal systems. 
In blood smears or histology sections, they appear as bilobed cells with eosinophilic 
granules in the cytoplasm. The immune response mediated by CD4+ TH2 cells (release 
of IL-5 and other cytokines) is the stimulus for the bone marrow to produce more 
eosinophils and their release in the blood stream. Basophils are closely related to 
eosinophils, but are present in the circulation at lower numbers. The cytoplasm of 
basophils is often packed with dark blue staining granules, which have similar function 
of the eosinophils (Parham 2005; Kierszenbaum 2007).  
Mast cells resemble basophils, with large basophilic granules in their cytoplasm. These 
cells originate in the bone marrow, but mature in all well-vascularised tissues, where 
they serve as sentinels of the immune system (like macrophages), following stimulus of 
various growth factors.  Mast cell granules contain histamine, heparin, TNF-α among 
other mediators of the inflammation. In eutherian mammals (humans and mice) two 
types of tissue mast cells have been described, the connective-tissue mast cell and the 
mucosa mast cell (Galli 1990). Several Polyprotodont marsupial species, however, have 
been shown to harbour an abundance of unique mast cell populations in the lymph 
nodes. These mast cells appeared to have unusually enlarged cytoplasmatic granules and 
are restricted to the lymphatic sinuses of the medullary areas, in close association with 
macrophages and other cell populations of the lymph node. The function of this mast 
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cell population still remains to be elucidated (Haynes 1991; Chiarini-Garcia and 
Machado 1992; Chiarini-Garcia and Pereira 1999; Chiarini-Garcia et al. 2000). 
1.4.2.2 – Primary lymphoid tissues 
The timetable to the development of young marsupials is very much affected by their 
mode of reproduction. Mammals belonging to this sub-class are born at a very early 
stage of development and have a long and complex lactational period. The gestational 
period varies from as short as 11 days for the stripe-faced dunnart (Sminthopsis 
macroura) to 35 days in the koala (Tyndale-Biscoe 2005). All marsupial neonates are 
born with an incompetent immune system, with no mature or functional lymphoid tissue 
in an equivalent developmental stage of the embryonic eutherian. Despite this, 
two-thirds of their organogenesis is completed in a non-sterile pouch environment 
(Yadav et al. 1972; Old and Deane 2000). Immune competence is achieved by the 
second week of pouch life, which is a very early stage of development (but analogous 
time after birth) compared to placental mammals (Tyndale-Biscoe 2005). The period of 
transference of antibodies from the mother’s milk to the young and consequent capacity 
of the gut to absorb them, however, is much longer in marsupials than in eutherian 
(Deane and Cooper 1988). 
Primary lymphoid organs are the sites of regulation of lymphocyte development, where 
lymphocytes first mature and express antigen receptors. Thymus, bone marrow and 
bursa (only found in birds) are generative organs, or primary lymphoid organs. All 
immune cells in vertebrates originate from primordial stem cells, which are capable of 
replication by cell division and subsequent differentiations into specialised cell lines, 
such as neutrophils, lymphocytes and macrophages (Tizard 2008). The formation of 
blood cells (haematopoiesis) in the early embryo takes place initially in the yolk sac and 
later in the liver, spleen and finally in the bone marrow. In adult eutherians, 
haematopoiesis is performed solely by the bone marrow, although liver and spleen have 
the capacity to also take up this function if necessary (Burkitt et al. 1993). At birth, no 
mature lymphoid organs are apparent in marsupials and the main haematopoietic tissue 
is the liver. A significant number of immature erythroblasts and leukocytes are apparent 
in the blood of the new born (Old and Deane 2000).  
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1.4.2.2.1 – Bone marrow 
The primary function of the bone marrow is haematopoiesis. In addition to this function, 
the bone marrow is the place of differentiation of B-cells in mammals (this function in 
birds is undertaken in the bursa) as well as proliferation of antibody-producing B-cells. 
The bone marrow, together with the spleen and liver, also removes old or defective red 
blood cells from the circulation (Burkitt et al. 1993). 
In young animals, the bone marrow is said to be red, as direct indication of its 
erythropoietic formation. As the animal matures, fewer active sites of erythrocytic 
production occur and the marrow spaces are filled with adipose cells (yellow bone 
marrow). At this stage, all sites can resume the activity if necessary. In adult eutherians, 
bone marrow is present and active in flat bones (skull, pelvis, etc) and in the proximal 
ends of long bones (femur, humerus, etc). There are two main compartments in the bone 
marrow: 1) the marrow stromal compartment, in which a framework of different cell 
lineages support the haematopoiesis process, producing growth factors and cytokines 
(endothelial and stromal cells and fibroblasts), providing a physical barrier for the 
exiting of immature cells (endothelial cells), local energy source (adipose cells) and 
undertaking removal of unwanted cellular residues from the marrow (macrophages). 
Haematopoiesis is carried out by primitive pluripotential stem cells, which divide 
slowly and can originate different cell lineages; 2) the haematopoietic cell compartment, 
which is the site of development of erythroid, myeloid, lymphoid and megakaryocytic 
lineages. It is highly vascularised and contains a range of other cell types with diverse 
physiological functions (Burkitt et al. 1993; Kierszenbaum 2007). Haematopoietic stem 
cells inhabiting the marrow cavity, are capable of self-renewal and produce two cell 
lineages, the myeloid stem cell (which originates red blood cells, platelets, 
macrophages, neutrophils, eosinophils, mast cells) and the lymphoid stem cell (which 
originates T- and B-lymphocyte precursors) (Kierszenbaum 2007). 
The marsupial bone marrow has only been subjected to a few studies. Analyses of the 
bone marrow in pouch young marsupials (a Polyprotodont, the stripe-faced dunnart and 
a Diprotodont, the tammar wallaby) failed to reveal lymphocytes expressing CD3 or 
CD79b (cellular markers present in mature lymphocytes) (Old and Deane 2003a; Old et 
al. 2004b). Nevertheless, the pattern of development of the bone marrow was similar to 
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that observed in eutherian mammals (Old et al. 2004a). It appeared that the bone 
marrow of stripe-faced dunnarts started haematopoietic activity by Day 11 after birth, 
and although mitotic cells were still observed in 170 days-old animals, adipocytes were 
commonly found infiltrating the marrow spaces by Day 60 (Old et al. 2004a).  In 
another study, 12 day-old tammar wallabies were observed to have islands of 
haematopoiesis in the bone marrow and intense activity by Day 30 (Basden et al. 1996). 
Adult stripe-faced dunnarts were found to have only few haematopoietic cells in the 
bone marrow, the majority of the marrow tissue consisted of adipose cells (Old et al. 
2003a).  
1.4.2.2.2 – Thymus 
The function of the mammalian thymus remained essentially unknown until the 1960’s, 
when it was demonstrated that mice thymectomized soon after birth would undergo a 
series of impairments of the immune function (Miller 1960; McIntire et al. 1964; Miller 
2002). Differentiation of different subsets of T-cells, such as CD4+ (T helper cells) and 
CD8+ (cytotoxic T-cells), proliferation of mature T-cells, development of self tolerance, 
secretion of hormones involved in T-cell maturation and proliferation are some of the 
functions of the thymus (Burkitt et al. 1993; Tizard 2008). 
The thymus is composed of two lobes, each subdivided into lobules and surrounded by 
a fine connective tissue capsule. Each lobule has an outer cortex and a central medulla. 
The stroma of the organ contains thymic epithelial cells, present in close association 
with thymocytes (T-cell precursors that originated in the bone marrow). These epithelial 
cells play important function in the cortex (clonal selection of T-cells) and in the 
medulla (clonal deletion of potentially autoreactive T-cells). The thymic cortical 
epithelial cells expressing both MHC Class I and II on their surface positively select 
CD4+ T-cells (which bind to MHC II molecules) or CD8+ T-cells (which bind to 
MHC I molecules) (clonal selection). T-cells that do not recognise MHC molecules are 
eliminated by apoptosis (programmed cell death). Thymic medullary epithelial cells 
negatively select T-cells that recognise both self-MHC and self-antigens (clonal 
deletion) (Kierszenbaum 2007). Thymic epithelial cells also accumulate in the medulla 
forming onion-like structures, the characteristic Hassall’s corpuscles, which produce 
hormones and cytokines involved in maturation of T-cells (Tizard 2008). 
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In contrast to eutherians, where the thymus is developed before birth, the development 
of this organ in marsupials usually occurs after birth and during pouch-dependency. 
Some anatomical differences in the location of the gland amongst the two major groups 
of marsupials exist: Polyprotodonts (carnivorous marsupials) have a thoracic thymus, 
while most Diprotodonts (herbivorous marsupials) have both thoracic and cervical 
glands. The thoracic gland is usually absent in wombats (Vombatus ursinus) and koalas 
(Deane and Cooper 1988; Old and Deane 2000; Hayes 2001). The marsupial thymus 
may be diffusely scattered in the thorax and often is present in close association with the 
parathyroid gland (Hayes 2001). The marsupial thymus is thought to have a similar role 
to that in eutherian mammals, being the predominant T-cell development organ (Old et 
al. 2004b).  
The Dasyurid stripe-faced dunnart, the koala and the tammar wallaby have a similar 
histological distribution of T-cells and a similar pattern of development of the thymus to 
other mammals. In these marsupials studied, T-cells are observed initially in the 
medulla and after further maturation, in the medulla and cortico-medullary junction of 
the thymus (Canfield et al. 1996; Old and Deane 2002; Old et al. 2004b). This stands in 
contrast with thymogenesis studies in two antechinuses, Antechinus stuartii and 
Antechinus swainsonii, which are born with a well-developed thymus that achieves its 
maximum size just before weaning.  At the time of weaning it starts to involute 
(180-190 days old) and this is complete 60 days prior sexual maturation.  There is no 
other known vertebrate that exhibits complete involution of the thymus in all 
pre-pubescent individuals (Poskitt et al. 1984) and whether these features of the thymus 
correlate with the unusual life history strategy of Antechinus is unknown (Deane and 
Cooper 1988).  
The appearance of Hassall’s corpuscles in the medulla of the thymus is correlated with 
maturation of the thymus. This event varies in marsupials from five days after birth (in 
the Virginian opossum – Didelphis virginiana) to 40 days after birth (in the stripe-faced 
dunnart) (Old et al. 2003a). The appearance of Hassall’s corpuscles in Diprotodont 
marsupials varies; for example, in the quokka (Setonix brachyurus) corpuscles first 
appear in the cervical thymus by Day 10, but in the thoracic thymus only by Day 60. 
This implies an earlier maturation of cervical thymus in this species and probably 
reflects its principle role in lymphocyte maturation (Deane and Cooper 1988). 
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1.4.2.3 – Secondary lymphoid tissues 
Secondary lymphoid organs, or peripheral organs, are the sites where lymphocytic 
response is initiated and developed. Spleen, lymph nodes and mucosa-associated 
lymphoid tissue (MALT) are secondary lymphoid organs, generally designed to harbour 
dendritic cells and macrophages (which process the antigens) in close association with 
T- and B-cells (which mediate the immune response) (Tizard 2008). 
1.4.2.3.1 – Spleen  
The spleen is a large abdominal organ, enclosed by a fibrous capsule. This organ has 
two main functions: initiate the immune response against blood-borne antigens and 
eliminate aged red blood cells from the circulation. In eutherian mammals, the spleen 
also acts as a reservoir of blood. The white pulp is the immune component of the spleen, 
where lymphocytes are organised in irregular lymphoid aggregations surrounding a 
central artery or arteriole, forming periarteriolar lymphoid sheaths (PALS). The spleen, 
therefore, receives antigens from blood, as opposed to via the lymph. These sheaths are 
segregated from the red pulp by a marginal zone, composed mainly of macrophages. 
Adjacent to the T-cell areas are primary lymphatic nodules (or primary follicles), which 
are rich in B-cells. Following antigenic stimulation, these primary follicles develop into 
germinal centres (or secondary follicles). The red pulp is the area where macrophages 
trap and destroy defective or aged red blood cells and the site of blood storage. It is rich 
in macrophages and, in some species, in haematopoietic cells (Burkitt et al. 1993; 
Kierszenbaum 2007; Tizard 2008). 
The spleen has been described in some marsupial species, resembling the histological 
architecture of the eutherian spleen (Hayes 1968; Cisternas and Armati 1999; Canfield 
and Hemsley 2000; Old and Deane 2002; Old et al. 2003a).  The number of marsupial 
spleen white pulp areas appears to vary with the species and age; stripe-faced dunnarts 
and the Didelphid pouchless opossum (Marmosa mitis) have only a few white pulp 
areas (Bryant and Shifrine 1974; Old et al. 2003a), whereas adult Virginian opossums 
appeared to completely lack PALS and have only residual white pulp areas (Hayes 
1968). The spleen of bandicoots (Isoodon macrourus) and quokkas appears to mature 
just before weaning, when most antigenic challenge would start (Ashman and 
Papadimitriou 1975; Cisternas and Armati 1999).  Similarly, the spleen of the pouch 
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young (60-day old) tammar wallaby contained few white pulp areas, which increased in 
number as the animals aged (Basden et al. 1996).  
The marsupial spleen appears to be a site of haematopoiesis even for adult animals. This 
has been evidenced by the constant appearance of numerous megakaryocytes and other 
erythroid cell precursors in the red pulp (Ashman and Papadimitriou 1975; Cisternas 
and Armati 1999; Young et al. 2003). The presence of thick trabecula in the spleen of 
marsupials also has been a constant finding and provides evidence for blood storage. 
Rufous hare-wallabies affected by Mycobacterium spp. have extensive white pulp 
proliferation, high degree of fibrosis and thickened blood vessel walls in the spleen, 
characterising the immune role of the spleen in this species (Young et al. 2003). 
1.4.2.3.2 – Lymph node 
Lymph nodes are encapsulated round-shaped structures displayed strategically on 
lymphatic vessels throughout the body. Lymph nodes, therefore, filter antigens from the 
lymph, as opposed to the spleen, which receives antigens from the blood. Lymph nodes 
have been described as “information marketplaces” where antigen presenting cells come 
after patrolling the body lymph to meet lymphocytes, which are looking for their 
specific target antigens (Willard-Mack 2006). 
This lymphatic fluid is derived from the interstitial fluid and contains antigen-presenting 
cells carrying engulfed antigens from elsewhere in the body. Lymph enters the node 
through afferent lymphatic vessels, which have internal valves to prevent the reflux of 
lymph, in the outer surface of the node and then passes in close contact through a range 
of structures with different cell types: in the cortical area of the node, lymph comes in 
contact with lymphoid follicles (or outer cortex), which are areas rich in B-cells and the 
paracortex (or inner cortex), which is rich in CD4+ cells (helper T-lymphocytes). 
Lymphoid follicles also harbour numerous resident follicular dendritic cells (FDC), 
migrating dendritic cells and macrophages. In response to antigenic stimulation, the 
lymphoid follicle develops a germinal centre, with intense B-cell proliferation. The 
germinal centres of secondary lymphoid follicles are recognized as dynamic structures 
where B-cells undergo clonal expansion, class switching, antibody gene diversification 
and affinity maturation (Schwickert et al. 2007). The function of FDC is to trap antigens 
entering the node and present them to B-cells for recognition. In the inner cortex, 
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helper T-cells interact with B-cells to induce B-cell proliferation and differentiation in 
antibody-producing cells, or plasma cells. Activated B-cells migrate to a region in the 
medulla of the node (medullary cords), where antibodies are secreted at the exit point, at 
the concave surface of the node. At this site, the hilum swathe the efferent lymphatic 
vessel, which transports the lymphatic fluid back to the main circulation (Kierszenbaum 
2007).  
The main histological and immunohistological characteristics of the lymph nodes of 
marsupials have been demonstrated to be similar to the eutherian counterparts, with 
similar T- and B-cell distribution pattern (Coutinho et al. 1995; Hemsley et al. 1995; 
Old and Deane 2003a; Old et al. 2006). The number and distribution of nodes within 
marsupials, however, varies greatly among the species (Old and Deane 2000). An 
abundance of mast cells in the lymph nodes has been described in a Dasyurid, the fat-
tailed dunnart (Smithopsis crassicaudata) and in six Didelphid marsupials (Didelphis 
aurita, D. albiventris, Metachirus nudicaudatus, Philander opossum, Marmosops 
incanus and Gracilinanus agilis). These mast cells were restricted to the lymphatic 
sinuses, contained large cytoplasmic granules and were thought to be of a different type 
from the connective tissue and mucosal mast cell populations (Haynes 1991; Chiarini-
Garcia and Machado 1992; Chiarini-Garcia and Pereira 1999; Chiarini-Garcia et al. 
2000). Mast cells are key mediators of inflammation, but the role of these specific mast 
cell populations in the lymph nodes of marsupials is unknown.  
1.4.2.3.3 – Mucosa-associated lymphoid tissue 
The mucosae are the most likely site of entrance of antigens into the body. The immune 
system of mammals contains specialised lymphoid tissues to undertake surveillance at 
these entry points, the mucosa-associated lymphoid tissues (MALT). These tissues are 
composed of well-organised aggregations of lymphoid cells associated to the mucosa of 
different parts of the body and are named accordingly. For example, in the 
gastrointestinal tract these aggregations are called gut-associated lymphoid tissues 
(GALT), in the lung, bronchus-associated lymphoid tissues (BALT) and so on. In 
addition, lymphoid cells can be present diffusely throughout the connective tissue, in 
close association to the epithelium (Burkitt et al. 1993; Hemsley et al. 1996b). 
Immunoglobulin A (IgA) is the most common Ig found in the mucosa of the 
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gastrointestinal and respiratory tract. The immune aggregations at these sites (composed 
of helper T-cells and epithelial cells) continuously produce cytokines that play an 
important role in maturation and proliferation of IgA-producing B-cells (Hannant 2002). 
The gastrointestinal mucosa-associated lymphoid tissue is composed of two main 
aggregations: the Peyer’s patches in the small intestine (lymphoid aggregations are also 
common in the large intestine) and the oropharyngeal tonsils (palatine or soft palatine 
tonsils). Because a range of antigens are in constant contact with these structures, these 
lymphoid tissues have to be able to discriminate the antigens between harmful and 
harmless while keeping homeostasis (Burkitt et al. 1993; Mason et al. 2008). Peyer’s 
patches are located in the epithelium above the basement membrane and are composed 
of lymphoid follicles with germinal centres rich in B-cells.  T-cell rich areas are found 
between germinal centres. Tonsils are present at the opening of the pharynx in most 
mammals and are enclosed by stratified squamous epithelium. This epithelium 
invaginates into the surrounding connective tissue and forms blind-ended tonsillar 
crypts. The histological organisation of the tonsils is similar to the Peyer’s patches 
(Burkitt et al. 1993).  
Bronchus-associated lymphoid tissues are found in the lungs and airways of mammals 
and are involved both in the immune response against antigens and infectious agents. 
Similarly to the gut-associated lymphoid tissues, BALT is composed of follicles rich in 
B-cells. T-cells are also common in BALT and may play a role in tolerance to harmless 
inhaled antigens (Bienenstock and McDermott 2005). 
 It is likely that GALT is as well developed in metatherians as in eutherians and that it is 
the last lymphoid tissue to mature (Basden et al. 1997). Several marsupial species have 
been demonstrated to have well-developed Peyer’s patches and active tonsils, including 
South American and Australian Polyprotodonts and Diprotodonts (Coutinho et al. 1994; 
Hemsley et al. 1996b, a; Old and Deane 2001). It has been suggested that an increase of 
antigen load (via gastrointestinal tract) at the time of weaning and changes in the milk 
composition in marsupials might lead to the development of the gut lymphoid tissues or, 
alternatively, GALT might be dependent of maturation of some other lymphoid tissue 
(Old et al. 2004b). BALT has been recorded as few aggregations in the lung tissues of 
stripe-faced dunnart, red-tailed phascogale (Phascogale calura) and in 
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mycobacteria-affected rufous hare-wallaby, but whether or not the presence of this 
tissue was a response to antigenic stimulation (as is observed in eutherian mammals) is 
not known (Young et al. 2003; Old et al. 2004b; Old et al. 2006). Surprisingly, no 
BALT was observed in lung sections of adult and pouch young tammar wallabies (Old 
and Deane 2002, 2003a). 
1.4.3 – Innate immunity 
The body is protected against a range of infections by the innate immune responses, 
which are simple mechanisms where previous exposure to the pathogen is not required. 
Epithelial surface barriers, proteins of the complement cascade, NK cell killing and 
phagocytosis by neutrophils and macrophages are some of the mechanisms of innate 
immunity. 
The complement system is composed of several serum and cell surface proteins 
involved in opsonisation of microorganisms to promote phagocytosis, enhancement of 
the inflammatory response to the site of infection and cellular lysis. As discussed in 
Section 1.4.2.1.1, NK cells participate in the innate immune response by killing virus or 
bacteria-infected cells and tumour cells expressing low levels of MHC I. The 
mechanism of killing by NK cells is similar to the cytotoxic T-cell counterparts (Abbas 
et al. 2007; Jobim and Jobim 2008).  In this section, phagocytosis will be discussed. 
1.4.3.1 – Phagocytosis  
Phagocytosis is the process by which a cell engulfs particles into its cytoplasm. Two 
cell populations of the immune system, macrophages and neutrophils, undertake 
phagocytosis. These cells recognise and bind to receptors on the cell surface of the 
pathogen and project pseudopodia around the particle in an actin-dependent process. 
The newly formed phagosome fuses to lysosomes (forming a phagolysosome) and 
matures, appearing as an acidic and hydrolytic compartment into the immune cell where 
the particle is killed and, if undertaken by a macrophage, prepared for antigen 
presentation. Recognition of foreign particles by macrophages and neutrophils is greatly 
enhanced by coating of the target microorganism with Igs or proteins of the complement 
(opsonisation) (May and Machesky 2001; Aderem 2003). 
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Once internalised into the phagolysosome, the microorganism is subject to microbicidal 
oxidants, such as the reduced nicotinamide adenine dinucleotide phosphate (NADPH) 
oxidase pathway, which culminates in toxic compounds (oxygen radicals and hydrogen 
peroxide). Nitric oxide (NO) is also generated and reacts with oxygen radicals to 
produce highly toxic peroxynitrite. The combination of these sub-products is capable of 
killing most Gram positive and negative bacteria and fungi. This mechanism of killing 
is accompanied by a transient increase in oxygen consumption, known as the 
respiratory burst. Macrophages that undertake phagocytosis of foreign bodies can 
process the antigens and express them on MHC II molecules for presentation to 
CD4+ T-cells. Neutrophils, on the other hand, undergo apoptosis and are phagocytosed 
by macrophages (Quinn and Gauss 2004; Parham 2005).   
1.4.4 – Acquired immunity 
Acquired, or adaptive immune responses are highly organised reactions of the immune 
system, carried out mainly by lymphocytes (effector cells), which are activated 
following the exposure of the organism to an antigen. The adaptive immune response is 
more specific than the innate immune response, recognises a wider range of antigens 
and, importantly, generates stronger responses with successive exposure to the same 
antigen – memory. Nevertheless, both components of the immune response work 
together in several mechanisms, one complementing the other towards the elimination 
of the infection. There are two types of adaptive immune response: humoral immunity, 
mediated by B-cells through the production of antibodies, and cellular immunity, 
mediated by T-cells through cytotoxic activity. 
1.4.4.1 – Humoral immunity 
Cells of the B-lymphocyte lineage are the effector cells of the humoral immune 
response. Activated B-cells clonally proliferate and differentiate in antibody-secreting 
cells, or plasma cells, and memory cells (Section 1.4.2.1.1).  B-cells are present in the 
secondary lymphoid tissues, waiting for specific antigens that bind to the Ig receptor on 
their cell membrane. The binding of the antigen to the Ig is the signal that activates the 
B-cell to proliferate, migrate to T-cell areas and present the antigen (if it is a peptide) to 
CD4+ helper T-cells (T-dependent antigen). Responses to polysaccharide or lipid 
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antigens do not require helper T-cell collaboration (T-independent antigen). 
Helper T-cells induce B-cells to produce Igs (antibodies), promote heavy chain isotype 
switching and affinity maturation (production of antibodies that bind to the antigen with 
higher affinity). Isotype class switching is mediated following engagement in the CD40 
membrane molecule and cytokines. A primary response is activated by the exposure of 
an unknown antigen, whereas secondary responses are the result of clonal expansion of 
memory cells. The secondary response, therefore, is more rapid and produces larger 
amounts and higher affinity antibodies than the primary response. Antibodies opsonise 
the target antigen and activate the complement to make it more recognizable for the 
immune system, e.g. to facilitate phagocytosis by macrophages or neutrophils. In 
addition, antibodies may bind and block the pathogenic site of bacteria or viruses, 
preventing the microorganism to exert their deleterious effects (Parham 2005; Abbas et 
al. 2007).  
The genes encoding most Ig classes have been isolated and sequenced in some 
marsupials, describing the molecular aspects of the heavy and light chain classes in this 
group. These studies showed that marsupial Igs are highly similar to eutherian Igs 
(Belov et al. 1999a; Belov et al. 1999b; Miller and Belov 2000; Belov et al. 2001, 
2002). Functional studies in many marsupial species, however, have shown that the 
humoral response of this group is remarkably different from that of eutherian mammals. 
Studies have been undertaken with American didelphids, the opossums (Didelphis 
virginiana and Monodelphis domestica), and the Australian Macropods, the quokka and 
the tammar wallaby (Rowlands et al. 1964; Rowlands 1970; Major and Burrell 1971; 
Yadav 1971; Thomas et al. 1972; Croix et al. 1989; Kay and Kitchener 2003; Deakin et 
al. 2005). Other marsupials such as the common brushtail possum and the eastern 
barred bandicoot (Perameles gunnii), have also been analysed, but to a lesser extent 
(Bettiol 2000; Deakin et al. 2005). These marsupials were immunised with a range of 
antigens (including sheep red blood cells, various bacteriophages, bacterial flagella, 
bovine serum albumin) and the general conclusions from these studies were that the 
humoral immune response resembled the responses of cold-blooded vertebrates, 
because 1) the secondary response was usually similar to the primary with little or no 
discernible isotype class switching from IgM to IgG; 2) when compared to eutherian 
mammals, marsupials were observed to mount a weaker and a slower antibody response 
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and 3) booster immunisations in short intervals (3 to 4 weeks) did not increase the 
immune response. It would therefore appear that marsupials, in general, have a 
relatively poor humoral immune response when compared to eutherian mammals. 
However, most of these studies used eutherian immunisation protocols, which were not 
optimised for marsupials. In addition, a lack of consistency in the immunisation 
methods makes it difficult to compare responses for very different species that might 
respond in different ways. 
Despite these findings, more recent studies have demonstrated that marsupials are able 
to mount an effective humoral immune response; McLelland and colleagues (2005) 
demonstrated that neutralising (and protective) antibodies against encephalomyocarditis 
virus could be induced through vaccination in wallaroos (Macropus robustus), which 
was similar to that observed in three eutherian mammals. It was shown that IgG 
antibodies against synthetic peptides (luteinizing hormone and an androgen receptor) 
remained constant after immunisation in tammar wallabies, while brushtail possums did 
not respond or responded weakly to these antigens. Tammar wallabies immunised 
against porcine zonae pellucidae and spermatozoa showed reduced fertility in vivo and 
fertilization in vitro, respectively compared to controls and was similar to results in 
eutherian mammals, even though a secondary immune response was not well 
characterised in the wallabies (Kitchener et al. 2002; Deakin et al. 2005; McLelland et 
al. 2005; Asquith et al. 2006).  
Several studies have been undertaken to explain how the pouch young marsupial is able 
to survive in a non-sterile environment without active immune response (Yadav et al. 
1972; Deane and Cooper 1988). There has been some evidence showing the presence of 
maternal IgG antibodies against pouch bacteria in brushtail possum pouch young serum, 
probably a non-specific antibody (Deakin and Cooper 2004). In addition, an 
immunomodulador (named eugenin) was found in the pouches of female tammar 
wallabies carrying young in the early lactation period. It was suggested that such 
peptide might protect the pouch young through an increased proliferation of splenocytes 
(Baudinette et al. 2005).  
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1.4.4.2 – Cellular immunity 
T-lymphocytes dominate the adaptive cellular immune response. Helper T-cells (CD4+) 
are activated by APCs carrying antigen in association with the MHC II molecules, 
whereas cytotoxic T-cells are activated by antigens presented on the MHC I molecules 
of APCs. This first activation takes place in the lymph node and is undertaken almost 
exclusively by dendritic cells, which capture the antigens around other tissues and 
migrate to the lymph nodes.  Recognition of antigens occurs through the T-cell receptor 
(TCR), which is equivalent to the Ig receptor of B-cells. Activated T-cells produce a 
range of cytokines (mainly IL-2), proliferate and differentiate into effector T-cells. 
Depending on the presentation, effector CD4+ T-cells activate phagocytosis and B-cells, 
while effector CD8+ T-cells become functional cytotoxic T-cells. Section 1.4.2.1.1 
summarises the mechanism of killing by cytotoxic T-cells. 
Several cellular immune function tests exist, such as in vitro lymphocyte proliferation 
assays and mixed lymphocyte reaction and in vivo skin graft transplantation. 
Lymphocytes can be stimulated in vitro by mitogens, which are chemical substances 
(usually proteins) that bind non-covalently to specific carbohydrates on the cell 
membrane and induce DNA synthesis and cell division. Several plant extracts (lectins) 
are known for their mitogenic ability. Phytohemagglutinin (PHA), concanavalin A 
(Con A) and pokeweed mitogen (PWM) are the most common mitogens. PHA and 
Con A stimulate mainly T-cells to proliferate, whereas PWM stimulates both T- and 
B-cells to divide. In addition, bacteria cell wall extracts, such as lippopolysaccharide 
(LPS) from gram-negative bacteria is known to stimulate B-cells to proliferate 
(Kristensen et al. 1982; Tizard 2008). Lymphocyte stimulation test has often been used 
in investigations of immune function of wildlife animals, including tuataras (Sphenodon 
punctatus) and sea turtles (Caretta caretta) to sea otters (Enhydra nereis), bears (Ursus 
arctos) and dolphins (Tursiops truncatus) (Lahvis et al. 1995; Musiani et al. 1998; 
Burnham et al. 2005; Schwartz et al. 2005; Keller et al. 2006).  
Mitogen-induced proliferative responses have been studied in some marsupial species, 
such as the Virginian and grey short-tailed opossums, the quokka, the tammar wallaby 
and the koala. In general, these animals produced responses comparable to eutherian 
mammals for the T-cell mitogens PHA and Con A and for the T- and B-cell mitogen 
Chapter 1: Literature Review 
 
− 35 − 
PWM, but responses to LPS were consistently low or non-existent (Fox et al. 1976; 
Croix et al. 1989; Infante et al. 1991; Brozek et al. 1992; Wilkinson et al. 1992b; 
Young and Deane 2007).  
Skin graft tests have been performed in marsupial species for two reasons; Firstly, 
because marsupials are born in such immunological immature stage, an interest in 
transplantation immunology is evident. Although skin grafts were promptly rejected in 
adult animals (e.g. grey short-tailed opossum) (Infante et al. 1991; Stone et al. 1997), 
newborn pouch young of the Virginian opossum did not reject maternal skin grafts up to 
12 days after birth, but rejected the allografts after that age, suggesting maturity of 
T-cell responses by this age (LaPlante et al. 1966; LaPlante et al. 1969). Secondly, 
several marsupial species appear to have a lowered response in mixed lymphocyte 
reaction, which is a lymphocyte test that measures MHC functionality diversity (Fox et 
al. 1976; Infante et al. 1991; Wilkinson et al. 1992a). The mixed lymphocyte reaction 
and skin graft experiments are discussed further in Section 1.5.1. 
1.4.4.3 – Anti-tumour immunity 
The main lines of defence against tumours are delivered by cytotoxic T-cells and 
NK cells. Mutated cellular proteins or peptides or oncogenic viral particles may be 
presented to CD8+ T-cells in association with MHC I molecules to generate a cytotoxic 
T-cell response. In addition, dendritic cells may process tumour antigens and present the 
peptides to both CD8+ and CD4+ cells, via MHC I and II molecules, respectively. 
Cross-presentation is required to present antigens to CD8+ T-cells, whereas exogenous 
presentation is a more standard presentation pathway, resulting in CD4+ T-cell 
activation. This combination results in enhanced T-cell cytotoxicity and generates 
cytokines, such as IFNγ and TNF. MHC I expression by tumour cells is consequently 
up-regulated, making these cells more easily targeted by cytotoxic T-cells (Foss 2002; 
Benchetrit et al. 2003). 
Although NK cells have been demonstrated to perform several immune regulatory 
functions other than killing, this subset of lymphocytes are professional killer cells that 
target virally infected cells and tumour cells with reduced MHC I expression. 
Antibodies (against tumour antigens) coating the tumour cells also increase the 
cytotoxicity activity of NK cells (Walzer et al. 2005). Macrophages also have been 
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demonstrated to have anti-tumour activity against some tumour cells, triggered by 
macrophage colony-stimulating factor (Jadus et al. 1996; Jadus et al. 1998). 
1.5 – The Major Histocompatibility Complex genes and the Tasmanian 
devil 
Major histocompatibility complex (MHC) refers to a cluster of genes that were 
originally identified in mammalian cells to be grouped on a single chromosome, 
encoding specialised glycoproteins expressed on the cell surface of almost all nucleated 
cells of the body. These genes were first related to foreign tissue (allograft) 
transplantation (hence its name), but are now known to be essential in the immune 
recognition of pathogens and tumour cells. There are three MHC families or subgroups 
that have different functions, MHC Class I, MHC Class II and MHC Class III.  MHC I 
molecules are composed of a polymorphic α-chain associated with a non-polymorphic 
β2-microglobulin and present cytosolic peptides (intracellular antigens) to 
CD8+ cytotoxic T-cells. These molecules are present on all somatic cells, immune and 
non-immune. MHC II molecules are composed of a polymorphic α-chain attached to a 
polymorphic β-chain, and present endocytosed peptides (extracellular antigens) to 
CD4+ helper T-cells and are normally only located on the cell surface of professional 
antigen presenting cells, such as B-cells and macrophages. MHC III molecules are 
mostly involved in innate immune defence mechanisms and are classified as MHC 
simply because they were identified within the complex of the mammalian genome. 
Unlike MHC I and II, they have no role in immune recognition (Bernatchez and Landry 
2003; Kumanovics et al. 2003; Acevedo-Whitehouse and Cunningham 2006).  
1.5.1 – Transplantation immunology 
MHC alleles are the most variable functional genes in vertebrates and are highly 
polymorphic, mainly at the peptide-binding region (PBR), the region that recognises 
different peptides. This unusual polymorphism is responsible for the ability of MHC 
genes to recognise a wide range of pathogens and is subject to constant positive 
selection (Hughes and Nei 1988). In addition, MHC molecules provoke vigorous T-cell 
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responses against incompatible cells and regulate the immunological mechanisms of 
tissue graft rejection. 
A tissue graft transplanted from the same donor (e.g. skin transplanted from an area to 
another) is known as an autograft; tissue graft from a genetically unrelated donor is 
called an allograft and a tissue graft from a different species is called a xenograft. There 
are two mechanisms that govern allograft recognition, a direct recognition pathway and 
an indirect recognition pathway. In the direct recognition pathway, donor APCs (such 
as dendritic cells) migrate from the graft to the recipient lymph node and display 
allo-antigens to the T-cells from the recipient. In the indirect recognition pathway, 
dendritic cells from the recipient migrate to the graft, process allo-antigens and present 
these foreign peptides to recipient T-cells in the recipient lymph node (Watschinger 
1995; Benichou et al. 1999). 
Allografts may be rejected concomitantly by several different effector mechanisms, but 
the main mediators are CD8+ T-cells and CD4+ T-cells. Allo-peptides presented to 
CD8+ T-cells by MHC I molecules (mainly direct allo-recognition) stimulate the 
differentiation of cytotoxic T-cells, which kill nucleated cells expressing MHC I in the 
graft. Allo-antigens presented by MHC II molecules (mainly indirect allo-recognition) 
activate helper T-cells, which differentiate and produce cytokines (that damage the 
tissue graft). Allograft rejection mediated by CD4+ and CD8+ cells is acute rejection, as 
it can occur within days after the transplant. This form of rejection is primarily due to 
mismatching of the MHC loci. In contrast, a second mechanism of rejection is 
hyperacute rejection, which occurs when the recipient has pre-existing antibodies 
against peptides or carbohydrates, such as blood group antigens, from the donor, 
inducing the destruction of donor cells minutes or hours after the transplantation. 
Chronic rejection is mainly associated with fibrosis and loss of function of the graft 
several months to years after the transplantation. This form of rejection is primarily a 
consequence of the trauma of the transplant and pathological processes associated with 
repairing this trauma (Game et al. 2001). 
A predictive in vitro test for T-cell direct recognition of allogeneic MHC molecules is 
the mixed lymphocyte reaction (MLR) (Derks and Burlingham 2005). This assay has 
been used in clinical analyses of allogeneic impact of MHC I and II mismatches 
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between live donors (e.g. kidney donors) and recipients. Donors with low MLR 
responses against the recipient have lower incidence of graft rejection (Nishigaki et al. 
1990; Jeras 2002). Mixed lymphocyte reactions can be performed with cultured 
lymphocytes from both donor and recipient and measure the lymphocyte cell 
proliferation in response to differences in the MHC alleles of both individuals (two-way 
MLR). By inactivating the mononuclear cells from the donor (by X-irradiation or 
chemical mitotic inhibition), only the recipient response is evaluated (one-way MLR).  
Several outbred marsupial species have been analysed for MHC differences through 
MLR experiments, but only weak or non-existent MLR responses have been reported 
(Fox et al. 1976; Infante et al. 1991; Wilkinson et al. 1992a; Montali et al. 1998; Stone 
et al. 1998). This lowered response in MLR experiments prompted suggestions that 
marsupials have limited MHC I and MHC II diversity (McKenzie and Cooper 1994; 
Stone et al. 1998), although this lack of in vitro allogeneic recognition is not supported 
by genotypic analyses, which found similar level of polymorphism in immune genes in 
Monodelphis domestica as in eutherian mammals (Gouin et al. 2006a; Gouin et al. 
2006b). In addition, skin grafts between unrelated individuals were promptly rejected, 
corroborating the genetic analyses (Infante et al. 1991; Stone et al. 1997; Gouin et al. 
2006b). Therefore, the apparent paucity of MLR responses in marsupials presents a 
paradigm that needs to be resolved. In comparison to marsupial species, the failure of 
allogeneic mononuclear cell proliferation in domestic cats generated arguments that this 
species possessed limited polymorphism in MHC genes (Pollack et al. 1982). Further 
studies using appropriate culture conditions for this species (e.g. longer incubation 
period and cat or rabbit serum as supplement for the culture) however, demonstrated 
that the low proliferation was likely to be a result of technical problems rather than a 
lack of MHC diversity (Stiff and Olsen 1984; Wolfe et al. 1984; Gregory et al. 1987). 
1.5.2 – MHC expression and tumour evasion 
Tumour cells may utilise many different mechanisms to escape immune recognition and 
destruction. Mechanisms of tumour evasion include 1) down-regulation of MHC I 
expression and consequent loss of recognition of tumour antigens by MHC I-restricted 
CD8+ T-cells (Cormier et al. 1999), 2) over-expression of non-classical class I 
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expression, which interact with killing receptors to escape NK cell killing (Ikeda et al. 
1997), 3) resistance to cytotoxic molecules, such as perforin (Lehmann et al. 2000), 
4) decreased tumour antigen expression (Lee et al. 1998) and 5) secretion of 
immunosuppressive factors by the tumour cells, such as IL-4, IL-10 and transforming 
growth factor-β1 (TGF-β1) (Sarris et al. 1999; Hsiao et al. 2004).   
Tumour cells may lose or down-regulate MHC I expression due to several mechanisms, 
such as failure to express β2-microglobulin, loss of peptide transporter proteins (TAP1 
and TAP2) or mutation of the Class I α or β2-microglobulin chains.  In addition, MHC I 
loss may be caused by viral infection or as a result of genetic instability causing 
structural changes in the chromosome where the MHC locus is located (Ferrone and 
Marincola 1995; Rivoltini et al. 1995; Maeurer et al. 1996).  
The Canine Transmissible Venereal Tumour (CTVT) is an allografted transmissible 
tumour of the Canidae family that utilises several mechanisms to escape immune 
recognition, including down regulation of MHC machinery (Cohen et al. 1984; Murgia 
et al. 2006). CTVT also promotes a misbalancing in the dendritic cell apparatus, 
inhibiting the tumour-associated antigen processing and presentation to T-cells. This 
mechanism of immune evasion has also been demonstrated in cancers from humans and 
rodents (Liu et al. 2008; Tourkova et al. 2009). In addition, CTVT has been 
demonstrated to produce TGF-β1 to escape immunosurveillance (Hsiao et al. 2004). 
Other aspects of this transmissible cancer are discussed in Section 1.7.1. 
1.5.3 – MHC diversity and population fitness 
MHC allelic diversity can hypothetically be used as a measure of ‘fitness’ of a 
population, even though few studies have confirmed that higher allelic diversity at 
MHC loci in wild populations is associated to higher resistance to pathogens (Paterson 
1998; Langefors et al. 2001; Wegner et al. 2003; Xu et al. 2008). Lack of MHC 
variability has been found in several populations of wild animals, such as cheetahs and 
pocket gophers (Thomomys bottae). These animals are so inbred that allograft 
transplantation is possible between unrelated donors and several survival disadvantages 
have been associated to this inbreeding, such as reduced fertility, high infant mortality 
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and increased susceptibility to diseases (O'Brien et al. 1985; Sanjayan and Crooks 
1996).  
It is known that island populations have reduced genetic variation and are more prone to 
extinction than mainland populations (Frankham 1997). Tasmanian devils, as the top 
mammalian predators of an island would be, therefore, at increased risk of genetic 
inbreeding. Work published by Jones and colleagues (based on 11 polymorphic 
microsatellite loci), suggests that Tasmanian devils have a low heterozygosity and 
allelic diversity (Jones et al. 2003c, 2004). These neutral markers provide useful 
information regarding population history, individual dispersal and relatedness analyses, 
whereas the interaction of individuals with potential pathogens and their capacity to 
adaptively change, within and between populations, is better represented in analyses of 
MHC variability (Sommer 2005). Molecular typing at MHC loci using single-strand 
conformation polymorphism (SSCP) demonstrated that DFTD-affected devil 
populations severely lack MHC I variation (Siddle et al. 2007) and it was hypothesised 
that the species is, therefore, susceptible to a transmissible cancer, DFTD. Lack of MHC 
diversity allowing allograft transplantation, however, still needs to be characterised by 
functional studies, such as mixed lymphocyte reactions and skin grafts between 
unrelated devils. 
1.6 – The Devil Facial Tumour Disease – DFTD  
1.6.1 – Historic overview of DFTD 
The first description of a disease-like symptom in Tasmanian devils came from a report 
from Mr Henry Widowson to the king of England in 1829 about the animals and plants 
of the then called Van Diemen’s Land, saying that the devils head appeared to be 
covered in ‘scales’ as if it was diseased (Widowson 1829). Around the time of this 
report (1800-1820), Tasmanian devils appeared to be abundant on the island (Gunn 
1854) and this description is more suitable to the scarring often observed in adult devils 
due to fighting. At least two events involving population decline and recovery appeared 
to have occurred in the past, although these accounts are anecdotal; around the middle 
of the 19th Century the devil population appeared to be in decline, but appeared to be 
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more common by the end of the century. By early in the 20th Century, devils again 
appeared to be rare and were only present in remote areas. These early possible crashes 
in devil population have been related to ‘disease epidemic’, although no evidence for 
this has been found. The population again increased during the early 1990’s (prior to 
disease appearance), but informal estimates of 130,000-150,000 devils at this time were 
probably overestimates (Guiler 1961; Green 1967; Guiler 1992; Bradshaw and Brook 
2005; McCallum et al. 2007). Other factors, such as intense persecution and primary 
and secondary poisoning with strychnine and organophosphate compounds are likely to 
have affected devil numbers prior to the DFTD epidemic (Owen and Pemberton 2005; 
Obendorf and McGlashan 2008). 
In 1996 a wildlife photographer, Christo Baars, photographed Tasmanian devils from 
the far north east of Tasmania (Mount William National Park) and these devils had 
extensive growths on the faces. This was the first record of DFTD, as prior to that year, 
no sign of such a disease had been found, despite extensive trapping in most areas of 
Tasmania. From 2001 to 2004, the disease was observed to spread to south of Freycinet 
National Park, a peninsula on the east coast of Tasmania. Similarly, DFTD was seen to 
spread geographically southward and westward of the state, suggesting that DFTD was 
caused by an infectious agent that was spread by contact between devils.  
1.6.2 – Population impacts and demographic changes caused by DFTD 
Before DFTD arrival, Tasmanian devils were found throughout Tasmania. They were 
more common in the eastern half and north west coast at medium to high densities. 
Central Tasmania and the south east have always harboured devils in very low densities 
(Jones and Rose 1996; Hawkins et al. 2006). By 2008, 12 years after the first case was 
reported, DFTD was established throughout most of the devil’s range, but 
predominantly in the eastern half of Tasmania, in over 60% of the state. The devil 
populations in the far north west of Tasmania are partially isolated from the eastern 
populations by areas of unsuitable habitat for the species, habitat fragmentation due to 
intensive farming activities and mountainous geography. Maybe due to this isolation, 
these northwestern populations were unaffected by DFTD (as of 2008), although no 
monitoring has occurred in those areas since 2007 (Hawkins et al. 2006). Furthermore, a 
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pocket of DFTD-unaffected devils was found in the mid-north coast of Tasmania, in 
Narawntapu National Park. This population of devils was geographically located in 
areas surrounded by DFTD-affected animals, but only recently the area succumbed to 
the disease. The cause of this delay of DFTD appearance in this location is unknown 
(M. Jones, personal communication).  
This disease does not appear to be density-dependent, i.e., it remains present in the 
population even at low devil numbers. Statistical modelling has predicted that, as a 
consequence of DFTD, devils face extinction in 20-25 years (McCallum and Jones 
2006; McCallum et al. 2007; Jones et al. 2008). Declines in populations of Tasmanian 
devils have been recorded both locally and throughout the state by spotlight transect 
visual observations, road-kill reports and trapping of devils with mark-recapture data. In 
Mount William National Park, where the disease was first observed, a decline in devil 
numbers of more than 90% was recorded (Lachish et al. 2007). The first impact 
observed in affected populations is the dramatic reduction in adult animals. Freycinet 
National Park has been monitored since 1999, before arrival of DFTD, and the survival 
of adult (2+ years old) and subadult (1+ year old) devils halved one year after DFTD 
arrival. These age groups have declined to almost zero five years after disease arrival 
(Lachish et al. 2007). These catastrophic impacts of DFTD have been observed in other 
areas of eastern Tasmania, such as Bronte Park and Forestier Peninsula, but at an 
apparent much slower rate in central-western areas of the island (Cradle Mountain and 
West Pencil Pine areas), but the reason for this is unknown (Coupland and Anthony 
2007).  
Forestier Peninsula is a virtually isolated peninsula in the south east of the island that is 
connected to mainland Tasmania by a single bridge. In this area, removal and 
euthanasia of all devils showing signs of DFTD tumours have been undertaken with 
intensive four or five 10-day trapping trips a year. Although the number of devils with 
large tumours was reduced, the population density has decreased substantially, but at a 
slower rate compared to Freycinet Peninsula, a peninsula of approximate size without 
disease suppression (Hawkins et al. 2006; Jones et al. 2007). 
The most striking impact of DFTD in the wild population of Tasmanian devils is 
possibly the change that is has caused in the life-history strategy of the species. In areas 
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of DFTD prevalence, Tasmanian devils have become semelparous; females have the 
first litter in their first year of age (as opposed to the second) and generally do not 
survive to breed on the second year. Similarly, males have the opportunity to breed in 
their first year, but succumb to the disease before the next breeding season.  This is the 
first known infectious agent to lead to precocious breeding in a mammal (Jones et al. 
2008). In addition to semelparity, DFTD-affected mothers have significantly more 
female-biased litters, since investment in daughters is less costly than in sons (Lachish 
et al. 2008). Although DFTD appears to have caused the species life-history to evolve 
rapidly, it is unlikely these new reproductive strategies will have long-term effects in 
population growth, because females may not survive long enough to rear the young to 
independence (Hawkins et al. 2006; Lachish et al. 2008). 
1.6.3 – Case definition 
The prevalent characteristic of Devil Facial Tumour Disease, as the name suggests, is 
the presence of tumour(s) on the facial area. In addition to the facial area, tumours occur 
inside the mouth (gingival mucosa, hard palate, lips), on the head and neck. More than 
one tumour is often observed, which often show considerable variation in size and 
external appearance. The tumours will often show signs of ulceration with epithelium 
break up, necrosis, exudation and bacterial contamination (Figure 1.2 A-F). The 
majority of DFTD-affected devils (65% of cases in a study of 91 DFTD-affected devils) 
showed signs of metastases, principally to the regional lymph nodes, but also to the 
lungs and spleen (Loh et al. 2006a).  
Under histological examination, DFTD tumours are “pleomorphic round cells with high 
nuclear to cytoplasmic ration; fibrillar, eosinophilic cytoplasm; and often indistinct cell 
borders” (Loh et al. 2006a); DFTD neoplasms are well-vascularised and non-invasive 
with high mitotic indices. A study by Loh and colleagues (2006) reported lymphocyte 
infiltration in only 7% of cases (Loh et al. 2006a). Although DFTD was initially thought 
to be a lymphoid originated tumour (Ladds et al. 2003), immunohistochemical analyses 
revealed that the tumour cells expressed a range of neuroendocrine related markers, 
including vimentin, S-100, melan A, neuron specific enolase, chromogranin A and 
synaptophysin, but did not express lymphoid markers, such as leukocyte-specific 
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protein 1 (LSP1) and CD3, prompting suggestions that this neoplasia is of 
neuroendocrine origin (Loh et al. 2006b; Pyecroft et al. 2007). More recent work 
utilising transcriptome and miRNAome techniques, corroborated by 
immunohistochemistry labelling has demonstrated that DFTD tumour cells are most 
likely to be of peripheral nerve origin (C. Tovar, personal communication). Markers for 
several proteins involved in the myelination pathway, such as periaxin and myelin 
protein zero (MPZ) and expressed exclusively in Schwann cells, were found to be 
highly expressed in DFTD tumour cells, but not in other tissues (Murchison et al. 
submitted). 
The most remarkable characteristic of DFTD would be its transmissible nature and 
several independent lines of research have provided support for this concept. Early 
epidemiological observations suggested that DFTD is a transmissible disease, as the 
disease would spread geographically over time, but the infectious agent was unknown 
(Hawkins et al. 2006). Transmission electron microscopy, cDNA subtraction and 
microarray hybridisation techniques have been used to identify signs of virus aetiology 
in DFTD, but all have failed to provide evidence for any oncogenic virus aetiology 
(Pyecroft et al. 2007). However, it would appear prudent not to rule out putative viruses 
implicated in DFTD transmission (McGlashan et al. 2006).  
Cytogenetic research on the constitutional chromosomes of the devils and of the 
tumours, led Pearse and Swift (2006) to hypothesise that DFTD tumour cells are 
themselves the infectious agent. The DFTD allograft is transmitted by biting, through 
an infected devil that transmits DFTD cells to a healthy one. The transmitted cells 
establish in the tissues, multiply and form a tumour in the recipient animal. The 
karyotype of DFTD tumour cells had undergone several abnormalities, such as loss of 
both chromosomes 2, both sex chromosomes and one chromosome 6 and a deletion of 
the long arm of chromosome 1. In addition, there were four new unidentified markers. 
All these alterations were consistently seen in all analysed tumours, independent of sex 
or age of the animal or size of the tumour. Further evidence for the ‘allograft theory’ 
came from the finding of a devil with a pericentric inversion of chromosome 5 in the 
constitutional karyotype, but such inversion was not observed in either chromosome 5 
of the tumour from this devil (Pearse and Swift 2006).  
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Molecular studies on the MHC genes of DFTD tumours and eastern devils showed that, 
although most animals were genetically unique, all tumours analysed had identical 
genotype at multiple microsatellite and MHC loci (Siddle et al. 2007). Further genetic 
studies using transcriptome technology found markedly similarity amongst DFTD 
tumours, which was distinct from that of the hosts (Murchison et al. submitted). These 
findings strongly suggest that DFTD tumour is a rogue cell line capable of growth in 
MHC disparate devils. Clinical evidence for the transmissibility of DFTD came from 
transmission trial experiments, which successfully demonstrated that cultured DFTD 
tumour cells could ‘infect’ previously non-affected devils, adding support for the 
transmissible nature of this tumour (Pyecroft et al. 2007). No evidence of this disease in 
other species has been found (Hawkins et al. 2006). 
1.7 – Other transmissible tumours 
A report of a human surgeon who accidentally infected himself with the tumour from a 
patient that he was operating on challenged the established concept that tumours cannot 
be transmitted. The fibrous histiocytoma in the hand of the surgeon (who was fully 
immunocompetent) was demonstrated to be histologically and genetically identical to 
the tumour that had been removed from the abdomen of the patient (Gartner et al. 
1996). Reports of this nature are extremely rare and have not been fully understood, but 
changes in MHC expression of the tumour are likely to occur. In addition, allograft 
tumour transplantation is possible in patients receiving organ transplants, where the 
allografted organ may harbour non-detectable tumour cells (especially melanotic cells), 
which will thrive and cause cancer in the new immunosuppressed host (Kauffman et al. 
2002).  
Devil Facial Tumour Disease is almost unique in its transmissible nature. Only two 
other naturally transmissible tumours in mammals are known to science, the Canine 
Transmissible Venereal Tumour, CTVT, that affects members of the Canidae family 
and a transmissible sarcoma in captive Syrian hamsters (Mesocrycetus auratus), which 
was either spontaneously or artificially induced and can be naturally transmitted by 
social interactions. The canine tumour has been widely studied and even used as a 
model for cancer research, but the cancer in Syrian hamsters was studied only in the 
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1960’s and 1970’s. Comparison studies of these two transmissible tumours might shed 
some light in the understanding of the pathogenesis of DFTD. 
1.7.1 – Canine Transmissible Venereal Tumour 
It has long been suspected that CTVT, a contagious cancer of the external genitalia of 
dogs, is transmitted as a cell-allograft. Evidence from different lines of research points 
to this hypothesis: Firstly, the disease cannot be experimentally induced with tumour 
cell extracts or dead cells, but only when whole cells are transferred (Cohen 1985). 
Secondly, several chromosomal aberrations are present in the CTVT tumour cells and 
the karyotype is consistently similar in CTVT tumours from different continents; the 
tumour cells, for example, have only 58 or 59 chromosomes, whereas normal dog cells 
have 78 (Oshimura et al. 1973). Thirdly, all CTVT tumours present an insertion near the 
c-myc oncogene, that is not present in hosts (Katzir et al. 1985; Amariglio et al. 1991). 
Definitive evidence for the cell-allograft hypothesis, however, came only recently with 
research using genetic markers (including MHC genes), microsatellites and 
mitochondrial DNA in CTVT tumours and matched host tissues. CTVT tumour cells 
were genetically distinct from the hosts and, independent from the geographic origin of 
the tumour, were shown to be derived from a single clone (now separated in two strains) 
(Murgia et al. 2006). 
This cancer is present in dogs of all continents, except Antarctica, and is more prevalent 
in countries with high incidence of stray dogs, where breeding occurs without control. 
Although domestic dogs are the primary hosts, other immunocompetent members of the 
Canidae family, such as wolves, foxes, coyotes and jackals, can be successfully infected 
with CTVT across the MHC barriers. In addition, xenotransplantation of CTVT has 
been performed in imunodeficient mice (Harmelin et al. 2001; Mukaratirwa and Gruys 
2003). Recent phylogenetic analyses has dated the appearance of CTVT from 200 to 
2500 years ago, from a wolf or an Asian breed of dog, although CTVT could be even 
older (Murgia et al. 2006).  
Typically, CTVT is a benign disease, rarely causing the death of the host. In artificially 
infected dogs, there is a progressive growth phase (P phase), which may last three to 
nine months, followed by a spontaneous regressive phase (R phase), which leads to 
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clearance of the tumour. Older dogs, puppies or immunosuppressed dogs can have a 
generalised form of the disease, with metastases to other organs and death. There are at 
least two mechanisms by which CTVT can escape immune detection, but eventually the 
tumour is attacked by the immune system.  
It has been demonstrated that CTVT tumour cells express extremely low levels of 
MHC I molecules during P phase, which is reverted as R phase initiates. Similarly, the 
number of tumour-infiltrating lymphocytes (TILs) in the CTVT tumours increases 
significantly in the R phase, and other immune cells, such as NK cells, show marked 
cytotoxic effect on the tumours at this phase. CTVT, therefore, initially escapes immune 
recognition by T-cells and NK cells by down-regulating expression of MHC I 
molecules. In this initial phase, CTVT tumour cells appear to have adapted a 
mechanism of immune evasion, by producing large amounts of TGF-β, which is known 
to inhibit the expression of MHC I molecules and also the killing activity of T- and 
NK cells. At a later stage (R phase), TILs in CTVT produce high levels of IL-6, which 
antagonises the effect of TGF-β and restores the T- and NK cell cytotoxic activity into 
the tumours, leading to the regression of the tumour (Cohen et al. 1984; Hsiao et al. 
2002, 2004; Murgia et al. 2006). 
Dendritic cells are essential immune cells in the defence against cancer, by presenting 
antigens to cytotoxic T-cells and producing several cytokines crucial to the immune 
response. Dendritic cell impairment has been demonstrated to be an important 
mechanism of tumour evasion in humans and mice (Tourkova et al. 2009). It has been 
recently demonstrated that another mechanism by which CTVT escapes 
immuno-destruction is the down-regulation of dendritic cell function in affected dogs. 
Tumour cells appear to have several effects on dendritic cells: apoptotic effect on 
monocytes (precursors of dendritic cells), low differentiation rate from monocyte to 
dendritic cells, impairment of surface markers expression and altered antigen-uptake 
ability of dendritic cells. However, these functions appear to be restored in the later 
phases of CTVT, which coincides with tumour destruction (Liu et al. 2008).  
The humoral immune response against CTVT appears to play an important role in 
immunity against the tumour. Passive transfer of serum from dogs that have CTVT in 
the R phase inhibits CTVT in other dogs. In addition, dogs that recovered from CTVT 
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do not succumb to the infection a second time. Specific antibodies are essential to 
induce antigen uptake and cross-presentation by dendritic cells and effectuate the 
cytotoxic response (Schuurhuis et al. 2002).  A remarkable decrease in number of 
B-lymphocytes circulating in dogs bearing CTVT tumours (P phase), appeared to be 
caused by unidentified protein(s) released by CTVT tumours. This selective cytotoxicity 
appears to be another mechanism of immune evasion of CTVT (Liao et al. 2003).  
1.7.2 – Transmissible sarcoma in the Syrian hamster 
The significance of the transmissible sarcoma of the Syrian hamster is less understood 
than the CTVT. It was greatly studied until the middle of 20th Century, but an apparent 
abandonment of interest by the scientific community has resulted in no recent 
publication regarding this tumour.  
All laboratory Syrian hamsters originate from a single family (mother and two 
offspring) collected in the 1930’s in the deserts of Syria and are, therefore, highly inbred 
(Adler 1989). These captive Syrian hamsters appear to be susceptible to several 
spontaneous malignant tumours, such as melanomas, sarcomas and lymphomas, which 
often metastasize to other organs. These tumours were shown to be transmissible by 
graft transplantation and whole cell inoculation, and in some cases, even by mosquito 
bites, but not by filtered tumour macerates. The transfer of the tumours by cell-allograft 
was verified by karyotyping, which demonstrated similar chromosomal arrangements 
for all specific tumours (Ashbel 1945; Cooper et al. 1964; Banfield et al. 1965).  
In addition to spontaneous neoplasia, several carcinogenic compounds were used to 
induce tumours in the species. Similarly to the spontaneous tumours, induced sarcomas 
were apt to iatrogenic transference and also by social contact, such as licking. Several of 
these tumours were present in the subcutaneous tissues of the affected hamsters and in 
advanced stages were easily ulcerated. Hamsters were shown to contract the tumours in 
the throat by licking the ulcerated tumours or cannibalising their dead tumour-affected 
cage-mates. Most of these tumours were successively transplanted from animal to 
animal, acquiring morphological and karyotypic stability after the initial passages, 
which in some cases, were undertaken more than 200 times (Fabrizio 1965). 
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1.8 – Summary 
The Tasmanian devil is threatened with extinction by an infectious cancer, DFTD, 
which has spread throughout most of the species’ range. This disease causes the 
formation of severe growths on the face of the affected animals and causes death in a 
few months after the first signs of disease. This tumour is an allograft that has been 
transferred between devils for more than 10 years due to the biting behaviour of devils 
during social interactions. This tumour has a true ‘parasitic’ existence as it is transmitted 
(even passaged) between unrelated animals and it retains its phenotypic and karyotypic 
characteristics. Currently DFTD is present throughout more than 60% of the state and 
devils face the risk of extinction within 20 years. 
Tasmanian devils are marsupials, a group of mammals that developed an alternative 
mode of reproduction. Because marsupials are born in a very immature state, their 
immune system has many different features to the eutherian counterparts. The 
knowledge of the immune responses of this group is severely limited by a lack of 
specific reagents that would allow further studies.  The absence of devils that are 
resistant to DFTD, or that have recovered from this disease, raises questions about the 
immune competency of the Tasmanian devil. Research on the immune system of this 
species, however, is virtually non-existent, and comparison studies with the immune 
response of other marsupial species would be worthwhile. 
An impoverished diversity of MHC genes in the Tasmanian devil population is an 
alternative explanation for the easy transference of DFTD tumours amongst individual 
devils. Devils have been shown to have a diminished genetic diversity at 
11 microsatellite loci and a lack of MHC diversity in the eastern half of Tasmania. Two 
other free-living mammals, the cheetah and the pocket gopher, have similar levels of 
genetic inbreeding and were shown to accept skin allografts from unrelated donors. 
Functional studies in the genetic diversity of the Tasmanian devil are warranted to 
define whether DFTD is transmitted as a consequence of a lack of MHC diversity 
amongst the devil populations. 
There are only two other known transmissible tumours in mammals, CTVT and the 
transmissible sarcoma of the Syrian hamster. Both entities are likely to have arisen in 
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hosts that were genetically impoverished, although CTVT is likely to have evolved 
mechanisms to evade the immune system of MHC disparate dogs. Lessons learnt about 
the pathogenesis and pathobiology of these two tumours can be applied as a comparison 
for the understanding of DFTD. 
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Aim 1: To determine whether Tasmanian devils have the structural and functional 
components of the immune system for effective immune responses. 
Very little is known about the immune system of the Tasmanian devil. Because DFTD tumours are 
transferred as allografts between devils without immune recognition, analyses of the immune response of 
this species are paramount. Immunosuppression of the devil population is the first explanation for the 
easy transference of DFTD tumour cells between unrelated devils. In addition, comparison studies of 
Tasmanian devils from different regions of Tasmania are necessary to determine whether separate 
populations have different immune capabilities. 
Aim 2: To determine whether Tasmanian devils are capable of allo-recognition. 
A lack of MHC diversity in the DFTD-affected Tasmanian devil population would explain how a tumour 
allograft could be transferred between unrelated devils. Lack of genetic diversity allowing for allograft 
acceptance needs to be tested in functional experiments to test whether this is the case with DFTD.  
Aim 3: To determine whether artificial immunity against DFTD can be induced in 
Tasmanian devils. 
One of the main foundations in the control of infectious disease is prevention through vaccination of the 
host. Devil Facial Tumour Disease has devastated the devil population in Tasmania and immediate 
measures have to be taken to prevent extinction. The production of an effective immunogen would 
greatly enrich the few tools available to control DFTD.  
Aim 4: To determine whether natural immunity is present in the free-living 
Tasmanian devil population. 
Unusually for an infectious disease, no signs of resistance against DFTD have been found in the wild. 
However, in an area of western Tasmania, DFTD appears to be spreading in a much slower rate than in 
other eastern areas of the island. The finding of natural resistance against DFTD would be the ideal case 
scenario for the future of a viable free-living Tasmanian devil population. 
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2.1 – Commonly used reagents, disposables and equipment 
Details of the reagents, disposables and equipments with the suppliers, catalogue and 
model numbers used in this thesis are recorded in Table 2.1, 2.2 and 2.3. 
Table 2.1: Commonly used reagents. 
Reagent Supplier Catalogue number 
Acetic acid glacial BDH AnalaR Prod 10001 
3-Aminopropyltriethoxysilane (APTS) Sigma-Aldrich A3648 
Ammonium sulphate BDH AnalaR Prod 10033 
Antibody diluent Dako S0809 
Bovine serum albumin (BSA), cell 
culture grade CSL Limited 52090201 
Chlorexidine and cetrimide irrigation Pfizer DH 89 
51Chromium (Na251CrO4) Amersham CJS.4 
Citric acid Sigma-Aldrich C2404 
Clarion mounting medium Sigma-Aldrich C0487 
Compound Sodium Lactate 
(Hartmann’s solution) Baxter Viaflex® AHB 2325 
Concanavalin A (Con A) Sigma-Aldrich C 7275 
Diaminobenzidine (DAB) solution Dako K3466 
Dimethyl sulfoxide (DMSO) Sigma-Aldrich D-5879 
Eosin Sigma-Aldrich 2853 
Ethanol BDH AnalaR 28304.7K 
Fast-cal® decalcifier FRONINE UN Nº1760 
Foetal calf serum (FCS) Gibco 1099-141 
Formaldehyde Sigma-Aldrich 533998 
Formalin, 10% neutral buffered Sigma-Aldrich F5554 
Fluorescein isothiocyanate (FITC) Sigma-Aldrich F-7250 
Fluorescent mounting medium DakoCytomation S3023 
Freunds complete adjuvant Sigma-Aldrich F-5881 
Freunds incomplete adjuvant Sigma-Aldrich F-5506 
Gentamicin injection Pfizer 61022010 
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Reagent Supplier Catalogue number 
Gentian violet BDH AnalaR 17635 
Glucose Sigma-Aldrich G5400 
Haematoxylin Sigma-Aldrich 2852 
Haem Kwik® stain HDS Scientific Supplies R1C14 
Histopaque - 1077® Sigma-Aldrich 10771-100 
Histopaque - 1119® Sigma-Aldrich 11191-100 
Horse blood, defibrinated Oxoid SR0050 
Hydrochloric acid (HCl) APS Finechem A9G009 
Hydrogen peroxide, 30% w/w BDH AnalaR 10366 
Isofluorane® 1mL/mL VCA-Veterinary Companies of Australia AUST R 29562 
Lead nitrate Sigma-Aldrich L-6258 
L-glutamine Sigma-Aldrich G7513 
Lippopolysaccharide (LPS) Sigma-Aldrich L 4391 
Liquid scintillation cocktail Amersham Pharmacia Biotech NBCS104 
LSAB+ System-HRP Dako K0690 
Methanol APS Finechem H9LI28 
Montanide adjuvant essai 70M10 
645101 Seppic L 13206 
Montanide adjuvant essai gel 639101 Seppic 22118 
Montanide adjuvant ISA 51 VG Seppic 36362Z 
Montanide adjuvant ISA 763 A VG Seppic T52571 
Montanide adjuvant ISA 775 VG Seppic 02506 
Nitro blue tetrazolium (tablets) Sigma-Aldrich N-5514 
Nutrient broth Remel 454202 
Osmium tetroxoid (OsO4) PST ProSciTech C010 
Protein assay dye reagent  BIO-RAD 500-0006 
Permanent mounting medium Dakocytomation S3026 
Phorbol, 12-myristate 13-acetate 
(PMA) Calbiochem® 524400 
Phosphate buffered saline (PBS) tablet Oxoid BR0014G 
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Reagent Supplier Catalogue number 
Phytohaemagglutinin (PHA) Sigma-Aldrich L 9132 
PIPES powder Sigma-Aldrich P6757-500G 
Pokeweed mitogen (PWM) Sigma-Aldrich L 9379 
Propidium iodide Sigma-Aldrich P4170-100MG 
Propylene oxide BDH Prod 282904W 
Roswell Park Memorial Institute 1640 
medium (RPMI) CSL Limited 05182301 
Safranin Sigma-Aldrich S - 8884 
Sodium azide (NaN3) BDH AnalaR 301112G 
[methyl-3H]Thymidine Amersham Pharmacia Biotech TRA 310 
Toluidine blue 1% solution SERVA 36693 
Triton X 100 Sigma-Aldrich T6878 
Trypan blue Sigma-Aldrich T6146 
Uranyl acetate BDH 30550 
Xylene M & B Pronalys L864 
 
Table 2.2: Commonly used disposables. 
Product Supplier Catalogue number 
Centrifugal filter device Centricon Ultracell YM-100 
10 mL Centrifuge tube LabServ LBSCT 1203X 
50 mL Centrifuge tube Corning 430291 
Cotton wool bandage Smith+Nephew Soffban Natural 
Coverslip Deckglaser 22 X 22 mm 
Elastic bandage 3M 3MTMVetrapTM Bandaging tape 4’ 
Electron microscope film Kodak 4489 
Endotracheal tube 4 mm Emerham technologies ETT/1003 
Eppendorf tube Eppendorf 0030 125.150 
Filter paper Skatron Instruments 11731 
5 mL Graduated pipette Falcon 357543 
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Product Supplier Catalogue number 
10 mL Graduated pipette Falcon 356551 
10 mL Lithium heparin tube BD Vacutainer LH-367526 
Microscope slide Livingstone 7105-PPA 
Needle 21G Terumo 21GX1 1/4” 
Paediatric laryngeal mask number 2 Stiefel CE 0123 
0.1-20 µL Pipette tips Eppendorf 0030.000.838 
2-200 µL Pipette tips Eppendorf 0030.000.870 
50-1000 µL Pipette tips Eppendorf 0030.000.919 
10 mL Plain tube BD Vacutainer CAT-367895 
Plastic slide rack Ted Pella Inc 21078 
Protein A antibody purification kit Sigma-Aldrich PURE1A-1KT 
Punch biopsy 4 mm Stiefel CE 0120 
96 Round-bottomed well microplate 
with lid 
IWAKI 3870-096 
70 mL Sterile container BioLab LBS30002B 
2mL Sterile cryovial  IWAKI 2712-002 
Sterile transfer pipette SAMCO 225-15 
Surgical glue Johnson&Johnson Dermabond ProPen 
1 mL Syringe BD W12087 
10 mL Syringe Terumo SS10ESA 
T25 Tissue culture flask Greiner 690160 
T75 Tissue culture flask IWAKI 3110-075 
Tissue cassette National Scientific Supply Company Inc H-CG360 
96 V-bottomed well microplate Greiner bio-one 651101 
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Table 2.3: Commonly used equipment. 
Product Supplier Model number 
Autoclave Atherton Centenary Series 
Automated counter Technicon H2 counter 
Automatic cell harvester Skatron Combi 11025 
Automatic coverslipper Leica CV 5030 
Autostainer DakoCytomation AutostainerPlus 
Bench top centrifuge Sorvall® RT 6000D 
Bench top microcentrifuge Eppendorf 5415D 
Class II biological safety cabinet Gelman Sciences BH-204 
Confocal microscope Optiscan F900e 
Cytocentrifuge Thermo Electron Shandon Cytospin 4 
Dermatome knife Downs Surgical HG 165-01 
Digital camera Canon Powershot G3 
Digital microscope camera Diagnostic Instruments SPOT 241026 
Digital microscope camera Hamamatsu ORCA-ER 
Digital microscope camera Leica DFC320 
Electron microscope Philips 
CM 100 
Transmission electron 
microscope 
Flow cytometer Coulter EPICS Elite ESP 
Fluorescent microscope Leica DMLB2 
– 80°C Freezer Sanyo MDF-U50V 
Gammamaster automatic gamma 
counter LKR Wallac 1277 
Haemocytometer Hawksley 748 
Haematoxylin and eosin autostainer Leica Jung Autostainer XL 
Incubator Flow Laboratories 220 
Laryngoscope set Narang Medical Limited CE 0434 
Light microscope Leica DM2500 
Light microscope Olympus BX50 
Liquid scintillation counter Pharmacia 1214 Rackbeta 
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Product Supplier Model number 
Milli-Q® water Biocel QGARDOORI 
Milli-RO® water Biocel RPOGONPO2 
Microplate reader BIO-RAD Model 3550 
Microtome Leica RM 2255 
pH meter inoLab pH Level 1 
Platform mixer Ratek Instruments OM8 Orbital 
Portable anaesthetic machine AAS-Advanced Anaesthesia Specialists Stinger ST 205 
Portable gamma counter Neomedix Systems Series 900 Mini L 
Portable pulse oxymeter VetQuip OxiMax N-65 
Pressure cooker Russel Hobbs - 
Radiometer International Light Inc. IL-1700 
Scanner Epson 2450 Photo 
Scanning Confocal Krypton-Argon 
Microscope Optiscan 900e 
Small animal clippers Oster Corporation A5-00 
Thermometer Brannan 76 mm Immersion 
Ultra-microtome Leica Reichert Ultracuts 
Vacuum pump GEC Machines Ltd. BS2212 
Waterbath Leica H11210 
2.2 – Solutions  
2.2.1 – APTS solution 
 APTS    8 mL 
 Acetone   400 mL 
APTS was dissolved in acetone by inversion in a beaker. The solution was prepared a 
maximum of 10 minutes before use. 
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2.2.2 – Citrate retrieval buffer 
 Trisodium citrate  2.94 g 
 Milli-Q® water  1000 mL 
 Citric acid  
Trisodium citrate was dissolved in 900 mL of Milli-Q® water using a magnetic stirrer. 
The pH was adjusted to 6.0 with citric acid, and the volume adjusted to 1000 mL using 
Milli-Q® water. The solution was stored at room temperature. 
2.2.3 – Complete culture medium 
 RPMI 1640    450 mL 
 Heat inactivated FCS   50 mL 
 L-glutamine    5 mL (final 2 mM) 
 Gentamicin    375 µL (final 30 µL/mL) 
Under sterile condition, the RPMI 1640 medium was supplemented with the above 
solution and mixed by inversion. The solution was stored at 4ºC. 
2.2.4 – FACS fix solution 
 Formaldehyde    13 mL 
 Glucose    10 g 
 NaN3     1.5 mg 
 PBS     500 mL 
Formaldehyde, glucose and sodium azide were dissolved in PBS using a magnetic 
stirrer. The solution was stored at 4ºC. 
2.2.5 – 1% fluorescein isothiocyanate (FITC) 
 PBS     1 mL 
 FITC     10 mg 
FITC was dissolved in PBS by vortexing. The solution was stored at 4ºC and protected 
from light. The solution was used within 30 days of preparation.  
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2.2.6 – Freezing medium 
 FCS     90 mL 
 DMSO     10 mL 
Heat inactivated FCS was mixed with DMSO by inversion, and aliquoted into sterile 
10 mL tubes. The solution was stored at –20ºC. 
2.2.7 – Heat inactivated foetal calf serum (FCS) 
FCS was thawed at room temperature and heated for 1 hour at 57ºC. Aliquots were 
stored into sterile 10 mL and 50 mL tubes at –20ºC. 
2.2.8 – Hydrogen peroxide block 
 30% w/v hydrogen peroxide  500 µL 
 Milli-Q® water   50 mL 
Hydrogen peroxide and Milli-Q® water were mixed by inversion. The solution was 
prepared immediately prior to use. 
2.2.9 – Incomplete culture medium 
RPMI 1640    500 mL 
 L-glutamine (2 mM)   5 mL 
 Gentamicin (30 µL/mL)  375 µL 
Under sterile conditions, the RPMI 1640 medium was supplemented with the above 
solutions and mixed by inversion. The solution was stored at 4ºC. 
2.2.10 – Mitogens 
For each mitogen, the dehydrated powder was dissolved in RPMI 1640 under sterile 
conditions, and 200 µL aliquots were stored at –20ºC. When required, the solution was 
thawed and diluted to the required concentration. Table 2.4 summarises the 
concentration of stock and working solutions for each used mitogen. 
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Mitogen 
Concentration 
of stock 
solution 
Concentration 
of working 
solution 
Concanavalin A (Con A) 5 mg/mL 50 µg/mL 
Lippopolysaccharide 
(LPS) 1 mg/mL 25 µg/mL 
Phytohaemagglutinin 
(PHA) 5 mg/mL 100 µg/mL 
Pokeweed mitogen (PWM) 40 µg/mL 2 µg/mL 
Table 2.4: Concentration of stock and working solutions for each used mitogen. 
2.2.11 – Nitroblue tetrazolium (NBT) stock solution 
 PBS     1 mL 
 NBT     10 mg 
NBT tablet was dissolved in PBS by vortex mixing. The solution was prepared 
immediately prior to use.  
2.2.12 – NBT solution 
 Incomplete medium   1500 µL 
 NBT stock solution   300 µL 
 PMA     0.2 µg 
NBT and PMA were added to incomplete medium and mixed by vortexing for 
immediate use.  
2.2.13 – Nutrient broth 
 Milli-Q® water   1000 mL 
 Nutrient broth powder  8 g 
The powder was dissolved in Milli-Q® water and autoclaved for 20 minutes at 121ºC 
and 1 atmosphere of pressure. After cooling to approximately 60ºC, the broth was 
poured in sterile glass tubes under sterile conditions and stored at 4ºC. 
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2.2.14 – PBS / BSA / NaN3 
 PBS     490 mL 
 BSA     10 g 
 NaN3     0.25 g 
Using a magnetic stirrer, NaN3 and BSA were dissolved in PBS. The solution was 
stored at room temperature.  
2.2.15 – Phorbol myristate acetate (PMA) 
 Incomplete medium   10 mL 
 PMA     5 mg 
PMA was diluted in incomplete medium and aliquots of 20 µg/mL were frozen at −20ºC 
in Eppendorf tubes.  
2.2.16 – Phosphate buffered saline (PBS) 
 NaCl     8.00 g 
 KCl     0.20 g 
 Na2HPO4    1.44 g 
 KH2PO4    0.24 g 
 Milli-Q® water   1000 mL 
Using a magnetic stirrer, the reagents were dissolved in 950 mL of Milli-Q® water. The 
pH was adjusted to 7.3 and the volume adjusted to 1000 mL. The solution was 
autoclaved and stored at room temperature. This solution was used in experiments  
Alternatively, for cell culture work, PBS tablets were used: 
 PBS tablet    5 tablets 
 Milli-Q® water   500 mL 
Using a magnetic stirrer, the tablets were dissolved in the Milli-Q® water. The pH was 
adjusted to 7.3 and the solution was autoclaved and stored at room temperature. 
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2.2.17 – PIPES buffer 
 Milli-Q® water   250 mL 
 PIPES powder    15.12 g 
 Sucrose    6.25 g 
1N NaOH     
PIPES powder was added to 100 mL of Milli-Q® water in a beaker and mixed. 
1N NaOH was added dropwise to the solution until pH 7.3 was achieved and the 
volume was completed up to 250 mL with Milli-Q® water. 6.25 g of sucrose was mixed 
by inversion until the sucrose was dissolved. PIPES buffer (0.2 M) was stored at 4ºC for 
three months. When required, this solution was diluted in an equal volume of Milli-Q® 
water (PIPES 0.1 M).  
2.2.18 – Propidium iodide solution 
 PBS     10 mL 
 Propidium iodide   1 mg 
Propidium iodide powder was diluted in PBS by gentle mixing in a fume hood. The 
solution was stored at 4ºC and protected from light. 
2.2.19 – [methyl-3H]Thymidine solution 
 [methyl-3H]Thymidine  100 µL 
 Complete culture medium  900 µL 
Thymidine was added to complete culture medium in an Eppendorf tube and mixed by 
gentle inversion. The solution was prepared immediately prior to use and activity 
equivalent to 1 µCi was dispensed in each well. 
2.2.20 – Trypan blue solution 
 Trypan blue    25 µg 
 PBS     10 mL 
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Trypan blue was added to PBS and mixed using a magnetic stirrer. The solution was 
stored at room temperature. 
2.2.21 – Turk’s solution 
 PBS     48.5 mL 
 Glacial acetic acid   1.5 mL 
 Gentian violet    5 mg 
Acetic acid and gentian violet were added to PBS in a biological safety cabinet. The 
solution was stored at room temperature. 
2.3 – General procedures 
Common procedures used throughout the thesis are described here. Specific procedures 
are described in each individual chapter. 
2.3.1 – Cell culture 
2.3.1.1 – Tumour cell lines 
DFTD tumour cell lines were kindly donated by Ms Anne-Maree Pearse, from Mt. 
Pleasant Laboratories, Launceston (Department of Primary Industries and Water). 
Briefly, a piece of DFTD tumour (1 x 1 x 1 cm) was washed several times in sterile PBS 
supplemented with penicillin, streptomycin and amphotericin. Cells were disaggregated 
with a scalpel blade and the resultant solution was centrifuged at 300 g for 10 minutes. 
Cancer cells were cultured in complete culture medium in a humidified 5% CO2 
incubator at 35ºC (Pearse and Swift 2006).  
DFTD tumour cells were seeded into T25 or T75 culture flasks and assessed for 
confluence twice a week. Healthy DFTD tumour cells had a tendency to grow on the 
bottom of the flask, in ‘nests’ (Figure 2.1 A-F). When required, the tumour cells were 
harvested by vigorous flushing of the bottom of the flask using a sterile plastic pipette. 
These tumour cells would promptly be used for experiments described in Chapter 6, 
seeded into new flasks or frozen for future use. When overgrown, DFTD cell cultures 
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appeared with clumps of tumour cells floating in the culture medium (Figure 2.1 G-I) 
and would be discarded.  
K562 tumour cells were cultured in complete culture medium in T25 or T75 culture 
flasks, in a humidified CO2 incubator at 37ºC. Cells were checked for confluence twice 
a week. When required, cells would be split in two or more flasks with fresh culture 
medium or frozen for future use. 
2.3.1.2 – Freezing cells 
Cells to be frozen were centrifuged at 300 g for 10 minutes and the supernatant 
discarded. The tube containing the cell pellet was flicked vigorously to disaggregate the 
cells and was placed on ice. Approximately 2 mL of freezing medium was added 
dropwise while the tube was gently agitated. This solution was transferred to sterile 
cryovals and placed in a freezing box containing isopropyl alcohol. Cells were kept 
at −80ºC for short-term and then transferred to liquid nitrogen for long-term storage. 
This procedure was performed under sterile conditions. 
2.3.1.3 – Thawing cells 
Cells were thawed in a 37ºC water bath and then quickly transferred to a tube containing 
8 mL of complete culture medium. Cells were washed twice at 300 g for 10 minutes 
each time, to remove the DMSO. This procedure was performed under sterile 
conditions. 
2.3.2 – Animals  
2.3.2.1 – Animal ethics and other approvals 
The University of Tasmania Animal Ethics Committee and Tasmanian’s Park and 
Wildlife Services Animal Ethics Committee gave ethical approval for the use of all 
projects involving living animals. Department of Primary Industries and Water (DPIW) 
gave permission to collect road-killed Dasyurids. Table 2.5 summarises the approval 
number for each project. 
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Committee Approval number Project 
Tasmanian’s Park and 
Wildlife Services Animal 
Ethics Committee 
33/2004-5 and 
32/2005-6 
Bleeding Tasmanian devils for 
immunology research 
University of Tasmania 
Animal Ethics Committee A8830 
Production of rabbit polyclonal 
antisera against Tasmanian devil 
(Sarcophilus harrisii) serum 
immunoglobulin 
University of Tasmania 
Animal Ethics Committee A8877 
A study on the in vivo immune 
responses of the Tasmanian devil – 
Sarcophilus harrisii. 
University of Tasmania 
Animal Ethics Committee A9215 
Skin graft transplantation in 
Tasmanian devils (Sarcophilus 
harrisii) 
University of Tasmania 
Animal Ethics Committee A9491 
Immunisation of Tasmanian devils 
(Sarcophilus harrisii) with Devil 
Facial Tumour Disease (DFTD) 
tumour cells: potential as a vaccine. 
Department of Primary 
Industries and Water TFA 08088 
Permit to take threatened fauna for 
scientific purposes 
Table 2.5: Animal ethics approval for all projects involved in this research. 
2.3.2.2 – Free-living Tasmanian devils 
Free-living devils were caught in pipe traps designed for Tasmanian devil’s capture 
using sheep, wallaby or possum meat as bait (Figure 2.2 A-C). Devils were placed in a 
hessian bag and a complete examination of the mouth and face for signs of DFTD was 
undertaken (Figure 2.2 D-F). A 15-digit microchip was placed in the subcutaneous 
tissue of the neck of all captured devils and, to facilitate identification, devils used in 
this research were assigned a ‘TD’ number. Appendix 3 details the TD number, 
microchip number, origin, sex, age and disease status at the time of capture of all 
animals used in this study. Animals were anaesthetised for blood collection and released 
back into the wild after full recovery.  
A score from 0 to 5 was given to each Tasmanian devil, according to the gross physical 
appearance of lesion/s in the body. Table 2.6 summarises the DFTD status scoring 
system assigned to all animals. 
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DFTD status Gross appearance of lesion/s 
DFTD 0 No external sign of DFTD or abnormal scarring; 
DFTD 1 Presence of scar tissue, abscesses or wounds; 
DFTD 2 Lumps occurring anywhere on the body apart from facial area; 
DFTD 3 Tumour occurring around face/mouth and single lump/tumour 
DFTD 4 As DFTD 3, plus firm/solid feel, flat ulcerated surface and < 3 cm diameter 
DFTD 5 As DFTD 3, plus at least one tumour > 3 cm diameter and cut surface is solid, creamy/pale, nodular 
      Table 2.6: DFTD status and gross appearance of lesions on Tasmanian devils. 
2.3.2.3 – Captive Tasmanian devils 
Tasmanian devils were kept in captivity for two main purposes: first, for breeding as 
part of the ‘insurance’ population program held by DPIW and second, devils kept 
specifically for research. Devils kept as insurance population were utilised as source of 
blood for mitogen proliferation assays and/or mixed lymphocyte reactions, which 
required only a single blood collection. Tasmanian devils kept in captivity for research 
purposes were utilised in more invasive procedures, such as skin grafting and 
immunisation experiments. 
Captive devils were housed individually or in pairs in enclosures measuring 20 x 5 m 
containing logs and wooden boxes to mimic natural burrows (Figure 2.3 A). These 
devils were fed once a day with road killed wallaby or possum from non-diseased areas 
and water ad libitum.  
2.3.3 – Anaesthesia  
Devils were manually restrained and placed in a hessian bag by the devils’ keepers 
(Figure 2.3 B-C). General anaesthesia was induced via a non-rebreathing circuit and a 
disposable mask placed on the nose through the bag. The anaesthetic was vaporised 
with an oxygen flow in a portable anaesthetic machine (Figure 2.3 D). The anaesthetic 
drug of choice was Isofluorane®, which permitted quick recovery of the animal after 
the procedure. For short procedures, such as blood collection or immunisations, the 
devil was exposed to 5% isofluorane® for 3 to 5 minutes delivered at an oxygen flow 
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rate of 200 mL/Kg/min with a minimum of 1 L/min, after which the animal could be 
taken out from the bag. The anaesthesia was maintained with 2 to 3% of isofluorane® 
and depth of the anaesthesia was monitored through the blood oxygenation and heart 
rate measured by a portable pulse oxymeter. Absence of tension in the limbs, pedal 
withdraws and jaw tone were also monitored and used as parameters of depth of 
anaesthesia.  
For longer procedures (e.g. skin grafting), devils were pre-medicated with acepromazine 
(0.2 mg/Kg) and meperidine (1 mg/Kg) injected subcutaneously. Approximately twenty 
minutes after the pre-medication, general anaesthesia was induced as described above. 
Once the animal was unconscious, it was taken from the bag and the facial mask was 
substituted either by a paediatric laryngeal mask (number 2) or an endotracheal tube 
(4 mm), placed into the trachea with a laryngoscope after spraying xylocaine 1% on the 
larynx. The cuff of either tube was expanded with air to stabilize it into the trachea. 
Depth of anaesthesia was monitored as described above. 
2.3.4 – Blood collection 
Blood was collected from Tasmanian devils using a 10 mL syringe and a 21 G needle. 
The anaesthetised devil was placed on its back with a rolled towel underneath the neck, 
which helped to push the jugular vein ‘forward’ (Figure 2.3 D). The needle was inserted 
in the cranial jugular, which is located in a groove lateral to the sternohyoideous muscle 
belly, about 10 mm deep. Five to 10 mL of blood was collected each time and 
immediately transferred to plain tubes (for serum harvesting) and/or tubes containing 
lithium heparin (for lymphocyte and/or neutrophil harvesting) and kept at room 
temperature until arrival at the laboratory (Figure 2.3 E-F).  
2.3.5 – Production of rabbit anti-devil immunoglobulin 
Two rabbits from the breeding colony of the Central Animal House of the University of 
Tasmania were used for anti-devil immunoglobulin (Ig) production. Devil serum Igs 
were isolated from the peripheral blood of four healthy captive devils using ammonium 
sulphate precipitation (Delves 1996). Pooled serum was diluted in an equivalent amount 
of sterile PBS and stirred slowly while saturated ammonium sulphate solution was 
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gradually added until a concentration of approximately 40%. This solution was stirred at 
4ºC for one hour, centrifuged at 4ºC three times for 30 minutes at 10000 g and the 
supernatant removed. The resultant pellet was washed, resuspended in PBS and 
centrifuged for six hours at 15000 g through a centrifugal filter device (Ultracell YM-
100) with pore size of 100 kDa. The rabbits were immunised subcutaneously with 
400 µg of the resultant precipitate in Freunds complete adjuvant and then boosted with 
the same amount of precipitate in Freunds incomplete adjuvant three and six weeks 
later. Seven days after the last immunisation, the rabbits were anaesthetised and 
euthanased by exsanguination. Clotted blood was centrifuged at 1000 g for 10 minutes 
and the serum was aliquoted and stored at −20ºC until use. 
Rabbit anti-devil Igs were purified by affinity chromatography using a Protein A 
antibody purification kit. Hyper-immune rabbit serum was mixed with twice the volume 
of binding buffer and passed slowly through a regenerated cartridge containing the 
Protein A. The bound rabbit IgG was washed from the Protein A cartridge with the 
elution buffer. 
The eluate containing the purified immunoglobulins was assessed for the concentration 
of protein content using a Bradford assay. Ten microliters of double-dilutions of the 
purified rabbit IgG were placed into separate microtitre plate wells (in triplicates) and 
mixed with 200 µL of protein assay dye reagent (diluted 1:5 with Milli-Q® water). 
Doubling-dilutions of a solution of bovine serum albumin at 31.5 to 500 µg/mL were 
similarly prepared and used as a standard curve. Plates were left to incubate for at least 
one hour and absorbance at 595 nm was read using a microplate reader.  The protein 
content of the rabbit IgG could then be calculated.   
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3.1 – Introduction 
The immune system of vertebrate animals is composed of a variety of organs, tissues 
and cells responsible for the immune response. The first step to understand the immune 
function of the Tasmanian devil is to reveal the structural components of its immune 
system. There is a lack of basic knowledge about the cellular constituents and 
histological architecture of the lymphoid organs of this species. Descriptions of the 
lymphoid tissues of four small Dasyurids, the brown and dusky antechinus (Antechinus 
stuartii and A. swainsonii), the stripe-faced dunnart (Sminthopsis macroura) and the 
red-tailed phascogale (Phascogale calura), have been published (Poskitt et al. 1984a; 
Poskitt et al. 1984b; Poskitt et al. 1984c; Old and Deane 2003b; Old et al. 2003b, a, 
2004; Old et al. 2006) and provide important data about this group. Basic information 
about the immune tissues of the Tasmanian devil, however, is required to understand the 
adaptive immune response and its implications for the pathogenesis of DFTD.  
Since the late 1980’s it has been possible to label cells of the immune system from 
marsupial species using antibodies raised against highly conserved peptide sequences 
associated with T- and B-lymphocytes (Mason et al. 1989). In this chapter, these 
antibodies were used to label T- and B-cells of Tasmanian devils in the lymphoid tissues 
and DFTD tumours. In addition, an antibody against the α chain human HLA-DR, 
previously described to react against the homologous region in marsupial cells 
(Coutinho et al. 1994; Coutinho et al. 1995), was used to identify antigen presenting 
cells (MHC II+) in the above tissues of Tasmanian devils and DFTD tumours. 
The aims of this chapter were: 1) to describe the major features of the lymphoid organs 
of healthy Tasmanian devils (i.e. devils not affected by DFTD); 2) to analyse the 
lymphoid tissues of diseased devils and provide an indication of pathological changes 
associated with DFTD; 3) to analyse DFTD tumours and metastases for the presence of 
immune cells and 4) to assess whether DFTD tumour cells express MHC II at the cell 
surface level. Analyses of lymphoid tissues of healthy and DFTD-affected devils 
provide structural evidence for a capacity to mount an effective adaptive immune 
response and possible alterations related with the disease. Furthermore, the presence or 
absence of immune cellular components in DFTD tumours will characterise the 
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structural elements of the immune response against DFTD. In addition, it has been 
shown that DFTD tumour express MHC II at mRNA levels (Siddle et al. 2007). 
However, it still remains unknown whether this translates to a functional expression of 
the protein. The use of an antibody directed to MHC II will determine whether DFTD 
tumour cells express MHC II proteins.  
3.2 – Methods 
3.2.1 – White blood cell analyses 
3.2.1.1 – Tasmanian devils used for white blood cell analyses  
Blood that had been collected from devils for mitogen assays (Chapter 4) was analysed 
for white blood cells. Eleven healthy Tasmanian devils (six captive and five free-living) 
and 18 DFTD-affected devils (seven animals with small tumours and 11 with large 
tumours) were included in this study. Although most tumours were irregular in shape, 
an attempt to establish the approximate tumour size (and consequently the stage of 
disease) was made by calculating the tumour volume using the formula: 
Tumour volume (cm3) = π x (width x length x thickness/3)/2 
This formula is commonly used for measurement of tumours transplanted in mice 
(Pinthus et al. 2000) and gives the dimension of the tumour in cm3. When more than 
one tumour was present, the sum of all individual tumours was calculated to indicate the 
final tumour volume. Tumours were considered small if the total volume was equal to, 
or smaller than, 75 cm3 and large if larger than 75 cm3. 
3.2.1.2 – White blood cell count  
On arrival of samples, a volume of 500 µL of heparinised whole blood was analysed for 
white blood cell counts in an automated counter (Technicon H2 Automated Counter) 
and a blood smear was prepared. Air-dried blood smears were fixed in methanol for 
1 minute and stained with buffered eosin (40 seconds) and phosphate buffered azure B 
(1 minute) (Haem Kwik® stain).  
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3.2.1.3 – Electron microscopy images 
Electron microscopy processing of cells and tissues was performed by Ms Helena 
Coles, Department of Anatomical Pathology, Royal Hobart Hospital. For representative 
ultra-electron microscopy micrographs of cells of the immune system, two different 
sources of cells were used: for neutrophils, the buffy coat from whole blood of a healthy 
Tasmanian devil was used. For lymphocytes and monocytes (macrophages), the spleen 
of a healthy devil was fixed and processed as described below.  Samples were washed 
several times in 0.1M PIPES buffer, pH 7.3 before being post-fixed in 1% osmium 
tetroxide (OsO4) made up in 0.1M PIPES buffer for 1 hour.  Following post-fixation, 
samples were again washed in PIPES buffer before being en bloc stained with 
5% alcoholic uranyl acetate for 1 hour.  Samples were then dehydrated through a series 
of increasing concentrations of alcohol (70%-100%), cleared in propylene oxide, 
infiltrated and embedded into Procure 812 resin.  Survey sections (1 µm) were cut on an 
ultra-microtome and stained with toluidine blue until a region of interest was found and 
ultrathin sections (70-90 nm) were then cut using a diatome diamond knife and placed 
into copper/paladium electron microscopy 200 hexagonal mesh grids.  Sections were 
then stained with uranyl acetate and lead citrate and viewed using a Philips CM100 
transmission electron microscope.  Electron micrographs were photographed on 1 1/3" x 
4" film and scanned using an Epson Perfection 2450 Photo scanner. 
3.2.1.4 – Data and image analysis 
Statistical analysis was performed using Excel program and Student’s t test. Images of 
the white blood cells were acquired from the blood smears using a Leica DM 2500 
microscope and representative micrographs were obtained with an ADCIS Spot Insight 
digital camera and Image-Pro® Plus 5.1 program. Final figures were prepared using 
Photoshop CS3. 
3.2.2 – Histology and immunohistochemistry 
3.2.2.1 – Tasmanian devils used as source of tissues 
Tasmanian devils have been classified as ‘endangered’ under the Tasmanian Threatened 
Species legislation and access to devils’ tissues is under strict regulation. Consequently, 
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the number of healthy devils used in this study was limited. Sporadic opportunistic 
events, for example, road-related trauma, provided an important avenue to source study 
material. 
Seven healthy Tasmanian devils were collected over a period of two years. Four devils 
were recently killed wild animals that had sustained road-related trauma. Two captive 
devils were included in this study, one that died of hypoxia under anaesthesia (TD 113) 
and another that was euthanased due to age-related spinal degeneration (TD 73). A 
pouch young (approximately three weeks old) was euthanased when its dam required 
euthanasia due to advanced DFTD.  
In addition, 12 Tasmanian devils visibly affected by DFTD lesions were collected for 
this aspect of the study. Nine carcasses were from devils euthanased following a 
long-term study to assess the effect of removing DFTD-affected devils from an isolated 
area (‘suppression trial’), undertaken at the Forestier Peninsula, south east of Tasmania 
(Jones et al. 2007). In addition, two devils were euthanased as a result of a metastases 
related illness (TD 74 and TD 61) and one devil was killed in a road accident (TD 68). 
Tasmanian devils used in this study were divided into three groups:  
1) Healthy Tasmanian devils with no visible signs of DFTD; 
2) DFTD-affected Tasmanian devils with small tumours (total tumour volume 
of ≤ 75 cm3) and no signs of metastases, representing early DFTD lesions; 
3) DFTD-affected Tasmanian devils with tumour volume of > 75 cm3 and/or 
metastases, representing more advanced DFTD lesions.  
Table 3.1, 3.2 and 3.3 summarise the disease status, sex and age, brief description of 
gross pathology and material collected for each animal used for the histology and 
immunohistochemistry studies. 
3.2.2.2 – Tissues 
Animals were necropsied at varying times after death. All devils killed in road accidents 
selected for this study were necropsied and tissues fixed as soon as possible. Euthanased 
devils were necropsied within two to four hours after death. Lymphoid tissues (spleen, 
peripheral lymph node, thymus, bone marrow, tonsil), DFTD tumours, metastases and 
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the whole pouch young were collected and fixed in 10% buffered formalin for between 
two days and four weeks. The pouch young was divided longitudinally and each portion 
was serially sectioned for haematoxylin and eosin (H&E) staining. Only thymic tissue 
was analysed in the pouch young. Thymus was analysed only in devils from Group 1. 
Mucosa-associated lymphoid tissue (MALT) and bone marrow were analysed only in 
devils from Groups 2 and 3 because these tissues were only available from some of the 
animals in these two groups. For bone marrow analyses, a small piece of bone (sternum, 
rib or a section from a long bone) was fixed in formalin for at least 24 hours and than 
decalcified in a solution of hydrochloric acid (Fast-cal® decalcifier) for 12-24 hours. 
Tissues were processed, embedded in paraffin blocks and sectioned (3 µm thickness) 
onto 3-aminotriethoxysilane-coated slides. Sections were deparaffinised in xylene and 
rehydrated through graded alcohol solutions to water. Four sections were stained using a 
standard H&E staining technique for histological examination and coverslipped on an 
automated coverslipper, performed by the Royal Hobart Hospital Anatomical Pathology 
Department. Ten to 12 slides were used for immunohistochemistry. 
3.2.2.3 – Immunohistochemistry  
Preferred tissue sections were treated with specific antibodies: rabbit anti-human CD3 
(for T-cells), rat anti-human CD79b (for B-cells) and mouse anti-human HLA-DR (for 
MHC II+ cells, such as B-cells, macrophages and dendritic cells), as described in 
Table 3.4. Selected tissues were labeled with mouse anti-human LSP1 (for leukocytes). 
The pouch young sections were labeled only with the anti-T and B-cell antibodies. 
Negative controls included sections labeled with mouse universal negative control, 
mouse IgG1 negative control, rabbit Ig fraction and sections labeled without the primary 
antibody (replaced with phosphate buffered saline). Positive controls consisted of 
canine (Canis lupus familiaris) lymph node, koala (Phascolarctos cinereus) 
gut-associated lymphoid tissue and lymph node of Eastern quoll (Dasyurus viverrinus). 
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Antibody Source Cell specificity Dilutions 
Polyclonal rabbit anti-
human CD3 Dako (A0452) T-lymphocytes 1:800 
Monoclonal rat anti-
human CD79b Serotec (MCA 2209) B-lymphocytes, plasma cells 1:500 
Monoclonal mouse 
anti-human HLA-DR Dako (M0746) 
Antigen presenting cells 
(dendritic cells, macrophages, 
B-lymphocytes, activated 
T-lymphocytes) 
1:100 
Monoclonal mouse 
anti-human LSP1 
(culture supernatant) 
Dr Jacqueline Cordell 
University of Oxford 
Bone marrow derived cells of 
myeloid and lymphoid origin 
(neutrophils, macrophages, 
lymphocytes, etc) 
1:40 
Table 3.4: Source of antibodies, target antigen and dilutions used. 
Tissue sections were deparaffinised in xylene and rehydrated through graded alcohol 
solutions to water as described above and boiled in citrate buffer solution (pH 6) in an 
electric pressure cooker for 10 minutes at medium heat. Slides were left to cool to 35ºC 
and placed on an autostainer (Dako Autostainer Universal Staining System) (Baszler et 
al. 2006). The autostainer was programmed to quench endogenous peroxidase activity 
by incubating sections with a solution of 3% H2O2 for 15 minutes and block non-
specific protein binding with 10% horse serum or 5% bovine serum albumin for 
30 minutes. The antibodies were diluted with an antibody diluent (Dako S0809) and the 
required concentrations of primary antibodies were placed onto the slides for 
60 minutes. Primary antibody binding was detected with a commercial kit (LSAB 
kit-Dako K0690), which was designed to react with primary antibodies from several 
species and was composed of a biotinylated link universal and a streptavidin-
horseradish peroxidase conjugate. The biotinylated link universal was added to the 
section for 30 minutes, which bound to the primary antibody. The next step was to add 
the streptavidin-horseradish peroxidase conjugate for 30 minutes, which bound to the 
biotinylated link. A solution of diaminobenzidine was placed onto the slides for five 
minutes to allow for brown colour development of positive cells and then washed with 
distilled water. Sections were counterstained with haematoxylin for 40 seconds, 
dehydrated through graded alcohol solutions to xylene and coverslipped.  
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3.2.2.4 – Toluidine blue staining 
Selected lymph node sections were stained with toluidine blue for mast cell 
characterisation. Sections were deparaffinised and rehydrated as described above, and 
1% aqueous toluidine blue solution was filtered directly onto sections and incubated for 
four minutes. Sections were then rinsed in distilled water, dried and coverslipped 
(Carson 1990).  
3.2.2.5 – Analysis 
Sections were visually analysed using a Leica DM 2500 or an Olympus BX50 
microscope and representative micrographs were obtained either with an ADCIS Spot 
Insight digital camera and Image-Pro® Plus 5.1 program or a Leica FireCam DFC320 
camera.  
3.3 – Results 
3.3.1 – White blood cell counts 
A significant difference in the total white blood cell count (TWBCC) was observed 
between most groups (Figure 3.1 A). The exception was healthy free-living devils. 
Although this group had a higher TWBCC compared to healthy captive animals, the 
difference was not significant. However, all healthy devils had a consistently lower 
TWBCC compared to DFTD-affected devils with either small or large tumours. The 
significance increased when comparing all groups with DFTD-affected devils with large 
tumours.  The higher TWBCC was predominantly due to an absolute neutrophilia 
compared to healthy devils.  
Analyses of neutrophil counts (Figure 3.1 B) revealed that the high TWBCC in the 
diseased animals was due to a significant increase in neutrophils. DFTD-affected 
animals with large tumours had more than four times the number of neutrophils than 
healthy devils. In contrast, diseased devils had lower lymphocyte numbers than healthy 
devils. Although this difference was not as marked as the neutrophil count, there was a 
significant lower number of lymphocytes in DFTD-affected devils with large tumours 
compared to healthy captive devils (Figure 3.1 C) 
Figure 3.1. Total and differential white blood cell counts in healthy (non DFTD-
affected) captive and free-living Tasmanian devils and DFTD-affected Tasmanian 
devils with small and large tumours.  
 
A: Total white blood cell count (TWBCC) amongst the different groups. Healthy 
captive devils had the lowest values compared to all other groups. DFTD-affected devils 
with large tumours had the highest values.  
B: Total neutrophil (mature and immature) counts amongst the different groups. Healthy 
captive devils had the lowest values compared to all other groups. DFTD-affected devils 
with large tumours had the highest values.  
C: Lymphocyte counts amongst the different groups. Healthy captive devils had the 
highest values compared to the other groups. DFTD-affected devils had the lowest 
values, although this difference was significant only when compared to healthy captive 
devils.  
 
Significant differences between groups are represented as asterisks; p values are 
represented as below: 
* p < 0.05 
** p < 0.01 
*** p < 0.005 
**** p < 0.001 
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Other cell types (monocytes, eosinophils and basophils) did not vary greatly in number 
in the different groups. Of significance was the finding that only devils with large 
DFTD tumours had young banded neutrophils in the circulation. Table 3.5 shows the 
absolute number and ranges of white blood cells in the analysed Tasmanian devils. 
Table 3.6 shows the relative number of white blood cells in the analysed devils. 
  
Healthy captive 
devils 
 n=6 
Healthy free-living 
devils 
 n=5  
DFTD-affected 
devils with small 
tumours 
 n=7  
DFTD-affected 
devils with large 
tumours  
n=8  
TWBCC 9.1±1.7 (6.7-10.7) 
10.3±3.1 
(6.3-13.9) 
14.5±3 
(10.1-18.7) 
25.4±7.1 
(14.3-30.1) 
Neutrophils 2.8±0.9 (1.8-4.2)  
4±1 
(2.7-5.4) 
9.3± 3.7 
(3.5-12.6) 
21.5±6.4 
(12.6-23.7) 
Banded 
neutrophils - - - 
1.6±0.8 
(0-2.4) 
Lymphocytes 4.4±1.3 (2.2-6.1) 
3.3±1.7 
(1.4-6.0) 
3±1.3 
(1.8-5.7) 
2±1.4 
(0.8-5.8) 
Monocytes 1.4±0.6 (0.5-2.2) 
1.4±0.4 
(1.1-2.0) 
0.8±0.4 
(0.3-1.6) 
1.58±0.9 
(0.6-3.1) 
Eosinophils 0.04±0.04 (0-0.1) 
0.04±0.02 
(0-0.7) 
0.06±0.09 
(0-0.2) 
0.08±0.04 
(0-0.1) 
Basophils 0 0 0.2±0.2 (0-0.2) 
0.16±0.03 
(0-0.1)  
Table 3.5: Absolute differential white blood cells of healthy captive Tasmanian devils, healthy free-
living devils and DFTD-affected devils with small and large tumours. Mean values 
(109/L), ± standard deviations and numbers of devils examined (n) are demonstrated. Ranges for 
the examined devils are shown in brackets. 
 
Healthy captive 
devils  
n=6 
Healthy free-living 
devils  
n=5 
DFTD-affected 
devils with small 
tumours  
n=7 
DFTD-affected 
devils with large 
tumours  
n=8 
Neutrophils 33±14 41±10 63±16 77±10 
Banded 
neutrophils - - - 6±3 
Lymphocytes 49±10 31±8 23±13 9±7 
Monocytes 15±0.6 15±4 5±2 11±6 
Eosinophils 0.5 0.4 0.4 0.3 
Basophils 0 0 1.4±1.3 0.1  
Table 3.6: Relative differential white blood cells of healthy captive Tasmanian devils, healthy free-
living devils and DFTD-affected devils with small and large tumours. Mean values, ± standard 
deviations and numbers of devils examined (n) are shown as percentages. 
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3.3.2 – Leukocyte morphology and ultra-structure 
The morphological appearance of the various types of mature white blood cells of 
Tasmanian devils in blood smears is illustrated in Figure 3.2 A-D. Neutrophils 
demonstrated eosinophilic cytoplasm and highly segmented nuclei, sometimes with a 
‘donut’ shape. Lymphocytes appeared as smaller cells, with little cytoplasm and nuclei 
intensely basophilic stained. Monocytes appeared as large cells with irregular shaped 
nuclei and eosinophils as small cells with eosinophilic cytoplasm and characteristic 
bilobed nuclei. The morphological appearance of the white blood cells of Tasmanian 
devils did not show differences to those of other marsupials. 
Figure 3.3 A-D illustrates the ultra-structural outline of cells of myeloid and lymphoid 
origin of the blood and spleen of the Tasmanian devil. Neutrophils presented with 
numerous primary and secondary granules in the cytoplasm, which were identified 
according to size. Mitochondria were frequently seen in the cytoplasm. Lymphocytes 
were observed in groups in the spleen, with rounded nuclei and little cytoplasm. 
Macrophages were observed in irregular shapes, with cytoplasmatic projections, 
numerous mitochondria and, sometimes, large phagosomes, providing evidence for 
capable immune function.  
3.3.3 – Histology and immunohistochemistry 
3.3.3.1 – Control tissues 
Negative controls (tissue sections labeled with mouse IgG1 and rabbit IgG) showed 
some non-specific labeling around the perimeter of most tissues, predominantly 
capsular cells (presumed mesothelial) from most organs, but no lymphoid cells were 
labeled (Figure 3.4 A).  The absence of primary antibody resulted in no labeling. 
Positive control tissues were used to optimise the technique and define the best antibody 
dilutions. All positive control tissues showed definite cellular labeling within distinct 
zones of various tissues at the expected locations for each of the antibodies 
(Figure 3.4 B-D).  
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3.3.3.2 – Group 1: Healthy Tasmanian devils 
3.3.3.2.1 – Thymus 
The thymus appeared as a brown, flattened amorphous tissue in the cranial 
mediastinum, in close proximity to the base of the heart of three juvenile devils 
(one-year old). Figure 3.5 A illustrates the general organization of the thymus. The 
thymus of the three-week old pouch young was identified with H&E staining at a 
similar location (Figure 3.5 B-C). No cervical thymus was seen in any of the animals. 
Microscopically, the thymus appeared as two lobes subdivided into several incomplete 
lobules by trabeculae originating from a thin capsule of connective tissue. The thymus 
of all animals examined was well vascularised and had strong basophilic staining of the 
outer cortex due to a high density of lymphocytes, with paler staining of the central 
medullary cellular components. Structures resembling Hassall’s corpuscles were seen in 
the medullary areas of the thymus of the juvenile devils and sparsely in the same area of 
the pouch young (Figure 3.5 D-E). Adipocytes were seen frequently in the thymus of 
the three juvenile devils, but not in the pouch young. 
In the juvenile devils (two were selected for immunohistochemistry – TD 175 and 
TD 115), the majority of cells were CD3+, although the lymphoid cells in the medulla 
labeled more intensely than in the cortex. In the three-week old pouch young, fewer 
cells were CD3+, and the positive cells were located mainly in the medulla (Figure 
3.6 A-B). MHC II+ cells were primarily located in the medulla (Figure 3.6 C), but the 
number of labeled cells varied between devils, for example, the outer cortex of one devil 
(TD 115) contained many MHC II+ cells whereas the same region of another devil 
(TD 175) had only a few MHC II+ cells. The thymus of the pouch young devils was not 
analysed for MHC II. Only a small number of CD79b+ cells were seen scattered 
throughout the medulla in all devil thymic tissues (Figure 3.6 D). 
3.3.3.2.2 – Spleen 
The spleen of all animals had a distinctive ‘Y’ shape, consisting of a flattened, dark red 
organ with a smaller lobe off the main longitudinal axis; it was anatomically located in 
the left upper abdominal area, lying next to the stomach. At the microscopic level, the 
spleen consisted of typical red pulp areas and numerous follicular aggregates of white 
Figure 3.5. Thymus architecture of healthy Tasmanian devils. 
 
Figures are displayed in horizontal order. 
A: Diagram of thymus tissue of eutherian mammals. Cortex (Cx), medulla (M), 
trabeculae (T), Hassall’s corpuscle (Hc) and blood vessel (Bv) are represented. Drawing 
based on image from the Department of Biological Sciences, University of Delaware 
website. 
B: Three-week old whole pouch young (TD 83F2) after fixation in 10% formalin. 
C: Whole pouch young (TD 83F2) after sectioning and staining with H&E. Note the 
thymus tissue in close proximity to the heart (box). 
D: Thymus section of TD 83F2 (H&E). Trabeculae (T) dividing the cortex (Cx) into 
lobules and abundant capillaries are seen throughout the cortex and medulla (M). A 
Hassall’s corpuscle (Hc) is present in the medulla. 
E: Thymus section of TD 83F2 (H&E). A Hassall’s corpuscle (Hc) is seen in medulla 
(M). Observe the intense basophilic staining of the lymphocytes. Cortex (Cx) and a 
blood vessel (Bv) are also represented. 
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pulp in association with trabecular collagen and smooth muscle: these tissues also made 
up the outer capsule of the spleen (Figure 3.7 A-B).  
The red pulp routinely contained large numbers of mature erythrocytes. Amongst the 
nucleated cells of the red pulp, there were cells labeled for MHC II (morphologically 
consistent with macrophages), CD3 and CD79b. In addition, most animals had 
aggregates of cells typical of erythroid and myeloid stem cell series as well as 
megakaryocytes, features typical of extramedullary haematopoiesis. Megakaryocytes 
were abundant in all sections and reliably identified morphologically by their large size 
and often-apparent bilobed nucleus (Figure 3.7 C). 
The white pulp consisted of scattered aggregations of lymphoid cells, frequently 
associated with central arterioles, thereby comprising periarteriolar lymphoid sheaths 
(PALS). Immediately surrounding the central arterioles, dense aggregates of CD3+ cells 
were easily identified. Lymphoid follicles extended from the PALS and consisted 
mainly of CD79b+ and MHC II+ cells (Figure 3.7 D-F). Primary and secondary follicles 
were distinguished by the lighter central area (germinal centre) of the latter, which 
characterises B-cell proliferation. A defined marginal zone was observed enclosing the 
PALS, composed mainly of CD79b+ and MHC II+ cells. Many of these cells weakly 
expressed CD79b and had small round to ovoid shaped nuclei. With H&E staining, 
these cells had nuclei with marginated chromatin and ample basophilic cytoplasm with a 
paler paranuclear crescent, suggestive of plasmacytoid and native plasma cells.  
3.3.3.2.3 – Lymph nodes 
Well-defined lymph nodes were consistently found in various locations of all animals 
(lymph nodes were not analysed in the pouch young), associated with lymphatic 
drainage from the limbs, head and internal organs. As a standard procedure, peripheral 
lymph nodes (sub-mandibular, axillary and inguinal) were examined and collected; 
mesenteric and mediastinal lymph nodes were identified, but not examined 
histologically. The sampled lymph nodes were located within loose connective tissues 
underlying the dermis and consisted of pale, reniform, encapsulated structures 
surrounded by adipose tissue.  
Figure 3.7. Spleen architecture of healthy Tasmanian devils. 
 
A: Diagram of spleen tissue of eutherian mammals. Capsule (Cp), trabeculae (T), 
arteriole (A) and periarteriolar lymphoid sheets (PALS) are represented. Drawing based 
on image from the Department of Biological Sciences, University of Delaware website. B:  Spleen section of a Tasmanian devil (H&E). Red pulp and periarteriolar lymphoid 
sheaths (PALS) are evident. Thick trabeculae (T), arterioles (A) and capsule (Cp) are 
present in the section. 
C: Spleen section of a Tasmanian devil (H&E). The marginal zone (MgZ) surrounding 
the white pulp and many megakaryocytes (Mk) are seen in the section. 
D: Spleen section of a Tasmanian devil (anti-HLA-DR antibody). Positive cells for 
MHC II are seen throughout the spleen, and aggregated in the lymphoid follicles. 
Abundant cells are positive for MHC II in the marginal zone (MgZ). Arterioles (A) are 
also present. 
E: Spleen section of a Tasmanian devil (anti-CD3 antibody). Periarteriolar lymphoid 
sheaths (PALS) strongly labeled with anti-CD3 are seen surrounding the arterioles (A). 
The marginal zone (MgZ) contains few CD3+ cells. Arterioles (A) are also seen in the 
section. 
F: Spleen section of a Tasmanian devil (anti-CD79b antibody). Lymphoid follicles in 
the PALS labeled positively for CD79b. Arterioles (A) and the marginal zone (MgZ) are 
also seen. 
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Histologically, the lymph nodes consisted of a simple connective tissue capsule, an 
underlying subcapsular sinus into which the afferent lymphatic vessels drained, a cortex 
consisting of lymphoid follicular aggregates and a loose medullary region draining to an 
efferent hilus on the concave side of the node. The cortex consisted principally of dense 
clusters of lymphoid cells arranged in follicles whilst the medullary cords stretching 
toward the hilus were composed of linear aggregates of cells. The subcapsular sinus was 
linked to trabecular sinuses within the cortex. The cortex of all sections contained two 
distinct cellular areas: the outer cortex and the inner cortex (or paracortex) (Figure 
3.8 A-C). The outer cortex was rich in lymphoid follicles, which contained a large 
number of CD79b+ and MHC II+ cells, while the inner cortex was rich in CD3+ cells. 
The lymphoid follicles were clearly divided into a mantle zone, high in CD79b+ cells, 
and a germinal centre with MHC II+ cells. Germinal centres were occasionally detected 
deep in the inner cortex (Figure 3.8 D-F).  
The medulla consisted of numerous medullary cords forming a maze-like complex of 
channels or medullary sinuses. The medullary cords were rich in CD79b+ cells, which 
were principally plasma cells, although expression of CD79b by plasma cells was not as 
strong as for small lymphocytes (Figure 3.9 A-B). The medullary sinuses housed a 
mixture of CD79b+, CD3+ and MHC II+ cells. 
Cells morphologically consistent with mast cells were seen throughout the medulla and 
medullary sinuses of lymph nodes of all devils. One captive devil (TD 113) had these 
cells present in both submandibular and inguinal lymph nodes, but in higher numbers 
than in the other animals. These cells stained metachromatically with toluidine blue 
(Figure 3.9 C-D). 
3.3.3.3 – Group 2: DFTD-affected Tasmanian devils with small tumours 
3.3.3.3.1 – Mucosa-associated lymphoid tissue (MALT) 
Two palatine tonsils of one devil (TD 123) and one lung section from another (TD 213) 
were analysed by histology and immunohistochemistry as representatives of the MALT.  
The bilateral tonsils were present at the base of the pharynx, adjacent to the epiglottis; 
each tonsil was situated in a depressed fossa in the oral mucosa. Histologically, the 
tonsils consisted of non-encapsulated masses of lymphoid tissue distributed as follicles. 
Figure 3.8. Lymph node architecture of healthy Tasmanian devils.  
 
A: Diagram of lymph node tissue of eutherian mammals. Capsule (Cp), afferent 
lymphatic (Al), efferent lymphatic (El), cortex (Cx), paracortex (or inner cortex) (PCx), 
trabeculae (T), medulla (M) and medullary cords (Mc) are represented. Drawing based 
on image from the Department of Biological Sciences, University of Delaware website. 
B: Lymph node section of a Tasmanian devil (H&E). Two germinal centres (Gc) are 
evident in the cortex (Cx), paracortex (PCx) underlies the germinal centres. Capsule 
(Cp) is also shown.  
C: Higher magnification of the highlighted area in lymph node section of a Tasmanian 
devil shown in B (H&E). Germinal centre (Gc) is seen in detail. 
D: Lymph node section of a Tasmanian devil (anti-HLA-DR antibody). The cortex 
(Cx), medullary region (M) and capsule (Cp) are represented. The two regions contain 
rich areas of MHC II cells. 
E: Lymph node section of a Tasmanian devil (anti-CD3 antibody). The cortex (Cx), 
medullary region (M) and capsule (Cp) are represented. The inner cortex is densely 
populated with CD3+ cells. 
F: Lymph node section of a Tasmanian devil (anti-CD79b antibody). The cortex (Cx), 
medullary region (M) and capsule (Cp) are represented. Areas rich in CD79b+ cells in 
the outer cortex composed the lymphoid follicles. The medullary region has scattered 
CD79b+ cells. 
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Stratified squamous epithelium was present in the lumen surface and invaginated into 
the tonsillar connective tissue to form deep crypts (Figure 3.10 A-C). In several 
locations in the tonsillar folds, the epithelium appeared attenuated and contained 
immunogenic cells. LSP1 antibody labeled most cells, except cells of epithelial origin 
and some cells in the germinal centres (Figure 3.10 D). A meshwork of MHC II+ and 
CD79b+ cells appeared to migrate from lymphoid follicles into the mucosa and the 
lumen of the tonsillar crypts (Figure 3.10 E-F). The organ was formed by eosinophilic 
follicular areas (germinal centres), which labeled strongly for MHC II and consisted of 
CD79b+ and CD3+ cells. Surrounding the distinct follicular areas, less structured 
aggregations of cells resembling “parafollicular” areas of lymph nodes (rich in CD3+ 
cells) were present (CD3 labeling is not shown). Abundant plasma cells (expressing 
CD79b) were present in the interfollicular spaces.  
In one devil (TD 213) a lung section was examined for the presence of MALT. Three 
areas of bronchus-associated lymphoid tissue (BALT) were seen, which consisted of 
simple follicular aggregates associated with the bronchial mucosa (Figure 3.11 A-C). 
These aggregates labeled strongly for MHC II and were mainly CD79b+ cells. A 
smaller number of cells expressed CD3 (Figure 3.11 D-F). 
Interspaced throughout the lung tissue, MHC II+ cells were seen in moderate numbers 
and were consistent in morphology to alveolar macrophages. Many CD3+ and fewer 
CD79b+ cells were also seen throughout the section.  
3.3.3.3.2 – Bone marrow 
Bone marrow tissue from only one animal (TD 123) from this group was analysed by 
histology and immunohistochemistry.  
The histological features of devil bone marrow were similar to that seen in other 
mammals. Sections of decalcified long bone showed typical haematopoietic stem cells 
filling the marrow spaces formed by a labyrinth of trabecular bone. The soft tissues of 
the bone marrow contained the progenitor stem cells of the erythroid, myeloid and 
megakaryocytic cell series; other cells noted were plasmacytes, cells resembling 
lymphoblasts, mature red blood cells, adipocytes and fibrovascular cells 
(Figure 3.12 A-B). 
Figure 3.10. Palatine tonsil architecture of a Tasmanian devil (TD 123). 
 
A: Diagram of palatine tonsil tissue of eutherian mammals. Epithelium (Ep), connective 
tissue (CT), germinal centres (Gc), crypts and an area of epithelium “break out” with 
lymphocytes invading the crypt are represented. Drawing based on image from the 
Department of Biological Sciences, University of Delaware website. 
B: Palatine tonsil section of a Tasmanian devil (H&E).  Stratified epithelium (SEp) 
invaginating and forming crypts is seen. Germinal centres (Gc) are easily distinguished. 
C: Higher magnification of the highlighted area in palatine tonsil section of a 
Tasmanian devil shown in B (H&E). Area of epithelium “break out”, where 
lymphocytes invade the crypt is shown. 
D: Higher magnification of the highlighted area in palatine tonsil section of a 
Tasmanian devil shown in B labeled with anti-LSP1 antibody, showing positive labeling 
of lymphoid and myeloid cells.  
E: Higher magnification of the highlighted area in palatine tonsil section of a Tasmanian 
devil shown in B labeled with anti-HLA-DR antibody, showing positive labeling of 
MHC II+ cells invading the crypt. 
F: Higher magnification of the highlighted area in palatine tonsil section of a Tasmanian 
devil shown in B labeled with anti-CD79b antibody, showing positive labeling of 
B-cells invading the crypt. 
 

Figure 3.11. Bronchus-associated lymphoid tissue architecture of a Tasmanian 
devil (TD 213). 
 
A: Diagram of bronchus-associated lymphoid tissue (BALT) of eutherian mammals. 
Epithelium (Ep), connective tissue (CT), germinal centre (Gc) and cortex (Cx) are 
represented. Drawing based on image from the Department of Biological Sciences, 
University of Delaware website. 
B: Bronchus-associated lymphoid tissue (BALT) (H&E), showing encapsulated 
lymphoid cells in close association with a bronchiolus.  
C: Higher magnification of the highlighted area in bronchus-associated lymphoid tissue 
(BALT) section of a Tasmanian devil shown in B (H&E). 
D: Higher magnification of the highlighted area in bronchus-associated lymphoid tissue 
(BALT) section of a Tasmanian devil (anti-HLA-DR antibody), showing positive 
labeling of MHC II+ cells.  
E: Higher magnification of the highlighted area in bronchus-associated lymphoid tissue 
(BALT) section of a Tasmanian devil (anti-CD79b antibody), showing positive labeling 
of B-cells.  
F: Higher magnification of the highlighted area in bronchus-associated lymphoid tissue 
(BALT) section of a Tasmanian devil (anti-CD3 antibody), showing positive labeling of 
T-cells.  
  

Figure 3.12. Bone marrow architecture of a Tasmanian devil (TD 123). 
 
Figures are displayed in horizontal order. 
A: Bone marrow section of a Tasmanian devil (H&E), showing a diversity of cell 
populations.  
B: Higher magnification of the bone marrow section of a Tasmanian devil shown in B 
(H&E). Plasma cells (Pc), polymorphonuclear cells (PMNc), red blood cells (RBC) and 
fat cells (Fc) can be seen. 
C: Bone marrow section of a Tasmanian devil (anti-LSP1 antibody), showing positive 
labeling of lymphoid and myeloid cells.  
D: Bone marrow section of a Tasmanian devil (anti-HLA-DR antibody), showing 
positive labeling of MHC II+ cells.  
E: Bone marrow section of a Tasmanian devil (anti-CD79b antibody), showing intense 
positive labeling of B-cells.  
F: Bone marrow section of a Tasmanian devil (anti-CD3 antibody), showing positive 
labeling of T-cells throughout the section.  
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Anti-LSP1 antibody labeled most cells of lymphoid and myeloid origin, comprising 
mature and immature polymorphonuclear cells, lymphocytes, lymphoblasts, cells 
resembling macrophages and earlier precursors and megakaryocytes. There was a 
profusion of cells labeled for MHC II seen throughout the section, most characteristic in 
morphology of B-cells and macrophages. Abundant number of cells expressed CD79b 
in the bone marrow of this animal, outnumbering greatly the number of cells expressing 
CD3. CD79b+ cells resembled both small lymphocytes and plasma cells 
(Figure 3.12 C-F). 
3.3.3.3.3 – Spleen  
There was general similarity in the histological appearance of the spleen of the devils 
from this ‘DFTD-affected devils’ group and of the healthy devils. Immune cells were 
labeled consistently with MHC II, CD79b and CD3 antibodies as described for the 
healthy devils. LSP1 labeled cells of the lymphoid and myeloid lineage.  
The spleen of TD 210 contained a large number of megakaryocytes and an abundance 
of LSP1+ and MHC II+ cells throughout the red pulp (Figure 3.13 A-B). The PALS and 
germinal centres of TD 123 labeled strongly with anti-LSP1, MHC II, CD3 and CD79b, 
but its red pulp areas contained only scattered positive cells for these antibodies 
(Figure 3.13 C-F). The splenic section of this devil also contained fewer follicles than 
other examined devils from this group and devils from Group 1. 
3.3.3.3.4 – Lymph nodes 
The general histological appearance of lymph nodes of the animals from this group was 
similar to the nodes of the Group 1. A varied number of follicles and germinal centres 
was present in the cortex, comparable to the healthy devils. A paracortical region 
underlying the follicles and a medullary area composed of sinuses and cords were easily 
identified. All nodes were enclosed by a capsule of connective tissue.  
TD 124 had extensive mast cell numbers distributed throughout the medullary cords, 
similarly to a devil from Group 1 (TD 113). TD 120 had few germinal centres, but a 
pronounced plasma cell proliferation in the medullary cords and sinuses of both 
submandibular and axillary lymph nodes. These plasma cells expressed CD79b 
(Figure 3.14 A-B). The submandibular lymph node of TD 123 contained large follicles 
Figure 3.13. Spleen architecture of DFTD-affected Tasmanian devils with small 
tumours 
 
Figures are displayed in horizontal order. 
A: Spleen section of Tasmanian devil TD 210 (anti-LSP1 antibody). Abundance of 
LSP1+ cells in PALS and in the red pulp is seen.  
B: Spleen section of Tasmanian devil TD 210 (anti-HLA-DR antibody). Abundance of 
MHC II+ cells in PALS and in the red pulp is observed.  
C: Spleen section of Tasmanian devil TD 123 (anti-LSP1 antibody). Few LSP1+ cells 
are seen in the red pulp, although many positive cells are present in a follicle. 
D: Spleen section of Tasmanian devil TD 123 (anti-HLA-DR antibody). A 
concentration of MHC II+ cells in a follicle and scattered positive cells in the red pulp. 
E: Spleen section of Tasmanian devil TD 123 (anti-CD79b antibody). A concentration 
of B-cells in a follicle and few positive cells in the red pulp are seen. 
F: Spleen section of Tasmanian devil TD 123 (anti-CD3 antibody). Abundance of 
T-cells in a follicle and scattered positive cells in the red pulp are seen. 
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and extensive interfollicular plasma cell proliferation. CD79b+ cells were prominent 
and CD3+ cells were present, principally compressed between follicles. LSP1 labeled 
leukocytes, including lymphocytes, plasma cells and macrophages, but few cells in the 
interior of the germinal centres (Figure 3.14 C-D). 
3.3.3.3.5 – DFTD tumours 
DFTD tumours were always located in the subcutaneous tissue of the head and/or 
sub-mucosa of the mouth in the affected animals. Tumours presented as lumps or 
masses enclosed by intact epithelium or, more commonly, ulcerated onto a surface 
epithelium. Tumours varied in number, appearance and size; for example, TD 120 had a 
single spherical closed tumour between the lip and left eye, whereas TD 210 and 
TD 212 had three to five small-ulcerated nodules around the mouth (Figure 3.15 A-D). 
Traumatic debridement of the fragile aggregates of these sarcoma-like tumour cells was 
common.  
Microscopically, DFTD tumours presented as a high-grade malignant tumour in which 
the morphological features were somewhat variable in appearance. The cytomorphology 
was similar in each tumour, though there was some variation in the architectural pattern 
between tumours. Hemorrhage, polymorphonuclear leukocyte infiltration and bacterial 
contamination were often seen in ulcerated tumours. Only scattered cells characteristic 
of lymphocytes were seen in DFTD tumour tissue. 
In some areas, DFTD tumours were composed of diffuse sheets of small rounded to 
polygonal shaped cells with ovoid hyperchromatic nuclei.  The nuclear chromatin was 
coarse and nucleoli were small and predominantly centrally located, though in many 
cells were inconspicuous.  Mitotic figures were frequent.  A moderate amount of 
amphophilic cytoplasm was present and in some areas the nuclei were eccentrically 
located resulting in a plasmacytoid appearance. Elsewhere, tumour cells appeared more 
cohesive and epithelioid in appearance and formed elongated trabecular and solid 
alveolar structures.  There was no evidence of acinar differentiation.  A minor spindle 
cell component was apparent in some areas (Figure 3.16 A-F). 

Figure 3.16. DFTD tumour histological appearance of a DFTD-affected Tasmanian 
devil with small tumours (TD 120). 
 
A: Diagram of the micro-architecture of a DFTD tumour. Epithelium (Ep), muscle 
fibers (M), blood vessel (Bv) and necrotic areas of a DFTD nodule are represented. 
B: DFTD tumour section of TD 120 (H&E). DFTD tumour cells are arranged in nests, 
enclosed by fibrous connective tissue (CT) bundles. Blood vessels (Bv) are also present. 
C: Higher magnification of the highlighted area in the DFTD tumour section of TD 120 
shown in B (H&E). 
D: Diagram of the micro-architecture of a DFTD tumour nodule, representing healthy 
tumour cells surrounding a blood vessel and pycnotic and apoptotic cells close to a 
necrotic area. 
E: DFTD tumour section of TD 120 (H&E). Mitotic figures (Mf) are a constant finding. 
F: Higher magnification of the highlighted area in the DFTD tumour section of TD 120 
shown in ‘E’ (H&E). 
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Extensive areas of confluent tumour necrosis were present in many tumours with the 
formation of a peritheliomatous pattern.  In these areas, a mantle of viable tumour cells 
surrounded a central blood vessel.  
None of the antibodies employed labeled the tumour cells. CD79b labeling often 
resulted in moderate diffuse background throughout the sections, but no cells 
resembling B-lymphocytes were seen in the tumour sections labeled with anti-CD79b 
antibody. Two tumour sections were labeled for LSP1, which resulted in labeling of a 
few cells, present mainly in the connective tissues surrounding the tumour. Few LSP1+ 
cells, characteristic of neutrophils, were seen scattered throughout the tumour. All 
tumour sections contained MHC II+ and CD3+ cells, although sparsely distributed, 
mainly surrounding the tumour. Labeling of immune cells in DFTD tumours is 
illustrated in Section 3.3.3.4.5. 
3.3.3.4 – Group 3: DFTD-affected Tasmanian devils with large tumours 
3.3.3.4.1 – Mucosa-associated lymphoid tissue (MALT) 
The tonsils from one devil (TD 269) with large DFTD tumours were analysed. This 
lymphoid tissue was present in the basis of the pharynx, similarly to devil from Group 
2, and histologically consisted of lymphoid cells encapsulated by stratified epithelium, 
organised in follicles. The tonsils had extensive CD3+ cell labeling amongst the cells 
surrounding the follicular areas. MHC II+ cells were intensely labeled in the germinal 
centres of follicles and, to a lesser extent, in the parafollicular areas. CD79b+ cells were 
seen in the germinal centres and scattered underneath the epithelium and in greater 
abundance associated with areas where lymphoid cells migrate through the stratified 
epithelium into the tonsillar crypts. These features were similar to the features observed 
in the tonsils of a devil from Group 2 (TD 123), hence not reproduced here. 
Two lung sections from TD 61 were analysed for MALT, but only a small lymphoid 
aggregate (BALT) was observed in one of the sections, contrasting to the several 
aggregates observed in a lung section of a devil bearing small DFTD tumours (TD 213). 
The only one small lymphoid aggregate was observed in association to a bronchiole and 
consisted of cells expressing MHC II and CD79b. The lung sections from TD 61 
contained numerous alveolar macrophages (MHC II+) and T-cells (CD3+) throughout 
Chapter 3: Analyses of cells and tissues of the Tasmanian devil’s immune system and of DFTD tumours 
 
− 89 − 
the section. Numerous nodular DFTD metastases were present in these sections, which 
are described below.  
3.3.3.4.2 – Bone marrow 
The bone marrow from three animals with large tumours was analysed. Two (TD 74 
and TD 67) had the bone (sternum and rib) sectioned while TD 61 had the marrow 
cavity of a long bone processed. The basic features observed in the bone marrow of 
TD 123 (Group 2) were present in the bone marrow of the three devils from this group. 
The bone marrow from TD 67 was fatty; it had adipocytes in great abundance but with 
all the cellular and structural components previously described in Section 3.3.4.2. The 
bone marrow of TD 74 was hypercellular, with an abundance of cells showing open 
nuclei and marginated chromatin, resembling DFTD tumour cells. Other cells normally 
resident in the bone marrow were also present, but outnumbered by the metastatic cells. 
These cells did not label with any of the antibodies, suggesting that they were indeed 
metastatic proliferations of DFTD tumour cells (Figure 3.17 A-C). The bone marrow 
from TD 61 presented with a high number of CD79b+ cells, suggesting B-cell 
proliferation (Figure 3.17 D-F). 
3.3.3.4.3 – Spleen  
At the histological level, the spleen of devils from Group 3 was similar to those of the 
other groups, containing areas of red pulp and areas of white pulp, forming PALS and 
germinal centres. All spleen sections showed thick trabecula and were enclosed by a 
fibro-elastic capsule. 
One section of one devil, TD 61, was uncharacteristic; the normal splenic tissues were 
compressed by a large nodular DFTD metastasis. The section analysed was in close 
proximity to the secondary tumour and the spleen tissue around this metastasis 
presented a depletion of cells in the red pulp and no typical PALS were noted. Cells 
present in the red pulp areas were mainly plasma cells and MHC II+ cells and fewer 
CD3+ cells. The spleen of all devils from this group had an abundance of plasmacytoid 
cells, some of them with cytoplasmic and nuclear appearance not necessarily typical of 
mature plasma cells (Figure 3.18 A-C). These cells were both CD79b+ and MHC II+, 
suggesting they may be progenitor B-cells. These plasmacytoid cells in the spleen of 
Figure 3.17. Bone marrow architecture of DFTD-affected Tasmanian devils with 
large tumours and/or metastasis (TD 74 and TD 61).  
 
A: Bone marrow section of TD 74 (H&E). Note the hyper cellularity of the section. The 
majority of the cells resemble DFTD tumour cells. 
B: Higher magnification of the bone marrow section of TD 74 shown in ‘A’ (H&E). 
C: Bone marrow section of TD 74 (anti-CD79b antibody). Only few scattered B-cells 
are seen throughout the section. 
D:  Bone marrow section of TD 61 (H&E). Note extensive plasma cell proliferation. 
E: Higher magnification of the bone marrow section of TD 61 shown in ‘D’ (H&E). 
F: Bone marrow section of TD 61 (anti-CD79b antibody). Extensive plasma cell and 
B-cell proliferation throughout the section is observed. 
 

Figure 3.18. Plasma cell proliferation in spleen and lymph node of DFTD-affected 
Tasmanian devils with large tumours and/or metastasis (TD 67 and TD 74). 
 
A: Spleen section of TD 67 (H&E). Extensive plasma cell proliferation is seen.  
B: Higher magnification of the spleen section of TD 67 shown in ‘A’ (H&E).  
C: Spleen section of TD 67 (anti-CD79b antibody). Extensive labeling of plasma cells 
surrounding a trabecula in the red pulp. 
D: Submandibular lymph node section of TD 74 (H&E). Extensive plasma cell 
proliferation is seen.  
E: Higher magnification of the lymph node section of TD 74 shown in ‘D’ (H&E). Note 
almost all cells present are plasma cells. 
F: Submandibular lymph node section of TD 74 (anti-CD79b antibody). Extensive 
plasma cell proliferation is observed. 
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TD 269, however, did not label for MHC II. TD 74 had a depletion of MHC II+ cells in 
the red pulp, even though many cells in the PALS and germinal centres labeled strongly 
for MHC II (similar to a devil from Group 2, TD 123). TD 89 presented profuse 
numbers of megakaryocytes, suggesting extramedullary haematopoiesis. 
3.3.3.4.4 – Lymph nodes 
The submandibular lymph nodes of all analysed devils from this group had DFTD 
metastases in the outer cortex, except TD 68. Metastases in the lymph nodes are 
described in Section 3.3.3.4.5.  
All lymph nodes from this group (including the axillary lymph node of TD 74) had a 
remarkable abundance of CD79b+ cells outside the follicles, distributed from the inner 
cortex to the medulla of the node. A large proportion of these cells were plasma cells, 
which labeled positively for CD79b, but not always for MHC II (as in TD 269). Similar 
to the spleen, many of these cells in the lymph nodes resembled plasma cells. These 
plasmacytoid cells in the lymph nodes had a somewhat aberrant morphology in relation 
to its overall cell size and size, shape and staining quality of the nucleus 
(Figure 3.18 C-D). Despite these variations from mature plasma cells, their location in 
immunological tissues and the general tendency to label with a B-cell marker suggests 
this population of cells may represent early stage plasmacytes. Cells in the germinal 
centres and throughout the node of most devils labeled intensely with MHC II. T-cell 
areas were present, but appeared reduced in comparison with the B-cell areas.  
3.3.3.4.5 – DFTD Tumours 
Four devils from this group had large primary tumours. Ulceration and exudation of the 
tumour masses and general poor body condition were common features 
(Figure 3.19 A-D).   Most DFTD tumours were accompanied by metastases in multiple 
organs (e.g. TD 74, Figure 3.20 A-C). TD 89 had only two small, ulcerated tumours on 
the mucosa of the mouth and TD 61 had a primary tumour on the muzzle surgically 
removed. However, both devils had multiple and extensive metastases in internal organs 
and for this reason were included in this group (Figure 3.20 D-F and Figure 3.21 A-F). 
DFTD tumours had a cut surface that appeared nodular, often with a central necrotic 
cavity (see TD 68, Figure 3.22 A-B). 

Figure 3.20. Gross appearance of DFTD tumours and metastases of TD 74 and 
TD 89 (Group 3 – DFTD-affected Tasmanian devils with large tumours and/or 
metastasis). 
 
A: DFTD tumour on the mandible of TD 74, showing ulceration and exudation.  
B-C: DFTD metastases (arrows) on the kidney and lung of TD 74. 
D: DFTD ulcerated tumour on the gingival mucosa of TD 89. 
E: Large DFTD metastases on both kidneys of TD 89. 
F: Several DFTD metastases (arrows) on the peritoneum of TD 89 
 

Figure 3.21. Gross appearance of DFTD tumour and metastases of TD 61 
(Group 3 − DFTD-affected Tasmanian devils with large tumours and/or 
metastasis).  
 
A: Small nodular DFTD tumour thought to be the index primary tumour on the nostril 
of TD 61 (arrow). 
B: Close up of the nostril of TD 61 two months after the removal of the DFTD nodule. 
Note the depigmented scar tissue where the primary tumour was surgically removed. 
C: Extensive metastases in the internal organs of TD 61. 
D: Gross appearance of the liver of TD 61 showing extensive DFTD metastases in/on 
the organ. 
E: Close up of the liver of TD 61. 
F: Close up of the spleen of TD 61, showing a large DFTD nodule. 

Figure 3.22. Gross and microscopic appearance of large DFTD tumours. 
 
Figures are displayed in horizontal order. 
A: DFTD tumour of TD 68 showing a chronically ulcerated large tumour with dried 
epithelial edges. 
B: Cut surface of the DFTD tumour shown in ‘A’. Nodular masses and central necrotic 
cavity are observed. 
C: DFTD tumour section (H&E). A large blood vessel is seen in the connective tissue 
(CT). 
D: Higher magnification of DFTD tumour section shown in ‘C’ (H&E). A mitotic figure 
is seen in the insert. 
E: DFTD tumour section (H&E). Necrotic centres (Nc) and thin layers of connective 
tissue are seen. Caseation of cell debris is also observed in and directly adjacent to the 
necrotic centre. 
F: Higher magnification of DFTD tumour section shown in E (H&E). Pycnotic and 
apoptotic cells next to a necrotic centre are observed.  
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Microscopically, DFTD tumour tissues of devils from this group were similar in 
morphology and staining quality of the DFTD tumours of devils from Group 2. These 
tumour sections presented as bundles of large cells, with round to spindeloid 
morphology. Thin layers of connective tissue surrounded the tumour parenchyma 
forming a capsule or pseudo-capsule. Occasionally this infiltrated the parenchyma and 
divided the bundles of tumour cells in islands or nests (Figure 3.22 C). Extensive 
vascularisation was a constant finding and necrotic centres were often present in areas 
of the tumour. Mitotic figures were frequently seen (Figure 3.22 D). Extensive areas of 
necrosis were a constant finding, especially TD 269 and TD 68 (Figure 3.22 E-F).  
Most tumours had only a sparse population of MHC II+ and CD3+ cells in the tumour, 
mainly in the condensed fibrous connective tissue surrounding the tumour. Occasionally 
CD3+ cells were observed within connective tissue and vascular trabecula of the interior 
of these tumours and close to aggregates of tumour cells. TD 269 and TD 68 had 
moderate to intense CD3+ cell infiltration in some areas of the tumour 
(Figure 3.23 A-D). In TD 89 several areas of polymorphonuclear cell infiltration 
associated with sepsis and cell necrosis were observed, and such areas labeled positively 
for LSP1 (Figure 3.23 E-F).  
3.3.3.4.6 – Metastases  
TD 68 was the only devil from this group that did not have any visible metastases. The 
submandibular lymph node was the most common location for DFTD metastases, 
followed by lung and kidney. In addition, TD 74 and TD 89 had large numbers of white 
solid nodules (≅0.5 cm in diameter) under the mesodermal membranes of the thorax and 
abdomen. TD 89 also had subcutaneous secondary tumours, far from the primary facial 
tumour, in the subcutaneous tissue of the chest, rump and pouch. TD 61 had multiple 
metastases in lungs, liver, spleen and kidneys, varying from 0.5 to 5 cm in diameter. 
Under histological observation, metastases were morphologically similar to the primary 
facial tumours, and were usually arranged in bundles or nests of cells surrounded by a 
passive perimeter of connective tissue with fine trabeculae of vascularisation in the form 
of capillaries within the secondary tumour masses. A feature commonly observed, 
which is characteristic of most DFTD tumours and often seen in the metastases, was the 
Figure 3.23. Immunolabeling of DFTD tumours. 
 
Figures are displayed in horizontal order. 
A: DFTD tumour section of TD 269 (anti-HLA-DR antibody). Moderate number of 
MHC II+ cells in association with the connective tissue (CT) at the edge of the tumour 
mass is seen. 
B: DFTD tumour section of TD 269 (anti-CD3 antibody). Moderate number of T-cells 
in association with the connective tissue (CT) at the edge of the tumour mass is 
observed. 
C: DFTD tumour section of TD 68 (anti-HLA-DR antibody). Scattered MHC II+ cells 
in association with the connective tissue within the tumour is seen. 
D: DFTD tumour section of TD 68 (anti-CD3 antibody). Presence of T-cells in 
association with the connective tissue (CT) within the tumour is seen. 
E: DFTD tumour section of TD 89 (H&E). A nest of polymorphonuclear cells is evident 
in the tumour. 
F: DFTD tumour section of TD 89 seen in ‘E’, labeled with anti-LSP1 antibody. Intense 
positive labeling of neutrophils in the DFTD tumour is observed. 
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aggregation of viable DFTD tumour cell nests around large blood vessels (arterioles) 
with focal necrosis in areas distant from these vascular sites. A common observation of 
splenic and pulmonary metastases was the thin layer of connective tissue surrounding 
the aggregates of tumour cells.  
Three devils (TD 61, TD 74 and TD 89) had metastases in the cortex of the kidneys. 
The lung of TD 61 had various DFTD tumour cell proliferation throughout the lung 
tissues and on the visceral pleura (Figure 3.24 A-B). As a rule, MHC II+ and CD3+ 
cells were abundant in the connective tissue of the capsule, but sparse or rare with the 
substance of the tumour itself. An exception was the presence of two small, isolated 
groupings of MHC II+ and CD3+ cells seen in the multiple haematogenous DFTD 
metastases of liver of TD 61 and kidney of TD 74 (Figure 3.24 C-F). 
Metastases in the submandibular lymph nodes were mostly located in the outer cortex 
and varied in size, from a single small nodule comprising a dense mass of proliferating 
DFTD tumour cells (TD 269 and TD 67) to a mass that occupied large areas of the node 
and compressed the surrounding tissues (TD 74). Although in close proximity to cells of 
the immune system, metastases in lymph nodes did not present with infiltration of 
T-lymphocytes or MHC II+ cells (Figure 3.25 A-F). This lack of immune cell 
infiltration was similar in DFTD metastases in other organs as well as in primary 
tumours.  
3.3.4 – Summary of results 
The main results observed in this chapter were: 
• Significant increase in numbers of mature neutrophils in the peripheral blood of 
diseased devils with either small or large tumours compared with healthy devils; 
• Presence of immature neutrophils in the circulation of devils with large tumours 
and/or metastasis; 
• Significant reduction in numbers of circulating lymphocytes from devils with 
large tumours compared to captive devils; 
Figure 3.24. Microscopic structure of DFTD metastases. 
 
Figures are displayed in horizontal order. 
A: Lung section of TD 61 (H&E). DFTD tumour cells adjacent to and infiltrating 
through the visceral pleura.  
B: Lung section of TD 61 (anti-CD3 antibody). Few T-cells are present and mainly 
associated with the connective tissue. The same is true for MHC II+ cells (insert). 
C: Liver section of TD 61 (H&E). DFTD tumour cells diffusely distributed and 
irregularly invading the hepatic parenchyma. 
D: Liver section of TD 61 (anti-CD3 antibody). Moderate number of T-cells at the edge 
between liver parenchyma and DFTD tumour cells. Insert shows the same section 
labeled with HLA-DR antibody. 
E: Kidney section of TD 74 showing DFTD tumour metastasis. 
F: Kidney section of TD 74 (anti-CD3 antibody). Few T-cells are present and mainly 
associated with the connective tissue. The same is true for MHC II+ cells (insert). 
 
 

Figure 3.25. Microscopic structure of DFTD metastasis in the submandibular 
lymph node (TD 269). 
 
A: Submandibular lymph node of TD 269 (H&E). Nodular DFTD metastasis in the 
outer cortex. Capsule (Cp) of the lymph node, germinal centre (Gc) and connective 
tissue (CT) are represented. The necrotic centre (Nc) of the metastasis is also shown. 
B-C: Higher magnification of the submandibular lymph node section of TD 269 shown 
in A. 
D: Submandibular lymph node of TD 269 (anti-CD3 antibody). Intense labeling of 
T-cells in the lymph node tissue, but sparse presence of these cells in the metastatic 
nodule. 
E: Submandibular lymph node of TD 269 (anti-HLA-DR antibody). Intense labeling of 
MHC II+ cells in the lymph node tissue, but poor presence of these cells in the 
metastatic nodule. 
F: Higher magnification of the submandibular lymph node of TD 269 (anti-CD3 
antibody) shown in D. Arrows indicate positive cells. 
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• All lymphoid organs of Tasmanian devils appeared to be anatomically and 
histologically similar to both the eutherian and other marsupial mammals, with 
all cellular and architectural elements for competent immune function; 
• Spleen and lymph nodes of DFTD-affected devils had considerable populations 
of plasmacytoid cells; 
• DFTD tumours showed a moderate to high number of cells in mitosis and areas 
of abundant necrosis, whereas a very limited number of immune cells (especially 
CD3 positive cells) were infiltrating the tumour tissue; 
• Metastases occurred in several well vascularised organs and had a similar 
histological aspect of the primary tumours; 
• DFTD tumour cells did not label with HLA-DR antibodies. 
3.4 – Discussion 
This study has shown that Tasmanian devils have the haematological, cellular and the 
histological tissues required for effective cell mediated and humoral immune responses, 
effected through T- and B-cell lineages. However, these structural and conformational 
studies need to be supported by functional immunological analyses of this species, as 
the presence of immune components may not translate into efficient adaptive immunity. 
For example, in DFTD, the tumours behave as a successful ‘cell-allograft’ that is not 
recognised and rejected by the immune system of the infected devil.  
The white blood cell counts consistently revealed the entire range of leukocytes 
identified in other mammals. The only two other reference ranges available for 
Tasmanian devils are provided by The Australian Registry of Wildlife Health (ARWH) 
and the International Species Information System (ISIS) websites. These two 
organizations collated reference ranges for captive Tasmanian devils from different zoos 
around the globe (Table 3.7). The haematological parameters for healthy Tasmanian 
devils found in this study were within the range of the two data sets albeit with minor 
variation.  
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ARWH 
 n=12 
ISIS 
 n=10  
 Mean 
 (109/L) 
Reference 
 range 
Mean (±SD) 
(109/L) 
Reference  
range 
TWBCC 10.5  6.7-16.6 6.1±2.4 3.4-13.2 
Neutrophils 5.2 2.6-7.9 3.8±2.2 0.8-9.3 
Banded 
neutrophils 1.0 0.0-2.5 0.2±0.1 0.1-0.6 
Lymphocytes 4.5 1.0-7.4 2.2±1.1 0.8-4.6 
Monocytes 0.1 0.0-0.2 0.1±0.07 0.04-0.2 
Eosinophils 0.1 0.0-0.3 0.1±0.2 0.01-0.6 
Basophils 0.04 0.0-0.09 0.1±0.0 0.1-0.1 
Table 3.7: Suggested haematological reference ranges for captive Tasmanian devils (ARWH and 
ISIS websites). 
The neutrophil:lymphocyte ratio is useful diagnostically in cases of acute bacterial and 
viral infections, chronic debilitation, immunosuppression and ongoing physiological 
stress and it has been used to assess the changes associated with these responses in a 
range of mammals (Boily et al. 2006). This ratio was found to be more diverse in 
DFTD-affected devils than in those reported in the previous studies. Variation in 
absolute and relative leukocyte numbers may be identified with circadian rhythm, 
oestrus and a range of acute and chronic stress-associated conditions.  
Captive devils are rarely wounded by intraspecific fighting and are treated promptly if 
any injury occurs. In addition, the diet of captive devils is mainly derived from fresh 
rather than putrefying carcasses. Consequently, the neutrophil numbers were consistent 
within the normal reference ranges for healthy captive devils provided by the ARWH 
and ISIS. Healthy free-living devils in this study had average TWBCC and neutrophil 
numbers that were slightly higher than the captive animals, which is likely to be a result 
of inflammatory injuries and higher pathogen exposures that such animals would endure 
in the wild. DFTD-affected devils had a pronounced neutrophilia, which substantially 
increased the TWBCC. DFTD tumours are often ulcerated, hemorrhagic and subject to 
ongoing trauma and bacterial contamination. As neutrophils are the first effector cells to 
proliferate in response to invading microorganisms, it is not surprising that these cells 
were present in higher numbers in DFTD-affected devils, particularly in animals with 
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grossly disfigurating and extensively ulcerated tumours seen with advanced stages of 
the cancer. The main cytokine that regulates neutrophil proliferation (in humans and 
mice) is granulocyte colony-stimulating factor (G-CSF) (Christopher and Link 2007; 
von Vietinghoff and Ley 2008). Therefore, the presence of high numbers of circulating 
neutrophils due to acute inflammation and microbial invasion into ulcerated facial 
wounds (including DFTD lesions) is likely to be expression of the innate immune 
response through an increase on G-CSF. Relative and absolute lymphopenia and a 
regenerative shift to the left were also present in devils with large tumours, which are 
other haematological features that commonly accompany severe inflammatory 
processes, viral infections and chronic debilitation. 
Stressor conditions are of particular significance in some small Dasyurid species, which, 
with the distantly related Didelphid group in South America, are the only mammals to 
exhibit semelparity. Annual male mortality in many species of this group is a 
consequence of an imbalance between corticosteroids and testosterone, causing a 
collapse of the immune system and death by opportunistic infections and otherwise 
benign pathologies (Naylor et al. 2008). Tasmanian devils are the largest Dasyurids and 
have only recently been demonstrated to exhibit this extreme life history strategy (Jones 
et al. 2008). In addition, it is likely that the breeding season has a deleterious effect on 
the immune function and ratios of circulating immune cells.  Data collected for the 
present study and the sources cited above did not take into account the time of year, 
reproductive status or correlation with plasma cortisol in the samples collected, which 
might account for the variation found in this study. 
The histological architecture of the thymus, spleen and lymph nodes of healthy 
Tasmanian devils was similar to other eutherian and marsupial mammals. The spatial 
distribution of T-, B- and MHC II+ cells was consistent within all other marsupial 
species (Canfield and Hemsley 2000). 
The thymus of all animals contained characteristic Hassall’s corpuscles. In eutherian 
mammals these structures (formed by accumulations of thymic epithelial cells) produce 
cytokine thymic stromal lymphopoietin, which is involved in maturation of T-cells to 
optimise negative selection and ensure tolerance (Kierszenbaum 2007). The age in 
which Hassall’s corpuscles appears in marsupials varies within different species (Old 
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and Deane 2003a, b; Old et al. 2003b). Eastern quolls have Hassall’s corpuscles from 7 
days after birth (Hill and Hill 1955) and stripe-faced dunnarts (S. macroura) from 40 
days of age (Old et al. 2003b). Although only one three-week old devil was analysed, it 
did contain Hassall’s corpuscles, suggesting that the thymus of devils also differentiates 
and matures in the early stages of pouch life. The one-year old devils (i.e. juvenile 
independent devils) had a higher proportion of CD3+ cells in the medulla and cortico-
medullary regions than the pouch young devil. In addition, the juvenile devils had signs 
of involution of the organ, such as indistinct cortico-medullary septa boundaries and a 
large number of adipose cells, which were not seen in the pouch young. In eutherian 
mammals the thymus is the primary lymphoid organ where naïve T-lymphocytes 
migrate to undergo maturation and differentiation into immunocompetent T-cells. 
Further work in a range of pouch young devils at different stages is required to 
determine the ages at which the thymus matures, enlarges and then starts the process of 
involution, but these observations suggest that juvenile devils are armed with the 
adequate mature T-cells to cope with the range of pathologies that the species undergoes 
in the wild.  
Similarly to other marsupial species studied, the spleen of the devils was histologically 
arranged into the red and white pulp, with the red pulp involved in blood storage (Hayes 
1968; Young et al. 2003) and the white pulp in immune function. In the spleen of 
mature Tasmanian devils, there was evidence in the red pulp for extramedullary 
haematopoiesis, as indicated by many megakaryocytes and distinct aggregates of cells 
typical of erythrocytic lineage and polymorphonuclear cell precursors. The presence of 
thick trabeculae composed of smooth muscle and fibro-elastic tissues is indicative of the 
capacity of the spleen to contract and expand, which may be indirect evidence for blood 
storage. In addition, the red pulp harboured transiting immune cells, as evidenced by 
labeling with anti-MHC II, CD79b and CD3 antibodies. The contribution of the 
Tasmanian devil spleen to its active immune function was demonstrated by the 
consistent finding of well-developed lymphoid aggregations in the white pulp regions 
(PALS) rich in CD3 expressing cells and germinal centres rich in CD79b+cells in all 
healthy devils examined. 
In the red pulp areas of the spleen from two DFTD-affected devils there was a paucity 
of MHC II+ cells, even though germinal centres and PALS from both devils had 
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abundant cells labeled with this antibody. This finding did not appear to be related to the 
stage of the disease in this study, as one devil had advanced DFTD, while the other had 
only small tumours. HLA-DR was used as a marker of the status and responsiveness of 
cellular immunity and is up regulated with immune stimulation, i.e. an increase in 
HLA-DR expression typically denotes an abundance of antigenic challenge, potentially 
foreign in origin. Immunolabeling of the spleen of TD 74 (a devil with a large tumour 
mass, see Figure 3.17 A) indicated significant compromise of this organ’s function, 
although systemic organ failure was evident and might have been caused by other 
factors than DFTD. TD 123 was included in the Group 2 based on the size of its tumour, 
and it did not appear to have histological evidence of systemic pathology.  A wider 
range of DFTD-affected devils would need to be examined to define any pattern of 
MHC II down regulation in immune cells.  
The histological architecture of the peripheral lymph nodes of all healthy devils in this 
study resembled those of other eutherian and marsupial mammals with distinct cortical 
and medullary regions and the presence of dense aggregates of lymphocytes, which 
formed primary and secondary lymphoid follicles. Germinal centres of secondary 
lymphoid follicles were present in the lymph nodes of all healthy devils. These are very 
dynamic structures, where B-cells undergo a series of maturation and differentiation 
processes (Schwickert et al. 2007), thereby suggesting that B-cell stimulation and 
proliferation is proficient. It would therefore be predicted that Tasmanian devils’ 
humoral immune response through antibody production is competent. Immunolabeling 
was not specific for follicular dendritic cells, but the presence of MHC II+ cells in the 
lymph node can be interpreted as follicular dendritic cells, which were within the 
germinal centres in close association with CD79b+ cells, implying close contact 
between these cells and B-cells. Similarly, the T-cell rich areas in the nodes were well 
developed in all devils; this was characterised by dense populations of CD3+ cells 
within the inner cortex in all lymph nodes. These T-cells are likely to be of the helper 
T-cell subset (CD4+) (Kierszenbaum 2007), but until a specific marker for CD4 in 
marsupials is developed, it is only possible to speculate about different T-lymphocyte 
subsets.  
The medullary sinuses of lymph nodes in several devils contained large numbers of 
toluidine blue positive cells, morphologically consistent with large granular mast cells. 
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By their location and abundance, it is likely that these cells are similar to those seen in 
the lymph nodes of other marsupials. Abundance of mast cells in the lymph nodes has 
been described in another Dasyurid, the fat-tailed dunnart (S. crassicaudata) and in five 
Didelphid marsupials (Haynes 1991; Chiarini-Garcia and Machado 1992; Chiarini-
Garcia and Pereira 1999; Chiarini-Garcia et al. 2000; Santos et al. 2003). These mast 
cells were restricted to the lymphatic sinuses, contained large cytoplasmic granules and 
were thought to differ from the connective tissue and mucosal mast cell populations. 
Two related Tasmanian Dasyurids, the eastern quoll and the spotted-tailed quoll (D. 
maculatus), are also known to similarly produce large populations of mast cells in the 
peripheral lymph nodes (D. Obendorf, personal communication). A more detailed study 
would reveal the cell interactions and histochemical properties of the mast cells of 
devils, particularly where florid mast cell proliferations are recognised with specific 
pathologies. 
Sub-mandibular lymph nodes are the principal nodes which drain lymph from the facial 
soft tissues. Histology and immunohistochemistry of the sub-mandibular lymph node of 
devils with small tumours did not differ greatly from the nodes of healthy devils, 
although two animals with small tumours had an abundance of mature plasma cells, 
located in the parafollicular and medullary cord areas, suggesting B-cell proliferation. 
Devils with large DFTD lesions had enlarged sub-mandibular lymph nodes with 
proliferation of lymphoid follicles, many characterised by abundance of germinal 
centres and profusion of mature plasma cells. DFTD tumours often were ulcerated with 
tissue trauma and secondary bacterial infection; these conditions might cause a localised 
hyper-reactive node.  
A feature of devils with large tumours was an apparent over abundance of plasma cells 
compared to healthy devils, both in the spleen and lymph nodes. Plasma cells proliferate 
in response to chronic antigenic stimulation and produce antibodies in response to 
primary infection or microbe invasion following tissue damage. As previously 
mentioned, DFTD tumours are often found with opportunistic bacterial contamination, 
which is likely to induce systemic plasma cell proliferation.  Some sections from these 
animals had populations of plasmacytoid cells with features somewhat uncharacteristic 
of normal plasma cells. Most of them labeled positively for CD79b and MHC II, 
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suggesting that these cells do belong to the B-cell lineage, but may be indicative of a 
hyper-proliferative response.  
Mucosa-associated lymphoid tissue (MALT) includes non-encapsulated lymphoid 
aggregates engaged in immunosurveillance in various tissues of the body, such as the 
respiratory, uro-genital and gastro-intestinal tracts. Gut-associated lymphoid tissue 
(GALT) comprises tonsils (palatine or oropharyngeal, lingual and tubal, which together 
form the Waldeyer’s ring), aggregated lymphoid nodules of the small intestine (Peyer’s 
patches) and large intestine lymphoid patches. Bronchus-associated lymphoid tissue 
(BALT) is composed of lymphoid aggregations in sub-mucosa of the 
bronchial/bronchiolar system of a range of mammals and is involved in the immune 
response to inhaled foreign bodies and infectious antigens (Bienenstock and McDermott 
2005). These masses of concentrated lymphoid tissue have similar function to the lymph 
nodes, with T- and B-cell zones and the presence of antigen-processing accessory cells. 
Plasma cells in the MALT produce all immunoglobulin subsets, predominantly IgA, 
which is released directly into specific secretions (such as saliva and respiratory 
mucous) and protects the mucosa against microorganism infections (Burkitt et al. 1993).  
Of interest for this study was MALT from the upper gastro-intestinal tract, such as 
tonsils, and within the bronchoalveolar respiratory system. GALT has been described in 
some marsupial species (Coutinho et al. 1994; Hanger and Heath 1994; Hemsley et al. 
1996; Old and Deane 2001, 2003a; Old et al. 2003a). In this study, the distinct palatine 
tonsils were examined from DFTD-affected devils. Anatomically, the devils’ palatine 
tonsils were situated at a similar location to the tonsils of other three marsupial species, 
the koala (Phascolarctos cinereus), and the brushtail and ringtail possums (Trichosurus 
vulpecula and Pseudocheirus peregrinus) (Hemsley et al. 1996). Not surprisingly, it had 
all the components commonly found in other mammals and it might be suggested that it 
plays similar role in the devil’s mucosa-associated immune responses.  
Detection of BALT in marsupials has been more ambiguous than detection of GALT; 
only few lymphoid aggregates were seen in two Dasyurid species, the red-tailed 
phascogale and the stripe-faced dunnart, but were easily identified in lung tissue of a 
macropod, the rufous hare-wallaby (Lagorchestes hirsutus), in which most animals 
examined were positive for mycobacteria infection. In contrast, no BALT was observed 
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in lungs of adult and developing tammar wallabies (Macropus eugenii) (Old and Deane 
2002, 2003a; Young et al. 2003; Old et al. 2004; Old et al. 2006).  
Lymphoid aggregates were seen in lung sections of DFTD-affected devils and contained 
mainly B-cells, which is typical for other mammals (Bienenstock and McDermott 
2005). Only a small lymphoid aggregate was seen in two sections of lung of a devil 
severely affected with multiple DFTD metastases (including in the lung), and it is 
possible that this devil had inadequate structural immune function, but a more extensive 
study would help to understand this phenomenon in devils with metastases. This 
observation contrasts to the study in the rufous hare-wallaby, in which BALT was easily 
observed. It was unknown whether these lymphoid aggregates in the wallaby developed 
in response to a specific antigenic challenge or were a basic histological feature of this 
species.  
Bone marrow is the primary organ for the formation of blood cellular components; it 
contains the haematopoietic stem cells, which give rise to erythroid, myeloid and 
lymphoid cell lineages (Burkitt et al. 1993). These cell populations are the originators of 
circulating mature white and red blood cells, megakaryocytes and all cells involved in 
immunity.  
Although no bone marrow of healthy devils (i.e. non DFTD-affected devil) was 
examined, the histological features from the DFTD-affected devils were similar to those 
present in other mammals, suggesting that the cellular function of this organ is not 
substantially compromised by DFTD. The exception for this was the development of 
bone marrow DFTD metastasis in one animal (TD 74) and florid B-cell proliferation 
(TD 61), in another devil with severe DFTD metastases in various organs, but not 
evident in the examined bone marrow. As discussed earlier, B-cell proliferation may 
occur in response to extensive systemic inflammation. 
Immune cell association was seen in all DFTD tumours examined in this study, 
independent of the size or stage of disease. This observation does not appear to 
correspond to the study of Loh and colleagues, which detected lymphocytes in 
association with DFTD tumours in H&E sections in only 7% of the cases and the 
detection of CD3 and LSP1+ cells in 8 of 18 DFTD tumours examined (44%) (Loh et 
al. 2006a; Loh et al. 2006b). However, both studies by Loh and colleagues and the 
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results presented here, consistently identified a paucity of immune cells infiltrating 
amongst the neoplastic cells. The location of the immune cells in the peripheral 
connective tissues adjacent to the tumour masses and occasionally in association with 
perivascular beds suggests that the lymphoid cell presence is not tumour specific.  
Antibodies against the highly conserved domains of antigens related to lymphoid and 
myeloid origin cells, CD3 and LSP1, labeled successfully the Tasmanian devil 
lymphoid cells, but not DFTD. This finding was consistent with the work done by Loh 
and colleagues (2006b), which attempted to classify the tissue of origin of DFTD. These 
authors also found antibody against CD79b to be non-reactive in devil’s immune 
tissues, however, results described here clearly show strong positive labeling of devils’ 
B-lymphocytes and plasma cells with this antibody in a range of immune system tissues. 
DFTD tumour cells, however, were negative for CD79b, although a non-specific 
background was constantly observed.  
It has been suggested that DFTD tumour cells are of neuroendocrine origin, based on 
the positive expression of vimentin, S-100, neuron specific enolase, chromogranin A 
and synaptophysin and negative labeling for cytoskeletal subunit proteins of muscle, 
neural, endothelial and myeloid origin (Loh et al. 2006b). In contrast, the mRNA 
expression of MHC II by DFTD tumour cells (Siddle et al. 2007), suggests an immune 
related origin cell, such as macrophage, dendritic cell or B-lymphocyte. The 
immunolabeling of DFTD tumours presented here corroborate the view that these 
malignant cells are not of lymphoid or myeloid origin, although this cannot be 
completely discarded, as only few antibodies react against devil’s lymphoid cells.   
Tumours can migrate and invade tissues far from the primary tumour, i.e., metastasize, 
which is a hallmark of malignant tumours. Five out of six DFTD-affected devils with 
large tumours had metastasis in the analysed submandibular lymph node. This is the 
first node to drain antigens from the mouth and facial area, and most likely, encounter 
dislodged DFTD tumour cells that travel through the lymphatic vessels. Lungs and 
kidneys were also common organs bearing DFTD metastasis. Loh and colleagues 
recorded 65% of metastasis involvement in DFTD cases, mostly involving the regional 
draining lymph node, followed by lungs and spleen (Loh et al. 2006a). Results showed 
here illustrate the high incidence of spread of DFTD tumour cells into lymph node 
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tissue in devils with advanced tumours. Metastases to lungs and kidneys were a constant 
finding in this last group and, interestingly, in two devils with small tumours. One devil 
(TD 61) had the initial tumour surgically removed from a highly vascular area of the 
face and it could be suggested that this procedure promoted the haematogenic spread of 
DFTD tumour cells. The other animal (TD 89), however, was a wild devil, which had 
obvious haematogenic spread of DFTD throughout the body. Auto-infection (transfer of 
DFTD tumour cells from one site to another) in and round the mouth has been proposed 
(D. Obendorf, personal communication) and bronchogenic transfer of DFTD tumour 
cells is likely to happen through accidental inhalation and subsequent seeding of the 
tumour in lung tissue, although this was not definitely demonstrated in the cases 
presented here.  
This study has established that healthy and DFTD-affected Tasmanian devils have all 
the structural and cellular elements for an adaptive immune response. This is illustrated 
by the blood leukocyte ranges according to disease status, the histo-architecture of the 
primary and secondary lymphoid organs and the distribution and abundance of T-, B- 
and MHC II cells, as demonstrated by immunohistochemistry studies. Analyses of the 
lymphoid tissues of devils affected by DFTD provided important information about the 
immune response (or tolerance) induced by the disease; plasma cell proliferation was 
the most common alteration found in the lymphoid tissues and that could be caused by 
inflammatory reaction induced by bacterial contamination in the tumours. 
Myeloproliferation and plasmacytosis in organs of the immune system have been seen 
in other cancer studies, such as the transmissible sarcoma of the Syrian hamster 
(Fabrizio 1965), and may have a correlation with DFTD. In the case of conventional 
tissue allografts amongst animals with genotypic diversity, it might be expected that an 
immune response would cause a florid reaction, but this has not been demonstrated 
against DFTD tumours. Indeed, immune cells did not infiltrate into the primary tumours 
and metastases, but rather were present in low numbers at the outer margins, suggesting 
that DFTD cells have evolved mechanisms to avoid immune detection. Using an 
antibody against the HLA-DR region, it has been shown that DFTD tumour cells did not 
express MHC II at the cell surface level. Further studies using different techniques, such 
as western blot, would help to characterise the MHC machinery of DFTD tumour cells.  
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It is not yet clear why DFTD-affected devils fail to develop effective immunological 
rejection of the facial tumour allografts that establish through devil-to-devil transfer of 
viable tumour cells. The apparent inability of DFTD-affected devils to recognise these 
neoplasms and develop a tumour-specific immunological response, coupled with the 
absence of any free-ranging devil cases demonstrating tumour regression reinforces the 
need to continue research into the immunogenetic aspects of this serious disease. 
Functional studies of the immune system of the Tasmanian devils will demonstrate 
whether the species experiences immunosuppression and is, therefore, susceptible to a 
tumour graft infection. 
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4.1 – Introduction 
The transmissibility of DFTD by cell implantation raises many questions about the 
status of immune responses of Tasmanian devils. The marsupial immune system has 
many different features to its eutherian counterparts and it was arguably thought to be 
more primitive, therefore, it might be possible that Tasmanian devils demonstrate 
impaired immune responses against pathogens. However, recent genomic research has 
challenged this idea (Wong et al. 2006) and further functional studies are warranted. 
 Some marsupials, such as brushtail possums (Trichosurus vulpecula), tree kangaroos 
(Dendrolagus sp.), opossums (Didelphis sp.), quokkas (Setonix brachyurus) and koalas 
(Phascolarctos cinereus), are known to exhibit somehow diminished cellular and 
humoral immune responses (Stanley et al. 1972; Croix et al. 1989; Wilkinson et al. 
1992b; Cooke et al. 1995; Montali et al. 1998) and are therefore likely to exhibit poor 
anti-tumour immunity. Cellular immune responses are the main effector mechanisms by 
which the immune system deals with tumours and therefore studies in T-cell 
competency are of paramount importance. Of particular relevance for the devil is the 
lack of evidence for infiltrating T-lymphocytes within the tumour (Loh et al. 2006a; 
Loh et al. 2006b), implicating a lack of immune involvement and suggesting impaired 
immunity. 
One way to evaluate T-cell responses is to use in vitro mitogen proliferation of 
lymphocytes, which is easily performed and does not require invasive procedures to the 
animal. Mitogens have been shown to stimulate lymphocytes to polyclonaly activate 
and proliferate in a range of immunocompetent vertebrates (Kristensen et al. 1982), 
therefore being a suitable assessment for cellular immune response in Tasmanian devils.  
An antibody response to an antigen (or a group of antigens) would indicate a functional 
immune response and support the concept that DFTD is not transmitted as a 
consequence of seriously impaired immunity. In addition, this experiment would be a 
necessary in vivo study to gauge the response of Tasmanian devils to an antigen that 
requires the cooperation of several different immune mechanisms.  
Cytotoxic T-lymphocytes (CD8+) are the main effector cells against tumours. In the 
presence of an effective in vitro and in vivo cellular and humoral immune response, the 
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next aspect to investigate was the capacity of Tasmanian devils to produce cytotoxic 
T-cells. This experiment should indicate whether DFTD tumours are not rejected due to 
a lack of effector cells to carry out the immune response. 
Under normal circumstances, when any organ or tissue, including cancer, is 
transplanted from one host to another, it is rejected by the immune system of the 
recipient.  Even closely matched transplants are rejected unless the recipient receives 
therapy to severely suppress their immune system. With the ease of transfer of DFTD 
between unrelated devils, the status of their immune system must be questioned and 
consequently immune investigations are clearly warranted. The immune system of the 
Tasmanian devil has all the major components for an immune response (Chapter 3), but 
the function of its immune system needs to be tested. 
In this chapter, the cellular and humoral immune responses of Tasmanian devils were 
evaluated; phagocytosis of bacteria by neutrophils, mitogen induced lymphocyte 
proliferation, antibody production in response to a cellular antigen and cytotoxic T-cell 
responses were used to determine whether an impaired immune response may help 
explain how Tasmanian devils can succumb to an ‘infectious’ cancer. 
4.2 – Methods 
4.2.1 – Cellular immune response experiments 
4.2.1.1 – Animals  
For the mitogen assays, devils were divided in four groups (Table 4.1). Captive 
Tasmanian devils were maintained by the Department of Primary Industries and Water 
(DPIW), Tasmania, and were housed as described in Section 2.3.2.3. Disease free and 
diseased Tasmanian devils were obtained from different regions in Tasmania. The 
free-living devils from areas where DFTD was not present at the time of this research 
(north west coast of Tasmania and Narawntapu National Park) are referred to as disease 
free area devils. Healthy free-living devils from areas where the disease had been 
present for varying periods of time (eastern half of Tasmania) are referred to as diseased 
area devils. Diseased devils were all free-living and from various regions of eastern 
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Tasmania. Anaesthesia and blood collection were performed as described in 
Section 2.3.3 and Section 2.3.4.  
Group Description 
Healthy captive devils 
Devils that were born in captivity or had been kept 
in captivity for at least 1 year 
Healthy devils from 
disease free areas 
Devils showing no sign of DFTD from areas where 
DFTD was not present at the time of collection 
(north west of Tasmanian and Narawntapu National 
Park) 
Healthy devils from 
diseased areas 
Devils showing no signs of DFTD from the eastern 
half of Tasmania, where the disease had been 
present for varying periods of time 
Diseased devils Devils with varying stages of DFTD 
Table 4.1: Groups of Tasmanian devils from which blood was collected for the 
mitogen assays. 
 
In addition, mitogen assays were carried out using three Tasmanian devils that were 
infected with DFTD as part of a DFTD transmission trial, undertaken at Mount Pleasant 
Laboratories (DPIW) by Dr Stephen Pyecroft. Two Tasmanian devils received a DFTD 
tumour implant in the subcutaneous tissue and one animal received injections of 106 
DFTD tumour cells (from culture). Table 4.2 summarises the protocol used for these 
devils.  
4.2.1.2 – Cell separation 
On arrival of the samples, the blood was transferred to 10 mL centrifuge tubes and 
centrifuged at 1300 g for 15 minutes at room temperature. Plasma was collected and 
stored in a 10 mL tube until use. The buffy coat was collected and diluted to 20 mL 
with RPMI 1640 incomplete culture medium. All steps were performed under sterile 
conditions. 
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 TD 22 TD 44 TD 52 
Procedures 
Injected with 106 DFTD 
tumour cells in the 
cheek and shoulder. 
Developed tumours in 
both locations on Week 
2 
Implanted with 1 cm3 
active tumour tissue 
(from a diseased devil) 
in the lip and shoulder. 
Developed tumours in 
both locations on Week 
14 
Implanted with 1 cm3 
active tumour tissue 
(from a diseased devil) 
in the lip and shoulder. 
Developed a tumour in 
the cheek on Week 14 
 Bc Mitogen Bc Mitogen Bc Mitogen 
Week 0 ✓ 
Con A and 
PWM 
✓ 
Con A and 
PWM 
✓ 
Con A and 
PWM 
Week 3 ✓ Con A ✓ 
Con A and 
PWM 
✓ 
Con A and 
PWM 
Week 5 ✓ Con A ✓ 
Con A and 
PWM 
✓ 
Con A and 
PWM 
Week 7 ✓ Con A ✓ Con A ✓ 
Con A and 
PWM 
Week 11 ✓ 
Con A and 
PWM 
✓ 
Con A and 
PWM 
✓ 
Con A and 
PWM 
Blood 
collection 
Week 19 ✗ Con A ✓ 
Con A and 
PWM 
✓ 
Con A and 
PWM 
Table 4.2: Mitogen experiments performed with Tasmanian devils used in the DFTD transmission 
trial.  Bc: blood collection. 
4.2.1.2.1 – Mononuclear cell preparation 
For the mitogen assays, six aliquots of 3.5 mL of diluted buffy coat was overlayed 
carefully onto 4 mL of Histopaque 1077®. Samples were centrifuged at 700 g for 30 
minutes at room temperature with the brake off. The interface containing the 
mononuclear cells was collected using a sterile plastic Pasteur pipette, avoiding clumps 
or aggregates of red cells that could still be present. The remained buffy coat after the 
mononuclear cell separation was collected for the experiments in the next section.  Cells 
were washed twice in 10 mL of RPMI 1640 incomplete, centrifuging at 200 g for 
10 minutes each time. The pellet was resuspended in 1 mL of RPMI 1640 incomplete 
and a cell count was performed. In the first experiments, vital dye exclusion was 
performed using trypan blue and cell viability was found to be > 95%. Therefore, 
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Turk’s solution was used instead of Trypan blue in subsequent experiments. The main 
advantage of using this solution is that the nuclei of the cells were stained dark blue, 
allowing for counting of only mononuclear cells. Briefly, 20 µL of cell suspension was 
mixed in a well with 20 µL of Turk’s solution. After 5 minutes, 20 µL of this cell 
suspension was placed on a haemocytometer chamber and cells were counted within the 
central 25 squares under 400 x magnification. Total cell concentration (TCC) was 
calculated using the following formula: 
TCC = number of MNC counted/number of squares counted x 25 x dilution factor x 104 
In general, a contamination of 5 to 10% of polymorphonuclear (PMN) cells was found 
in the samples, but never exceeding 20%. Cells were then diluted to a concentration of 
106 mononuclear cells/mL using RPMI 1640 incomplete and supplemented with 
autologous plasma (final concentration of 10%). 
Mononuclear cell separation for cytotoxic T-cell experiments is described on Section 
4.2.1.7.2. 
4.2.1.2.2 – Polymorphonuclear cell preparation 
The buffy coat from the Histopaque 1077® was collected and diluted in 5 mL of RPMI 
1640 incomplete. This cell suspension was overlayed carefully on 4 mL of 
Histopaque 1119® and centrifuged at 700 g for 30 minutes with the brake off. The 
interface containing the PMN cells was collected and washed twice in 10 mL of RPMI 
1640 incomplete, centrifuged at 200 g for 10 minutes each time. 
The pellet was resuspended in 1 mL of RPMI 1640 and cells were counted as described 
above. When required, cells were diluted to a final concentration of 2-6 x 106 PMN 
cells/mL with RPMI 1640 incomplete. Figure 4.1 illustrates the main steps performed 
for mononuclear and polymorphonuclear cell separation. 
4.2.1.3 – Phagocytosis uptake assay 
4.2.1.3.1 – Preparing bacteria stock 
Escherichia coli was cultured for 18 hours at 37ºC in nutrient broth. The culture was 
centrifuged at 1300 g for 20 minutes; the pellet was resuspended in 20 mL of PBS and 
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centrifuged again at 1300 g for 20 minutes. The pellet was resuspended in 20 mL of 
PBS and vortex mixed. Bacteria were enumerated by serial dilutions and heat 
inactivated at 60ºC for one hour. The solution was centrifuged and resuspended in 
20 mL of PBS and divided into aliquots of 1 mL in Eppendorf tubes, which were frozen 
at –80ºC until use. The final concentration of the bacterial suspension was usually 
between 6-7 x 107 cells/mL. 
4.2.1.3.2 – Labelling the culture 
Prior use, a 1 mL aliquot of bacteria stock was thawed and incubated with 25 µL of 
FITC at 1 mg/mL on a platform mixer at 37ºC for 2 hours. Bacteria stock was 
microcentrifuged at 11300 g for 1 minute three times using PBS as a washing solution. 
The fluorescence was checked under a UV microscope and more washes were 
performed if necessary. For opsonization of bacteria, 100 µL of plasma from the animal 
to be tested was added and incubated at 37ºC for 15 minutes. The suspension was 
microcentrifuged at 11300 g for 30 seconds, the supernatant discarded and the pellet 
resuspended to 1 mL with PBS. 
4.2.1.3.3 – Phagocytosis uptake 
The phagocytosis uptake assay was modified from previously published technique (van 
Eeden et al. 1999). Aliquots of 200 µL of the neutrophil suspension were added to 
200 µL of inactivated FITC labelled Escherichia coli suspension and incubated at 37ºC 
for 30 minutes. The ratio of fluorescent bacteria:neutrophil was approximately 10:1. At 
these time points, an aliquot of this suspension was taken from the tube and cellular 
metabolism was stopped by adding a solution of PBS / 2% BSA / 0.05 % NaN3 and kept 
on ice until analysis, at which time the conjugated solution was washed three times and 
placed in tubes for flow cytometry analysis. Fifty microlitres of trypan blue (0.25%) 
was added to quench the fluorescence of non-internalised bacteria. For the flow 
cytometry analysis, a minimum of 10000 events was evaluated and the neutrophil 
population gated on the basis of forward and side scatter. 
Samples were also analysed with an ultraviolet microscope; cell suspension was fixed 
with FACS FIX solution and the nuclei of the cells were stained with propidium iodide. 
Confocal laser microscopy was also used to confirm that bacteria were internalised.  
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4.2.1.4 – Nitroblue tetrazolium assay 
The nitroblue tetrazolium assay was adapted from Gifford and Malawista (1970). 
Neutrophils were suspended in a solution of 2 mg/mL of nitroblue tetrazolium (NBT) 
and 0.1 µg/mL of phorbol myristate acetate (PMA) and incubated at 37ºC for 
15 minutes. The suspension was washed three times and the cells attached to glass 
slides and counterstained with 0.25% saffranin red solution. Positive cells were 
enumerated using light microscopy. 
4.2.1.5 – Mitogen assays 
Mitogen assays were adapted from Kristensen and colleagues (1982). Mitogen assays 
were performed in 96 well plates, U bottomed with lids. To the first three wells (A1 –
 A3) 200 µL of double the highest concentration of the mitogen required was added. 
One hundred microlitres of RPMI 1640 incomplete was mixed in the following wells 
(A4 – A12). One hundred microlitres of mitogen from the first three wells was added to 
the following three wells (A4 – A7), resulting in doubling dilutions of the mitogen, and 
allowing the experiment to be performed in triplicate. This was repeated 4 times for 
each mitogen and the remaining 100 µL of mitogen from the last three wells were 
discarded. This provided the cell suspensions with four doubled dilutions for each 
mitogen. One hundred microlitres of the mononuclear cell suspension in RPMI 
supplemented with 20% autologous plasma was added to the wells, plus to three wells 
with only RPMI incomplete (as a control). The highest mitogen dilutions used are 
shown in Table 4.3. 
Mitogen Highest concentration 
Concanavalin A (Con A) 50 µg/mL 
Phytohemagglutinin (PHA) 100 µg/mL 
Pokeweed mitogen (PWM) 2 µg/mL 
Lippopolysaccharide (LPS) 25 µg/mL 
Table 4.3: Highest mitogen concentration used. 
Cells were incubated for 72, 96, 120 or 144 hours with serial dilutions of the mitogens 
PHA, Con A, PWM and LPS and pulsed during the last 18 hours with 1 µCi [methyl-
3H] Thymidine. Cells were then harvested onto a filter paper on a cell harvester and 
tritiated thymidine incorporation measured with a liquid scintillation counter. In order to 
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compare the four different groups, the results were expressed as stimulation index (SI) 
where SI = counts per minute stimulated cells / counts per minute unstimulated cells. 
Other results are expressed as counts per minute (CPM). 
As a comparison, lymphocytes from two eastern quolls (Dasyurus viverrinus), a close 
relative of Tasmanian devils, as well as lymphocytes from two human volunteers were 
stimulated with Con A and PWM. These cultures were supplemented with autologous 
plasma and foetal calf serum respectively. Other incubation conditions were as 
described for the Tasmanian devils. 
4.2.1.6 – Statistical analysis 
Statistical analyses were performed by Mr Stephen J. Quinn from the Menzies Research 
Institute. For each study factor, where possible, a linear mixed model of the form  
Yij = β0 + β1cij + β2gj + β3cgij + µ0j + µ1jcij + εij  
was fitted, where Yij is the observed outcome factor for the ith concentration level of the 
jth devil, β0 is the mean exposure level at concentration zero for the reference group, β1 
is the mean slope for the linear concentration trend cij, β2 is fixed effect associated with 
the categorical variable gj denoting a devil grouping, β3 is the fixed effect associated 
with the interaction of concentration by group cgij, µ0j is the random effect associated 
with the jth devil specific intercept, µ1j is the random effect associated with the linear 
affect of concentration and εij is the residual associated with the ith concentration level 
for the jth devil.  Appropriate covariance structures were fitted for the random effects, 
and residual and influence diagnostics were investigated to ensure model validity.  
Mean differences and confidence intervals were calculated between groups for each 
concentration level. All analyses were conducted using Stata 9.2. 
4.2.1.7 – Cytotoxic T-cell assay 
4.2.1.7.1 – Immunisation with K562 tumour cells 
One captive female devil (TD 114) was immunised subcutaneously with 108 K562 
tumour cells (a human leukaemia tumour cell line) suspended in 1 mL of sterile PBS 
and 1 mL of Montanide 639101 adjuvant. Immunisation was carried out on Day 1 and 
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Day 28 and blood was collected prior to the first and seven days after each 
immunisation. 
4.2.1.7.2 – 51Chromium release assay 
This assay was adapted from Brunner and colleagues (1968) and performed by Miss 
Gabriella Brown. Whole blood was diluted 1:2 in sterile PBS, overlayed on half the 
volume of Histopaque 1077® and centrifuged at 700 g for 30 minutes with the brake 
off. Mononuclear cells were harvested, washed and counted as described on Section 
4.2.1.2.1 and diluted to 5 x 106 cells/mL in 700 µL of complete RPMI 1640. 
K562 tumour cells were harvested from the culture flask and washed once with fresh 
complete RPMI 1640 medium (300 g for 10 minutes). The supernatant was decanted 
and the cell suspension was resuspended in a minimum volume of complete medium.  
One hundred microcurie (µCi) of Na251CrO4 (thereafter referred as 51Chromium) was 
added to the cell suspension and incubated in a water bath at 37ºC for 2 hours. Cells 
were washed twice with incomplete medium as described above and resuspended in 
1 mL of complete medium. Cells were checked for radiation labeling with a portable 
gamma counter before the assay was performed. Cells were resuspended in 3 mL of 
complete medium at a concentration of 105 cells/mL. 
The experiment was set up in 96 well plates (as described for the mitogen assay). Two 
hundred microlitres of the diluted mononuclear cells were placed in three wells and a 
double dilution (with complete medium) was performed 5 times (100 µL in each well). 
One hundred microlitres of the labeled tumour cells were placed in each well and 
mixed, so that the ratio of lymphocyte: target cells was from 50:1 to 3:1. Target cells 
were placed in wells with complete medium (as a control for spontaneous 51Chromium 
release) and with a solution of Triton 1% (as a control for maximum 51Chromium 
release). Plates were incubated for 18 hours at 37ºC and 5% CO2. Maximum release 
was usually 10 to 20 x higher than the spontaneous release. 
After incubation, the plate was centrifuged for 4 minutes at 200 g and 100 µL of the 
supernatant of each well was placed in a previously labeled acrylic tube. Tubes were 
covered with parafilm and gamma radiation was counted in a gamma counter. Results 
were given in % cytotoxicity, which was calculated with the formula: 
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% cytotoxicity = (experimental CPM – spont CPM) / (max CPM – spont CPM) x 100, 
where CPM are counts per minute.  
4.2.2 – Humoral immune response experiments 
4.2.2.1 – Animals and blood collection 
Four Tasmanian devils were maintained by DPIW and kept in secure pens, as described 
in Section 2.3.2.2. Anaesthesia and blood collection was performed as described in 
Sections 2.3.3 and 2.3.4. Clotted blood was centrifuged at 1000 g for 10 minutes and the 
serum was aliquoted and stored at –80ºC. Blood in tubes containing lithium heparin 
were kept at room temperature until arrival in the laboratory and processed on the same 
day. 
4.2.2.2 – Horse red blood cell immunisation protocol 
Four captive Tasmanian devils (2 males & 2 females) were divided into two groups and 
either immunised subcutaneously or intraperitoneally against defibrinated and washed 
horse red blood cells (HRBC). The ‘intraperitoneal immunisation group’ consisted of 
two adults (one male and one female), which were immunised intraperitoneally with 
0.5 mL of 100% HRBC per Kg of body weight. The ‘subcutaneous immunisation 
group’ consisted of one juvenile female and one adult male, which received 500 µL of 
50% HRBC mixed with the adjuvant Montanide ISA 775 VG for the first immunisation 
and Montanide ISA 763 VG for the following injections. All animals were immunised 
on Weeks 0, 4, 8 and 32 and blood was collected prior to the immunisation (pre-
immune) and after immunisation at regular intervals throughout a 40-week period. 
Table 4.4 summarises the protocol for both groups.  
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 Animals Description Dose of HRBC Adjuvant 
TD 111 Adult female  
Intraperitoneal 
immunisation 
TD 113  Adult male  
0.5 mL of 100% 
HRBC per Kg of 
body weight 
Not used 
TD 114 Juvenile female  
Subcutaneous 
immunisation 
TD 112 Adult male 
500 µL of 50% 
HRBC 
Montanide ISA 
775 VG and ISA 
763 VG 
Table 4.4: Animals, dose of HRBC and adjuvant used. 
4.2.2.3 – Haemagglutination assay 
Direct and indirect haemagglutination assays were performed in 96 V-bottomed well 
plates. For direct haemagglutination assays, 50 µL of serum samples diluted 1:25 were 
placed in the first well and serial double dilution performed in PBS, with the final well 
containing PBS only, to serve as a negative control. Twenty-five microlitres of a 
solution of 2% washed HRBC was then added to each well and incubated at 37ºC for 
one hour in a fully humidified atmosphere. For indirect haemagglutination assays the 
same procedure was employed with the addition of 10 µL of rabbit anti-devil Ig (see 
Section 2.3.5) diluted 1:20 in PBS after the first 30 minutes of incubation. Plates were 
shaken and incubated for a further 30 minutes. 
Haemagglutination was read by inclining the plates in a 45º angle and a positive result 
was recorded when at least 50% of the HRBC agglutinated. All experiments for each 
animal were performed at the same time to reduce experimental error and were repeated 
at least once.  
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4.3 – Results  
4.3.1 – Cellular immune response experiments 
4.3.1.1 – Chemotaxis and phagocytosis uptake assay 
The first mechanism of the phagocytic process is chemotaxis, i.e., the effector cells (e.g. 
neutrophils) must be able to respond to signals of inflammation and migrate to the 
injured tissue. This was demonstrated through the presence of neutrophils in 
histological sections of bacteria infected tumours (see Chapter 3, e.g. Figure 3.23 E-F).  
In order to determine whether the neutrophils were functional, phagocytic assays were 
undertaken on captive devils as the blood from these animals could be analysed more 
rapidly than the free-living devils. From the flow cytometry assay, most neutrophils 
effectively attached to the bacteria. A representative example is shown in 
Figure 4.2 A-B. The average attachment to bacteria for nine devils was 66% (±23) and 
internalisation (fluorescence of bacteria after quenching with trypan blue) 48% (±22), 
indicating active internalisation of the bacteria. This leads to the conclusion that 
neutrophils from the peripheral blood of healthy Tasmanian devils can attach to, and 
phagocytose, bacteria. Ultraviolet microscopy and confocal laser microscopy confirmed 
phagocytosis through the visualisation of internalised bacteria (Figure 4.2 C-G).  
4.3.1.2 – Nitroblue tetrazolium assay 
Phagocytosis also requires that internalised bacteria are digested and evidence for an 
active oxygen dependent pathway can be determined by analysis of the respiratory burst 
using the NBT assay. 
All devils analysed (nine captive devils and three devils from disease-free areas) 
demonstrated that more than 90% of cells had the characteristic features of NBT 
oxidation, thus indicating that the neutrophils of Tasmanian devils have a functional 
oxidative pathway (Figure 4.2 H). 
Figure 4.2. Phagocytosis uptake 
 
A-B: Representative flow cytometry dot plots showing fluorescence intensity of 
neutrophils before (A) and after (B) adding trypan blue following 30 min incubation 
with FITC-labeled E. coli. Numbers represent mean ± standard deviation from nine 
experiments. Results show that most neutrophils were capable of phagocytosing 
bacteria. 
C: Ultraviolet microscopy of a fixed neutrophil stained with propidium iodide showing 
FITC-labeled E. coli internalized in its cytoplasm. 
D-G: Confocal microscopy sectioning of a neutrophil with FITC-labeled E. coli. 
H: Positive cells for NBT test. NBT is reduced to formazan by products of the 
respiratory burst (mainly superoxide). Positive cells show a degenerated aspect with an 
associated blue-back precipitate (arrows). 
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4.3.1.3 – Lymphocyte proliferation 
4.3.1.3.1 – Establishment of lymphocyte proliferation assays 
Preliminary experiments were undertaken to determine the ideal culture conditions. 
Different periods of incubation (72, 96, 120 and 144 hours) were initially analysed and 
as shown in Figure 4.3 A, 96 hours of incubation produced the best proliferation for 
Con A, PHA and PWM.  
The next step was to compare foetal calf serum with autologous plasma as a culture 
supplement and, as DFTD tumour cells appear to prefer a lower culture temperature, 
incubation temperatures of 35ºC were compared to 37ºC. Autologous plasma was more 
stimulatory than FCS and 37ºC produced superior proliferation than 35ºC 
(Figure 4.3 B). The choice of autologous plasma over FCS was also based on the 
assumption that autologous plasma more closely mimics the in vivo situation than FCS 
and 37ºC was also favoured as this is the body temperature of devils. 
4.3.1.3.2 – Lymphocyte proliferation responses 
Lymphocyte stimulation response was analysed using the mitogens Con A, PHA, PWM 
and LPS. No response to LPS was demonstrated (n=6, Table 4.5), even when higher 
mitogen concentrations were attempted (50 and 100 µg/mL). However, Con A, PHA 
and PWM all showed varying degrees of lymphocyte stimulation.  
Concentration of LPS (number 
of animals) 
Stimulation index 
(SD) 
6.2 µg/mL (5) 1.3 (±1) 
12.5 µg/mL (6) 1 (±0.4) 
25 µg/mL (6) 1.3 (±0.4) 
50 µg/mL (1) 1.7 
100 µg/mL (1) 1.2 
Table 4.5: Stimulation indices in response to LPS. 
Consistent with all the mitogens was the wide range of responses in each of the four 
groups of devils. With each mitogen, and within each group, there were devils that only 
responded slightly above background as well as devils that showed strong responses, 
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thereby indicating a wide variation (Figure 4.4). Con A induced the strongest response 
but there were also very strong responses to both PHA and PWM. 
Within each group of devils and with all mitogens, most devils produced stimulation 
indices of greater than 10, representing a 10-fold greater stimulation than background. 
Further, within each group, and with each mitogen, some devils produced stimulation 
indices greater that 100, demonstrating that lymphocytes from some animals could be 
highly stimulated. It was also clear from the data that most devils showed strong 
proliferation and only a minor proportion proliferated poorly with stimulation 
indices < 10. 
Of further relevance is the high concentration of mitogens required to induce maximum 
proliferative responses. For each mitogen it would appear that the highest concentration 
used did not reach the maximum response for all devils as some of the proliferative 
curves were still increasing. 
4.3.1.3.3 – Comparison of lymphocyte proliferative responses of males and females 
To determine if there was a difference between male and female devils, mitogen 
responses were compared between males and females (Figure 4.5). Both male and 
female devils showed a large variation in the responses. Using the linear mixed model 
outlined in Section 4.2.1.6, there was no significant difference between males and 
females. 
4.3.1.3.4 – Comparison of lymphocyte proliferative responses of adults and juveniles 
As DFTD is more common in devils older than 2 years or age (adults), the responses to 
mitogen induced lymphocyte proliferation of these animals was compared with devils 
of 1 year of age (juveniles), to determine whether the immune response of adults is 
weaker than juveniles, which may make them more susceptible to DFTD. Figure 4.6 
shows a similar trend as both adults and juveniles responded to a similar extent and a 
wide variation again was identified. Using the linear mixed model outlined in Section 
4.2.1.6 there was no significant difference between the adults and juveniles. 
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4.3.1.3.5 – Comparison of lymphocyte proliferation of healthy and diseased animals 
As shown in Figure 4.4, there was a wide range of responses with both healthy and 
diseased devils, with the diseased devils showing a similar range of responses to the 
healthy devils. To determine if diseased devils had similar responses to healthy devils 
we compared healthy devils from diseased areas with diseased devils using the linear 
mixed model outlined in Section 4.2.1.6 and there was no significant difference between 
these groups.  
4.3.1.3.6 – Comparison of lymphocyte proliferative responses with other species 
To determine whether the range of responses within devils was comparable with other 
animals, Con A and PWM stimulation was undertake with lymphocytes from another 
marsupial, the eastern quoll, as well as from humans. Results for devils, quolls and 
humans are shown in Figure 4.7 and demonstrate that when the optimum mitogen 
concentration was used, lymphocytes from devils produced responses greater than the 
eastern quolls and were comparable to the human lymphocytes. However, the mitogen 
concentrations were greater with devils. 
4.3.1.3.7 – Analyses of lymphocyte proliferative response variation 
Substantial variation among devils was a common feature of mitogen-induced 
proliferation. To determine whether the variation was due to individual animals failing 
to respond or due to a variation in an individual animal’s response, two devils (TD 1 
and TD 5) were tested on three separate occasions. The maximum stimulation indices 
from each culture are shown in Figure 4.8 A, and it can be seen that repeat blood 
samples from the same devil showed variation in mitogen induced lymphocyte 
proliferation. For example TD 5 responded poorly on the 1st and 3rd test but extremely 
well on the 2nd test. 
As variation occurred with repeated sampling, different plasma samples were tested to 
determine whether the variation in proliferation could be due to inhibitory factors 
present in the plasma. When the same lymphocytes were cultured with allogeneic 
plasma from different animals, the lymphocyte proliferation was supported to different 
extents (Figure 4.8 B) indicating a varied ability of different plasmas to support 
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lymphocyte proliferation. Interestingly, lymphocytes from TD 42 did not proliferate in 
autologous plasma, but responded well to allogeneic plasma. 
To determine whether lymphocytes from different devils would show variation in the 
proliferation, lymphocytes from three different devils (TD 46, TD 49 and TD 51) were 
stimulated with Con A in the presence of the same allogeneic plasma. Again a variation 
in responses was identified, indicating that lymphocytes from different animals vary 
with their ability to proliferate (Figure 4.8 C). 
4.3.1.3.8 – Mitogen responses in DFTD transmission trial devils 
To determine whether a low lymphocyte proliferation response could be detected in 
Tasmanian devils prior to, and after infection with, DFTD tumours, three Tasmanian 
devils were tested for Con A and PWM stimulation during the course of DFTD 
infection and tumour development. Results are expressed as the highest CPM achieved 
for each mitogen at any concentration. All devils demonstrated high stimulation with 
the tested mitogens, prior to and after the infection and the growth of tumours 
(Figure 4.9 A-F). 
Little variation was seen for all experiments, except for PWM stimulation of TD 44 and 
TD 52, which increased from Week 0 and reduced after Week 5. Tumour development 
was apparent at Week 14, hence it is unlikely that it would affect the proliferation. 
Indeed, on Week 19 lymphocyte proliferations achieved high CPMs. Proliferations 
using Con A were high and uniform for all devils through the period of tumour 
infection and development, suggesting that immunosuppression is not required for 
DFTD tumour establishment.  
4.3.1.4 – Cytotoxic T-cell experiment 
To test T-cell cytotoxic activity, one Tasmanian devil was immunised with a human 
leukaemia tumour cell line, K562. No cytotoxic activity was detected prior the 
immunisation with K562 tumour cells. Seven days after the immunisation, however, 
approximately 20% of the target cells were killed at 50:1 lymphocytes per target cell 
ratio and 6% at half this ratio. After the second immunisation, a three-fold increase was 
seen in the 51Chromium release of K562 tumour cells, indicating an active cytotoxic 
T-cell killing process (Figure 4.10). 
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4.3.4 – Humoral immune response 
4.3.4.1 – Direct haemagglutination 
The direct haemagglutination (DHA) assay was performed to detect IgM-like 
agglutinating antibodies. The devils from both groups (intraperitonial and subcutaneous 
immunisation) showed high levels of antibody production, which exhibited an 
immediate and rapid rise in antibody production with responses identified within one 
week after immunisation (Figure 4.11 A-D). The antibody titres in all devils then 
declined by up to two to eight fold three weeks after the initial response; the second 
(Week 4) and third (Week 8) immunisations did not increase antibody titres in any of 
the devils. Antibody titres then remained constant until the fourth immunisation 
(Week 32), which further increased antibody levels up to eight fold. There was very 
little difference between the antibody titres in the male and female devils and the 
intraperitoneal versus subcutaneous routes of inoculation also produced similar titres. 
4.3.4.2 – Indirect haemagglutination 
Indirect haemagglutination assays were performed to detect total agglutinating and 
non-agglutinating antibodies, IgM and IgG-like. The devils immunised intraperitoneally 
had a similar trend in antibody titres to the DHA assay, as the antibody levels peaked at 
Week 1, with no increase in antibody titres after booster immunisations at Week 4 
and 8, but the third boost at Week 32 produced a moderate increase in antibody 
production. The devils immunised subcutaneously had antibody titres that peaked on 
Week 2. Individual variability was noted after the first immunisation between these two 
devils; at Week 4 there was a large increase in the antibody titre in the female devil that 
was not detected in the male devil. As with the DHA assays, the second boost at 
Week 8 did not alter antibody titres, but after the third boost (Week 32), a large increase 
(between 16 & 32-fold) was identified within both devils (Figure 4.11 A-D). 
Immunisation via the subcutaneous route, in the presence of adjuvant, produced 
detectable antibody titres and was clearly superior over injecting red blood cells 
intraperitoneally. Nonetheless, both routes produced antibody responses, reflecting a 
competent humoral immune response.  
Figure 4.11. Direct and indirect haemagglutination assay.  
 
Responses of intraperitoneal immunisation group (A-B) and subcutaneous immunisation 
group (C- D) are represented as individual curves. Dotted lines represent direct 
haemagglutination of horse red blood cells (IgM-like antibodies) and solid lines 
represent indirect haemagglutination of horse red blood cells (IgM and IgG-like 
antibodies). Arrows represent the time of immunisation with HRBC. Titres are the 
highest serum dilution which agglutinated at least 50% of horse red blood cells.  
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4.3.5 – Summary of results 
The main findings of this chapter were: 
• Neutrophils isolated from Tasmanian devils appeared to competently perform all 
steps in the phagocytosis process; 
• There was no significant differences in lymphocyte proliferation assays utilising 
lymphocytes isolated from healthy and DFTD-affected Tasmanian devils;  
• There was no significant differences in lymphocyte proliferation assays utilising 
lymphocytes isolated from male and female Tasmanian devils and adult and 
juvenile Tasmanian devils; 
• Lymphocyte proliferative responses of the Tasmanian devil appeared to vary 
with repeated sampling and different plasma samples (as supplement); 
• Tasmanian devils utilised in DFTD transmission trial experiments did not show 
impaired lymphocyte proliferation as demonstrated in stimulation assays with 
Con A and PWM; 
• One Tasmanian devil immunised against K562 tumour cells was shown to have 
cytotoxic T-cell activity in a 51Chromium release assay; 
• Four Tasmanian devils immunised against HRBC demonstrated anti-HRBC 
antibodies immediately after immunisation. The subcutaneous route, in the 
presence of adjuvant, was superior over the intraperitoneal route. 
4.4 - Discussion 
Studies on a range of marsupials (Stanley et al. 1972; Croix et al. 1989; Wilkinson et al. 
1992a; Cooke et al. 1995; Montali et al. 1998) have provided evidence suggesting that 
some immune responses in marsupial species may be poorly developed.  The immune 
response of Dasyurids (including the Tasmanian devil) has only received limited 
attention and it would be predicted, given above, that these animals would also have a 
poor immune response.  In order to evaluate this, cellular and humoral aspects of the 
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innate and specific arms of immune response of healthy and diseased animals were 
analysed. 
Analysis of neutrophil function was performed against E. coli as this is one of the most 
common species isolated from the faeces of Macropodidae family (Gordon and 
FitzGibbon 1999), which represents the major proportion of the devils’ food supply 
(Jones and Barmuta 2000). Flow cytometry, immunofluorescence assays and NBT dye 
reduction assays demonstrated strong evidence for the major features of the phagocytic 
process as effective bacterial attachment, uptake of bacteria and oxidative burst were 
identified. Additional work with gram positive bacteria may further demonstrate the 
devils’ neutrophil phagocytic function.  Other phagocytic cells such as macrophages 
(e.g. alveolar and peritoneal macrophages) were not analysed as the extraction process 
of such cells was deemed too invasive.  
Many marsupial species immunised with a range of antigens demonstrated lowered 
humoral immune response, compared to eutherian mammals (Rowlands et al. 1964; 
Rowlands 1970; Major and Burrell 1971; Yadav 1971; Thomas et al. 1972; Rowlands et 
al. 1974; Croix et al. 1989; Deakin et al. 2005). It would therefore appear that 
marsupials, in general, have a relatively poor humoral immune response when 
compared to eutherian mammals, which is emphasised by their slower induction of 
antibody production and a poor secondary or anamnestic response. This lower immune 
response, however, might still be protective against viral and bacterial diseases. In order 
to analyse in vivo immunity of the Tasmanian devil, the humoral immune response of 
this species against a cellular antigen, horse red blood cells, was evaluated.  
Direct haemagglutination assays were performed to represent agglutinating (IgM-like) 
antibodies. Of particular significance was the observation that within one week 
following the subcutaneous and intraperitoneal injection, antibody titres were already 
detectable, indicating a rapid response. The booster injections that were administered at 
4 and 8 weeks following the initial immunisation failed to evoke an increase in antibody 
titre, suggesting that the response had already peaked and there was an inability to 
recruit further naïve effectors’ cells. Nonetheless, these antibody levels remained 
relatively high until a further booster was given at 32 weeks. At this time there was 
evidence for an immediate (although moderate) secondary response, which increased 
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antibody titres by at least 8-fold. These findings are consistent with those in the 
literature (Rowlands 1970; Yadav 1971; Thomas et al. 1972; Croix et al. 1989; Deakin 
et al. 2005). 
Indirect haemagglutination assays were utilised to evaluate total antibody levels 
(agglutinating and non-agglutinating – i.e. IgM-like and IgG-like).  In a similar manner 
to the DHA, the intraperitoneal route showed a rise in antibody titre and boosts at 4 and 
8 weeks did not increase total antibody levels. There was evidence for a relatively weak 
memory response as a boost at 32 weeks slightly increased (2-fold) antibody titres. It 
would therefore appear that the intraperitoneal route does not produce a strong 
secondary, or anamnestic, response, a feature commonly associated with marsupials.  In 
contrast, devils immunised through the subcutaneous route did show evidence for a 
strong secondary response, with total antibody levels raised between 32 and 64-fold 
following the first booster. A memory response was also well recognised for both devils 
as the booster at Week 32 rapidly increased the antibody response up to 64-fold. These 
antibody titres were high, suggesting that the Tasmanian devil has a competent humoral 
immune system and shows evidence for a memory response following subcutaneous 
immunisation.   
A higher dose of antigen has been associated with higher and earlier humoral immune 
responses (Rowlands 1970; Deakin et al. 2005). In the study showed here, a much 
higher dose of HRBC in the peritoneum generated a weaker antibody production than a 
smaller dose of antigen coupled with an adjuvant. The adjuvants used in this experiment 
(Montanide ISA 775 VG and ISA 763 VG) proved to be safe, as it did not cause any 
adverse effect in any devil and it is possible that it was the reason for the higher titres in 
the subcutaneous immunisation group. 
Although only four animals could be tested, these findings support the concept that this 
species has a proficient immune function. Potentially this is a consequence of their 
lifestyle as they devour entire carcases, including the entrails, which are rich sources of 
bacteria and parasites. Furthermore, devils often bear severe biting wounds, which are 
accessible sites for bacterial infections. As discussed above, the neutrophilic phagocytic 
system of the Tasmanian devil appears to be functional and together with a competent 
antibody response, this species is likely to be well armed against a range of bacterial 
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and parasitic infections. These immune responses, however, would not be directed 
against other diseases, such as viruses or cancer. 
Similar to most members of the Dasyurid family, devils appear to be more susceptible 
to develop tumours rather than infection diseases when compared to other marsupials 
(Canfield et al. 1990). The only bacterial infection described to affect devils is 
trichinellosis, caused by Trichinella pseudospiralis. This bacteria was found to be 
present in up to 30% of the Tasmanian devil population, although the origin and the 
pathogenicity of such parasite is undetermined (Obendorf et al. 1990). Given the 
outstanding phagocytic and humoral immune response demonstrated by the devils in the 
experiments showed here, it is not surprising that few infectious diseases affect the 
health of the Tasmanian devil. The apparent susceptibility to develop tumours in this 
species, however, highlights the need to investigate T-cell immune response 
competency. 
Analysis of lymphocyte proliferation induced by mitogens was an important part of this 
research as anti-tumour immunity relies heavily on T-cell function. Initial experiments 
were undertaken to establish baseline parameters. For mitogen induced proliferation, 
96 hours in culture was optimal and autologous plasma was more supportive than foetal 
calf serum. Of interest was the requirement for high mitogen concentration to induce 
optimal responses, as this concentration was at least 10-fold higher than that required 
for eastern quolls and humans. A possible explanation could be a reduced level of 
receptor expression. This could be extrapolated to the in vivo situation where strong 
signalling may be required to induce lymphocyte activation.  
Similar to other marsupials such as the brushtail possum (Trichosurus vulpecula) and 
two species of opossum (Monodelphis domestica and Didelphis virginiana) peripheral 
blood lymphocytes showed strong proliferative responses to the T-cell mitogens Con A 
and PHA (Brozek et al. 1992) but, in the presence of autologous plasma, required 
higher concentrations than would be expected for eutherians. In order to keep 
conditions similar to the in vivo environment of the host animal, lymphocytes were 
cultured in autologous plasma and therefore factors present in the plasma may have 
reduced the effectiveness of the mitogens. This was overcome by higher mitogen 
concentrations, therefore a greater stimulatory signal was required.  Related 
Chapter 4: The immune response of healthy and diseased Tasmanian devils 
 
− 127 − 
experiments performed with foetal calf serum did not require such high mitogen 
concentrations for maximum proliferation, supporting the possibility that a factor in the 
devil plasma reduced effectiveness of the mitogens. 
The B-cell mitogen LPS did not induce proliferation in the lymphocytes of any devil 
tested despite the wide range of attempted concentration (6.25 to 100 µg/mL). LPS has 
been generally regarded as non-mitogenic to non-rodent species, although positive 
responses have been demonstrated in cow, pig and sheep (reviewed in Kristensen et al. 
1982). The absence of mitogenic stimulation by LPS is consistent with the responses 
observed in some eutherians (Kristensen et al. 1982) and other marsupials (Brozek et al. 
1992; Wilkinson et al. 1992a; Bettiol 2000) and it appears to be related to the source of 
gram negative bacteria used to extract LPS. PWM, on the other hand, induces T- and 
B-cells to proliferate and stimulated strong responses in the devil’s lymphocytes. As 
discussed above, the devil is at high risk of bacterial infections, and it is therefore not 
surprising that B-cells can be readily activated as these cells, through antibody 
production, play a vital role in protection against bacterial infections. 
In a heterogeneous outbred population of any species it is expected that a variation in 
immune responses would occur, e.g. vaccination responses in possums (Deakin et al. 
2005) but, with the low genetic diversity of Tasmanian devils (Jones et al. 2004) it 
would be predicted that the mitogen responses would not show much variation. The 
substantial range of mitogen responses was a particularly noteworthy finding as some 
animals completely failed to respond to the mitogens. This wide variation was observed 
between all groups of animals and within all groups, and therefore animals that failed to 
respond to the mitogens were not restricted to diseased areas.  There was also no 
correlation with age, gender or presence of DFTD, as a wide variation was found in all 
of these groups.  Particularly important was the observation that lymphocytes extracted 
from devils with DFTD responded to mitogen stimulation at similar levels to their 
disease free counterparts. This provides strong evidence that immune suppression at the 
lymphocyte proliferation level does not account for the exquisite susceptibility of these 
animals to the infectious cancer. Definitive evidence for this came from the experiments 
with the DFTD transmission trial devils, where no reduction in mitogen responses was 
seen in animals that were injected with DFTD tumours, before or after the procedure or 
after the tumour establishment. 
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A clue for the wide variation in mitogen induced lymphocyte proliferation was provided 
from follow up experiments with the same animal which showed that when analysed 
over a period of time there was substantial variation in responses ranging from very 
strong to a total failure to respond. Counts per minute of unstimulated controls were 
consistently low throughout the experiments, therefore data was presented as 
stimulation indices, allowing comparison between different groups. For individual 
comparisons, counts per minute were favoured. 
This was a combined effect of both the lymphocytes as well as the supporting plasma. 
Tasmanian devils brought to captivity have been shown to have normal baseline plasma 
cortisol levels four weeks after capture (Jones et al. 2005). Devils that showed variation 
in the proliferation of lymphocytes had been in captivity for at least one year and it is 
unlikely (although not impossible) that plasma cortisol release was responsible for the 
lower proliferations. If immunosuppression is an important contributing factor to the 
transmission of DFTD, it was not due to an inability to induce lymphocyte stimulation 
and proliferation.  
Cytotoxic T-cell activity was demonstrated in one captive devil through a standard 
51Chromium release assay. The target cell used was a human leukaemia tumour cell 
line, K562, which is widely used for natural killer cell assays due to the low MHC 
expression on these cells. This cell line was chosen due to the easily maintenance in 
culture and satisfactory labeling with 51Chromium.  After the first and especially the 
second immunisation, the lymphocytes of the immunised devil were shown to 
effectively kill the target cells, demonstrating an effective collaboration among different 
mechanisms of immune cells: cytokine production by helper T-cells, proliferation of 
cytotoxic T-cells and interactions with antigen presenting cells to promote target cell 
destruction. Although only one animal could be tested, these findings suggest a 
proficient cytotoxic T-cell response in the species. 
In this study, it was concluded that devils have an effective, although variable, cell 
mediate immune system.  Importantly, susceptibility to DFTD is not a consequence of 
severely impaired cell mediate immunity. However, as the variability in responses was 
large, one may hypothesise that devils undergo transient periods of immunosuppression, 
potentially during periods of high stress, such as during the mating season, and at this 
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stage could be more susceptible to DFTD. However, this is unlikely as demonstrated by 
the responses of the DFTD transmission trial devils to mitogens. The lack of immune 
response in DFTD-affected devils is unlikely to be caused by a humoral immune 
impairment, as all four devils in the immunisation experiment showed antibody titres 
against the tested antigen. These results, together with the evidence presented in 
Chapter 3 of normal anatomy and histology of the immune cells and tissues of the 
Tasmanian devil, provide compelling evidence for a fully functional immune response. 
The similarity in MHC genes amongst devils affected with these transmissible tumours 
and the DFTD cancer cells suggests that the tumour cells evade immune recognition in 
devils due to a similar MHC genotype to the tumour cells. Allograft acceptance, 
however, is only possible between identical MHC matches. Research on the MHC 
diversity of the Tasmanian devil population should cast light on this hypothesis and 
determine whether lack of MHC diversity is responsible for DFTD acceptance. 
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5.1 – Introduction 
Devil Facial Tumour Disease tumours are not rejected by devils, despite being a 
species-specific ‘cell allograft’. Under normal circumstances, when any organ, tissue or 
cell, including neoplastic tissue, is transplanted from one host to another, it is rejected 
by the immune system of the recipient. Organ transplants in humans are successful only 
by carefully matching immune response genes (MHC) between the transplanted organ 
and the recipient. Even then, closely matched transplants are rejected unless the 
recipient receives therapy to suppress their immune system. Identical MHC matches 
(e.g. between homozygous twins) are the exceptions that generally do not require 
immunosuppression (Berlanda et al. 2008). With strong evidence for a competent 
immune system within the free-ranging devil population, another explanation for the 
successful transmission of DFTD needs to be sought.  
Based on 11 polymorphic microsatellite loci, work published by Jones and colleagues 
(2004), suggests that devils have a low heterozygosity and allelic diversity (Jones et al. 
2004). Variation at these neutral markers, however, cannot be used to gather 
information on adaptive processes involving the interaction of individuals with their 
environment and their capacity to change, especially relevant to the analyses of the 
interaction between pathogen and host. This information (and much more, related to kin 
recognition, mating preferences and so on) is better represented in analyses of MHC 
variability (Sommer 2005; Schwensow et al. 2007). Molecular typing at MHC loci 
using single-strand conformation polymorphism (SSCP) demonstrated that the 
DFTD-affected devil population lacks MHC I diversity (Siddle et al. 2007) which may 
account for the successful acceptance of DFTD tumour cell allograft within a very high 
proportion of the eastern devil population (Hawkins et al. 2006).  
As a consequence of this lack of diversity, the Tasmanian devil could be compared with 
cheetahs (Acynonyx jubatus), one of the world’s most inbred species (Menotti-Raymond 
and O'Brien 1995). Loss of polymorphism in wild animals has been suspected to 
correlate with several survival impairments, such as low reproductive rates, high infant 
mortality, genetic abnormalities and predisposition to parasites and other infections 
diseases (O'Brien et al. 1985; Schwensow et al. 2007). This correlation is particularly 
difficult to prove with a limited amount of data in wild threatened species such as 
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cheetahs (Munson et al. 2005; Summers et al. 2005). If it can be shown that depletion 
of MHC diversity was responsible for the spread of DFTD in wild Tasmanian devils, 
this would be the first direct link between spreading and susceptibility of a disease and 
loss of MHC diversity (Siddle et al. 2007).  
The lack of MHC diversity to allow allograft transplantation still needs to be 
characterised through a functional analysis of MHC genes. In addition, although the 
devil population from the north west of Tasmania exhibited slightly lower 
heterozygosity and allelic diversity than its eastern counterpart (Jones et al. 2004), 
preliminary data indicates that there is a greater MHC diversity within the western devil 
population (K. Belov, personal communication), making analysis of this subpopulation 
imperative. 
An effective assay to test functional MHC diversity in a species is an in vitro 
experiment, the mixed lymphocyte reaction (MLR). Briefly, lymphocytes from different 
animals are cultured together and the allogeneic response should be higher within 
animals with more diversity in their MHC genes than within animals with poor MHC 
gene diversity. MLR assays have been performed in several species of marsupials and 
results from these experiments have been poor, as low, or even no, responses were 
detected (Fox et al. 1976; Infante et al. 1991; Stone et al. 1998). Due this lack of 
allogeneic response, marsupials have been tagged as “lazy immune responders” 
(Wilkinson et al. 1992a). However, an eutherian animal, the domestic cat (Felis catus), 
was once thought to be unresponsive in MLR cultures (Pollack et al. 1982) and later 
demonstrated to respond in MLR assays with a different protocol (Stiff and Olsen 1984; 
Gregory et al. 1987). Therefore, a protocol for MLR in the Tasmanian devil is of 
paramount importance in the investigation of MHC diversity in this species. 
If poor MHC diversity is to account for the successful allograft transplantation of DFTD 
tumour cells, devils from affected areas should not respond, or respond only weakly, in 
MLR experiments. By comparison, Tasmanian devils from the north west of the state, 
that possibly carry a more diverse range of MHC genotype than eastern devils, should 
respond strongly against each other and against the eastern devils.  
A more effective analysis of MHC function is the skin graft. Skin grafts between devils 
with various MHC genotypes, and especially between devils from the DFTD-affected 
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population, will demonstrate whether a lack of functional MHC diversity accounts for 
the successful allograft transplantation of DFTD tumour cells. Genetic inbreeding 
allowing allograft transplantation in wild animals has been characterised in at least two 
species, the cheetah and the pocket gopher (Thomomys bottae). Both species lack MHC 
variability in the population, probably due to a genetic bottleneck and inbreeding 
(O'Brien et al. 1985; Sanjayan and Crooks 1996).  
In this chapter, the MHC diversity of the Tasmanian devil population was investigated 
by mixed lymphocyte reactions amongst devils from the east and north west of 
Tasmania. DFTD has devastated the first population, while the second possibly carries a 
more diverse combination of MHC genes, making comparison between these two 
populations crucial.  Skin grafts between unrelated eastern devils from different 
geographic locations were performed to determine whether the low MHC diversity from 
the susceptible population was responsible for the DFTD tumour graft acceptance. 
5.2 – Methods 
5.2.1 – Mixed lymphocyte reaction 
5.2.1.1 – Animals 
Two sets of two-way mixed lymphocyte reactions were performed; the first used a pool 
of lymphocytes from 30 eastern devils (as stimulatory cells) against freshly isolated 
lymphocytes from individual animals (as responder cells). The second set was 
performed by mixing the lymphocytes from two individual devils from a range of 
different regions of Tasmania. These experiments were adapted from Nanra et al (1979, 
1980). 
For the first set of experiments, blood was collected from 30 eastern Tasmanian devils 
and used as a source for a pool of lymphocytes in the initial experiments. This pool of 
lymphocytes was cultured against freshly isolated lymphocytes from devils sourced 
from four regions of Tasmania, eastern Tasmania (Badger Island and Port Arthur), 
Narawntapu National Park, Granville Harbor and Birthday Bay (Table 5.1). Figure 5.1 
illustrates the locations and number of animals from each region used for these 
experiments and the origin of donors for the pool of lymphocytes. 
 
Origin Tasmanian devil 
Eastern Tasmania (all animals from Badger Island, 
except TD 5, which was from Port Arthur) 
TD 5, TD 6, TD 44, TD 52 and TD 53 
Narawntapu National Park TD 101, TD 102, TD 103 and TD 104 
Birthday Bay TD 63, TD 64, TD 65 and TD 66 
North west Tasmania (Granville Harbor) TD 69, TD 70, TD 71 and TD 72 
Table 5.1: Origin and identification of the Tasmanian devils used in the MLR against pooled 
lymphocytes. 
Figure 5. 1. Map of Tasmania showing the origin of Tasmanian devils used as 
source for the pool of lymphocytes used as “target” cells and four groups of 
Tasmanian devils used as source of “responder” lymphocytes. 
 
Red dots indicate the areas in eastern Tasmania where the lymphocyte donors for the 
pool of lymphocytes originated. Numbers next to the red dot indicate the number of 
donors. 
Black dots indicate the group of Tasmanian devils that were used as “responder” cells. 
The Eastern Tasmanian devil group comprised four animals from Badger Island and one 
devil from Port Arthur. Each of the remaining groups (Narawtapu National Park, 
Granville Harbor and Birthday Bay groups) comprised four Tasmanian devils. 
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For the second set of experiments, 15 Tasmanian devils of eastern Tasmania origin and 
nine devils of northwestern Tasmania origin were used. Devils from eastern Tasmania 
were divided in five groups and devils from the north west in four groups, according to 
the place of origin (Table 5.2). Figure 5.2 details origin and grouping of all animals. 
Housing, anaesthesia and blood collection were performed as detailed in 
Sections 2.3.2.3, 2.3.3 and 2.3.4.  
5.2.1.2 – Cell preparation 
Blood collected in lithium heparin tubes was transported to the laboratory and processed 
on the same day. Exception for this was for the MLR experiments using the devil 
pooled lymphocytes against fresh lymphocytes from devils from Narawntapu National 
Park, Birthday Bay and Granville Harbor, which were collected in the wild and 
processed on the following day. Whole blood was diluted 1:2 in sterile PBS (maximum 
10 mL of diluted blood) and carefully overlaid onto 5 mL of Histopaque 1077® in a 
15 mL sterile centrifuge tube. Tubes were centrifuged at 700 g for 30 minutes with the 
brake off. The layer containing the peripheral blood mononuclear cells (thereafter 
referred as lymphocytes) was gently harvested with a sterile plastic pipette into a 10 mL 
centrifuge tube. For the pooled lymphocytes, mononuclear cells were washed with 
sterile PBS twice (300 g for 10 minutes each wash) and then slowly frozen in a solution 
of 10% DMSO and 90% FCS at –80ºC. In addition, a pool of lymphocytes from six 
human donors was established for MLR in a comparison study. Peripheral blood was 
obtained from healthy human donors by venipuncture and cells were isolated and frozen 
as described for the devils. For the freshly isolated lymphocytes, washed cells were 
adjusted to 106 cells/mL in RPMI 1640 incomplete medium supplemented with 
10% devil pooled plasma (from at least ten healthy Tasmanian devils), glutamine and 
gentamicin. 
5.2.1.3 – Mixed lymphocyte reaction 
Initially, the pool of lymphocytes from 30 Tasmanian devils from various regions of 
eastern Tasmania was used against freshly isolated lymphocytes. When required, the 
pooled lymphocytes were thawed and diluted to a concentration of 106 cells/mL in 
RPMI 1640 incomplete medium supplemented with 10% devil pooled plasma, 
 Origin Group Tasmanian devil 
Nugent Group 1 TD 186, TD 187, TD 189 and TD 190 
Forestier Pen. Group 2 TD 188 and TD 191 
Bronte Park Group 3 TD 192 and TD 193 
Epping Forest Group 4 TD 196, TD 197, TD 198 and TD 199 
East 
Tasmania 
 Mt. William National 
Park 
Group 5 TD 194, TD 195 and TD 200 
Milkshake Hills Group 6 TD 180, TD 181 TD 206 and TD 207 
Granville Harbor Group 7 TD 184 and TD 185 
Temma Group 8 TD 182 and TD 204 
North 
west 
Tasmania Woolnorth Group 9 TD 183 and TD 205 
Table 5.2: Origin, grouping and identification of the Tasmanian devils used for MLR. 
Figure 5.2. Map of Tasmania showing the origin of Tasmanian devil groups used 
for the two-way mixed lymphocyte reaction. 
 
The eastern Tasmanian devils comprised five groups, from Nugent (Group 1), Forestier 
Peninsula (Group 2), Bronte Park (Group 3), Epping Forest (Group 4) and Mt. William 
National Park (Group 5).  
The western Tasmanian devils included four groups, from Milkshake Hills (Group 6), 
Granville Harbor (Group 7), Temma (Group 8) and Woolnorth (Group 9). 
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glutamine and gentamicin. The human pool of lymphocytes was cultured as described 
above, but supplemented with FCS. The freshly isolated lymphocytes were prepared as 
described above. For the second set of experiments (using freshly isolated lymphocytes 
from only two devils against each other), cells were isolated and prepared as described 
above. 
Mixed lymphocyte reactions were conducted in U-bottomed 96 well plates, mixing 
100 µL of pooled lymphocyte suspension (or one single devil’s lymphocyte suspension) 
with 100 µL of lymphocytes from another devil. Controls consisted of 200 µL of 
mononuclear cells from individual devils incubated alone and mononuclear cells of 
individual devils incubated with 50 µg/mL of Con A. Mixed lymphocyte cultures were 
incubated at 37ºC and 5% CO2 for 72 to 168 hours for the first experiments and 
144 hours for the second experiments. Mitogen controls were incubated under the same 
conditions, but for 96 hours. Eighteen hours prior the harvesting, cultures were pulsed 
with 1µCi tritiated thymidine to assess proliferation. All experiments were conducted in 
triplicates. 
Cells were harvested onto a filter paper and dried overnight at room temperature or for 
2 hours at 37ºC. The filter paper discs containing the cells were placed in plastic tubes 
with 2 mL of scintillation liquid and uptake of thymidine by proliferating cells was 
measured by radiation emittance using a liquid scintillation counter. Results were 
obtained in counts per minute (CPM) and stimulation indices (SI) could then be 
calculated. Stimulation index was calculated by the formula:  
SI = Average CPM of mixed culture / Average CPM of control cultures  
All SI controls were considered to be one in the MLR experiments, as no stimulation 
was characterised in autologous cultures. Mitogen stimulated culture controls were 
calculated by dividing the average of incorporated thymidine in stimulated cultures by 
non-stimulated cultures. 
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5.2.2 – Skin grafts 
5.2.2.1 – Animals 
Eight unrelated captive devils of eastern Tasmania were used for skin grafting 
experiments. Figure 5.3 shows the origin of each animal and the pairing for each 
experiment. 
5.2.2.2 – Surgery field preparation 
These procedures were performed simultaneously with two devils and with the help of 
at least one other veterinarian (Barrie Wells, Colette Harmsen or Kim Scogvold). 
General anaesthesia was performed as described in Section 2.4. For further analgesia, 
xylocaine 1% was injected in the subcutaneous tissue around the surgery site (not 
exceeding 20 mg/Kg). The animals were partially covered with towels or blankets to 
prevent heat loss and hypothermia during the procedure. 
The hair of the surgery field site (the dorsal area of the devil) was clipped and shaved 
and the surgery site was disinfected with a solution of chlorexidine (4.5 mg) and 
cetrimide (45 mg/30 mL). The surgery field was covered with a sterile fenestrated 
drape. 
5.2.2.3 – Skin grafting 
A plastic surgeon, Mr. Frank Kimble, performed all skin graft surgeries. A square 
(3 x 8 cm) was drawn on the skin of the mid-dorsal region of each devil and a 
dermatome knife with a sterile blade was used to “shave” 1 mm thick dermis and 
epidermis of the demarked skin. This loose piece of skin was divided into 
approximately two equal squares (approximately 3 x 4 cm) and one of them slid in to 
the cranial wound (autograft). The other piece (allograft) was placed in sterile 
Hartmann’s solution, until the same procedure had been performed on the other devil. 
The allograft skin pieces were then placed in the caudal position of the wound. Surgical 
glue was placed on the borders of the grafts to “secure” the skin. 
A sterile dressing was applied to the surgical wound and the thoracic and chest areas 
were covered with cotton wool and elastic bandages under firm pressure. Bandages 
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were changed on Day 7 and removed on Day 14. Figure 5.4 illustrates the sequence of 
surgical events. 
5.2.2.4 – Skin grafting monitoring 
On Days 7, 14 and 21 the grafts were visually inspected for signs of rejection. The 
grafts were photographed and a punch biopsy (3-4 mm) was taken from the autograft 
and the allograft and fixed in 10% buffered formalin solution for one to four weeks. 
After adequate fixation, skin biopsy punches were processed and paraffin embedded. 
Four to six sections (3 µm thickness) were cut for H&E staining (as detailed in 
Section 3.2.2.2) and the same number of sections was prepared for 
immunohistochemistry.  
Histology sections were examined for signs of immunological rejection and a 
pathological score was given to each section, adapted from a previous study in human 
hand transplantation (Kanitakis et al. 2005): 
Grade 0: no rejection. This grade corresponds to biopsies from macroscopically normal 
skin. No histological changes or occasional small number of lymphocytes near blood 
vessels.  
Grade I: mild rejection. The skin would appear normal at gross examination. 
Histologically, mild lymphocytic infiltration (likely to be of the recipient’s origin) in the 
dermis would be present. Epidermis unaffected. Sparse CD3+ cells in the dermis.  
Grade II: moderate rejection. The gross examination of the skin would reveal no 
alterations. Mildly dense infiltrate, predominantly lymphocytic, in the dermis, with 
perivascular cuffs spreading between collagen bundles would be observed in 
histological sections. Occasional histiocytes or epithelioid cells would be found 
between collagen bundles. Epidermis is either not affected or shows some exocytosis 
and/or spongiosis. Presence of sparse to moderate CD3+ cell infiltration in the dermis.  
Grade III: severe rejection. Changes associated with this grade of rejection would be 
seen in biopsies taken from skin that had brown colouration, exudates and scaly 
papules. Microscopically, dense lymphocytic infiltration (mainly CD3+) around blood 
vessels of the dermis and epidermis would be evident. Epidermis may present with 
Figure 5.4. Sequence of surgical events in the skin graft experiments. 
 
A-B: Two squares of approximately 3 x 4 cm were drawn on the shaved skin of the 
back of two Tasmanian devils. 
C: Schematic representation of the harvesting of a skin graft using a dermatome. The 
dermis and epidermis were “shaved” using a sterile blade. The approximate thickness of 
the graft was 1 mm. 
D-E: The skin autograft was slid from the caudal position to the cranial position. The 
skin allograft was harvested from the other devil and placed gently on the caudal 
position. 
F-H: Dressing and bandaging of the surgery site. Bandages were changed on Day 7, 
when the grafts were first assessed, and removed on Day 14.  
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spongiosis or exocytosis and some apoptotic keratinocytes. Extensive to severe CD3 
infiltration in the dermis and possibly in the epidermis.  
Grade IV: very severe rejection. Macroscopically, the skin would appear necrotic, dry 
with a marked brown to black colouration. A tendency for the biopsy to lose attachment 
to the adjacent epidermis and underlying dermis would be seen. Under histological 
examination, confluent epidermal necrosis associated with epidermal lymphocytic 
exocytosis and lymphocytic infiltration of the dermis would occur. 
Immunohistochemistry would reveal extensive to severe CD3+ cell infiltration.  
5.2.2.5 – Immunohistochemistry 
Biopsies were labeled for T-cells with a rabbit anti-human CD3 antibody. Negative 
controls included sections labeled with rabbit Ig fraction and sections labeled without 
the primary antibody (replaced with phosphate buffered saline). Positive controls 
consisted of devil lymphoid tissue. 
Tissue sections were deparaffinised in xylene and rehydrated through graded alcohol 
solutions to water and boiled in citrate buffer solution (pH 6) in an electric pressure 
cooker for 10 minutes at medium heat as described in Section 3.2.2.3. Slides were left to 
cool to 35ºC and placed in PBS. Endogenous peroxidase activity was quenched by 
incubating sections with a solution of 3% H2O2 for 15 minutes and non-specific protein 
binding was blocked with 5% bovine serum albumin for 30 minutes. The antibody was 
diluted with an antibody diluent (1:800) and placed onto the slides for 60 minutes. 
Antibody binding was detected by placing a biotinylated link universal followed by 
streptavidin and horseradish peroxidase (30 minutes each). A solution of 
diaminobenzidine was placed onto the slides for five minutes to allow for brown colour 
development of positive cells and then washed with distilled water. Sections were 
briefly counterstained with haematoxylin (40 seconds), dehydrated through graded 
alcohol solutions to xylene and coverslipped using an automated coverslipper.  
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5.3 – Results 
5.3.1 – Mixed lymphocyte reaction 
5.3.1.1 – Mixed lymphocyte reaction of pooled lymphocytes  
Pooled lymphocytes from six human donors were co-cultured between 72 to 168 hours. 
Similarly, the pooled lymphocytes from 30 eastern Tasmanian devils were co-cultured 
between 72 and 168 hours. Table 5.3 shows results obtained for one set of MLR using 
human lymphocytes and four repeated MLR experiments using devil lymphocytes. 
Human pooled lymphocytes reacted strongly at later incubation periods and produced 
the highest proliferation following 168 hours of incubation. The four experiments using 
devil-pooled lymphocytes produced extremely low responses with maximum results 
achieved after 168 hours of incubations, similar to the human assay. These results 
indicate a higher ability of human lymphocytes to proliferate in an allogeneic reaction 
than the devils. Subsequent experiments were performed using the pool of devil 
lymphocytes as “stimulatory” and freshly isolated lymphocytes as “responders". 
 
Human pooled 
lymphocytes 
Devil pooled 
lymphocytes 
(1stexperiment) 
Devil pooled 
lymphocytes 
(2ndexperiment) 
Devil pooled 
lymphocytes 
(3rdexperiment) 
Devil pooled 
lymphocytes 
(4thexperiment) 
72 h 996 (±113) 29 (±10) 19 (±9) 22 (±5) 24 (±6) 
96 h 2865 (±191) 45 (±12) 27 (±6) 74 (±47) 35 (±15) 
120 h 5078 (±1307) 56 (±37) 51 (±29) 52 (±2) 26 (±13) 
144 h 8970 (±3295) 33 (±5) 36 (±6) 58 (±30) 47 (±9) 
168 h 22109 (±5479) 339 (±27) 199 (±27) 201 (±107) 23 (±2) 
Table 5.3: Average CPM (± sd) of mixed lymphocyte reaction cultures undertaken with human 
pooled lymphocytes and devil pooled lymphocytes (four separate experiments) incubated from 72 
to 168 hours.  
5.3.1.1.1 – Pooled lymphocytes against lymphocytes from eastern Tasmanian devils 
Table 5.4 demonstrates the stimulation indices (SI) obtained for the two-way MLR of 
the frozen-thawed pooled lymphocytes against lymphocytes from five eastern 
Tasmanian devils and SI for the Con A (50 µg/mL) responses of each devil. The best 
results for the MLR were achieved after 144 hours of incubation, although all SI were 
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much lower than the SI from the mitogen stimulation. Nevertheless, TD 53 produced 
the best response in the MLR, followed by TD 6 and TD 52. All animals responded to 
the mitogen stimulation, which were much greater than the MLR responses indicating 
poor allogeneic stimulation. The pooled lymphocytes were tested for mitogen 
stimulation and reached high proliferation (SI 387), indicating that these cells remained 
functional and their ability to not only be “stimulatory” but also “responders”. 
 TD 5 TD 6 TD 44 TD 52 TD 53 
Pooled 
lymphocytes 
72 h 1.0 1.0 1.2 1.1 1.2 - 
96 h 1.0 1.0 1.0 1.2 1.0 - 
120 h 1.0 1.0 1.0 2.6 1.0 - 
144 h 1.6 4.6 2.2 3.8 7.4 - 
168 h 1.0 1.0 1.0 4.3 3.4 - 
Con A 88 298 179 192 102 387 
Table 5.4: Average stimulation index of mixed lymphocyte reaction cultures between lymphocytes 
from eastern Tasmanian devils against pooled devil lymphocytes incubated from 72 to 168 hours. 
Stimulation index of mitogen proliferation (Con A at 50 µg/mL) for each devil and for the pooled 
lymphocytes is also shown. 
5.3.1.1.2 – Pooled lymphocytes against lymphocytes from devils from Narawntapu 
National Park 
Animals from this group responded strongly to the mitogen stimulation. However, 
responses for the MLR were consistently low amongst all animals (Table 5.5), showing 
very poor allogeneic reactions. The best incubation time was achieved after 144 hours, 
with maximum response demonstrated by TD 104 (SI 3.3), followed by TD 101 and 
TD 102.  
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 TD 101 TD 102 TD 103 TD 104 
72 h 1.0 1.0 1.0 1.0 
96 h 1.0 1.0 1.0 1.0 
120 h 1.0 1.0 1.0 1.0 
144 h 1.8 1.5 1.0 3.3 
168 h 1.0 1.0 1.0 3.1 
Con A 619 555 324 292 
Table 5.5: Average stimulation index of mixed lymphocyte reaction cultures between lymphocytes 
from Tasmanian devils from Narawntapu National Park against pooled devil lymphocytes 
incubated from 72 to 168 hours. Stimulation index of mitogen proliferation (Con A at 50 µg/mL) 
for each devil is also shown. 
5.3.1.1.3 – Pooled lymphocytes against lymphocytes from devils from Birthday Bay 
Devils from Birthday Bay were chosen because this population is isolated in the south 
west of Tasmania and could potentially represent a different gene pool from other 
locations. Although all animals from this group responded to mitogen stimulation, no 
MLR culture reached SI above 1, except TD 66 at 144 hours of incubation (SI 2.5) 
(Table 5.6). 
 TD 63 TD 64 TD 65 TD 66 
72 h 1.0 1.0 1.0 1.0 
96 h 1.0 1.0 1.0 1.0 
120 h 1.0 1.0 1.0 1.0 
144 h 1.0 1.0 1.0 2.5 
168 h 1.0 1.0 1.0 1.0 
Con A 254 88 61 106 
Table 5.6: Average stimulation index of mixed lymphocyte reaction cultures between lymphocytes 
from Tasmanian devils from Birthday Bay against pooled devil lymphocytes incubated from 72 to 
168 hours. Stimulation index of mitogen proliferation (Con A at 50 µg/mL) for each devil is also 
shown. 
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5.3.1.1.4 – Pooled lymphocytes against lymphocytes from devils from north west 
Tasmania (Granville Harbor) 
No MLR responses were detected within this group. All animals responded to the 
mitogen stimulation, although TD 69 showed a low proliferation response to Con A 
(Table 5.7). 
 TD 69 TD 70 TD 71 TD 72 
72 h 1.0 1.0 1.0 Not done 
96 h 1.0 1.0 1.0 Not done 
120 h 1.0 1.0 1.0 Not done 
144 h 1.0 1.0 1.0 1.0 
168 h 1.0 1.0 1.0 Not done 
Con A 37 93 178 131 
Table 5.7: Average stimulation index of mixed lymphocyte reaction cultures between lymphocytes 
from Tasmanian devils from Granville Harbor against pooled devil lymphocytes incubated from 72 
to 168 hours. Stimulation index of mitogen proliferation (Con A at 50 µg/mL) for each devil is also 
shown. 
5.3.1.2 – Mixed lymphocyte reaction variation 
Very poor, or no responses, were achieved in the MLR against pooled lymphocytes, 
therefore, two-way MLR between two individual devils were undertaken in the 
subsequent experiments to determine if there were any individual devils sufficiently 
different to cause an allogeneic response. This was intended to be a more accurate 
measurement, as MHC alleles that could induce an allogeneic reaction would not be 
‘diluted out’ by the non-reactive MHC alleles in the culture. Because the best results for 
the MLR with pooled devil lymphocytes were routinely obtained at 144-168 hours of 
incubation, 144 hours was chosen as the incubation period for the remaining 
experiments.  
Variation in the mitogen responses was found in the devil population (Chapter 4), hence 
six Tasmanian devils (from eastern Tasmania) were selected for the MLR at two 
separate occasions. Stimulation indices amongst these devils in the first MLR are 
summarised in Table 5.8 and results for the subsequent MLR in Table 5.9. Mitogen 
stimulation using Con A (50 µg/mL) is also shown. To better visualise the results, a 
SI / CPM TD 188 TD 189 TD 191 TD 192 TD 196 TD 200 
 Colour 
code (SI) 
Colour 
code (CPM) 
TD 188 1 / 46 76 37 3288 1199 1798   1-10 1-100 
TD 189 1 1 / 91 441 683 662 210  11-20 101-500 
TD 191 1 7 1 / 33 1564 751 586  21-30 501-1000 
TD 192 61 9 33 1 / 62 2174 529  31-40 1001-2000 
TD 196 14 6 10 24 1 / 122 247  ≥41 ≥2001 
TD 200 61 4 26 14 4 1 / 13  Background Background 
Con A 
(SI) 
420 33 93 35 182 139 
 
Mitogen Mitogen 
Table 5.8: First MLR between lymphocytes from Tasmanian devils from eastern Tasmania at 144 
hours of incubation. Mitogen stimulation (Con A at 50 µg/mL) for each devil is also shown. Results 
are given in SI (lower left side) and CPM (right upper side) and are colour-coded: darker shading 
represents higher SI or CPM and red represents SI equal or above 40 or CPM equal or above 2000. 
Gray cells represent the background stimulation in SI / CPM. 
 
 
SI / CPM TD 188 TD 189 TD 191 TD 192 TD 196 TD 200 
 Colour 
code (SI) 
Colour code 
(CPM) 
TD 188 1 / 83 209 107 2322 1846 3368  1-10 1-100 
TD 189 3 1 / 44 27 776 1934 1843  11-20 101-500 
TD 191 2 1 1 / 31 444 470 1507  21-30 501-1000 
TD 192 40 20 14 1 / 33 1703 2652  31-40 1001-2000 
TD 196 32 50 15 51 1 / 33 1985  ≥41 ≥2001 
TD 200 26 17 15 26 19 1 / 174  Background Background 
Con A 
(SI) 
1060 247 592 603 201 312 
 
Mitogen Mitogen 
Table 5.9: Second MLR between lymphocytes from Tasmanian devils from eastern Tasmania at 
144 hours of incubation. Mitogen stimulation (Con A at 50 µg/mL) for each devil is also shown. 
Results are given in SI (lower left side) and CPM (right upper side) and are colour-coded: Darker 
shading represents higher SI or CPM and red represents SI equal or above 40 or CPM equal or 
above 2000. Gray cells represent the background stimulation in SI / CPM. 
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colour-coded system has been used. Darker shading represents higher SI or CPM and 
red represents SI equal or above 40 or CPM equal or above 2000. Wide variation in the 
mitogen responses was detected (e.g. up to 20 fold in TD 192) between the two 
experiments, even though the same pool of plasma was used for both assays. 
Additionally, considerable variation in the MLR cultures was present. For example, 
MLR cultures between TD 189 and TD 192 and between TD 196 and TD 200 achieved 
poor SI (all < 10) for the first experiment, but considerably high proliferation in the 
second assay. Some MLR cultures, on the other hand, were consistent; for example, 
MLR cultures among TD 188, TD 189 and TD 191 were consistently low. These results 
indicate that low responses in MLR culture might be transient (as it is with the mitogen 
responses) and are likely to depend on multiple factors, but high responses are likely to 
be representative of MHC allelic differences between the two animals. 
5.3.1.3 – Mixed lymphocyte reaction amongst eastern Tasmanian devils 
Two-way MLR between two individuals resulted in higher stimulation indices than the 
MLR using a pool of lymphocytes. Table 5.10 summarises the results for the two-way 
MLR from 15 different eastern Tasmanian devils and the mitogen stimulation response 
to Con A (50 µg/mL). Results are shown as SI and CPM and are colour-coded as 
outlined on Section 5.3.1.2. TD 188 and TD 196 had the highest SI and CPM amongst 
all animals, indicating a higher disparity in the MHC genes. TD 195 and TD 200 had 
SI > 10 in most reactions, but only few reactions had CPM > 1000, indicating that 
baseline background proliferation was probably too low (12 and 13 CPM respectively). 
All animals responded to some extent to the mitogen Con A. TD 197, TD 189 and 
TD 192 had the lowest mitogen responses, while TD 193 and TD 188 had the highest, 
indicating some variation in the ability of the cells to proliferate. Three devils from 
Nugent (TD 186, TD 187 and TD 189) had the lowest MLR responses (only TD 190 
from this group produced high proliferations), although all of them had at least one 
reaction with SI above 10 (which was not achieved by any devil against the pool of 
lymphocytes). A third (five of 14) of TD 188 MLR responses were above SI 40, 
therefore correlating to the mitogen response. However, TD 193 (which had the second 
highest mitogen response) responded poorly in the MLR, with only one reaction with SI 
above 40 (against TD 188), suggesting that the mitogen response does not always 
Table 5.10: MLR between lymphocytes from Tasmanian devils from eastern 
Tasmania at 144 hours of incubation.  
 
Tasmanian devil from the Group 1 are identified in green, Group 2 in purple, Group 3 in 
blue, Group 4 in orange and Group 5 in beige. Mitogen stimulation (Con A at 
50 µg/mL) for each devil is also shown. Results are given in SI (lower left side) and 
CPM (right upper side) and are colour-coded: darker shading represents higher SI or 
CPM and red represents SI equal or above 40 or CPM equal or above 2000. Gray cells 
represent the background stimulation in SI / CPM. 
SI/ 
CPM 
TD 
186 
TD 
187 
TD 
189 
TD 
190 
TD 
188 
TD 
191 
TD 
192 
TD 
193 
TD 
196 
TD 
197 
TD 
198 
TD 
199 
TD 
194 
TD 
195 
TD 
200 
TD 186 1 / 37 158 46 202 663 231 160 61 1027 371 134 91 59 225 399 
TD 187 2 1/156 1008 898 508 388 909 862 1577 737 496 355 2405 689 1445 
TD 189 1 8 1 / 91 284 76 441 683 286 662 815 403 115 111 491 210 
TD 190 4 8 4 1 / 57 104 219 1281 388 1212 241 438 27 1244 1894 1107 
TD 188 16 5 1 2 1 / 46 37 3288 2199 1199 1092 1970 241 2190 835 1798 
TD 191 7 8 7 5 1 1 / 33 1564 372 751 448 878 165 314 337 586 
TD 192 3 8 9 22 61 33 1 / 62 44 2174 1060 90 163 1341 765 529 
TD 193 1 8 4 7 46 9 1 1 / 49 1483 347 70 21 88 102 341 
TD 196 13 11 6 14 14 10 24 17 1/122 898 225 49 1356 1326 247 
TD 197 8 7 11 4 20 10 17 6 10 1 / 62 31 40 1503 703 313 
TD 198 4 5 7 10 53 29 2 2 3 1 1 / 23 30 776 438 294 
TD 199 2 4 2 1 6 4 3 1 1 1 1 1 / 41 84 133 120 
TD 194 2 27 2 32 65 12 32 3 19 36 32 3 1 / 21 675 299 
TD 195 9 8 9 55 28 15 21 3 20 19 22 5 41 1 / 12 279 
TD 200 16 17 4 32 61 26 14 11 4 8 14 4 18 22 1 / 13 
Con A 
(SI) 41 98 33 185 420 93 35 340 182 29 90 140 166 75 139 
                
Colour 
code 
Group 
1 
Group 
2 
Group 
3 
Group 
4 
Group 
5 
SI 1-
10 
SI 11-
20 
SI 21-
30 
SI 31-
40 SI ≥41 
CPM 
1-100 
CPM 
101- 
500 
CPM 
501- 
1000 
CPM 
1001-
2000 
CPM 
≥2001  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correlate reliably to the MLR response. After TD 188, devils from the Group 5 (Mt. 
William National Park) had the highest MLR responses, indicating that this group had 
the highest MHC diversity amongst all groups.  
In order to better assess whether there was any correlation between MLR and 
geographic origin of individual devils, MLR cultures were analysed according to the 
location of origin of each devil. 
5.3.1.3.1 – Mixed lymphocyte reaction of Group 1 (Nugent) 
The four devils from this group reacted weakly against each other (all SI < 10). The 
reaction against devils from other groups, however, produced some high responses, with 
the higher stimulation indices achieved after culture with lymphocytes from animals 
from Group 5 (from Mt. William National Park). TD 190 reacted strongly against 
TD 195 and with SI above 10 with five other animals (Figure 5.5).  
5.3.1.3.2 – Mixed lymphocyte reaction of Group 2 (Forestier Peninsula) 
Figure 5.6 shows that the Group 2 devils (TD 188 and TD 191) did not react against 
each other and only weakly against devils from the Group 1 (Nugent). However, both 
reacted well against all devils from the other groups (except TD 199), indicating higher 
diversity among devils from more geographically distant populations. TD 188 had the 
highest reaction results, achieving five SI above 40. 
5.3.1.3.3 – Mixed lymphocyte reaction of Group 3 (Bronte Park) 
The two devils from Group 3 (TD 192 and TD 193) did not react against each other in 
the MLR. TD 192, however, reacted well against all animals, except devils from Nugent 
(although a high SI was detected against TD 190) and two devils from Epping Forest 
(Group 4). TD 193 had low SI against all devils, except TD 188, TD 196 and TD 200 
(Figure 5.7). 
5.3.1.3.4 – Mixed lymphocyte reaction of Group 4 (Epping Forest) 
Two devils from this group (TD 196 and TD 197) reacted against each other, although 
SI was not above 10. TD 196 reacted against almost all other devils (except TD 189 and 
Figure 5.5. Two-way mixed lymphocyte reaction (MLR) – Group 1 (Nugent). 
 
A: “Within group MLR”. Stimulation index (SI) as a result of MLR amongst devils 
from Group 1. No SI higher than 10 was detected. 
B: “Between groups MLR”. Stimulation index (SI) as a result of MLR with devils from 
Group 1 against Groups 2, 3, 4 and 5 (from eastern Tasmania). Higher stimulation 
indices were achieved after culture with lymphocytes from animals from Group 5 (from 
Mt. William National Park). TD 190 reacted strongly against TD 195 and with SI above 
10 with five other animals. 

Figure 5.6. Two-way mixed lymphocyte reaction (MLR) – Group 2 (Forestier 
Peninsula).  
 
A: “Within group MLR”. Stimulation index (SI) as a result of MLR amongst devils 
from Group 2. SI were not above background stimulation (SI≅1). 
B: “Between groups MLR”. Stimulation index (SI) as a result of MLR with devils from 
Group 2 against Groups 1, 3, 4 and 5 (from eastern Tasmania). TD 188 and TD 189 
reacted well against all devils from the other groups (except TD 199), indicating higher 
diversity among devils from more distant locations. TD 188 had the highest reaction 
results, achieving five SI above 40. 

Figure 5.7. Two-way mixed lymphocyte reaction (MLR) – Group 3 (Bronte Park). 
 
A: “Within group MLR”. Stimulation index (SI) as a result of MLR amongst devils 
from Group 3. SI were below background stimulation (SI≅1). 
B: “Between groups MLR”. Stimulation index (SI) as a result of MLR with devils from 
Group 3 against Groups 1, 2, 4 and 5 (from eastern Tasmania). TD 192 reacted well 
against all animals, except devils from Nugent (although a high SI was detected against 
TD 190) and two devils from Epping Forest (Group 4). TD 193 had low SI against all 
devils, except TD 188, TD 196 and TD 200. 
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TD 200). TD 197 and TD 198 reacted against many devils from Group 2 and 5 and 
TD 197 also against Group 3 (Figure 5.8). 
5.3.1.3.5 – Mixed lymphocyte reaction of Group 5 (Mt. William National Park) 
This is the only group of eastern Tasmanian devils that showed reactions within the 
group. This group was also the most stimulatory for all the other groups, indicating 
higher MHC diversity amongst devils of Group 5; only three devils from other 
populations (TD 189, TD 193 and TD 199) did not react or reacted weakly against 
devils from this group (Figure 5.9). 
5.3.1.4 – Mixed lymphocyte reaction amongst northwestern devils 
Table 5.11 shows the results for MLR amongst devils from north west of Tasmania and 
Con A (50 µg/mL) responses. Devils from the same area are labeled with the same 
colour and results are given in SI (lower left) and CPM (upper right). Results are 
colour-coded, as outlined on Section 5.3.1.2.  
Only a limited number of lymphocytes was isolated from TD 181, hence limited MLR 
were performed and Con A stimulation was not possible to carry out. TD 206 and 
TD 204 showed low responses for Con A stimulation (SI 16 and 32, respectively), 
indicating low ability to proliferate at this time point. Nevertheless, TD 206 or was 
stimulatory to two other devils (TD 184 and TD 205), with SI > 30. TD 205 had the 
highest MLR CPM within all groups, but (due high background) this was translated 
only in two reactions with SI > 40. 
Although three animals from Milkshake Hills and two from Temma did not react within 
their groups, some devils from the same location produced strong MLR. For example, 
TD 184 and TD 185 (both from Granville Harbor) had SI 42 when co-cultured and 
TD 183 and TD 205 (both from Woolnorth) had SI > 30 in the MLR. 
Analyses were carried out according to the location of origin from each devil. 
5.3.1.4.1 – Mixed lymphocyte reaction of Group 6 (Milkshake Hills) 
Tasmanian devils from Milkshake Hills reacted poorly against each other with 
responses at background levels. Poor responses were observed against TD 182 and 
Figure 5.8. Two-way mixed lymphocyte reaction (MLR) – Group 4 (Epping 
Forest). 
 
A: “Within group MLR”. Stimulation index (SI) as a result of MLR amongst devils 
from Group 4. Two devils from this group (TD 196 and TD 197) reacted against each 
other, although SI was not above 10.  
B: “Between groups MLR”. TD 196 reacted against almost all other devils (except 
TD 189 and TD 200). TD 197 and TD 198 reacted against many devils from Group 2 
and 5 and TD 197 also against devils from Group 3. 
  

Figure 5.9. Two-way mixed lymphocyte reaction (MLR) – Group 5 (Mt. William 
National Park). 
 
A: “Within group MLR”. Stimulation index (SI) as a result of MLR amongst devils 
from Group 5. The three devils from this group had high SI. MLR between TD 194 and 
TD 195 yielded SI 40 and MLR between the other devils from this group resulted in SI 
above 10. 
B: “Between groups MLR”. Most devils reacted in the MLR against this group. Only 
TD 189, TD 193 and TD 199 did not react or reacted weakly against devils from 
Group 5. 

SI/CPM 
TD 
180 
TD 
181 
TD 
206 
TD 
207 
TD 
184 
TD 
185 
TD 
182 
TD 
204 
TD 
183 
TD 
205 
TD 180 1/26  - - -  -  -  -  183 -  421 
TD 181  - 1/432 404 227 2797 592 178 1834 3328 1920 
TD 206  - 2 1/15 26 627 55 23 16 25 997 
TD 207  - 1 1 1/44 3487 78 44 185 244 2599 
TD 184  - 12 35 108 1/21 3593 760 558 2219 3370 
TD 185  - 2 1 1 42 1/150 37 158 490 2863 
TD 182  - 1 1 1 35 1 1/23 28 176 123 
TD 204 9 8 1 7 33 2 2 1/13 353 411 
TD 183  - 13 1 4 42 4 3 7 1/84 2203 
TD 205 12 8 33 58 102 29 4 14 34 1/45 
Con A 
(SI)  - 541 16 558 407 124 81 32 525 157 
           
Colour 
code 
Group 
6 
Group 
7 
Group 
8 
Group 
9 
Back 
ground - - - - - 
Colour 
code SI 1-10 
SI 11-
20 
SI 21-
30 
SI 31-
40 SI ≥41 
CPM 
1-100 
CPM 
101-
500 
CPM 
501- 
1000 
CPM 
1001- 
2000 
CPM 
≥2001 
Table 5.11: MLR between lymphocytes from Tasmanian devils from western Tasmania at 144 
hours of incubation. Tasmanian devil from the Group 6 are identified in green, Group 7 in purple, 
Group 8 in blue and Group 9 in orange. Mitogen stimulation (Con A at 50 µg/mL) for each devil is 
also shown. Results are given in SI (lower left side) and CPM (right upper side) and are colour-
coded: darker shading represents higher SI or CPM and red represents SI equal or above 40 or 
CPM equal or above 2000. Gray cells represent the background stimulation in SI / CPM.  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TD 185, from Temma and Granville Harbor, respectively. Highest responses were 
reached against TD 184 (above 100 SI in one case) and against TD 205, from 
Woolnorth. Responses against TD 204 (other animal from Temma) and TD 183 were 
above background levels (Figure 5.10). 
5.3.1.4.2 – Mixed lymphocyte reaction of Group 7 (Granville Harbor) 
Only two devils from Granville Harbor were tested in MLR. The response against each 
other was strong (40 SI). TD 184 reacted well against all other western devils, 
indicating differences in the MHC alleles of this devil. TD 185, however, had an 
allogeneic response only against TD 205, from Woolnorth. All other responses from 
this animal were weak (Figure 5.11).  
5.3.1.4.3 – Mixed lymphocyte reaction of Group 8 (Temma) 
The two devils from this group (TD 182 and TD 204) reacted weakly to each other. 
However, both of them had consistent allo-recognition against TD 184, a devil from 
Granville Harbor. TD 204 had SI responses close to 10 with all other devils from other 
areas, except against TD 206 (from Milkshake Hills), which had a response resembling 
background levels. TD 182 had poor responses against all other western devils 
(Figure 5.12). 
5.3.1.4.4 – Mixed lymphocyte reaction of Group 9 (Woolnorth) 
The two devils from Woolnorth had SI of almost 40 when tested against each other. 
TD 205 had some strong reactions against devils from all other western groups, except 
TD 182, from Milkshake Hills. TD 183, on the other hand, produced a strong response 
only against TD 184 and TD 181, from Temma and Milkshake Hills, respectively 
(Figure 5.13). 
5.3.1.5 – Mixed lymphocyte reaction amongst eastern and northwestern devils 
Table 5.12 and 5.13 show the MLR responses between eastern and northwestern devils 
in SI and CPM, respectively and are colour-coded as described on Section 5.3.1.2. Only 
a few MLR cultures resulted in low SI or low CPM and, even more remarkably, about a 
third of the reactions (17 of 60) resulted in strong responses (SI ≥ 40 or CPM ≥ 2000), 
Figure 5.10. Two-way mixed lymphocyte reaction (MLR) – Group 6 (Milkshake 
Hills). 
 
A: “Within group MLR”. Stimulation index (SI) as a result of MLR amongst devils 
from Group 6.  There were four devils in this group, but lymphocytes from TD 180 
were enough for MLRs between other devils. The three other devils from this group did 
not react against each other (S≅1).  
B: “Between groups MLR”. A devil from Granville Harbor (TD 184) and a devil from 
Woolnorth (TD 205) had strong reactions against devils from Milkshake Hills. The 
other three devils (TD 185, TD 182 and TD 183) reacted weakly against devils from this 
group. 

Figure 5.11. Two-way mixed lymphocyte reaction (MLR) – Group 7 (Granville 
Harbor). 
 
A: “Within group MLR”. Stimulation index (SI) as a result of MLR amongst devils 
from Group 7. The two devils from this group had a strong mixed lymphocyte reaction 
(SI≅40).  
B: “Between groups MLR”. Most devils from all other western groups reacted strongly 
against TD 184, but only weakly against TD 185. The exception was TD 205, that 
mounted a strong response against TD 185. 

Figure 5.12. Two-way mixed lymphocyte reaction (MLR) – Group 8 (Temma). 
 
A: “Within group MLR”. Stimulation index (SI) as a result of MLR amongst devils 
from Group 8. The two devils from this group did not react against each other (S≅1).  
B: “Between groups MLR”. Most devils from other western Tasmania areas had 
reactions close to SI≅10 against TD 204, but weak reactions against TD 182. TD 184 
reacted strongly against both devils from Temma. 

Figure 5.13. Two-way mixed lymphocyte reaction (MLR) – Group 9 (Woolnorth). 
 
A: “Within group MLR”. Stimulation index (SI) as a result of MLR amongst devils 
from Group 9. The two devils from this group reacted strongly against each other 
(S≅34).  
B: “Between groups MLR”. Most devils from other western Tasmania areas reacted 
well against TD 205, except TD 182. TD 183 had a strong reaction against TD 184 and 
reacted well against TD 181, but weakly against other devils from western Tasmania. 

Table 5.12: MLR between lymphocytes from Tasmanian devils from eastern 
Tasmania (blue) and western Tasmania (green) at 144 hours of incubation. 
 
Mitogen stimulation (Con A at 50 µg/mL) for each devil is also shown. Results are 
given in SI and are colour-coded: darker shading represents higher SI and red represents 
SI equal or above 40. 
 
Table 5.13: MLR between lymphocytes from Tasmanian devils from eastern 
Tasmania (blue) and western Tasmania (green) at 144 hours of incubation.  
 
Mitogen stimulation (Con A at 50 µg/mL) for each devil is also shown. Results are 
given in CPM and are colour-coded: darker shading represents higher CPM and red 
represents CPM equal or above 2000.  
 SI TD 189 TD 188 TD 191 TD 192 TD 196 TD 200 
Con A 
(SI) 
 Colour 
code 
TD 180 5 44 20 14 16 12 -  1-10 
TD 181 6 13 11 11 16 8 541  11-20 
TD 206 25 15 3 46 11 5 16  21-30 
TD 207 29 76 40 79 75 17 558  31-40 
TD 184 120 95 97 131 72 21 407  ≥41 
TD 185 22 21 24 12 24 13 124  Eastern 
TD 182 2 45 8 4 19 13 81  Western 
TD 204 22 23 24 45 79 6 32  Mitogen 
TD 183 10 31 34 3 31 15 525  - 
TD 205 43 33 10 47 51 18 157  - 
Con A 
 (SI) 
247 1060 592 603 201 312  -  -   
 CPM TD 189 TD 188 TD 191 TD 192 TD 196 TD 200 
Con A 
(CPM) 
 Colour 
code 
TD 180 170 2357 555 407 458 1206 -  1-100 
TD 181 1463 3265 2616 2485 3816 2528 10798  101-500 
TD 206 752 747 79 1120 261 498 97  501-1000 
TD 207 1271 4796 1499 3066 2896 1817 6682  1001-2000 
TD 184 3917 4922 2525 3561 1943 2039 4061  ≥2001 
TD 185 2094 2410 2163 1118 2184 2125 2233  Eastern 
TD 182 51 2347 203 107 539 1314 894  Western 
TD 204 622 1121 525 1030 1828 546 346  Mitogen 
TD 183 661 2575 1973 184 1801 1952 12045  - 
TD 205 1947 2131 387 1825 1994 2007 1254  - 
Con A 
(CPM) 
1968 12689 6491 3604 2403 8093  -  -  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suggesting a higher degree of variability in the MHC genes between these two 
populations than within populations. 
TD 184 had the highest responses in this experiment, with all CPM results close to or 
exceeding 2000. This was translated in similar SI results, where five reactions (out of 
six) were close to or exceeding 100. This was also true for TD 207 and, to some extent, 
TD 188, which had high CPM in almost all reactions, but fewer were converted in high 
SI. TD 192 and TD 196 also showed high proliferations when cultured with some of the 
western devils. 
Overall, only 20% (12 of 60) of all reactions had poor results (SI ≤ 10 or CPM ≤ 500). 
Weak CPM results (≤ 100) were seen only in two reactions, between TD 189 and 
TD 182 (51 CPM) and between TD 191 and TD 206 (79 CPM). Interpretation of these 
results is complicated by the fact that the responses for the mitogen were not uniform. 
For example, TD 206 had a weak proliferation in response to Con A (CPM < 100), 
indicating that at this time point it was poorly reactive.  
5.3.2 – Skin grafting 
5.3.2.1 – Skin graft between TD 190 and TD 199 
5.3.2.1.1 – Gross appearance 
TD 190, a female devil from Nugent and TD 199, a female from Epping Forest, were 
used for the first autograft/allograft exchange experiment. Mixed lymphocyte reaction 
between these two devils resulted in SI 1, indicating poor MHC differences.  
Seven days after the surgery, both auto and allografts from both devils appeared healthy 
macroscopically, showing pink colouration and capillary bed evident after “pinching” 
the center of the graft, showing effective vascular supply. At this time point, the 
allografts were indistinguishable from the autografts and appeared viable.  
On Day 14, both the auto and allograft of TD 199 appeared viable and to have healed. 
However, on Day 17, the allograft on this devil showed moderate brown colouration 
and coagulated exudates, which were obvious by Day 21. The same visual changes 
were observed on the allograft of TD 190 but on Day 14, and were obvious by Day 21 
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(black colouration). The autografts from both devils appeared viable on Day 21. 
Figure 5.14 shows the gross appearance of the grafts for both devils.  
5.3.2.1.2 – Histopathology and immunohistology 
The main histopathological findings and CD3 labeling of the skin graft biopsies of 
TD 190 and TD 199 are shown in Tables 5.14 and 5.15, respectively. TD 190 had 
alterations in the allograft skin biopsy consistent with Grade II (moderate) rejection on 
Day 7 and Grade IV (very severe) rejection on Day 14. No abnormalities were observed 
in the autograft biopsies from this devil. Figure 5.15 illustrates the histology and CD3 
labeling of the grafts of TD 190. 
The allograft skin biopsy of TD 199 had no significant alterations on Day 7. However, 
on Day 14 and Day 21, Grade III and Grade IV rejection was evident (severe and very 
severe rejection), respectively. The autograft skin biopsies from this devil showed no 
abnormalities. Figure 5.16 shows the histology and CD3 labeling of the grafts of 
TD 199. 
5.3.2.2 – Skin graft between TD 187 and TD 200 
5.3.2.2.1 – Gross appearance 
TD 187 was a male devil from Nugent and TD 200 was a female from Mt. William 
National Park. Mixed lymphocyte reaction between these two devils resulted in SI 17, 
indicating some allogeneic recognition.  
On Day 14 the autograft of TD 187 appeared non-viable, showing brown colouration 
and exudates. It was concluded that this graft had undergone some mechanical trauma 
post-operatively. By comparison, TD 200 autograft appeared viable during the whole 
period of observation. Between Day 7 and Day 14, the allograft of both animals began 
to show distinctive signs of unhealthy skin, as the grafts were dry, containing scaly 
surface and a brown to black colouration. 
5.3.2.2.2 – Histopathology and immunohistology 
Table 5.16 and 5.17 describe the main histopathological alterations and CD3 labeling 
seen on the skin graft biopsies of TD 187 and TD 200, respectively. The biopsied 
Figure 5.14. Gross appearance of skin grafts of TD 190 and TD 199 at different 
days after the surgery. 
 
Arrows indicate the autografts (on the left) and arrowheads indicate allografts (on the 
right). 
A: Both autograft and allograft of TD 190 were indistinguishable at Day 7. 
B-C: Autograft of TD 190 looked healthy, while the allograft presented scaly lesions 
and brown coloration at Day 14 and almost black on Day 21. 
D-E: Both autograft and allograft of TD 199 were indistinguishable at Day 7 and Day 
14. 
F: The allograft of TD 199 presented scaly lesions and coagulate exudates on Day 17. 
G: Progression of the lesions seen on TD 199 on Day 21, with extensive brown 
coloration and exudates. 
 
Darkened spots on the grafts are biopsy punch holes. 

 Normal 
skin 
A-B: Healthy keratinised stratified epithelium, presence of sparse CD3+ cell infiltration 
in the dermis of TD 190 
TD 190 Day 7 Day 14 Day 21 
Autograft 
C-D: No abnormality. 
Sparse CD3+ cells in the 
dermis. 
E-F: No abnormality. 
Moderate CD3+ cells in the 
dermis and few in the 
epidermis. 
Figure not shown. No 
abnormality. Sparse CD3+ 
cells in the dermis.  
Allograft 
G-H: Grade II 
(moderate) rejection.  
A perivascular and 
interstitial, moderate 
predominantly lymphocytic 
inflammatory cell infiltrate 
was noted within the upper 
half of the dermis. The 
overlying epidermis 
showed mild spongiosis 
with scattered lymphocytic 
exocytosis. No necrotic 
keratinocytes were seen. 
Extensive CD3+ cells 
infiltrating the dermis. 
I-J: Grade IV (very 
severe) rejection.  
Confluent necrosis of the 
full thickness of the 
squamous epithelium. No 
viable epithelium was 
noted. Moderate infiltrate 
of CD3+ cells, few in the 
epidermis. 
Not done. 
Table 5.14: Microscopic appearance and alterations observed in the autograft and allograft biopsies 
of TD 190 at Day 7, Day 14 and Day 21 after the surgery. 
 


 TD 199 Day 7 Day 14 Day 21 
Autograft 
A-B: No abnormality. 
Sparse CD3+ cell 
infiltration. 
C-D: No abnormality. 
Moderate CD3+ cells in the 
dermis. 
E-F: No abnormality. 
Sparse CD3+ cell 
infiltration. 
Allograft 
G-H: No evidence of 
rejection.  
Sparse to moderate CD3+ 
cell infiltration in the 
dermis. 
I-J: Grade III (severe) 
rejection.  
A mild to moderate, 
perivascular and interstitial, 
predominantly lymphocytic 
inflammatory cell infiltrate 
was seen within the upper 
dermis associated with 
epidermal spongiosis and 
scattered, individual 
necrotic keratinocytes. 
Severe CD3+ cell infiltrate 
in the dermis and 
epidermis. 
K-L: Grade IV (very 
severe) rejection.  
Confluent necrosis of the 
full thickness of the 
squamous epithelium was 
seen. No viable epidermis 
was noted. Moderate CD3+ 
cell infiltration. 
Table 5.15: Microscopic appearance and alterations observed in the autograft and allograft biopsies 
of TD 199 at Day 7, Day 14 and Day 21 after the surgery. 
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autograft of TD 187 showed no alterations on Day 7, but had changes associated with 
mechanical trauma on Day 14. The biopsied allograft of this devil had ambiguous 
alterations on Day 7, and it was not possible to differentiate between mechanical trauma 
and immunological rejection. On Day 14, severe CD3+ cell infiltration was observed, 
indicating an immunological reaction. Figure 5.17 shows the histological alterations and 
CD3 labeling of the grafts for TD 187. 
The biopsy of skin autograft from TD 200 revealed no physiological abnormalities 
during the monitoring period. The allografted skin biopsy, however, showed alterations 
that were compatible with mechanical trauma on both Day 7 and Day 14. Figure 5.18 
demonstrates the histological sections under H&E staining and CD3 labeling of the 
biopsies taken from TD 200. 
5.3.2.3 – Skin graft between TD 188 and TD 189 
5.3.2.3.1 – Gross appearance 
TD 188 was a female devil from Forestier Peninsula and TD 189 a female from Nugent. 
Mixed lymphocyte reaction was undertaken between these two devils twice; the first 
MLR resulted in SI 1 and the second in SI 3, indicating low MHC diversity between 
these two animals.  
By the first post-operative observation at Day 7, the skin autograft of TD 188 had 
evident macroscopic abnormalities, which culminated on discharge of fluid exudates 
and appeared brown by Day 14. The allograft of this devil did not show abnormalities 
on Day 7, but it did not appear viable by Day 14 and Day 21. The autografted skin on 
TD 189 had no visible abnormalities by Day 7, but appeared unhealthy on Day 14 and 
Day 21. Similarly, the allografted skin on this animal appeared viable on Day 7, but 
macroscopic changes were observed on Day 14 and Day 21. 
5.3.2.3.2 – Histopathology and immunohistology 
The main histopathological findings and CD3 labeling of the skin graft biopsies of 
TD 188 and TD 189 are shown in Table 5.18 and 5.19, respectively. The autografted 
skin biopsy of TD 188 showed signs consistent with mechanical trauma from the first 
day of observation post-operatively (Day 7). The allograft biopsy, however, had no 
 TD 187 Day 7 Day 14 
Autograft A-B: No abnormality. Sparse CD3+ cells in the dermis. 
C-D: Non-specific parakeratosis with 
small numbers of neutrophils, suggestive 
of trauma. Sparse CD3+ cells in the 
dermis. 
Allograft 
E-F: Surface parakeratosis with fibrin 
deposition and florid neutrophil 
infiltration and epidermal spongiosis. A 
significant dermal lymphocyte infiltrate is 
not identified under H&E staining. 
Moderate to extensive CD3+ cell 
infiltrate in the dermis with few 
infiltrating the epidermis. Unable to 
differentiate between mechanical 
trauma and immune rejection. 
G-H: Grade IV (very severe) rejection.  
Full thickness confluent necrosis with 
surface parakeratosis. Significant 
lymphocytic infiltration in the dermis. 
Extensive to severe CD3+ cell infiltrate 
in the dermis and epidermis. Given 
significant CD3 infiltration, very severe 
immune rejection is presumed.  
Table 5.16: Microscopic appearance and alterations observed in the autograft and allograft biopsies 
of TD 187 at Day 7 and Day 14 after the surgery. 
 

 TD 200 Day 7 Day 14 
Autograft A-B: No abnormality. Sparse CD3+ cells in the dermis. 
C-D: No abnormality. Sparse to 
moderate CD3+ cells in the dermis. 
Allograft 
E-F: Focal confluent necrosis. Intact 
squamous epithelium shows overlaying 
parakeratosis, fibrin and neutrophil 
collections. A significant dermal 
lymphoid infiltrate is not seen. Sparse 
CD3+ cell infiltration in the dermis.  
Mechanical trauma is favoured over 
immune rejection. 
G-H: Same as Day 7, with sparse to 
moderate CD3+ cell infiltrate in the 
dermis.  
Mechanical trauma is favoured. 
Table 5.17: Microscopic appearance and alterations observed in the autograft and allograft biopsies 
of TD 200 at Day 7 and Day 14 after the surgery. 
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abnormalities on Day 7, but signs of Grade III (severe) rejection on Day 14 and 
Grade IV (very severe) rejection on Day 21. Figure 5.19 shows the histological sections 
of the auto and allografts of TD 188 stained with H&E and labeled with anti-CD3. 
The biopsied skin autograft from TD 189 had no abnormalities on Day 7, but appeared 
with signs of inflammation on Day 14 and Day 21, consistent with mechanical trauma. 
The allograft biopsy did not show signs of alterations on Day 7, but changes associated 
with mechanical trauma on Day 7 and Day 14. Figure 5.20 show the histology and CD3 
labeling of the grafts of TD 189  
5.3.2.4 – Skin graft between TD 190 and TD 191 
5.3.2.4.1 – Gross appearance 
TD 190 was a female from Nugent, which had been used for the first graft surgery (the 
other side of the back was chosen to undertake the surgery) and TD 191 was a female 
from Forestier Peninsula. The MLR response between these two devils resulted in SI 5, 
indicating weak allogeneic recognition.  
The autograft from TD 190 looked unhealthy on Day 7 and Day 14, with signs 
associated with pathological changes. Similarly, the allograft of this devil appeared 
non-viable since Day 7, which was observed again on Day 14. These visual features 
were rapid in onset compared to other devils skin grafts and were assessed as either the 
result of poor graft establishment and vascular anastomosis to the underlying dermis 
caused by mechanical trauma or acute immunological rejection, as this devil had been 
involved in other skin graft procedure several months before.  
The autograft from TD 191 appeared normal on Day 7 and Day 14. The allograft, 
although appeared viable on Day 7, showed brown to black colouration with fluid 
exudation by Day 14, indicating that either mechanical trauma or immune rejection had 
occurred. 
5.3.2.4.2 – Histopathology and immunohistology 
Table 5.20 and 5.21 describe the main observations seen on histology sections and CD3 
labeling of the auto and allografts of the skin graft biopsies of TD 190 and TD 191, 
respectively. The biopsied skin autograft and allograft of TD 190 had alterations 
 TD 188 Day 7 Day 14 Day 21 
Autograft 
A-B: Full thickness 
necrosis and ulceration. 
Sparse CD3+ cells in the 
dermis. 
C-D: Surface fibrin and 
neutrophil collections 
consistent with mechanical 
trauma. Sparse CD3+ cells 
in the dermis. 
E-F: Parakeratosis and 
neutrophil infiltration, 
sparse CD3+ cells in the 
dermis. 
Allograft 
G-H: No abnormality. 
Sparse CD3+ cells in the 
dermis. 
I-J: Grade III (severe) 
rejection.  
Dermal lymphocytic, 
perivascular and interstitial 
infiltrate associated with 
prominent necrotic 
keratinocytes and 
lymphocytic exocytosis. 
Confluent epidermal 
necrosis was not seen. 
Extensive to severe CD3+ 
cell infiltrate in the dermis. 
K-L: Grade IV (severe) 
rejection. 
 Confluent epidermal 
necrosis. Extensive CD3+ 
cell infiltrate in the dermis. 
Table 5.18: Microscopic appearance and alterations observed in the autograft and allograft biopsies 
of TD 188 at Day 7, Day 14 and Day 21 after the surgery. 
 


 TD 189 Day 7 Day 14 Day 21 
Autograft 
A-B: No abnormality. 
Sparse CD3+ cells in the 
dermis. 
C-D: Epidermis contained 
a moderate neutrophil 
inflammatory infiltrate. 
Sparse CD3+ cells in the 
dermis. 
E-F: Focal full thickness 
necrosis associated with 
florid neutrophil infiltrate. 
Where the epidermis was 
intact parakeratosis was 
noted. Sparse CD3+ cells in 
the dermis.  
The changes on Day 14 
and 21 were consistent 
with mechanical trauma. 
Allograft 
G-H: Sparse CD3+ cells in 
the dermis. No evidence of 
rejection. 
I-J: Parakeratosis with 
spongiosis and focal 
neutrophil collections. 
Moderate CD3+ cells in the 
dermis.  
Favour mechanical 
trauma. 
K-L: Confluent epidermal 
necrosis with neutrophil 
rich inflammatory cell 
infiltrate. Sparse CD3+ 
cells in the dermis. 
Table 5.19: Microscopic appearance and alterations observed in the autograft and allograft biopsies 
of TD 189 at Day 7, Day 14 and Day 21 after the surgery. 
 


Chapter 5: The allo-reactivity of the Tasmanian devil 
 − 152 − 
consistent with mechanical trauma on both Day 7 and Day 14. Figure 5.21 shows the 
histology and CD3 labeling of the grafts of TD 190. 
The autograft biopsy of TD 191 had no alteration on both Day 7 and Day 14. 
Ambiguous alterations were observed under H&E staining in the allograft biopsy of 
TD 191 on Day 14, but CD3 labeling defined the alterations as Grade II (mild) 
rejection, as opposed to mechanical trauma (Figure 5.22). 
5.3.2.5 – Summary of skin graft experiments 
Table 5.22 summarises the results of all skin graft experiments undertaken with the 
seven Tasmanian devils. 
 
 Autograft Allograft Conclusion 
TD 190 Viable 21 days after surgery Immune rejection between Day 7 and Day 14 
Immune 
rejection 
TD 199 Viable 21 days after surgery Immune rejection between Day 14 and Day 21 
Immune 
rejection 
TD 187 Alterations consistent with mechanical trauma 
Immune rejection between 
Day 7 and Day 14 
Immune 
rejection 
TD 200 Viable 21 days after surgery Alterations consistent with mechanical trauma 
Not possible to 
assess 
TD 188 Alterations consistent with mechanical trauma 
Immune rejection between 
Day 7 and Day 14 
Immune 
rejection 
TD 189 Alterations consistent with mechanical trauma 
Alterations consistent with 
mechanical trauma 
Not possible to 
assess 
TD 190* Alterations consistent with mechanical trauma 
Alterations consistent with 
mechanical trauma 
Not possible to 
assess 
TD 191 Viable 21 days after surgery Immune rejection between Day 7 and Day 14 
Immune 
rejection 
Table 5.22: Summary of the skin graft experiments with seven Tasmanian devils (TD 190* indicates 
the second surgery in this devil). Outcome of autografts and allografts from each devil and the 
conclusion for the experiment are shown.  
 TD 190 Day 7 Day 14 
Autograft 
A-B: Focal parakeratosis and neutrophil 
collections. Sparse CD3+ cells in the 
dermis. 
C-D: Prominent surface parakeratosis, 
fibrin and neutrophils. Sparse CD3+ 
cells in the dermis.  
Consistent with mechanical trauma. 
Allograft 
E-F: Parakeratosis and neutrophil 
collections. No significant dermal 
lymphoid cells. Sparse to moderate 
CD3+ cells in the dermis.  
Consistent with mechanical trauma. 
G-H: Parakeratosis and few neutrophils 
infiltrating the dermis. Sparse CD3+ 
cells in the dermis. 
Consistent with mechanical trauma.  
Table 5.20: Microscopic appearance and alterations observed in the autograft and allograft biopsies 
of TD 190 at Day 7 and Day 14 after the surgery. 

 TD 191 Day 7 Day 14 
Autograft A-B: No abnormality. Moderate CD3+ cells in the dermis. 
C-D: No abnormality. Sparse CD3+ 
cells in the dermis. 
Allograft E-F: No abnormality. Sparse CD3+ cells in the dermis. 
G-H: Surface parakeratosis with 
neutrophil rich inflammatory cell 
infiltrate, but intense infiltrate of CD3+ 
cells in the dermis indicative of Grade 
II (mild) rejection. 
Table 5.21: Microscopic appearance and alterations observed in the autograft and allograft biopsies 
of TD 191 at 7 and 14 days after the surgery. 
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5.3.3 – Summary of results 
• Pooled lymphocytes from Tasmanian devils were able to proliferate in response 
to a mitogenic stimulus (Con A), but reacted poorly in allogeneic reactions; 
• Two-way MLR using freshly isolated lymphocytes from two Tasmanian devils 
yielded high responses in many experiments; 
• Poor allogeneic reactivity was observed in the two-way MLR within 
populations, except from one group from eastern Tasmania, Group 5 
(Mt. William National Park), and two groups from western Tasmania, Group 7 
and Group 9 (Granville Harbor and Woolnorth, respectively); 
• Some strong MLR allogeneic responses were detected between populations, 
especially between eastern and western devils; 
• Skin allograft experiments utilising seven Tasmanian devils (in eight 
procedures) resulted in five discernible immunological rejections. In the three 
other animals, the rejection (or acceptance) was not possible to characterise due 
to mechanical trauma to the surgery site. 
5.4 – Discussion 
Fusion of different organisms of the same species can occur in asexual reproductive 
primitive beings, although an allo-recognition system prevents this chimerism in 
non-clonal organisms. Highly polymorphic histocompatibility systems are known in all 
vertebrates and prevent the formation of chimeras, or parasitic forms of the same 
species, in incompatible individuals or colonies. Allogeneic responses in higher 
vertebrates, as most immune responses, rely on the presence of a major 
histocompatibility complex (MHC), a multigene complex that codes for the ligands 
expressed on a range of cells to present antigen fragments to T-cells (Buss 1982; Stoner 
and Weissman 1996; Belov et al. 2006). Natural transplantations (except in 
pregnancies) and the formation of chimerism in vertebrates are, therefore, very rare. A 
Tasmanian devil infected with DFTD tumour cells, however, could be defined as a 
chimera, i.e., two organisms of the same species with a different genome, somehow 
fused together.   
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In all analyses of MHC class I genes, very little diversity was evident between devils of 
the affected population (Siddle et al. 2007). In the presence of an effective immune 
response, a plausible explanation for the successful acceptance of DFTD tumour cell 
transplants from DFTD-affected devils would be a lack of allo-recognition as a 
consequence of limited MHC diversity. To determine whether a lack of MHC diversity 
could account for the inability of the devil’s immune system to reject DFTD tumour 
transplants, a functional analysis of MHC genes was essential. Two main techniques 
were performed and analysed in this study. An in vitro experiment, the mixed 
lymphocyte reaction (MLR), and an in vivo experiment, the skin graft between 
unrelated devils, were utilised to undertake these analyses. The mixed lymphocyte 
reaction assay quantifies the allogeneic responses of lymphocytes isolated from the 
blood stream of two or more individuals, whereas skin graft experiments provide direct 
indication for MHC variation between two individuals. In addition, skin grafting was 
used to mimic the transfer of DFTD tumour cells from devil to devil, but using a mixed 
cell graft (skin) instead of tumour cells. 
Mixed lymphocyte reactions in several marsupial species have yielded disappointing 
results, therefore, this assay had to be designed specifically for Tasmanian devils. The 
first approach was to use a pool of lymphocytes from a large number of devils to act as 
‘target’ cells, cultured with freshly isolated lymphocytes, or ‘responder’ cells. This was 
undertaken with two intentions: first, to mimic a one-way MLR, which would rely on 
the proliferation of the ‘responder’ cells only; second, to create a ‘MHC collection’ with 
representative MHC antigens from as many devils as possible from different geographic 
locations. These pooled lymphocytes failed to proliferate in the allogeneic reactions, but 
responded to the mitogen stimulus, indicating that they were functional. The lack of 
allogeneic reactivity supports the concept of a limited MHC diversity in the devil 
population and this is further emphasised by the strong proliferative response observed 
in the human pooled mixed lymphocyte reaction, performed under similar conditions.  
One possible explanation for the failure in the responses of this experiment is that more 
diverse MHC types (if present) would be ‘diluted out’ and not able to stimulate a 
response. Additionally, three of the four assays were performed on the following day 
after the blood collection, and it can be speculated that these lymphocytes lost their 
ability to proliferate. However, most of the mononuclear samples proliferated well in 
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response to the mitogen Con A in a concomitant experiment. Moreover, this would not 
explain the low proliferation results for the eastern devils group, for which blood was 
processed on the same day.  
The next approach was to perform a two-way MLR by co-culturing target-responder 
lymphocytes from one devil with target-responder lymphocytes from another devil, as 
opposed to a two-way MLR utilizing pooled lymphocytes. Because of the low 
stimulation in the previously described experiment and to maximise the responses, this 
was favoured over a one-way MLR, where the ‘target’ lymphocytes would be 
inactivated. Compared to the earlier lymphocyte allogeneic reactions, these experiments 
produced some surprising high results.  
The scientific literature referring to MLR studies in other marsupial species has 
demonstrated a uniformly weak allogeneic response. This has intrigued marsupial 
immunologists for sometime. Four species of marsupials have been tested in MLR and 
demonstrated low or non-existent responses, including the South American 
Polyprotodonts (Didelphis albiventris and Monodelphis domestica) and the Australian 
Diprotodonts, the koala (Phascolarctos cinereus) and the Matschie’s tree kangaroo 
(Dendrolagus matschiei) (Fox et al. 1976; Infante et al. 1991; Wilkinson et al. 1992b; 
Montali et al. 1998; Stone et al. 1998). Attempts to explain the lack of MLR responses 
in these marsupial species include technical problems in the culture conditions or lack 
of appropriate ancillary cells (Fox et al. 1976), stress of first capture and consequent 
depressed lymphocytic responses (Buddle et al. 1992) and lack of MHC II genes 
diversity (McKenzie and Cooper 1994).   
Although in human one-way MLR tests a correlation of mitogen (PHA) proliferation 
and MLR response was found (Nanra and Boettcher 1980), this was not always 
observed with the devils. For example, lymphocytes from some animals would respond 
well to the mitogenic stimulus, but poorly to the allogeneic stimulus, and surprisingly, 
some cultures would result in higher proliferations in the allogeneic responses than in 
the Con A stimulation. Because a two-way MLR was used, it is impossible to define 
which devil reacted more and which was the responder, but MHC variability between 
animals that respond well or strongly in the MLR experiments can be assumed.  
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Variation in the mitogen responses was observed in Chapter 4. Mitogen responses were 
used concomitantly with the MLR experiments as a quantification of cell proliferation 
ability, and were also found to vary in the experiments in this chapter. Such variation in 
proliferation ability was also noted in the retests of the MLR responses, therefore it 
appeared appropriate to present the data both as stimulation indices and counts per 
minute. Because stimulation index values can vary greatly according to the CPM value 
of the controls, comparative data has to be interpreted with care. Lack of consistency in 
the responses was identified in a follow up experiment, performed with the same 
animals at a different occasion. It is likely that high responses are indicative of MHC 
diversity between the two tested animals, where both SI and CPM results were found to 
be high, but low responses might be transient and therefore not truly representative of 
ability to proliferate/respond.  
It is apparent from the MLR results in this chapter that this species is capable of 
allogeneic responses and that some MHC functional diversity exists amongst the tested 
devil populations. Many MLR experiments consistently yielded low results, indicating a 
lack of allo-reactivity. On further analyses, the low proliferative responses were 
identified between devils from the same group, suggesting a limited gene pool and 
consequent limited MHC diversity within devils from similar areas.  
A severe lack of polymorphism in the protein-binding region, which is a highly 
polymorphic residue in other animals, was determined in the eastern devil population 
(Siddle et al. 2007). A comparison with the highly inbred Asiatic lion (Panthera leo 
persica) showed far fewer substitutions in the devil protein-binding region than in the 
lion (Sachdev et al. 2005). These results were corroborated here by some of the MLR 
responses, which yielded low MLR responses for some experiments involving two 
eastern devils, especially devils with similar origin. However, some MLR results 
between different populations from eastern Tasmania generated high responses, even 
comparable to the mitogen proliferations, indicative of functional MHC diversity 
between groups.  
The eastern devils from all groups, except Group 5 (from Mt. William National Park) 
reacted poorly with other devils from the same group, indicating that devils from similar 
regions are likely to be genetically related. The exception was the MLR responses of the 
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devils from Mount William National Park, which were unexpectedly high. This was 
surprising because the devil population from this region has been devastated due to 
DFTD and a loss of genetic diversity would be expected. Devils are non-territorial, with 
daily movements of about 9 Km, although some animals transit in a much wider area 
(Hawkins et al. 2006). This would explain a different origin (and higher genetic 
diversity) for those devils, which could have reached that area to occupy the niche 
created by the disease. Devils from this area also provided the highest allogeneic 
stimulus to all other groups.  
In general, devils from the north west of Tasmania showed higher stimulation indices 
than the eastern counterparts. Importantly, allogeneic reactivity within groups was 
generally more stimulatory than the eastern groups, and this is indicative of more 
functional MHC diversity in these groups. Access to animals from this area was more 
restricted than eastern devils, so that groups were mainly comprised of only two 
animals. Nevertheless, MLR between devils from Woolnorth and from Granville 
Harbor yielded strong reactions, indicating that devils from these regions possess higher 
MHC variability than the eastern counterparts. These functional results are consistent 
with preliminary molecular data, which indicates the presence of more disparate MHC 
genes in the western cohort than in the eastern devil population (K. Belov, personal 
communication). 
Tasmanian devils from western and eastern areas are partially separated by a strip of 
unsuitable habitat and it might be possible that these two sub-populations evolved 
independently and in response to different environment factors, developing diverse 
MHC genes. To confirm this, MLR experiments were undertaken between devils from 
eastern and western Tasmania. These experiments resulted in the highest allogeneic 
reactivity observed in this study and are indication for MHC gene disparity between the 
two populations. It is possible that the partial separation between these two cohorts led 
to the appearance of divergent MHC molecules. Although Tasmania comprises a 
relative small landmass, western and eastern areas have distinct ecosystems and are 
likely to represent different evolutionary challenges for their respective devil 
inhabitants. 
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The results for the MLR experiments suggest from a functional perspective that devils 
from similar areas are likely to have similar MHC genes, but devils from different 
geographic locations have more differences in the MHC genes. Importantly, the 
presence of functional MHC differences within, and between, populations indicate that 
lack of MHC diversity is not the only explanation for the acceptance of DFTD tumour 
allografts.  
The next step to evaluate functional allo-reactivity in the Tasmanian devil population 
was to perform in vivo skin graft experiments. Skin grafting between unrelated 
individuals has been performed to test MHC disparity in two species of wild living 
mammals, the cheetahs and the pocket gophers (O'Brien et al. 1985; Sanjayan and 
Crooks 1996). These animals were shown to be highly monomorphic at MHC I loci and 
were unable to quickly recognise allo-antigens as foreign. Cheetahs eventually rejected 
the allografts, but at a much later date than what it would be expected in disparate MHC 
animals (10-14 days). Were DFTD transmitted due to low polymorphism in MHC loci 
across the eastern devil population, skin grafts between unrelated devils would have to 
be either accepted or, if rejected, this would have to be delayed by a number of weeks.  
All devils involved in the skin grafting experiments were part of the eastern cohort, and 
belonged to a population that was susceptible to DFTD. Mixed lymphocyte reactions 
between the paired devils was generally low, suggesting that most of these devils had a 
similar MHC. Nevertheless, in the five animals where the graft was successfully 
transplanted, all of the allografts were strongly rejected by the immune system. This 
immunological reaction was rapid, taking 7 to 14 days to be macroscopically visible.  
The rejection of the foreign tissue was usually visible macroscopically and 
microscopically between the 7th and 14th day post-transplant, which is the normal timing 
for allograft rejection (Medawar 1944). The only devil to demonstrate a later rejection 
was TD 199. The allograft from this animal did not show macroscopic evidence of 
rejection on Day 14, although microscopically T-lymphocytes infiltrating the graft were 
observed. This devil was reassessed on Day 17 and the damage caused by the rejection 
could finally be appreciated macroscopically.  
The skin allografts that could be assessed had characteristic pathology associated with 
immunological rejection, such as florid lymphocytic infiltration and consequent damage 
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and necrosis of the foreign tissue. Apart from evidence for MHC differences between 
the tested devils, the skin graft experiments also provided evidence for competent 
cytotoxic T-cell activity, as these cells are the main effector cells in transplant rejection 
(Abbas et al. 2007). This was apparent in sections of allografted skin biopsies when 
numerous CD3+ T-cells were visible. Although no anti-CD8 antibody is available for 
marsupials, it is likely that these cells were involved in the rejection of the allogeneic 
tissue.  Furthermore, graft rejection requires effective antigen presentation as well as 
CD4+ T-cell activity and cytokine production, supporting the findings of competent 
immune response described in Chapters 3 and 4. 
Skin grafts were used to mimic the engrafting of DFTD tumour cells in unrelated devils. 
However, skin is a heterogeneous tissue, with many different components, each of them 
with a different morphology, surface phenotype and function. Importantly, the skin 
houses different cells of the immune system, such as Langerhan’s cells, dendritic cells 
and other leukocyte types (Galkowska 2004). Most of these cells express MHC II 
molecules on the surface, which can act as allo-antigens. In addition, cells originated 
from the ectoderm, such as epithelial cells, express MHC I molecules on the surface. 
Allo-recognition of foreign peptides may occur through several different mechanisms, 
all involving antigen presentation by MHC I or II molecules. In Chapter 3 it was 
demonstrated that DFTD tumour cells do not express MHC II proteins on the cell 
membrane, even though MHC II genes are present at the RNA level (Siddle et al. 
2007). The expression of MHC I proteins by DFTD tumour cells still needs to be 
resolved, particularly as DFTD tumour cells express MHC I genes at RNA level. A lack 
of MHC expression on DFTD tumour cells would explain the successful 
allo-transplantation of tumour cells from an unrelated devil to another and the failure to 
transplant skin tissue from a devil to another.  
Because DFTD is an infectious disease, the absence of Tasmanian devils resistant to 
DFTD in the wild was not expected. The western areas of Tasmania are the last refuges 
of DFTD-free populations of Tasmanian devils. The recent observation that DFTD 
spreads at slower rates in some western boundaries of the island (R. Hamede, personal 
communication), and in the presence of more disparate MHC genes devils in this area, 
lead to the expectation that natural resistance to DFTD could arise in some animals. In 
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addition, devils with MHC genes more distantly related to the MHC genes of DFTD 
tumour cells would be the ideal candidates for a DFTD vaccine development. 
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6.1 – Introduction 
Devil Facial Tumour Disease was first recognized in the north east of Tasmania in 
1996. Even 12 years after its first appearance, no resistance against DFTD has been 
found in the wild population. Currently DFTD is present throughout more than 60% 
of the state and devils face risk of extinction within 20 years (Hawkins et al. 2006; 
Jones et al. 2007). Strategies to preclude this event include isolation of healthy 
populations, removal of infected individuals, prevention of infection through 
vaccination and identification of resistant animals. Isolation of healthy devils has 
been performed by trapping and quarantining to form an insurance population, to be 
used as a genetic pool should the devils to become extinct in the wild. To break 
transmission of the disease, removal of infected devils is currently underway as a 
small-scale trial on a virtually isolated peninsula, but to undertake such a program 
throughout the entire island of Tasmania, substantial and unrealistic logistical and 
financial resources would be required. Rather than relying on removing the disease 
from the population, an alternative control measure would be to introduce resistance, 
either immunologically or genetically.  
In either human or animal populations, the introduction of resistance through 
vaccination is one of the most effective methods to control the spreading of disease 
throughout a population. Devil Facial Tumour Disease is considered an infectious 
disease and consequently vaccination strategies need to be considered. Although 
vaccination against diseases such as cancer has met with limited success in human 
patients, numerous experiments performed in mice have shown that tumours can be 
prevented in a well-controlled setting (Overwijk and Restifo 2001; Buckwalter and 
Srivastava 2008). 
For an effective anti-DFTD vaccine, many questions must be answered, including 
the identification of tumour antigens and whether the host can produce an effective 
anti-tumour response. Even when the host can produce effective anti-tumour 
immunity, numerous mechanisms remain that will allow tumour cells to escape 
immunologic destruction. These include factors such as a lack of T-cell help, 
inadequate T-cell stimulation, presence of regulatory T-cells, and failure of T-cells to 
enter the tumour. Factors relating directly to the tumour include inadequate tumour 
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antigen expression, lack of MHC expression, and production of immunosuppressive 
factors (Hsiao et al. 2004; Rosenberg 2004). In support of vaccination as an effective 
strategy to protect against DFTD, are the devil’s immune response (Chapter 3 and 
Chapter 4), the highly conserved tumour morphology (Loh et al. 2006), genetics 
(Siddle et al. 2007) and chromosomal abnormalities that are consistent among DFTD 
tumours (Pearse and Swift 2006). The transmissible nature and stability of the 
genome means that tumour antigens will be conserved and the immune response will 
have constant antigenic targets to react against, a critical factor for a successful 
vaccine approach. 
Karyotype abnormalities in the DFTD tumour cells are consistent in all DFTD 
tumours. However, six ‘strains’ of DFTD tumour cells appear to have evolved. These 
strains are classified according to small and consistent abnormalities in the 
rearrangement of one or more chromosomes. The strain 1 appears to be the oldest 
and probably originated the strains 2 and 6. Strain 2 is likely to have originated 
Strains 3, 4 and 5. Strain 1 and 2 occur state-wide, whereas strain 3 and 5 are 
commonly found in, and near, the Forestier Peninsula, strain 4 in the central east 
coast and strain 6 in the north of Tasmania (A. Pearse, personal communication). The 
clinical significance of the different strains is unknown, as no studies have been 
undertaken to elucidate the pathogenicity of any strain. The rapid evolution of DFTD 
tumour cells in different strains contrasts with the Canine Transmissible Venereal 
Tumour, which is many centuries older than DFTD and spreads over all continents, 
but has evolved only into two single strains (Murgia et al. 2006) . 
One of the most important differences between DFTD and other infectious diseases 
is the absence of convincing evidence for animals that are naturally resistant to this 
fatal tumour, which is unusual for an infectious disease. The main objectives in this 
chapter were to determine whether Tasmanian devils would be able to recognize 
DFTD tumour cells as foreign, mount an immune response against the disease and 
whether this immune response would protect against DFTD. Furthermore, an 
anti-DFTD antibody detection assay was developed and a range of serum from wild 
Tasmanian devils was tested for naturally acquired immune recognition against the 
tumour cells, indicating exposure to the tumour cells without development of DFTD.  
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6.2 – Methods 
6.2.1 – Immunisation with DFTD tumour cells 
6.2.1.1 – Animals 
Six captive Tasmanian devils were selected for this experiment. TD 111 was 
collected from the wild and had TD 146 in the pouch. This animal mated the 
following year with two males from Arthur River (TD 8 and TD 13) and gave birth 
to TD 145. The paternity of TD 145 was not possible to determine. The other three 
animals were collected from the wild when approximately 1 year old. Details, 
pedigree and history of each devil are shown in Table 6.1 and Figure 6.1.  
Housing, anaesthesia and blood collection were performed as detailed in Sections 
2.3.2.3, 2.3.3 and 2.3.3. 
6.2.1.2 – DFTD tumour cell immunisation protocol 
All animals were immunised with killed or inactivated DFTD tumour cells (for 
culture conditions of DFTD tumour cells see Section 2.3.1). DFTD cells were either 
killed by freezing/thawing cycles or inactivated by X-irradiation. The 
freezing/thawing process consisted of killing DFTD tumour cells by quick cycles of 
freezing (in liquid nitrogen) and thawing (in warm water). A cell count using trypan 
blue dye was used to confirm that all cells were dead. In addition, an aliquot of cells 
was returned to culture and analysed for cell growth. Tasmanian devils were 
immunised with DFTD tumour cell lines of different strains, mostly the strains 2 
and 3. Occasionally, to increase the number of tumour cells, DFTD tumour cell lines 
of different strains were pooled and used as the immunogen (Table 6.2).  
Inactivation of DFTD tumour cells was performed by harvesting the required amount 
of tumour cells and centrifuging in 1 mL volume of RPMI-1640 complete medium in 
a sterile cryoval. Irradiation of tumour cells was carried out at the Holman Clinic of 
the Royal Hobart Hospital, Tasmania. For inactivation, cells were treated with 40 Gy 
X-irradiation and placed in an incubator for 14 to 16 hours. Killed, or inactivated 
tumour cells, were than washed several times in sterile PBS (11300 g for 1 minute 
 Animal Age and sex  History 
TD 185 2 years old Female Trapped in Granville Harbor as a juvenile and brought to captivity 
TD 183 2 years old Male Trapped in Woolnorth as a juvenile and brought to captivity  
TD 184 2 years old Male Trapped in Granville Harbor as a juvenile and brought to captivity 
TD 111 6 years old Female 
Trapped in Woolnorth as a 3 yo, had four cubs in the pouch. Mated 
with two devils (from Arthur River) the following year. 
TD 146 3 years old Male Brought to captivity in TD 111’s pouch. 
TD 145 2 years old Male 
Born in captivity from TD 111 the year after she was brought to 
captivity. 
Table 6.1: Brief history of each Tasmanian devil used in the immunisation experiments. Age refers 
to the age at which the experiment started. 
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each wash) and mixed vigorously with the required adjuvant. Details of the adjuvants 
used are given in Section 2.1. 
All DFTD tumour cell immunisations were performed under aseptic technique in two 
locations of the subcutaneous tissue on both sides of the rump (Figure 6.2 A). 
Table 6.2 summarises the immunisation protocol for the six devils. Blood was 
collected before the immunisations and weekly, fortnightly or monthly thereafter for 
analysis of antibody levels (Section 6.2.1.3). 
6.2.1.3 – Antibody response 
A mixture of two or more DFTD cell lines from different strains was harvested from 
culture flasks, pooled and washed twice (300 g for 10 minutes each wash) in a 
solution of PBS with 5% FCS. Cells were diluted to at least 1 x 106 tumour cells/mL. 
Sera from the immunised animals were diluted 1:25 in PBS 5% FCS (final volume 
100 µL) and incubated for 10 minutes at room temperature with 100 µL of DFTD 
tumour cells (final dilution of the serum was 1:50 with at least 2 x 105 DFTD tumour 
cells). Cells were washed with PBS 5% FCS three times (11300 g for 1 minute each 
wash) and diluted with 100 µL of PBS 5% FCS. The secondary antibody 
(approximately 10 µg/mL of purified rabbit anti-devil Ig, see Section 2.7) was 
incubated with the tumour cells for a further 10 minutes and washed as described 
above. The tertiary antibody (1:100 dilution of FITC conjugated goat anti-rabbit Ig) 
was then incubated with the tumour cells and washed as described for the primary 
and secondary antibodies. Details of the antibodies used are given in Table 6.3. 
Negative controls consisted of DFTD tumour cells alone, DFTD tumour cells 
incubated without primary antibody (devil serum) and DFTD tumour cells incubated 
with pre-immune serum from the devil being tested and the secondary and tertiary 
antibodies. For the subsequent experiments, this last control (pre-immune serum of 
the devil being tested) was utilised as the appropriate control to compare with the 
post-immunisation serum.  
6.2.1.4 – Establishment of flow cytometry experiments 
To test the feasibility of a flow cytometry assay for detecting Tasmanian devil 
antibodies, horse red blood cells (HRBC) were incubated with the pre-immune and 

TD 185 Week  Strain Dose Adjuvant 
1st Week 0 1 5 x 107 tumour cells (inactivated) Montanide gel 645101 
2nd Week 10 1, 2 and 4 1 x 108 tumour cells (inactivated) Montanide ISA 51VG 
TD 183  Week  Strain Dose Adjuvant 
1st Week 0 3 1 x 107 tumour cells (inactivated) Montanide gel 645101 
2nd Week 3 3 4.5 x 107 tumour cells (inactivated) Montanide gel 645101 
TD 184 Week  Strain Dose Adjuvant 
1st Week 0 3 1 x 107 tumour cells (inactivated) Montanide gel 645101 
2nd Week 3 3 4.5 x 107 tumour cells (inactivated) Montanide gel 645101 
TD 111 Week  Strain Dose Adjuvant 
1st Week 0 3 8 x 107 tumour cells (inactivated) Montanide gel 645101 
Challenge Week 32 3 2 x 25,000 live tumour cells - 
Tumour Week 48 - - - 
2nd Week 51 3 7 x 107 tumour cells (inactivated) Montanide ISA 51VG 
3rd Week 53 1, 2 and 4 1 x 108 tumour cells (inactivated) Montanide ISA 51VG 
TD 145 Week  Strain Dose Adjuvant 
1st Week 0 2 1 x 108 tumour cells (killed) Montanide gel 645101 
2nd Week 1 2 1 x 108 tumour cells (killed) Montanide gel 639101 
3rd Week 2 2 1 x 108 tumour cells (killed) Montanide gel 639101 
4th Week 8 2 1 x 108 tumour cells (inactivated) Montanide gel 639101 
5th Week 30 2 1 x 108 tumour cells (inactivated) Montanide gel 639101 
Challenge Week 41 2 2 x 25,000 live tumour cells - 
Challenge Week 68 3 2 x 25,000 live tumour cells - 
Tumour Week 90 - - - 
TD 146 Week  Strain Dose Adjuvant 
1st Week 0 2 1 x 108 tumour cells (killed) Montanide gel 645101 
2nd Week 1 2 1 x 108 tumour cells (killed) Montanide gel 639101 
3rd Week 2 2 1 x 108 tumour cells (killed) Montanide gel 639101 
4th Week 8 2 1 x 108 tumour cells (inactivated) Montanide gel 639101 
Challenge Week 41 2 2 x 25,000 live tumour cells - 
Tumour Week 53 - - - 
Table 6.2: Immunisation protocol used for each Tasmanian devil. 
Period of immunisation, strain and number of DFTD tumour cells and adjuvant used are shown. The time 
of challenge with live tumour cells and time when the tumour was first seen is also shown. 
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hyper-immune serum from TD 114 (which had been immunised against HRBC, see 
Section 4.3.4 for haemagglutination assay results for this devil). The same procedure 
used for the DFTD tumour cells was used for the HRBC and this was used as a 
positive control of the assay for the first experiments.  
TD 114 was immunised four times against HRBC on Weeks 0, 4, 8 and 32. On 
Week 56 and 60 this devil was immunised against K562 tumour cells.  To test for 
variation in the responses, serum from TD 114 was incubated with DFTD tumour 
cells at four time points, on Week 0 (pre-immune), 4, 10 and 62. The protocol for the 
immunisations against HRBC and K562 are described in Section 4.2.1.7.1 and 
4.2.2.2.  
6.2.1.5 – Flow cytometry analysis 
The samples prepared as per Section 6.2.1.3 were analysed by a Coulter EPICS Elite 
ESP Cell Sorter and converted to digital data using a 488 nm argon laser with filter 
set at 525 band pass. Twenty thousand events were acquired and the data was 
analysed using Cell Quest®Pro.  
6.2.1.6 – Challenge with live DFTD tumour cells 
Due to ethical reasons, only three devils (TD 111, TD 145 and TD 146) were 
challenged with live DFTD tumour cells. Challenge was performed at two different 
sites by injecting 25,000 live tumour cells suspended in 500 µL of sterile PBS in 
each location; TD 111 was injected in the subcutaneous tissue of both cheeks 
whereas TD 145 and TD 146 were injected in the subcutaneous tissue of the right 
cheek and in the mucosa of the left lower jaw, close to the first molar 
(Figure 6.2 B-C). TD 145 was challenged a second time, with the inoculation 
performed on the subcutaneous tissue of both cheeks. TD 111 was challenged 
30 weeks after the immunisation and TD 145 and TD 146 40 weeks after the first 
immunisation. TD 145 was challenged one further time 25 weeks later. All animals 
were challenged with tumour cells from the same strain that was used in the 
immunisation, except the second challenge in TD 145, which was carried out with 
two cell lines from strain 3 DFTD tumour cells.  
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6.2.1.7 – Histology and immunohistochemistry of DFTD tumours allografted in 
Tasmanian devils 
To confirm that tumours were DFTD, tumour masses were biopsied from devils that 
had been challenged with DFTD tumour cells. Biopsies were taken with a 3-4 mm 
punch biopsy and the collected tissue was fixed in 10% buffered formalin solution 
for 24-48 hours. Tissues were processed and stained with haematoxylin and eosin 
(H&E) as described in Section 3.2.2.2. 
Immunolabeling of MHC II+ cells (using a mouse anti-human HLA-DR antibody) 
and T-cells (using a rabbit anti-human CD3 antibody) was performed in formalin 
fixed tumour tissue from TD 111 and TD 146 to determine whether a cellular 
immune response had been invoked against the allografted tumour. Table 6.3 details 
the source of antibodies and dilutions used in flow cytometry and 
immunohistochemistry experiments. Tumour tissues were treated as described in 
Section 3.2.2.3. The tumours from TD 145 were removed at an early stage and 
analysed only under histology to confirm the diagnostic of DFTD. A piece of tumour 
was analysed cytogenetically to determine the tumour strain. 
Antibody Source Dilutions 
Polyclonal purified 
rabbit anti-devil Ig Made in house 
Used at 
10 µg/mL 
Polyclonal FITC-goat 
anti-rabbit IgG Zymed (65-6111) 1:100 
Polyclonal rabbit anti-
human CD3 Dako (A0452) 1:800 
Monoclonal mouse 
anti-human HLA-DR Dako (M0746) 1:100 
Table 6.3: Source of antibodies and dilutions used. 
6.2.2 – Anti-DFTD antibody detection in free-living Tasmanian devils 
Blood was obtained from 17 free-living Tasmanian devils from West Pencil Pine, an 
area of the western half of Tasmania where DFTD had been present for two years 
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(see Figure 6.1). Devils from this area were chosen because the disease did not 
spread at the same speed as areas of eastern Tasmania (R. Hamede, personal 
communication). Blood was collected in March, just after the breeding season, when 
contact among animals would be the highest. Clotted blood was centrifuged (1000 g 
for 10 minutes) and the resultant serum was harvested, aliquoted and stored at –80ºC. 
Flow cytometry assays were performed as described in Section 6.2.1.4, except it was 
not possible to collect a ‘pre-immune’ serum and this was substituted by 
non-immune serum from TD 145. A positive control consisted of DFTD tumour cells 
incubated with serum from TD 145 three weeks after its immunisation with DFTD 
tumour cells.  
6.3 – Results  
6.3.1 – Preliminary experiments 
Using the flow cytometry method outlined in this chapter, it was considered that a 
positive response would be demonstrated by a shift to the right in fluorescence, and 
as supportive information, an increase in MFI value. TD 114 was immunised with 
HRBC and produced a strong antibody response as detected by direct and indirect 
haemagglutination assays (Section 4.3.4). The response of this devil against HRBC 
was readily apparent as the fluorescent curve had a strong shift to the right, 
indicating positive labeling of HRBC with antibodies from this devil. In addition, 
MFI value increased about 40-fold compared to the pre-immune serum 
(Figure 6.3 A). This result validated the assay to analyse devil serum samples for 
anti-DFTD tumour cell antibodies. 
DFTD tumour cells alone, DFTD tumour cells incubated with serum from an 
unprimed devil and DFTD tumour cells incubated with the secondary and tertiary 
antibodies (without the primary) were used as negative controls for the first 
experiments. Tumour cells incubated with unprimed devil serum had the highest 
background fluorescence (Figure 6.3 B), therefore, for the subsequent experiments, 
pre-immune serum or serum from non-immune devils was used as the appropriate 
negative control.  
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The next aspect to investigate was the variation in different serum samples from the 
same animal. This was intended to determine whether pre-immune serum samples 
were consistently negative and to test whether immunisation with adjuvants would 
induce non-specific antibody production that could cause cross-reactivity with DFTD 
tumour cells. TD 114 serum was incubated with DFTD tumour cells at varying time 
points after several immunisations against unrelated cellular structures. 
Figure 6.4 A-E shows no evidence for cross-reactivity with DFTD tumour cells as no 
shift in the curves had occurred after immunisation with HRBC and K562, even 
though minimal variation in MFI values was observed. This lack of fluorescence 
following incubation with serum from this devil throughout the tested period 
confirmed that the adjuvants did not cause unspecific fluorescence in the DFTD 
tumour cells. 
6.3.2 – Anti-DFTD response of TD 185 
TD 185 was immunised on Week 0 with strain 1 DFTD tumour cells and received a 
boost immunisation (a mixture of strain 1, 2 and 4) on Week 10. The first 
immunisation was carried out with 5 x 107 X-irradiated tumour cells and the boost 
immunisation with 1 x 108 X-irradiated tumour cells.  
Three weeks after the first immunisation, there were no detectable antibodies against 
DFTD tumour cells. At Week 12, two weeks after the boost immunisation, a small 
shift to the right was observed, accompanied by a limited increase in MFI compared 
to pre-immune levels. This indicates that antibody production (potential immune 
recognition against DFTD tumour cells) had occurred, although the response was 
very weak (Figure 6.5 A-D).   
6.3.3 – Anti-DFTD response of TD 183 and TD 184 
Both animals were simultaneously injected with strain 3 X-irradiated DFTD cell 
lines on Week 0 and Week 3. To determine if a reduced number of DFTD tumour 
cells could induce an antibody response, the first immunisation was performed with 
1 x 107 DFTD tumour cells. This immunisation did not induce the production of 
antibodies of either devil, as demonstrated in Figures 6.6 A-B and 6.7 A-B. In 
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addition, only a minor increase in MFI was observed, suggesting either that higher 
numbers of DFTD tumour cells are needed to trigger an immune response or that 
these devils were not capable of responding against these antigens.  
On Week 3 the two devils received a boost immunisation of 4.5 x 107 DFTD tumour 
cells. This boost produced a minor antibody production, as there was a limited shift 
to the right in the fluorescent curves from both devils. Nevertheless, a small increase 
in MFI values was observed. This minor antibody production was consistent for both 
devils and suggests that these Tasmanian devils recognized DFTD tumour cells and 
mounted a weak antibody response (Figure 6.6 C-D and Figure 6.7 C-D). 
6.3.4 – Anti-DFTD response of TD 111 
TD 111 was immunised once at Week 0 with 8 x 107 strain 3 X-irradiated DFTD 
tumour cells. Due to irregular blood counts this animal was not analysed until 
Week 29. At this time point there was no convincing evidence for an antibody 
response (Figure 6.8 A-B). As part of a transmission trial, this animal was challenged 
with live DFTD tumour cells at Week 32. Although the MFI had increased slightly 
by Week 41, there was limited evidence for antibody production as there were no 
differences in the fluorescence curve observed in any of the tested periods 
(Figure 6.8 C-F). On Week 48 two DFTD tumours were detected, 16 weeks after 
challenge, in the location where the live tumour cells had been injected. 
Figure 6.9 A-B shows both DFTD tumours on Week 53, five weeks after first 
detected. Under histological examination, these tumours had all the hallmarks of 
DFTD tumours (Figure 6.9 C-D). Moderate infiltration of MHC II+ cells was seen in 
tumour tissue, but only sparse numbers of CD3+ cells were seen throughout the 
sections (Figure 6.9 E-F), similarly to what was observed in naturally transmitted 
DFTD tumours (Chapter 3). This suggests that this devil’s immune system was not 
responsive to DFTD.  
Three and five weeks after the tumour appearance (Week 51 and 53, respectively), 
boost immunisations were performed with 0.7 to 1 x 108 DFTD tumour cells of the 
strain 3 and strains 1, 2 and 4, respectively. Immunisations after the tumour 
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appearance did not cause any detectable antibody as measured in the flow cytometry 
experiments. 
Tumours were surgically removed on Week 58, but recurred on the right side 
approximately 16 weeks after the surgery. This animal had to be euthanased shortly 
after the tumour recurrence due to poor condition caused by a hyperplasia of the gall 
bladder duct, not related to DFTD. No evidence for DFTD metastases was found on 
necropsy of TD 111. 
6.3.5 – Anti-DFTD response of TD 145 
TD 145 was immunised on Weeks 0, 1, 2, 8 and 30 with 1 x 108 strain 2 DFTD 
tumour cells. For the first three immunisations DFTD tumour cells were killed and 
for the subsequent two immunisations, DFTD tumour cells were inactivated by 
X-irradiation. For the three weeks after the initial immunisation there was convincing 
indication for an increase in antibody titres against DFTD tumour cells, as evidenced 
by a clear shift to the right in the fluorescent curve, accompanied by a rise in MFI 
values compared to pre-immune serum. By Week 6, the antibody titre had decreased 
to pre-immune levels. A further booster at Week 8 appeared to cause a minor 
increase in detectable antibodies, although MFI values at Weeks 9, 10, 11, 12 and 13 
were similar to pre-immune levels (Figure 6.10 A-J). 
At Week 30 this animal received another booster immunisation, which caused a 
slight increase in antibody titres compared to background levels. Challenge with live 
DFTD tumour cells was performed at Week 41, at a time when antibodies would 
have been present, and again, at Week 68, when antibody levels would have been 
undetectable (Figure 6.10 K-O). 
The first challenge with live DFTD tumour cells did not result in tumour growth, 
suggesting that the immunisation had been effective. The second challenge, however, 
resulted in tumour growth in both locations 22 weeks after the inoculation, on 
Week 90. Both tumours were surgically removed one week after detection and 
samples processed for histology and karyotyping at the Department of Primary 
Industries and Water of Tasmania. Haematoxylin and eosin stained sections 
determined that the tumour masses were DFTD (Figure 6.11 A-D) and karyotyping 
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showed that the tumours were strain 3 DFTD, which had been injected on the second 
challenge (A. Pearse, personal communication). 
6.3.6 – Anti-DFTD response of TD 146 
This animal was immunised on Weeks 0, 1, 2 and 8 with 1 x 108 strain 2 DFTD 
tumour cells. DFTD tumour cells were killed for the first three immunisations and 
inactivated for the last immunisation at Week 8. No change in the fluorescence curve 
was observed until Week 31 and only inconsistent MFI values were acquired 
throughout this period of testing. The booster inoculation at Week 8 appeared to have 
caused a slight increased in MFI, but this was not supported by the histogram curve 
and not considered to be a true antibody response (Figure 6.12 A-J).  
At Week 41 this devil was challenged with live DFTD tumour cells. Twelve weeks 
after the challenge (Week 53), two tumours were detected in both sites of inoculation 
with the live tumour cells. These tumours were detected at the same time point, 
however, the tumour on the cheek developed faster and to a larger size than the 
tumour on the gingival mucosa. The tumour on the gingival mucosa became 
ulcerated and necrotic 12 weeks after its appearance (Figure 6.13 A-F). These 
tumours had the same histological characteristics of naturally occurring DFTD 
tumours (Figure 6.14 A-D).  
An increase in MFI value was detected at Week 73, two weeks after the larger 
tumour in the cheek had been surgically removed (Week 71) and a slight shift to the 
right was observed in the fluorescence curve. Two weeks later (Week 75), MFI value 
had increased by 3-fold compared to pre-immune levels, however, this evidence of 
fluorescence activity was not fully supported by the histogram. By Week 78 antibody 
levels appeared to have decreased (Figure 6.12 K-O). Although potentially 
antibodies had been detected soon after the surgery, only a moderate MHC II+ cell 
and sparse T-cell infiltration was observed in the tumour from this devil 
(Figure 6.14 E-F), similarly to naturally developed DFTD tumours in wild 
Tasmanian devils (Chapter 3).  
The larger tumour on the cheek was surgically removed on Week 71, but the tumour 
in the gingival mucosa was not removed due to its inaccessible location. TD 146 
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presented with lack of appetite and vomiting 26 weeks after the first signs of DFTD 
and was euthanased. A post-mortem examination revealed that metastasis on the 
right submandibular lymph node had developed, and a DFTD nodule was present 
where the tumour had been removed. However, the necropsy failed to determine the 
cause of this devil’s symptoms. 
6.3.7 – Anti-DFTD antibody detection in free-living Tasmanian devils 
From the 17 free-living Tasmanian devils tested, three animals (TD 135, TD 141 and 
TD 144) appeared to have evidence for presence of anti-DFTD antibodies, as the 
MFI exceeded the MFI observed when DFTD tumour cells were incubated with 
serum from an unprimed animal (Figure 6.15 A-S). However, this was supported by 
the histogram only in TD 144. This Tasmanian devil had the most prominent 
response of all tested devils, as the histogram showed a significant shift, hence 
supporting the presence of antibodies. This animal was examined in the field a year 
later without signs of DFTD tumours. 
6.3.8 – Summary of results 
The main findings of this chapter were: 
• Most Tasmanian devils immunised against DFTD tumour cells had a very 
weak antibody response; 
• One Tasmanian devil produced a stronger antibody response and did not 
develop DFTD tumours after a first challenge with DFTD tumour cells, but 
succumbed to the disease after a second challenge; 
• Two Tasmanian devils that did not show immune response against DFTD 
developed tumours after challenge; 
• One wild Tasmanian devil from a western population was shown to have 
anti-DFTD antibodies without the development of the disease. 
Figure 6.15: Anti-DFTD antibody detection in free-living Tasmanian devils 
 
A: Histogram showing mean fluorescence intensity (MFI) of DFTD tumour cells 
incubated with serum from TD 145 before the immunisation (pre-immune, purple 
histogram) and at Week 3 after immunisation (positive control, blue overlay).  
B-R: Histograms showing mean fluorescence intensity (MFI) of DFTD tumour cells 
incubated with serum from TD 145 before the immunisation (pre-immune, purple 
histogram) and with serum from 17 free-living Tasmanian devils from West Pencil Pine 
(black overlay). 
S: Graph showing mean fluorescence intensity (MFI) of DFTD tumour cells incubated 
with serum from TD 145 before the immunisation (pre-immune, purple bar) and at 
Week 3 after immunisation (positive control, blue bar) and with serum from 17 free-
living Tasmanian devils (black bars). The red line indicates the MFI of DFTD tumour 
cells using unprimed serum. 
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6.4 – Discussion 
To produce a vaccine against any disease, many aspects relating to the nature of the 
pathogen and the immune response of the target species need to be considered. 
Further, the resources necessary to produce an effective vaccine are enormous. The 
Tasmanian devil is declining rapidly in the wild and the opportunity to test a vaccine 
against this malignant disease may not be available in the future, therefore, one of the 
aims of this chapter was to test whether Tasmanian devils would be capable of 
recognizing DFTD tumour cells, mount an immune response and be 
immunologically protected against challenge with live tumour cells. Because the 
devil population is genetically impoverished, low MHC I diversity has been 
hypothesized as the means of immune evasion by DFTD tumour cells (Pearse and 
Swift 2006; Siddle et al. 2007). Therefore, it could be possible that devils did not 
recognize the immunogen as foreign following immunisation.  
The devil’s immune system has the components required for effective immunity (see 
Chapter 3 and Chapter 4) and, although genetically impoverished, the immune 
recognition genes (MHC I and II genes) were shown to be functional (Chapter 5). 
Tasmanian devils from the north west of Tasmania were used in the immunisation 
experiments because this population appeared to have a higher MHC diversity 
compared to eastern devils (Chapter 5), and this could have implications for 
anti-DFTD immune response.  
A vaccine strategy relies on the ability of the animals to mount an immune response 
against the pathogen. In the case of DFTD, the pathogen is the tumour cell itself. 
T-cells effectuate the conventional anti-cancer immune response, but classical T-cell 
cytotoxic assays were not possible to perform due to the nature of the tumour cells. 
Such assays rely on the ability of the target cells to uptake a radioactive substance, 
traditionally radioactive 51Chromium. Although a range of techniques was tested, the 
DFTD tumour cells failed to consistently label with radioactive 51Chromium. In 
addition, DFTD tumour cell cultures contain many dead cells, even in the healthiest 
cultures and these caused difficulties to perform functional assays using DFTD 
tumour cells as the target. Therefore, the presence of anti-DFTD antibodies was 
employed to indicate anti-DFTD immune recognition.  
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Preliminary experiments were required to establish a reliable flow cytometry assay. 
These preliminary experiments utilized the anti-HRBC antibodies that were 
produced and analysed in Chapter 4. The devil anti-HRBC antibodies were reliably 
detected using this assay and this was adapted to detect antibodies to DFTD. Other 
approaches (such as ELISA) proved unsuccessful due to high background caused by 
the rabbit anti-devil Ig. High background was the main limitation of the flow 
cytometry assay, most likely due to non-specific antibodies adhering to the DFTD 
tumour cells. This reduced the specificity of the assay, which was overcome by using 
non-immune devil serum as a control for each experiment. Some cultures would 
appear in the histogram as two distinct populations of tumour cells, although no 
visible distinction could be detected under microscopy. Positive tumour cells were 
uniformly fluorescent, independent of the size or shape, so no gating for specific cell 
populations could be utilized. Within these limitations, the flow cytometry system 
was a reliable procedure. 
Three devils (TD 185, TD 183 and TD 184) were injected with inactivated tumour 
cells only twice and responses at both immunisations were evaluated. After the first 
immunisation, no antibodies could be detected in any of these animals. The boost 
immunisation, however, caused a meagre production of anti-DFTD antibodies. These 
three devils had been tested for MHC functional diversity in mixed lymphocyte 
reactions (Chapter 5) and were shown to develop strong proliferations against 
lymphocytes from eastern Tasmanian devils (see Section 5.3.1.5), suggesting MHC 
variability. This allelic diversity at MHC loci, however, did not appear to promote 
strong immune recognition against DFTD tumour cell antigens.  
No detectable immune response was observed in TD 111 against the DFTD tumour 
cells. After the first immunisation had been performed, this animal was found to 
have abnormal numbers of lymphocytes in the blood stream, although no physical 
symptom of proliferative lymphoid disease was detected. In addition, this was an old 
devil and it is possible that it was not capable of a normal immune response. 
Nevertheless, this animal was of northwestern origin and some MHC differences had 
been determined in the cells of this animal in comparison to DFTD tumour cells 
(K. Belov, personal communication). Challenge with live tumour cells was, 
therefore, undertaken to define whether these MHC allelic differences would be 
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protective. In addition, the vaccination could have induced memory cytotoxic T-cells 
to be formed, even though this was not possible to evaluate. This devil developed 
tumours 16 weeks after the inoculation with live tumour cells, indicating that 
immune recognition had not occurred.  
A different immunisation protocol was carried out for TD 145 and TD 146, with 
three weekly immunisations and a further boost on Week 8. This was an attempt at 
maximizing the T-cell response. Following the first two immunisations, there was 
indication for an anti-DFTD antibody response of TD 145, but this did not occur in 
TD 146. This was an encouraging finding, as it was the first time that an immune 
response against DFTD tumour cells had been detected. A reasonable explanation for 
this disparity in the responses would be differences in the MHC genes. Therefore, 
samples of these two devils were sent for MHC genotypic analyses at Sydney 
University, and it was determined that TD 145 had fundamental differences in the 
MHC I molecules compared to the DFTD tumour cells, whereas TD 146 shared 
many band patterns with eastern devils and the DFTD tumour cells. It is likely that 
these MHC differences were responsible for the immune recognition of DFTD 
tumour cells by TD 145 and these findings parallel the results of mixed lymphocyte 
reaction experiments between devils from different regions of Tasmania (Chapter 5). 
TD 145 received a further booster immunisation on Week 30 and, after the first 
challenge with live tumour cells, did not develop tumours. There are two alternative 
explanations for this; 1) the immunisation 10 weeks before the challenge in this devil 
was critical in the protection against the disease or 2) MHC differences of TD 145 
accounted for this apparent protection against DFTD. It is also possible that the first 
challenge did not result in tumour development due technical reasons. This is 
unlikely, as the challenge was successfully performed on TD 146 at the same time. In 
addition, all devils challenged with live tumour cells have produced tumours (6/6) 
(results presented here and S. Pyecroft, personal communication). To resolve this, a 
second challenge was performed, this time 38 weeks after the last boost 
immunisation and this resulted in tumour development in this animal. This suggests 
that the immunisation had provided this animal with anti-DFTD protection to the 
first challenge, but it was probably a short-term protection. Comparatively, immune 
responses against HRBC decreased significantly a few weeks after the peak 
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(Chapter 4) and it is likely that the immune response against DFTD tumour cells had 
weakened 38 weeks after the last immunisation.  
To distinguish between both challenges, the second challenge in TD 145 was 
performed with strain 3 DFTD tumour cells. The resultant tumours were shown to be 
of strain 3, confirming that these tumours originated from the cells injected the 
second time. It is possible that if anti-DFTD immunity was present in TD 145, was 
directed against the strain 2 and not against the strain 3, as all the immunisations had 
been undertaken with strain 2 DFTD tumour cells. However, as there are only little 
differences between these two strains (A. Pearse, personal communication) it is 
unlikely that the immune response would be directed against one and not the other 
strain.  
TD 146, which had a boost immunisation 33 weeks before the injection with live 
tumour cells, succumbed to the disease after the challenge with live tumour cells. As 
discussed above, this devil shared many MHC band patterns with DFTD tumour 
cells and it is possible that this resulted in the lack of recognition and protection 
against DFTD. However, TD 146 did not receive a boost at the same time of TD 145 
(10 weeks before challenge) and it is possible that this devil would be protected 
against the disease if the boost had been given. However, this is unlikely, as no 
detectable anti-DFTD response had been found previously.  
An interesting observation was that TD 146 had a slight rise in antibody levels after 
the tumour development. This apparent increase in antibody levels peaked two weeks 
after the removal of the largest mass, which was measuring approximately 100 cm3 
at the time of the surgery and could have acted as an immense boost for the immune 
system. The tumour mass, however, did not have any sign of lymphocyte infiltration, 
suggesting that anti-tumour immunity had not been invoked with the immunisations.  
The tumours that developed after challenge with live tumour cells in the three devils 
had the characteristic morphology of DFTD tumours and developed in the locations 
where the cells had been injected. The locations of DFTD tumour cell inoculation 
(subcutaneous tissue of the cheek and gingival mucosa) were chosen because the 
cheek and the gingival mucosa are the most commonly seen locations of natural 
transmitted DFTD tumours in wild devils. This did not cause variation in the 
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incubation period, as tumours in all three challenged devils were detected at the same 
time and at similar sizes, indicating that the micro-environment is not critical for the 
DFTD tumour growth. However, the tumours of TD 146 developed at different rates; 
the tumour in the cheek increased to a large mass in only 18 weeks, while the tumour 
in the gingival mucosa maintained a stable size throughout the period of 
experimentation. This difference in expansion is likely to be caused by the physical 
environment in which both tumours were inoculated. The tumour in the cheek had 
physical space to develop unrestrained by any major structure apart from the skin, 
which is malleable and can expand considerably. In addition, blood supply from 
many vessels would be readily available for tumour growth.  The tumour in the gum, 
however, was restrained by the mandibular bone and the blood supply was restricted 
to the mandibular artery, which feeds the bone and surrounding tissues. This tumour 
also ulcerated and became necrotic, probably due to mechanical abrasion with food. 
Because this tumour caused visible discomfort to the animal and because its location 
made it impossible to be surgically removed, the next inoculations (TD 111 and 
second challenge in TD 145) were carried out only in the subcutaneous tissue of the 
cheek.  
Preliminary transmission trial experiments had been undertaken by DPIW with 
unprimed devils and had shown that injection of 1 x 106 live tumour cells would 
cause development of DFTD tumour masses between two to four weeks (S. Pyecroft, 
personal communication). Challenge with live tumour cells performed with the 
present study was carried out utilizing only 25,000 cells in each side of inoculation. 
This lower number of cells was chosen to avoid an overwhelming growth of DFTD 
masses. Although the number of viable cells injected in each site was consistent, the 
period from the challenge to the first sign of tumour (thereafter referred as incubation 
period) varied from devil to devil. The incubation period for TD 146 was 12 weeks, 
for TD 111 was 16 weeks and for TD 146 it was 38 weeks. The reasons for this 
difference in the incubation period could be due to the tumour cells themselves or to 
the immune response of each individual devil.  DFTD tumour cells in culture grow at 
varied rates, but little information is available about DFTD tumour cells and much 
still needs to be learnt. TD 145 developed visible tumours 38 weeks after the second 
challenge, which is more than twice the time the other devils took to show signs of 
Chapter 6: Induced immune response of the Tasmanian devil to DFTD 
 
− 179 − 
DFTD. This devil could have been protected against DFTD on the first inoculation 
and some immune resistance might have taken place for the second challenge, 
although no sign of lymphocyte infiltration was observed in the tumours. 
Immunisations with the adjuvant Montanide proved to be safe, as no side effects 
were detected in any devil in this experiment. Different formulations of this adjuvant 
were used according to advice of the producer and intended to stimulate the T-cell 
response in the immunised animals, although this could not be assessed. DFTD 
tumour cells were prepared either by killing or by X-irradiation inactivation. The 
killing process, which involved freezing and thawing the cell suspensions several 
times, could potentially result in higher exposure of intra-cytoplasmatic antigens 
compared to X-irradiated tumour cells that would be intact. No attempt was made to 
compare these two methods, but the second was favoured for bio-security reasons.  
The next aspect of this chapter was to investigate whether anti-DFTD antibodies 
could be found in a population of free-living Tasmanian devils. A region of the west 
of Tasmania was chosen due to the observation that DFTD has spread at a slower 
rate among devils in this area compared to areas of eastern Tasmania (R. Hamede, 
personal communication). The usual trend in the eastern half of the state is a 
dramatic crash in devil numbers in the following year after the observation of the 
first cases of DFTD. By the second year, the remaining population is mostly 
composed of juvenile devils, as the adults would have succumbed to the disease 
(Hawkins et al. 2006; Lachish et al. 2007). In West Pencil Pine, however, the disease 
had been present for at least two years and few cases of DFTD had been observed. It 
is unknown what factors are responsible for this trend in this population, but as 
discussed earlier, northwestern devil populations have more diversity in the MHC I 
genes compared to the eastern cohort. Wild populations of vertebrates exhibiting 
high MHC diversity are thought to be more resistant to infectious diseases, such as 
parasitic diseases (Sommer 2005) and it is possible that this is also true for DFTD.  
Serum samples were collected in March, just after the breeding season, when most 
contact between males and females occur and, therefore, contact with DFTD tumour 
cells would be more likely. A limitation of this test is that, because a “pre-immune” 
serum from these devils was not possible to collect, serum from a captive unprimed 
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animal had to be used as the pre-immune control. Some individual variation might 
account for levels slightly higher than background, so were analysed with caution. 
The serum from an immunised animal was used as a positive control for the 
experiment and for comparison purposes.  
From 17 free-living devils, three had evidence for the presence of anti-DFTD 
antibodies. However, without a pre-immune serum as a control, it is possible that 
individual serum variation was responsible for high values in two animals. The other 
devil had levels twice as high as the background and the antibody level of this devil 
was even higher than the positive control and it is more likely that it represents a true 
antibody response. This is encouraging evidence, suggesting that it had been exposed 
to DFTD tumour cells and produced antibodies. This animal was a female that had 
bred a month earlier, as it was carrying pouch young at the time of the blood 
collection (hence it could not be brought into captivity). It is likely that a DFTD 
infected male with tumour(s) in its mouth bit TD 144, so that it would be exposed to 
DFTD tumour cells. This female was trapped a year later in the same location and 
did not have any DFTD lesion, indicating either that DFTD was in the incubation 
period or that it had not established itself in this animal due to immunity. Although 
the incubation period for naturally transmitted DFTD has not been established, it is 
likely that it correlates with the amount of tumour cells injected in the tissues of the 
devil. Because antibodies were detected, many tumour cells would have been 
injected to induce a response. The reason for a possible immunity against DFTD 
needs further investigation, but research on the MHC genes of this animal might 
clarify this. In addition, a much larger number of animals from a range of locations 
need to be tested to identify other possible ‘responders’.  
Experiments in this chapter were designed to determine the possibility of producing 
an effective vaccine against DFTD, in a captive situation. Although most animals 
showed signs of responding against the DFTD tumour cells, from the three 
challenged devils, all developed the disease. In addition, the observed responses were 
many fold weaker compared to the responses of a devil immunised with HRBC. 
However, one animal (TD 145) did not develop DFTD when challenged 10 weeks 
after the immunisation, suggesting that frequent boosters might be necessary for 
protection. In a free-living population, animals would have to be extensively 
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captured for the injection, unless an oral vaccine can be developed. Using whole 
cells as the immunogen is laborious and time consuming and might stimulate the 
immune system to respond against a range of epitopes, some of them that could have 
no vital function in the cell cycle. Future research on isolation of specific proteins of 
the tumour cells will lead to more suitable antigens for an anti-DFTD vaccine. 
The best-case scenario for the Tasmanian devil population is the presence of animals 
that will naturally be resistant to DFTD. These animals would survive the epidemic 
and pass their genes on to the following generations, so that DFTD would eventually 
die out. However, no signs for this have been found. The presence of one animal 
with natural anti-DFTD antibodies indicating pre-exposure and not development of 
the disease one year after is a ray of hope that might prove fruitful field for more 
research in the future.     
  
 
CHAPTER 7: 
FINAL DISCUSSION 
 
 
 
 
 
Chapter 7: Final Discussion 
 
− 182 − 
Chapter 7: Final Discussion 
7.1 – The Tasmanian devil and the Devil Facial Tumour Disease............................... 183 
7.2 – The immune responses of the Tasmanian devil .................................................. 184 
7.3 – Allo-reactivity of the Tasmanian devil................................................................ 185 
7.4 – Immune escape of DFTD .................................................................................... 187 
7.5 – Immunisation and resistance against DFTD ....................................................... 189 
7.6 – Limitations of research in wildlife immunology................................................. 191 
7.7 – Future Research ................................................................................................... 192 
7.8 – Concluding remarks ............................................................................................ 193 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 7: Final Discussion 
 
− 183 − 
7.1 – The Tasmanian devil and the Devil Facial Tumour Disease 
The Tasmanian devil, the world’s largest extant marsupial carnivore, is facing 
extinction due to an emergent disease, Devil Facial Tumour Disease. While drastic 
measures and resources have to be taken to prevent the extinction of this iconic 
marsupial, research efforts to understand the pathobiology of this disease still remain of 
paramount importance for the survival of the species in free-living populations.  
Research in the last three years has gathered much information about different aspects 
of this wildlife disease. DFTD is a contagious neoplasm in which infective tumour cells 
are transferred from an infectious devil to a recipient devil by biting. Unlike 
conventional neoplasms that develop and remain within the individual animal, this 
neoplasm is capable of continuous development as it is transmitted between devils.  
Tumours can result from the uncontrolled growth of transformed normal cells by 
different mechanisms. These transformed and genetically unstable cells may generate 
new antigens, express high levels of otherwise inactive genes leading to higher 
concentrations of encoded proteins, down-regulate molecules involved in immune 
recognition, such as MHC Class I and II. In addition, growth of a neo-tissue and 
disruption of the normal histological architecture can trigger inflammatory processes, 
which bring tumours in contact with the immune system (Pardoll 2003). How tumours 
can evade, or are recognised by, the immune response of the host is one of the factors 
that dictate the outcome of the disease. Tasmanian devils affected by DFTD have shown 
no immune response to the tumour, as there is no evidence for a tumour-specific 
lymphocytic infiltration and consequent remission. Demographically, there has been no 
evidence of individuals with innate resistance to tumour establishment.  
Many aspects of the immune system of the Tasmanian devil relating to DFTD are 
important to understand and predict the outcomes of such a devastating disease. 
Fortunately, studies of the immune response of the Tasmanian devil and the relation of 
its immune system and DFTD have been possible to undertake. The preliminary work 
presented here provides valuable information about functional aspects of the immune 
response of this species, an area that received almost no attention in the past. In 
addition, this research serves as a foundation for future studies. 
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7.2 – The immune responses of the Tasmanian devil 
The first objective of this thesis was to investigate the devil’s immune system and the 
devil’s immune response in relation to DFTD. This was undertaken by applying several 
methods and techniques, to determine whether this species’ immune system was 
functional. Compared to eutherian immunology, scientific progress in marsupial 
immunology has been slow, mainly due to a lack of specific reagents that would allow 
the recognition of fundamental molecules and cells of the immune system. In addition, 
the immune response of marsupials has many different aspects to that of the eutherian 
counterparts and much remains unknown. Consequently, the recent sequencing of a 
marsupial species genome (Monodelphis domestica) (Mikkelsen et al. 2007) has 
promised a new era in marsupial immunology research, especially in molecular aspects 
of the immune system. 
Tasmanian devils belong to the Dasyurid family, a group that is known for the extreme 
life-history strategy (semelparity) of some of its members. This unusual reproductive 
strategy has implications for the study on the immune responses of this group, as some 
small Dasyurids undergo severe immunosuppression caused by an imbalance in 
corticosteroid secretion, which leads to death by otherwise benign infections. 
Marsupials from this group also have a shorter life span and exhibit a higher 
susceptibility to cancers compared to other marsupials or eutherians. Devils live up to 
six years in the wild, whereas eutherian mammals of similar size would normally live 
twice as long. The main pathologies associated with aging Dasyurids, including 
Tasmanian devils, are neoplastic growths, especially of epithelial and mesothelial 
origin, but the reason for this high incidence of neoplasms in this group is unknown. 
This predisposition to develop tumours could be caused by a deficiency in the T-cell 
immune response of this species. In support of this, many marsupials are highly 
susceptible to other pathologies that require T-cell competency, such as toxoplasmosis 
and mycobacterial diseases. Devils are exposed to extreme conditions in the wild, often 
bearing extensive contaminated facial wounds and scarring due to intra-species fighting. 
As devils feed mainly on carrion they would normally be exposed to a range of potential 
pathogens. These pathogens are most likely to be bacterial in nature, rather than viral. 
Therefore, it would be expected that the species would develop a bias to innate 
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(phagocytosis) and humoral (antibody production) immune responses, as opposed to 
T-cell responses.  
Experiments to test T-cell immune responses demonstrated efficient T-cell 
mitogen-induced proliferation in the lymphocytes from most animals. The one devil 
analysed for functional cytotoxic T-cell activity provided further evidence for 
competent T-cell response. Rejection of skin allografts occurred in all successful graft 
surgeries. This was accompanied by a florid T-cell reaction, which is evidence for 
competent cellular immunity and effective interactions of T-cells with 
antigen-presenting cells. Similarly, in vitro and in vivo experiments designed to test 
innate and humoral immune function demonstrated competent responses. Structurally, 
devils appear to possess all basic cellular and histological components required for 
effective immune responses. Therefore, although this group (Dasyurid family) appears 
to have a higher predisposition to infections and malignancies that require T-cell 
competency, results presented here suggest that the Tasmanian devil has a competent 
T-cell response.  
An important finding of this thesis was the absence of any signs of generalised immune 
suppression amongst healthy wild and captive devils as well as DFTD-affected devils. 
This was significant, as down-regulation of the immune response was considered a 
plausible explanation for how DFTD tumours readily proliferate in individual devils. In 
the presence of a competent immune system, another explanation had to be sought, such 
as lack of MHC diversity in the affected devil population or manipulation of the MHC 
machinery by the DFTD tumour cells. 
7.3 – Allo-reactivity of the Tasmanian devil 
Another aspect of this thesis was to analyse the functional diversity of MHC genes in 
different populations of Tasmanian devils. Because this insular species has been shown 
to have impoverished heterozygosity, low allelic diversity (Jones et al. 2004) and lack 
of MHC diversity (Siddle et al. 2007), monomorphism at MHC loci would satisfactorily 
explain how this allogeneic tumour cells could be successfully transplanted from devil 
to devil.  
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Functional tests of MHC diversity (mixed lymphocyte reactions and skin grafts between 
unrelated individuals) found a higher allo-reactivity than previously suspected, although 
there was a definite lack of MHC diversity amongst devils from the same areas. 
Nevertheless, many MLR experiments resulted in prominent allogeneic proliferation 
and skin allografts were promptly rejected by the devil’s immune system. These were 
vital findings, as the most accepted theory for the easy transfer of DFTD tumour cells 
amongst disparate devils, was that this species had such low MHC diversity to allow 
graft transfer between unrelated individuals.  
Low MHC I diversity allowing for the acceptance of skin allografts has been detected in 
two wild mammals, the cheetah (Acynonyx jubatus) and the pocket gopher (Thomomys 
bottae) (O'Brien et al. 1985; Sanjayan and Crooks 1996) and it was suspected that 
allografts in devils would result in a similar outcome (Siddle et al. 2007). The strong 
immunological host-graft rejection seen against the skin allografts in devils indicates 
that other mechanisms are likely to be responsible for the natural transmission and 
establishment of DFTD tumour cells between wild devils.  
The other two known socially-transmissible tumours in mammals, the Canine 
Transmissible Venereal Tumour (CTVT) and the transmissible sarcoma of the Syrian 
hamster, may have initially originated amongst MHC monomorphic animals. This is 
clear with the transmissible sarcoma of the Syrian hamster, in which captive populations 
arose from only three related individuals, and consequently were highly inbred. The 
CTVT origin, however, is not nearly as clear as the tumour in the Syrian hamster. 
Whilst it is accepted that wild wolves were domesticated to become dogs in several 
parts of the world (Vila et al. 1997), the genesis of this now widespread sarcoma is 
unknown. It is possible that early populations of domesticated dogs underwent 
bottlenecking periods and consequent loss of allelic diversity, allowing for the 
transference of a sexually transmissible tumour. The modern dog population, however, 
is highly outbred and equally susceptible to CTVT. This disease uses several different 
mechanisms to overcome the immune response of the host (immunocompetent dogs), 
and this could be an adaptation that CTVT tumour cells evolved over time to infect 
other MHC disparate dogs (Murgia et al. 2006).  
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Since European settlement of the island of Tasmania in the early 19th Century, the 
Tasmanian devil was subjected to persistent human prosecution and poisoning pressures 
(Obendorf and McGlashan 2008). The historical recorded fluctuations in its population 
may have accentuated the reduction in its genetic diversity. With the advent of new 
roads and consequent influx of devils in new areas, however, DFTD might have to 
adapt to these new MHC-dissimilar devils and find new ways to cross the MHC barrier. 
With the continued westward spread of DFTD-affected devils into Tasmanian regions 
where currently there are still DFTD-free wild devils, monitoring the arrival and 
establishment of the disease in these populations is crucial. The phenotypic and 
genotypic differences recorded in these DFTD-free populations, including 
MHC-dissimilar genotypes, make this effort paramount.  
7.4 – Immune escape of DFTD 
Incorporating current knowledge from both the immunological and the genetic studies, 
it is now clear that an improved understanding of MHC expression by the tumour cells 
themselves will help to understand the apparent paradox between the observed rejection 
of skin tissue allografts and the universal acceptance of naturally transferred tumour 
cells.  
Tumour cells can utilise a range of mechanisms to evade the immune response of the 
host. Down regulation of the antigen-processing machinery, namely classical 
MHC Class-Iα, and up regulation of MHC Class-Iβ, are common mechanisms of 
immune tolerance used by many tumours, including the CTVT (Pardoll 2003; Algarra et 
al. 2004; Murgia et al. 2006). Phenotypic alterations in the MHC I of tumours can 
originate through a variety of mechanisms, however, the final outcome is the capacity to 
modify antigen presentation to T-cells and modulation of NK cells, making the tumour 
‘invisible’ by T-lymphocytes and NK cells (Garcia-Lora et al. 2003; Algarra et al. 
2004).  
It was shown that DFTD tumour cells express at least three MHC Class Ia loci and 
MHC Class II molecules (but no Class Ib loci) (Siddle et al. 2007), but whether these 
molecules are converted to the cell surface in the form of functional protein is unknown. 
Relevant to this proposition was the finding that an antibody against the α chain of the 
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HLA-DR molecule (a human MHC II molecule) did not label DFTD tumour cells, 
despite strong positive labelling of devil’s immune cells. Siddle and colleagues (2007) 
analysed MHC II expression in DFTD tumour cells using primers for the β1 and β2 
domains. Immunohistochemistry and western blotting techniques could be used with 
specific antibodies against these regions to characterize MHC II expression on DFTD 
tumour cells. MHC I molecule expression on the cell surface has been more difficult to 
determine. Preliminary experiments using several anti-MHC I antibodies (against other 
species) failed to label cells of Tasmanian devil tissues, but it is possible that 
down-regulation of MHC molecules is the mechanism of escape used by DFTD tumour 
cells.  
A range of tumours in humans and animal models produce cytokines that inhibit anti-
tumour activity or induce immune tolerance, with the classical example being 
transforming growth factor beta (TGF-β). TGF-β1 is the most significant in tumour 
development compared to TGF-β2 and TGF-β3. This cytokine belongs to a large family 
involved in regulation of different aspects of cell physiology and metabolism, including 
proliferation, differentiation, migration, apoptosis, adhesion, angiogenesis, immune 
surveillance and cell survival (Elliott and Blobe 2005; Jakowlew 2006). TGF-β1 has 
two conflicting effects on tumour growth. Tumour suppressor activity has been 
demonstrated in early stages of cancer, probably in an attempt to maintain homeostasis 
in the host tissue. However, TGF-β1 has also tumour promoter actions, such as 
angiogenesis and potent inhibition of immune function, such as reduction of 
proinflamatory responses and down-regulation of several cytolytic products (perforin, 
granzyme A, granzyme B, Fas ligand and interferon-γ), which are responsible for T-cell 
mediated tumour cytotoxicity (Pardoll 2003; Thomas and Massague 2005; Jakowlew 
2006). This pro-tumour action of TGF-β1 has been suggested to be the most prevalent, 
as TGF-β1 over-expression by tumour cells is associated with increased tumour 
progression, metastasis and death (Jakowlew 2006).  
The Canine Transmissible Venereal Tumour exploits TGF-β1, amongst other 
mechanisms to escape immune recognition by the host, and it is possible that both 
transmissible neoplasias, CTVT and DFTD, utilise similar approaches to evading 
immune recognition. The tumour cells of CTVT inhibit killing activity of tumour 
infiltrating lymphocytes by secreting TGF-β1, allowing the tumour to grow 
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substantially. TGF-β1 also interacts with host IL-6 and IFN-γ, promoting down 
regulation of expression of MHC I and II antigens (Hsiao et al. 2004; Hsiao et al. 2008). 
A similar mode of action can be suggested for the immune evasion of DFTD tumour 
cells in the Tasmanian devils, although in vitro inhibition of lymphocyte proliferation 
was not observed using DFTD tumour cell supernatants (Siddle et al. 2007). 
Preliminary work using immunohistochemistry showed that mouse anti-human TGF-β1 
antibody does not recognize Tasmanian devil tissues. However, this is an important 
mechanism of tumour evasion of the host defence system and it warrants further 
investigation, perhaps utilising a wider variety of antibodies against this molecule, other 
molecular techniques and more in vitro suppression studies.  
A very recent genetic transcriptome approach and immunohistochemistry research has 
shown that DFTD tumour cells express high levels of periaxin, a protein involved in the 
myelination pathway of Schwann cells. This coat of myelin on DFTD tumour cells 
could, therefore, protect these allografted cells from immune attack by T-cells. Another 
transcript, that of pro-opiomelanocortin, a peptide hormone precursor of 
adrenocorticotropin hormone (ACTH) was also found to be highly expressed in DFTD 
tumour cells, and it is possible that immunosuppressive hormones alter the physiologic 
response of devils to the tumour (Murchison et al. submitted). 
7.5 – Immunisation and resistance against DFTD 
Vaccination, together with improved hygiene practices, remains one of the main 
cornerstones of infectious disease prevention. Isolation, inactivation and injection of the 
causative microorganism are the basic principles created by Pasteur for vaccination over 
a century ago and these are still current for most vaccines. These principles were used 
for an anti-DFTD immunisation trial in this thesis. Research on the genomic aspects of 
many microorganisms has introduced new tactics for vaccinology, where the target 
microorganism does not need to be cultivated and more reliable antigens can be isolated 
and used as immunogens (Rappuoli 2004). However, genomic technology is not yet 
available for Tasmanian devil and DFTD research. 
Immunisation of six Tasmanian devils with killed or inactivated DFTD tumour cells 
resulted in limited responses. One devil showed detectable anti-DFTD antibodies after 
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immunisation and there was evidence for protection against live DFTD tumour cells 
challenge. The response of this devil is likely to be related to MHC differences between 
this animal and DFTD, but a larger trial with devils exhibiting a range of MHC gene 
patterns need to be undertaken to confirm this. 
Vaccination of wildlife has met with limited success. Induction of ‘herd immunity’ is 
necessary, and easy to deliver vaccines and long-term immunity are highly desirable.  
Two zoonotic infectious diseases, rabies and tuberculosis, have severe impacts in 
animal production and human public health and have been, therefore, more intensely 
used as target for vaccination of wildlife. Both diseases may have wildlife mammals as 
reservoirs, and as such, vaccination of targeted wildlife against the two causative 
pathogens of these diseases is very important for their prevention in livestock and 
human populations. The success of these vaccine programs depends greatly upon the 
deliverance of the immunogen; oral formulations of rabies vaccine are available, so that 
the immunogen can be delivered to wild animals in baits (Haydon et al. 2006).  
Similarly, an attempt to vaccinate brushtail possums (Trichosurus vulpecula) with 
aerosol formulations of a tuberculosis vaccine has yielded positive results in New 
Zealand (Collins et al. 2007). Another comparison example of vaccination of wildlife 
was the successful immune-protection against Erysipelas-associated infection of the 
highly endangered New Zealand parrot, the kakapo (Strigops habroptilus). This 
flightless bird was successfully vaccinated against Erysipelothrix rhusiopathiae in a 
remnant island population, providing artificial resistance and preventing further deaths 
due to this epizootic disease (Gartrell et al. 2005). 
The development of a possible vaccine formulation against DFTD would be only one, 
amongst many, means of managing DFTD in wild devil populations. Isolated areas, 
such as peninsulas or islands, would be potential scenarios to undertake immunisation 
of devils against DFTD, as the mainland area of Tasmania is too large and with variable 
topography to allow trapping of the majority of wild devils. A preliminary suppression 
trial has been undertaken in a semi-isolated peninsula (Forestier Peninsula), involving 
intensive trapping, visual assessment and culling of all DFTD-affected devils. Were a 
vaccine to be delivered, it would be ideal in this context, to provide artificial protection 
to visually DFTD-free devils before release. In addition, devils in insurance populations 
could be vaccinated before translocations to other areas. Much improvement in the 
Chapter 7: Final Discussion 
 
− 191 − 
formulation of an anti-DFTD vaccine and understanding of the immune response of 
devils against it is clearly warranted.  
Infectious diseases alone usually do not cause extinction of outbred wild populations, as 
resistant individuals survive and pass their genes on to the next generation.  
Nevertheless, there are exceptions to this, such as the emergence and global dispersal of 
the amphibian chytrid fungous (Batrachochytrium dendrobatidis). This disease has been 
directly responsible for the extinction of a number of highly specialised frog species in 
several parts of the world and is a lesson to be learnt about the fragility of some 
vertebrate animal populations (Rohr et al. 2008).  
Although devil numbers have decreased at alarming rates, some indications from the 
field and from the lab might prove to be hopeful. Devils are thought to be highly inbred, 
but functional diversity in MHC genes was one of the findings of this thesis, especially 
in devils from western areas of Tasmania. Functional MHC diversity is essential for the 
adaptation to new infectious challenges. The rate of spreading of DFTD in one of the 
western boundaries of DFTD (West Pencil Pine) has been slower than in other areas and 
it is possible that disease resistance related to higher MHC diversity is playing a role in 
that area. In addition, one of the animals from West Pencil Pine was shown to have 
anti-DFTD antibodies without developing the disease. This brings hopes that some 
animals might be resistant to DFTD and would survive long term in the wild.  
7.6 – Limitations of research in wildlife immunology 
Research in new and emerging diseases in wildlife has a number of inherent difficulties; 
these include the need for adaptation for species-specific physiology in experimental 
conditions, access and availability of animals and lack of specific reagents.  
Consequently, some work described here was somewhat limited or restricted in 
comparison to similar research using laboratory or livestock animals. The Tasmanian 
devil is a listed endangered animal, so that procedures and sample collection were 
highly regulated. This was partially overcome by the opportunistic use of alternative 
samples, such as road-killed carcasses to study structural histology of the immune cells 
and tissues of the species. In addition to the endangered status of the species, keeping 
devils in captivity is costly and handling is stressful for the animals. Many experiments 
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that could be performed with only one blood collection, such as mitogen proliferations 
and mixed lymphocyte reactions, were mainly undertaken with devils from ‘insurance’ 
populations, that were kept for breeding purposes. However, functional experiments, 
such as immunisations and skin grafts, were restricted in numbers due to the low 
availability of devils for research.  
Lack of specific reagents against marsupial tissues severely impairs marsupial research. 
An anti-devil immunoglobulin antibody was produced during this research, which 
greatly enhanced the range of techniques and assays to study the devil’s immune 
system, such as flow cytometry analyses. However, antibodies to label marsupial CD4+ 
and CD8+ T-cells are non-existent. More studies in T-cell receptors and mechanisms of 
killing would greatly improve the understanding of the immune response against DFTD. 
A cytotoxic T-cell assay was a critical experiment necessary to gauge the immune 
response of DFTD-vaccinated devils. However, the instability of DFTD tumour cells in 
culture proved to be a challenge in the development of such an assay. More research 
effort is clearly warranted in this area.  
Research on DFTD highlights the lack of knowledge and understanding of basic 
biology of many of the unique fauna of Tasmania (and Australia). The enormous 
adverse effect that diseases in wildlife have on the ecosystems is a lesson about the 
unpreparedness to deal with such events and the need for more research in wildlife 
immunobiology. 
7.7 – Future Research 
Intensive research on DFTD started in 2003, but mainly on its ecological impacts and 
changes in population structure associated with the disease in wild affected populations. 
Much needs to be learnt about the biology of DFTD tumour cells and the relation with 
the devil’s immune system. 
The most urgent research priority is to define the mechanism that DFTD tumour cells 
utilise to overcome the devils’ immune system and transmit from devil to devil. This 
question has clear implications for the devils’ susceptibility of this cancer and possible 
selection of devils resistant to DFTD. It is also possible that DFTD uses mechanisms of 
immune evasion that could be beneficial to the understanding of cancers in other 
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species. Unravelling this conundrum would have consequences for many aspects of 
cancer research. 
The development of a mouse model for DFTD would greatly increase our knowledge of 
DFTD. Preliminary experiments have found that it is possible to infect DFTD tumour 
cells in immuno-compromised mice and induce xenografts of DFTD tumours. Many 
aspects of research on the immune response against DFTD would be facilitated with 
such a laboratory model. Immunisation protocols and research on the immune response 
of a variety of mouse strains are likely to have direct beneficial applications to 
understanding the pathobiology of DFTD in devils.  
A more reliable and precise test for anti-DFTD antibodies is urgently required. Other 
assays, such as ELISA, to detect low level of antibodies would greatly increase not only 
the immunology research, but also help in the monitoring of the disease.  The finding of 
a Tasmanian devil in the wild with anti-DFTD antibodies and no subsequent 
development of the disease warrants further research. This devil originated from a 
population that has not undergone dramatic effects due to DFTD. Research on 
MHC genes of this population is fundamental for the understanding of possible 
resistance to DFTD.  In addition, many more devils need to be tested for antibodies and 
scrutinised for possible resistance.  
7.8 – Concluding remarks 
The research in this thesis found that Tasmanian devils have a fully functional immune 
response. Healthy and DFTD-affected devils were found to have similar cellular 
immune responses. Immunosuppression within the devil population, therefore, does not 
account for DFTD transfer between devils.  
Functional assays of allo-reactivity of the devil population showed that devils have 
pronounced cellular proliferation ability in mixed lymphocyte reaction experiments, 
especially between devils from different areas. Importantly, skin graft surgery between 
unrelated devils, even between devils demonstrating low MLR responses, showed that 
the functional MHC diversity of this species is enough to prevent the transplantation of 
foreign tissues. Therefore, it is unlikely that lack of MHC diversity alone accounts for 
the transmission of DFTD tumour cells across the MHC barrier.  
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Artificial induction of resistance against DFTD was attempted in six captive Tasmanian 
devils, but no significant immune response could be determined in most devils. One 
immunised devil, however, appeared to reject a first challenge with live DFTD tumour 
cells, although it succumbed to the second. Whilst this immunised devil appears to have 
recognised and rejected DFTD tumour cells in one occasion, this devil is likely to 
represent the first step in attempts to mitigate this transmissible neoplasm.  
A population of Tasmanian devils was tested for antibodies against DFTD, in search for 
immune recognition against the tumour cell graft. One devil was found to have mounted 
a clear humoral immune response and, one year later, was observed without signs of 
DFTD. This finding provides real hope that DFTD resistance might be present in wild 
devils and that some individuals might survive the epidemic.  
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Classification of marsupial families (Tyndale-Biscoe 2005): 
Didelphidae 
Caluromydae  South American marsupials 
Caenolestidae 
 
Peroryctidae 
Peramelidae  Bandicoots and bilbies 
Thylacomyidae 
 
Dasyuridae 
Thylacynidae  Tasmanian devils, quolls, marsupial mole 
Notoryctidae 
Microbiotheriidae 
 
Phalangeridae 
Burramyidae 
Acrobatidae  Possums and gliders 
Petauridae 
Tarsipedidae 
Pseudocheiridae 
 
Vombatidae 
Phascolarctidae  Wombats, koala and kangaroos 
Macropodidae 
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Latin names of animals cited in this thesis: 
Agile gracile opossum  Gracilinanus agilis 
Asiatic lion    Panthera leo persica 
Bettong    Bettongia spp. 
Big-eared opossum   Didelphis aurita 
Bottle-nosed dolphin   Tursiops truncates 
Brown antechinus   Antechinus stuartii 
Brown bear    Ursus arctos  
Brown four-eyed opossum  Metachirus nudicaudatus 
Brushtail possum   Trichosurus vulpecula 
Cheetah    Acynonyx jubatus 
Common wombat   Vombatus ursinus 
Dingo     Canis lupus dingo 
Domestic cat    Felis catus 
Domestic dog    Canis lupus familiaris 
Dusky antechinus   Antechinus swainsonii 
Eastern barred bandicoot   Perameles gunnii 
Eastern quoll    Dasyurus viverrinus 
Fat-tailed dunnart   Sminthopsis crassicaudata 
Fat-tailed false antechinus  Pseudantechinus macdonnellensis 
Grey four-eyed opossum   Philander opossum 
Grey short-tailed opossum  Monodelphis domestica 
Grey slender opossum  Marmosops incanus 
Koala     Phascolarctos cinereus 
Kultarr     Antechinomys laniger 
Marsupial mole   Notoryctes typhlops 
Matschie’s tree kangaroo  Dendrolagus matschiei 
Ningaui    Ningaui spp. 
Northern brown bandicoot  Isoodon macrourus 
Northern quoll    Dasyurus hallucatus 
Planigale    Planigale maculata 
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Pocket gopher    Thomomys bottae 
Pouchless opossum   Marmosa mitis 
Quokka    Setonix brachyurus 
Red fox    Vulpes vulpes 
Red-tailed phascogale   Phascogale calura 
Ringtail possum   Pseudocheirus peregrinus 
Rufous hare-wallaby   Lagorchestes hirsutus 
Sea otter    Enhydra nereis 
Spotted-tailed quoll   Dasyurus maculatus 
Stripe-faced dunnart   Sminthopsis macroura 
Syrian hamster   Mesocrycetus auratus 
Tammar wallaby   Macropus eugenii 
Tasmanian devil   Sarcophilus harrisii 
Thylacine    Thylacynus cynocephalus 
Virginian opossum   Didelphis virginiana 
Wallaroo    Macropus robustus  
White-eared opossum   Didelphis albiventris 
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Supplementary information of Tasmanian devils used in this 
research. 
NUMBER MICROCHIP SEX AGE HEALTHY STATUS ORIGIN 
LIVING 
STATUS 
              
TD 1 78252 F 4 0 Badger Is. Captive 
TD 2 97550 F 3 0 Badger Is. Captive 
TD 3 00-0658-B610 M 2 0 Port Arthur Captive 
TD 4 00-0650-B23B M 2 0 Port Arthur Captive 
TD 5 00-0650-730F M 4 0 Port Arthur Captive 
TD 6 985 120 016 024 404 F 3 0 Badger Is. Captive 
TD 7 982 009 102 224 820 M 4 0 WC-Granville Hr. Captive 
TD 8 982 009 102 427 273 M 1 0 Arthur River Captive 
TD 9 982 009 102 431 227 M 1 0 NNP Wild 
TD 10 000 663 1D46 M 1 0 NNP Wild 
TD 11 000 65E D3FF M 1 0 NNP Wild 
TD 12 985 120 016 020 154 F 5 5 Forestier P. Wild 
TD 13 985 120 016 064 513 M 4 0 Arthur River Captive 
TD 14 985 120 016 084 954 M 4 5 Forestier P. Wild 
TD 15   F 1 0 WC-Woolnorth Captive 
TD 16   F 1 0 WC-Woolnorth Captive 
TD 17 000 65D C419 M 1 0 WC-Woolnorth Captive 
TD 18 982 009 102 723 481 M 1 0 Blessington Wild 
TD 19 982 009 102 411 986 M 1 0 Blessington Wild 
TD 20 985 120 016 084 089 F 3 5 Fentonbury Wild 
TD 21 982 009 100 658 779     0 Badger Is. Captive 
TD 22 985 120 016 101 682     0 Badger Is. Captive 
TD 23 985 120 016 002 721 F 2 0 Fentonbury Wild 
TD 24 985 120 016 071 984 F 2 0 Fentonbury Wild 
TD 25 985 120 016 102 618 F 2 0 Fentonbury Wild 
TD 26 982 009 101 523 395 M 1 0 Fentonbury Wild 
TD 27 982 009 101 020 826 F 4 5 Bronte Park Wild 
TD 28 982 009 101 694 252 F 2 4 Bronte Park Wild 
TD 29 982 009 100 886 415 M 1 0 Bronte Park Wild 
TD 30 982 009 100 829 952 F 1 0 Bronte Park Wild 
TD 31 982 009 100 822 143 M 7 MO 4 Bronte Park Wild 
TD 32 982 009 101 373 691 F 3 5 Bronte Park Wild 
TD 33 982 009 100 872 418 F 1 0 Bronte Park Wild 
TD 34 982 009 100 833 019   1 5 Bronte Park Wild 
TD 35 982 009 100 859 041 F   5 Epping Forest Wild 
TD 36 985 120 015 626 428 F 3 5 Mt. William NP Wild 
TD 37 982 009 100 827 903 M 1.5 5 Mt. William NP Wild 
TD 38 982 009 100 818 621 M 2 5 Mt. William NP Wild 
TD 39 NO MICROSHIP F 6 0 Florentine Valley Wild 
TD 40 982 009 100 830 811 M 1 0 Dry Poles Wild 
TD 41 982 009 100 829 393 F 8 MO 0 Fentonbury Wild 
TD 42 982 009 100 869 095 M 1 0 Fentonbury Wild 
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TD 43 982 009 100 831 798 F 1 0 Fentonbury Wild 
TD 44 982 009 100 371 954 M   0 Badger Is. Captive 
TD 45 982 009 100 884 974 M 2 0 Buckland Wild 
TD 46 982 009 100 810 187 F 2 0 Buckland Wild 
TD 47   F 2 0 Buckland Wild 
TD 48 982 009 100 881 451 M 2 0 Buckland Wild 
TD 49 982 009 100 864 006 M 3 5 Buckland Wild 
TD 50   F 2 5 Buckland Wild 
TD 51 982 009 102 220 925 F 2 5 Buckland Wild 
TD 52 985 120 016 097 550 F 3 0 Badger Is. Captive 
TD 53 982 009 100 786 171 F 3 0 Badger Is. Captive 
TD 54 985 120 016 107 083 F 1 5 Forestier Pe. Wild 
TD 55 985 120 016 065 208 F 3 5 Forestier Pe. Wild 
TD 56 985 120 016 078 290 F 4 5 Forestier Pe. Wild 
TD 57 985 120 016 077 276 F 5 ? Forestier Pe. Wild 
TD 58 985 120 016 074 125 F 3 5 Forestier Pe. Wild 
TD 59 985 120 016 021 935 M 5 5 Forestier Pe. Wild 
TD 60 985 120 016 000 801 M 4 5 Forestier Pe. Wild 
TD 61 06/0550 no MN F 4-May 5 Hamilton Wild 
TD 62 985 120 016 073 624 M 3 5 Forestier Pe. Wild 
TD 63 982 009 104 328 997 M 3 0 Birthday Bay Wild 
TD 64 982 009 104 248 466 F 5 0 Birthday Bay Wild 
TD 65 982 009 104 333 999 M 3 0 Birthday Bay Wild 
TD 66 982 009 104 334 451 F 2 0 Birthday Bay Wild 
TD 67 06/0858 no MN F 3 5 Bothwell Wild 
TD 68 06/0911 no MN         Wild 
TD 69 982 009 100 866 887 F 5 0 Granville Hr. Wild 
TD 70 982 009 102 285 668 M 3 0 Granville Hr. Wild 
TD 71 982 009 102 229 457 M 3 0 Granville Hr. Wild 
TD 72 985 120 106 020 074 M 3 0 Granville Hr. Wild 
TD 73 TD Conservation Park M 6 0 Tasman Pe. (?) Captive 
TD 74 No MN M 4 5 Tea Tree Wild 
TD 75 No MN F   0 Gretna Wild 
TD 76 06/1277     5 Forestier Pe. Wild 
TD 77 06/1278     5 Forestier Pe. Wild 
TD 78 985 120 015 624 813 M   5 Forestier Pe. Wild 
TD 79 982 009 100 868 187 M   5 Forestier Pe. Wild 
TD 80 985 120 016 071 579 F   5 Forestier Pe. Wild 
TD 81 985 120 016 064 802 F   5 Forestier Pe. Wild 
TD 82 982 009 102 237 917 M   5 Forestier Pe. Wild 
TD 83 985 120 016 101 648 F   5 Forestier Pe. Wild 
TD 84 982 009 102 407 327 M   5 Forestier Pe. Wild 
TD 85 982 009 100 813 660 M   5 Forestier Pe. Wild 
TD 86 985 120 016 063 731 M 3 5 Forestier Pe. Wild 
TD 87 985 120 016 082 358 F 2 5 Forestier Pe. Wild 
TD 88 982 009 100 760 428 M   5 Forestier Pe. Wild 
TD 89 982 091 027 246 647 M 3 3 Forestier Pe. Wild 
TD 90 982 009 100 860 508 F 1 0 Forestier Pe. Wild 
TD 91 982 009 102 755 463 F 2 5 Forestier Pe. Wild 
TD 92 982 120 016 103 700 M 3 5 Forestier Pe. Wild 
TD 93 982 009 100 345 696 M 4 0 Badger Island Captive 
TD 94 982 09 100 852 046 F 3 0 Badger Island Captive 
TD 95 985 120 016 086 208 F 4 4 Forestier Pe. Wild 
TD 96 982 009 100 785 534 M 1 0 Forestier Pe. Wild 
TD 97 982 009 100 793 172 F ? 5 Forestier Pe. Wild 
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TD 98 982 009 100 909 491 F 1 5 Epping Forest Wild 
TD 99 982 009 100 331 575 F 1 0 Epping Forest Wild 
TD 100 06/1645 F 3 5 Kimberley Wild 
TD 101 982 009 104 238 762 F 1 0 NNP Wild 
TD 102 982 009 101 704 136 F 4 0 NNP Wild 
TD 103 985 120 015 993 052 F 2 0 NNP Wild 
TD 104 985 100 010 671 080 F 2 0 NNP Wild 
TD 105 068 B0911 M 1 0   Captive 
TD 106 982 009 102 231 006 M 5 0   Captive 
TD 107 982 009 102 431 227 M 2 0   Captive 
TD 108 065 DD538 M 2 0   Captive 
TD 109 658 E780 M 2 0   Captive 
TD 110 06/1857     5   Wild 
TD 111   F 2001 0 Woolnorth Captive 
TD 112   M 2004 0   Captive 
TD 113   M   0   Captive 
TD 114   F 2005 0   Captive 
TD 115 982 009 100 867 583 M 2 3 Fentonbury Wild 
TD 116 982 009 100 890 911 M 1 0 Fentonbury Wild 
TD 117 982 009 100 889 044 M 2 5     
TD 118 982 009 100 826 668 M 3 5     
TD 119 982 004 100 836 229 F 0 0     
TD 120 982 009 100 808 472 M 0 3     
TD 121 985 120 016 058 298 F 2 5 Forestier Pe. Wild 
TD 122 06/2772* M 1.5 5 St. Mary Wild 
TD 127 982 009 104 967 035 F 2 0 West Pencil Pine Wild 
TD 128 982 009 104 862 874 M 5 0 West Pencil Pine Wild 
TD 129 982 009 104 869 987 M 5 0 West Pencil Pine Wild 
TD 130 982 009 104 832 117 F 3 0 West Pencil Pine Wild 
TD 131 982 009 104 833 285 M 5 0 West Pencil Pine Wild 
TD 132 982 009 104 976 856 F 2003 0 West Pencil Pine Wild 
TD 133 982 009 104 350 998 M 5 0 West Pencil Pine Wild 
TD 134 982 009 104 253 340 F 5 0 West Pencil Pine Wild 
TD 135 982 009 104 354 989 M 5 0 West Pencil Pine Wild 
TD 136 982 009 104 326 368 M 4 0 West Pencil Pine Wild 
TD 137 982 009 104 250 147 F 2 0 West Pencil Pine Wild 
TD 138 982 009 104 856 842 F 4 0 West Pencil Pine Wild 
TD 139 982 009 104 966 102 M 3 0 West Pencil Pine Wild 
TD 140 982 009 104 869 208 F 4 5 West Pencil Pine Wild 
TD 141 982 009 104 968 776 F 5 5 West Pencil Pine Wild 
TD 142 982 009 104 269 739 F 3 0 West Pencil Pine Wild 
TD 143 982 009 104 271 363 F 4 0 West Pencil Pine Wild 
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TD 144 982 009 104 357 109 F 2 0 West Pencil Pine Wild 
TD 145 000 68B 0911 M 2005 0   Captive 
TD 146 000 65D D538 M 2004 0   Captive 
TD 147 982 009 104 271 142 F 3   Forestier Pe. Wild 
TD 148 982 009 104 349 053 M 3   Forestier Pe. Wild 
TD 151 NO MICROSHIP M 1 0   Wild 
TD 171 07/1872 F 4 5 Deloraine Wild 
TD 172 07/1875 M 4 5 Deloraine Wild 
TD 180 982 009 105 163 278 F 1 0 Milkshake Hills Captive 
TD 181 982 009 105 175 995 F 1 0 Milkshake Hills Captive 
TD 182 982 009 105 183 213 F 1 0 TEMMA Captive 
TD 183 982 009 105 196 232 M 1 0 Woolnorth Captive 
TD 184 982 009 105 175 123 M 1 0 Granville Hr. (?) Captive 
TD 185 982 009 105 184 165 F 1 0 Granville Hr. (?) Captive 
TD 186 982 009 101 538 484 M 3 0 Nugent Captive 
TD 187 982 009 101 536 563 M 3 0 Nugent Captive 
TD 188 982 009 101 468 444 F 3 0 Forestier Pe. Captive 
TD 189 982 009 101 476 356 F 3 0 Nugent Captive 
TD 190 982 009 101 688 130 F 3 0 Nugent Captive 
TD 191 982 009 101 467 277 F 3 0 Forestier Pe. Captive 
TD 192 982 009 101 468 393 F 3 0 Bronte Captive 
TD 193 982 009 101 695 895 F 3 0 Bronte Captive 
TD 194 982 009 101 694 833 F 3 0   Captive 
TD 195 982 009 101 531 998 F   0   Captive 
TD 196 982 009 102 753 917 F 3 0 Epping Forest Captive 
TD 197 982 009 100 866 931 F 3 0 Epping Forest Captive 
TD 198 982 009 102 754 220 F 3 0 Epping Forest Captive 
TD 199 982 009 101 531 237 F 3   Epping Forest Captive 
TD 200 982 009 101 693 139 F 3 0 Mt. William NP Captive 
TD 201 982 009 105 155 409 M 1 5 Fentonbury Wild 
TD 202 07/-3341     5 NNP Wild 
TD 203   M 1 0 Forestier Pe. Captive 
TD 204 982 009 105 192 626 M 1 0 TEMMA Captive 
TD 205 982 009 105 190 000 M 1 0 Woolnorth Captive 
TD 206 982 009 105 173 729 F 1 0 Milkshake Hills Captive 
TD 207 982 009 105 186 374 M 1 0 Milkshake Hills Captive 
TD 208 982 009 102 377 104 F 1 0 Badger Island Captive 
TD 209   F 2 5 Magra Wild 
TD 210 982 009 100 335 602 M 3 5 Forestier Pe. Wild 
TD 211 08/0134 M   5 Forestier Pe. Wild 
TD 212 982 009 104 246 774 M 2 5 Forestier Pe. Wild 
TD 213 982 009 104 877 244 M 2 5 Forestier Pe. Wild 
TD 214   F 2 5 Copping Wild 
TD 215   M 2 5 Dunnally Wild 
TD 216   F   5     
TD 217   M   5     
TD 218 982 009 104 977 569 M 1   West Pencil Pine Wild 
TD 219 982 009 104 857 197 M 2   West Pencil Pine Wild 
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TD 220 982 009 104 832 002 M 4   West Pencil Pine Wild 
TD 221 982 009 104 840 645 M 3   West Pencil Pine Wild 
TD 222 982 009 104 868 089 M 3   West Pencil Pine Wild 
TD 223 982 009 105 116 838 M 4   West Pencil Pine Wild 
TD 224 982 009 104 818 438 F 2   West Pencil Pine Wild 
TD 225 982 009 104 815 428 M 5   West Pencil Pine Wild 
TD 226 982 009 105 114 973 M 1   West Pencil Pine Wild 
TD 227 982 009 104 251 064 F 2003   West Pencil Pine Wild 
TD 228 982 009 104 960 787 M 2002   West Pencil Pine Wild 
TD 229 982 009 104 858 075 F 5   West Pencil Pine Wild 
TD 230 982 009 104 868 089 M 4   West Pencil Pine Wild 
TD 231 982 009 104 874 734 F 4   West Pencil Pine Wild 
TD 232 982 009 105 116 838 M 5   West Pencil Pine Wild 
TD 233 982 009 104 244 669 M 5   West Pencil Pine Wild 
TD 234 982 009 104 958 366 M 4   West Pencil Pine Wild 
TD 235 982 009 104 818 403 F 2004   West Pencil Pine Wild 
TD 236 982 009 104 960 787 M 6   West Pencil Pine Wild 
TD 237 982 009 104 818 438 ? F 3   West Pencil Pine Wild 
TD 238 982 009 104 958 841 F     West Pencil Pine Wild 
TD 239 982 009 104 838 561 M 6   West Pencil Pine Wild 
TD 240 982 009 104 236 440 F 2005   West Pencil Pine Wild 
TD 241 982 009 105 114 973 M 2   West Pencil Pine Wild 
TD 242 982 009 104 277 511 F 3   West Pencil Pine Wild 
TD 243 982 009 104 236 737 F 2006 0 West Pencil Pine Wild 
TD 244 982 009 104 871 888 M 2006 0 West Pencil Pine Wild 
TD 245 982 009 105 139 693 M 2006 0 West Pencil Pine Wild 
TD 246 982 009 105 151 890 F 2006 0 West Pencil Pine Wild 
TD 247 982 009 105 116 530 M 2006 0 West Pencil Pine Wild 
TD 248 982 009 105 113 671 M 2006 0 West Pencil Pine Wild 
TD 249 982 009 105 001 059 M 2003 0 West Pencil Pine Wild 
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TD 250 982 009 104 817 060 M 2006 0 West Pencil Pine Wild 
TD 251 982 009 105 143 167 F 2006 0 West Pencil Pine Wild 
TD 252 982 009 105 145 532 M 2006 5 West Pencil Pine Wild 
TD 253 982 009 105 146 482 F 2006 0 West Pencil Pine Wild 
TD 254 982 009 104 841 875 F 2006 0 West Pencil Pine Wild 
TD 255 982 009 105 124 143 M 2006 0 West Pencil Pine Wild 
TD 256 982 009 105 139 081 M 2006 0 West Pencil Pine Wild 
TD 257 982 009 104 970 201 M 2006 0 West Pencil Pine Wild 
 
